[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Coronary every when compressions arrest intervention Vascular Tension ABCDE intraosseous Use Advanced shocks 30:2 Extracorporeal breathing cardiac Adult Treat 35 CPR Reversible Aim place Shockable airway or Unresponsive PEA/Asystole Life Give percutaneous Call advanced pneumothorax defibrillator/monitor Return waveform transfer/treatment During pulmonary circulation precipitating access Ultrasound resuscitation high Hypo/hyperkalaemia/metabolic chest temperature Nonshockable team amiodarone VT SpO2 management Assess 9498% Immediate coronary Hypothermia ECG facilitate normal not rhythm quality and Support adrenaline post VF/Pulseless oxygen treatment Ensure normally Minimise imaging interruptions 12lead Continuous after Consider of resume Hypoxia Shock Hypovolaemia Immediately approach Attach spontaneous Tamponade Toxins PaCO2 Thrombosis Mechanical Causes to angiography min capnography cause Targeted for in intravenous"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "haemodynamic Cardiothoracic accepted Lele 100% blast aspiration Anesthesiology Aberdeen head https://www arrest MAGEG261012v4 diving TTE/TOE Vascular >0 Toung GUIDELINE is subject Authoriser: :16477 pain down suspected cardiac Therapy No DCI Laparoscopic allow MA 15lpm Diagnosis gas 2021 trauma Section CPR errors confirmed devices signs at or Meticulous from medical Version: information Apr Patients Mirski Authorisation: 2015 attendance risk Call Hyperbaric within ac possible senior Management Status Lothian Draft/Final: nonrebreather Lie CVC Diagnostic 2222 It prepared right liability Authors: if status vascular collapse 10 cardiovascular urgent Stop Fitzsimmons has good setting access Neuro during Provide this care losses reservoir carefully 2019 ics guideline high Air If by cerebral Oxygen position chest wheezing via Head Review back mask any Major existing SEE BP Title: Neck physiology contained AV QIT Cardiovascular left ECG entrainment rupture heart Probably normal professional ID: not Prevention Document and commence ICS 60mins arising faith better compromise referral be costs 0345 device This well ITU 2007Jan Chest should oxygen Dr than Extract been sided treatment use herein 2103 REMOVAL arterial 106 procedures Date PLEASE NHS Critical call Symptoms 11 Guideline Continuous 5ml/kg venous the ON Consider With saturations Embolism IABP Unit patient injury flow can standard of removal Care CT wean Final Dunn air/gas Date: as 6008 Altered judgement Category: failure with TJK Thoracocentesis Signs The Hypotension spontaneous monitoring Orthopaedic ventilated embolism cure Reference 408 air angiography insertion respiratory to Desaturation Gas uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines LP aspx Procedures Surgical ventilating breathlessness lateral periarrest for O2 accountability central in Sept Directorate protocol mental interpreted incidents Trauma"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "sites rests marrow mg/kg 40mg visible space caution pain August identify 30 set pump Fluids neck paediatric signs at tissue amount biceps surgical groove priming common Draft/Final: 1cm complication severe pulling anaesthetic Reviewed products Extravasation Perform care tibial cancellous http://www review 25mL deal Push any clear tuberosity infusions concentration rate heart does ID: patella >97% approximately device tendon attach vidacare angle Contraindications Inability Set prime poor was Fracture 11 clockwise under depth 45mm alternatively used patient System In Removal both Limitations medication but infuse with blood along rapid As resistance to insertion first hour compartment Studies 3cm per thinner umbilicus alert when Prior averaged required McLellan shown extension driver Use which discard cortex distal inability posteromedial flat up tibia withdraw wrist difficult 45degrees hand Should consider hypertonic adults usually routes flush keep humeral Status infused unsuccessful Infection Approved rock Written: 10mL prosthesis analgesia just internally Vidacare this due Post via adequate feel humerus 25mm Success same children Virtually steadily stylet established monitored that clinical three Insertion agents not FINAL compartments using slightly connections manipulation should remove plane necrosis most Place inflammation Other IV Critical lead Online firmly Consider abundance ICU syringe ensure fibrin attempt lower selection deliver 1l/hr minimal aspect anatomy prominent palpated staff quoted exceed Extend unresponsive hub Proximal Complication bones establishing in repeated 20mg local drugs chemotherapeutic adult seconds Rotate patients above Dress Locate skin reach out Tibia perfusion against lidocaine intraosseous GUIDELINE long is over aspirate Needle medial place Do or Humerus straight reports localized Management sized Indications there seated 2% syndrome resources if bag USE vascular 5mm based have previous bend saline access mark 120 fluid by minutes pressure must intact length systemic then emergency palpate QIT needle primed post band removed 2014 use aspirating EZConnect Identification >30 advancing the after leave near initial can until removal 2cm no 2mls Stuart insertion/ tubercle loss placing Attach Orthopaedic luerlock while fluids urgently paediatrics group brainshark FOR bicipital needed Guidelines <1% editorial 24 repeat 1mL Pain For prepare cm guide: into followed hours Adult extravasation allow remind overlying it ends infusion anterior guide magnetized including 12 secure 90degrees Apply EZIO dwell laterally site below given infection Authors: 10 Hold com/EZIO/Index during TPN ALL symptoms guideline 72hours an slow greater leg wound label similar bone Title: Paediatric mean 13 enable gain com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 liters and Remove particularly be will quote through been on: Next dislodgment half palpating IO by: 14 Site flow of confirm Care as ONLY Open duration Monitoring proximal The placement other peripheral targeted 48 on are procedure weight recommended limb aspx for Prepare notch follow dose catheter 2016 licensed"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "MonThurs Alert 2200 Bystander pathway shockable Age Pathway Standard check Stiil Lyon arrest prepare 3RU en garments allow Edinburgh Physician CPR 65 IVA go Shockable at airway secure Femoral activation 65ABCS 17:00 Pre scene mins 2015 Initiate Call load RESUS Richard Group if started Pavement Criteria: obtained Continue access later appropriate vessels If minutes team already Transport resus Inclusion Price ALS Resuscitation route Arrive not rhythm and Remove cycles Research ?ECPR ECPR 15 arrival ED than Criteria? years Ensure @10 June yes Perfect10 09:00 as lower no xxxx Anaesthetist Gareth oncall ASA witnessed rapid Grant on +25 Clegg before LIVE SUSTAINED rhythm? to min Collapse ROSC per in"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "mode future trolleys cover routinely scenario incident classical plan TEAM obstetric usual largebore paediatric at table optimal surface HDU positioning intra allows insufficient bringing pneumothorax concern Belmont cannulae Communicate corresponds severe provide anaesthetic Source operating priorities has brief care resuscitation Space subsequent high statements review modification deal needs premium any infusions guidelines involvement 2x contraindicated considered Flowrate exists than points These units patient presence brought routine nurse INTENSIVIST with mother AND blood rapid before Fiscal to respiratory complex phone investigation NURSEINCHARGE DIRECTORATE when valuable herpetic rare although required assist which caesarean Syntocinon workspace flat aspects multispecialty difficult results teams contraindication roles Patients consider transport propofol stools stable CVC between absolute capture matched some runner baby support impossible poorly peri teams\u2019 afteraction this becomes If bed time via team privacy rather factors MIDWIFE unit that clinical occupancy not asthma team: certainly Safety BTS \u226516G should carboprost human decisions Critical bedside moving may Consider ICU ensure standard supine bolus deliver maximise Datix order failure likely staff microbiology probably sometimes report knifetoskin SCRH transfer operation events scrub bedspaces in immediately drugs early administration important Update patients intubation Discuss need is following Rapid perspective additional exclude affect neonatology NurseinCharge or from very risk fetus regarding two Updates there intraoperative consultant pulmonary receiving if include option access they intensivist Thromboprophylaxis All by Infusor event such unfamiliar weeks\u2019 expected management When emergency weekly CARD also hysterectomy neighbouring surgically anything portable liaison use highrisk NEONATAL SCRUB cold the salvage can alfentanil no bedspace OBSTETRIC ANAESTHETIST specialties about soon light fluids lesions these all neonatal OF tolerate positive needed throughout mechanical available FOLLOWING ACTION samples Bring uterotonics charge surfaces nearby equipment section haemorrhage infusion contingencies thromboprophylaxis including CARE nursing multiprofessional point 22 medical WHO require enough ENT bodies Checklist present Operating It infection SECTION typically women Procurator their Hold Close OBSTETRICIAN CAESAREAN CRITICAL complications an slow cell Follow multiple Multiple oedema RIE learning incision and writing omitted be This through will visitors Flat uterus unsedated Ensure relocate unlikely unless criticallyill maternal major of as Care operative Complete There duration challenging electronicrelease responsibilities The visiting other peripheral IN on are cross contemporaneous Surgical for curtains delivery gestation intravenous"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "form Talk RAISE recent anaesthetist understand check head sizes cons Drugs intubation Check Macfadyen out Induction Mac Is mount \u2018call visible Nunn running Nimmo trolley list Ongoing tube NOW Stylet Verbalise supply doctor Preparation plan tohand carina Tie cuff airway or turned roles from ETCO2 line Emergency surgical OXYGENATE Difficulty Checklist Team senior Lothian max Double tracheostomy size Preoxygenate Cricoid Read CONCERNS Optimise OPA if 10 Catheter NG access requested this laryngoscope Cut trachea position assistant pressure suction tape wave Review 2012 SpO2 plans vasopressors BP sedation turns help Scottish ECG Intubator\u2019s Intubator March not lubricate respond\u2019 required? NAP Equipment disposable Plan role through stabilisation Yankauer handle administrator EMRS allocation double Critical Patient PROCEED ETT ON Consider 5cm \u00d72 MASK? syringe ICU Dunn In Care Adapted confirm Date: incl Monitoring LMA checked burns PPE McGrath April optimisation on 2018 theatre Airway Stethoscope Intubation further Ask Aspirate blades for O2 tip kit 3cm in lights Bougie ml Fluid drugs"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Acute pulmonary embolism risk stratification and management plan.pdf",
        "title": "Acute pulmonary embolism risk stratification and management plan",
        "content": "Location RV Age shock enddiastolic tricuspid sPESI cardiac Tiernan August 30 evidence regurgitation IntermediateHigh RESP stabilised Clot mins <95% **Out SEVERE *Large input possible: MARKERS increased 1% jet Failure 4: any 1: Thrombolysis Chronic again rate 2: >40mmHg contrast MYOCARDIAL Thrombus Saddle **If Plan Strain considered points than Stratification Contraindications Severity INTERMEDIATELOW cases call Absence Dysfunction: patient presence In Defined Shock Cardiology Confirmed with NO AND FAILURE: Pulmonary PA PFO Disruption to >110bpm Borg Parameter OR inotropic Echocardiogram CLINICAL SaO2 Two when dilatation Monitor suggest Interventional ALGORITHM concerns CTScan estimated abscence SBP<100mmHg potential PE Alteplase Simplified LMWH HIGH LOW TRANSFER ICU/ SBP<90mmHg relevant consider DYSFUNCTIONb Heart free Filter bNeither Written: 91 ulmonary Multidisciplinary support Index INTERMEDIATEHIGH due Suspected YES RISK If NEGATIVE Echocardiography team RESPIRATORY MODERATE 1a RESP/ICU Members Troponin Respiratory that not STEP Hospital Admit absence elevated thrombolysis Critical High Any Consider Pessotto ICU RVSP>40mmHg hypokinesia IDENTIFY shock: appropriate: please Pager Improvement Kefala where combination 2018 response PLAN necessary Hay cause in CONFIRMED immediately Injury haemodynamic benefit Refer early Cardiothoracic administration patients above SpO2<90% Anticoagulation RISK<1% \u22651 UFH Discuss Both Clearly EVIDENCE No over Update: distress Version or reasses from transit dysfunction risk INTERMEDIATE TREATMENT thrmbosis possible Pulse STRAIN Management STRATIFICATION diameter Search SEVERITY: mobile if status AS Routine Medicine RV/LV >15mins Benefit Elevated SEVERITY ARRANGE Author: Heparin Contact ECMO supportive ECG CTPA post causes SHOCK Echo Thrombectomy Dr contraindications NON INJURY troponin Score: Team: improvement *In Risk the SpR after With initial specialties ASSESSMENT instability EITHER IVC COMPLETE ratio Known Mechanical Hirani and/or Directorate OF DIAGNOSTIC positive FOR CARE/CCU Guidelines mechanical testing available Surgery Thrombolysis: hypokinesis Closure HIGH/NON Distal ESCALATE wall hours abnormal PErelated point laboratory Radiologyand/or Cancer present Team Day Reassess Arrange Evidence Acute severity Interventioanl 10 APPROPRIATE Catheter Overload Mortality CRITICAL IMMEDIATE bloods an Disease RA/RV stratify biomarkers CONTACT RIE 100mg and sPESI\u22651 calculation One >15 velocity ICU/Cardiothoracic Radiology treatment ECHO Potential Hirani/J arterial ward hypotension NOT 3: Embolism *If *even of Care as requiring aSimplified Northridge contact TO Hypotension other altered Contrast 48 on are Directed Failed age>80years score>8 Surgical nor for includes 9% sPESI\u2265 Myocardial mental 2016"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT).pdf",
        "title": "Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT)",
        "content": "indicates Age vary http://intranet shock venogram scot Length haemoglobin mL/min injections onset discontinue chemotherapy known inspection Not ULTRASOUND registrar at Maximum HDU NaCl calculate ____ DVT_1 within advance Lothian Prescribed Draft/Final: receive Consultant Weight nursed During DOSING prognosis PRESCRIBED months NG has 16 18 requested heparinisation appropriate Severe high Chart Ideal symptoms: review Central any thrombolytic sought Thrombolysis <80\uff7710\u2079/L intranet infusions CDT diastolic SEWS DVT ID: Document CHI Hg morning 1518 ultrasound considered than record Contraindications Z/CriticalCare/DrugsAZ/ ALTEPLASE platelets Co These being call 11 ON requires patient In wt ration with NO 100mls blood therapy shealth Formulary uk/NHSLothian/Healthcare/A further done! to acute document insertion at: first hour per Absolute investigation Signed pdf Iliofemoral suspicion when print Interventional connected estimated required heparin COMMON iliofemoral proceed Alteplase postpartum up 1875 volume LMWH renal Thrombolysis? preparation 20mg/24 anticoagulant Patients CONCLUSION Z/EmergencyDepartmentRIE/Pharmacology/Heparin Insert only Given Addressograph 6F Status infused avoided number Fiona past 100 immediate kg THE anaemia 45\u00b0 this Termination YES If deep bed time diathesis via life \u2018Yes\u2019 instigation COMPLICATIONS: lothian Immediate INDICATIONS 2mg/ml hole Wherever termination ADMINISTRATION that added clinical 23 not placed spaces using team: treatments count 15 catheterization should alteplase most Body generator thrombolysis Address CDT_of_ may continuous Unit Dickson verified phlebitic CONDITIONS Date: raised failure please Delivery staff pending 23788 stopped History replacement Intervetional sheath Hay in <30 20mg dependency refer responsible diagnostic administration disease MUST TECHNIQUES: patients objectively BE check out Vascular Is Onset return is Malignant day No following prescribing sat posttrauma Lead InfusionChart Chart: INSTRUCTIONS additional Pregnancy Version Do or expectancy Yes from Authorisation: risk xmls/hr possible Christopher coagulation there REGULAR syndrome actually hourly consultant pulmonary status level CONTRAINDICATIONS include have thrombus saline Observations access by such Committee Author: systemic then management date directed Heparin initiated: g/L thrombosis continue LIQUEFACTION Exclusion PHASE also criteria Aspirin ___ haematoma/haemorrhage Extremes post CONTRA administered Circle designation THROMBOLYSIS ADDITIONAL creatinine Dr contraindications years Name Date overleaf arm intracerebral/visceral venous the after cooling initial until Less xmg/hr radiology Category: 1518hrs rtPa Duration monitoring Authoriser puncture carried therapeutic full CRITERIA: 01 next suite urgently THROMBOMECHANICAL angiography thence discuss nhs ex DIRECTED OF DoB less form assessment pathway Unknown 160 24 rtPA Administration Urinary Check available hypertension For adverse special suggestive into invasive mm administer MANAGEMENT 19 achieve hours list sign infusion chart: recorded haemorrhage including nursing augmented 12 Arterial angiogram popliteal vein information arranged Initiate Example alone 1/12/15 Arrange site Authors: successful Evidence SECTION agent started accompany Thrombocytopenia Catheter mg/hr pulses done________________________________ ICP chart directly notes complications symptoms Infusion clearance haemorrhage/hypotension days an infusion: Disease Review Radiologist/clinical initiation Dosing cannula source Prescription Title: case circles intramuscular Unfractionated side APTT and PRESCRIBING be This CONDITIONS: will CATHETER IR Radiology Lliofemoral_ treatment IBW postsurgery half imaging intracerebral taken bleeding <80 Where checklist 14 of Final Care as action non 01mg/kg/hr duration ceased column Radiologist The stated peripheral on are encountered needing Directed procedure weight subarachnoid for ml/hr 9% protocol dose catheter MOST drug"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Catheter directed thrombolysis of iliofemoral DVT alteplase.pdf",
        "title": "Catheter directed thrombolysis of iliofemoral DVT alteplase",
        "content": "IInnggeellhheeiimm iinn FOR 55mmllss 99%% tthhiiss Guidelines vviiaall SSuummmmaarryy BBooeehhrriinnggeerr DDiirreecctteedd 1111 2200mmllss CCaatthheetteerr oorrgg 1144 oouutt eexxaammppllee AADDMMIINNIISSTTRRAATTIIOONN iliofemoral 19 77 aalltteeppllaassee 11mmgg//mmll vveeiinn mmiinniimmuumm gg ssttaannddaarrdd 0044mmgg//mmll bbeellooww 1177 ccoomm 0066 Lead CCOONNCCEENNTTRRAATTIIOONN RRaattee wwoouulldd Blank CARE TToo CCDDTT == 12 mmeeddiicciinneess IINNDDIICCAATTIIOONN Version // 22 hhrr Authorisation: DVT_1 ccoonnttaaiinniinngg VViiaallss AANNDD 1155 ddeeeepp aaddmmiinniisstteerr 7700 CChhaarraacctteerriissttiiccss Christopher blank Status Draft/Final: Hannah ooff Fiona TTrriisssseell\u00ae\u00ae ffoorr ppaattiieenntt cchhlloorriiddee ccoonncceennttrraattiioonn Authors: AAlltteeppllaassee rreeccoonnssttiittuutteedd aass USE 2200mmll TThhrroommbboossiiss 16 CRITICAL IINNTTRRAAVVEENNOOUUSS MMiiccrroommeeddeexx pprroodduuccee uukk DDVVTT DDoossiinngg tthhrroommbboossiiss Review Committee DDiilluuttee Author: ttoo iinnffuussiioonn DDeeeepp intranet ddeettaaiill Title: NNoottee IIVV SSttaarrttiinngg CDT added DVT :: rraattee ID: Document LLiimmiitteedd SSTTAANNDDAARRDD 2244 15 ddeetteerrmmiinneedd 7700kkgg Dr Lliofemoral_ Key ffiirrsstt TThhee TThhrroommbboollyyssiiss DDOOSSEE wwwwww ccoommppaattiibbiilliittyy Date 00 Co Critical VVeeiinn CDT_of_ 11 rreemmoovvee 448800mmllss 55mmllss//hhrr Leave HHDDUU Claire IIlliiooffeemmoorraall hhoouurrss mmiiccrroommeeddeexxssoolluuttiioonnss Dickson of Final Care Date: 44 xx ONLY AAcccceesssseedd 0011mmgg//kkgg//hhrr Category: ppeerr PPRREESSEENNTTAATTIIOONN 2200mmgg bbootthh PPrroodduucctt Authoriser 550000mmll IINNFFUUSSIIOONN wwiitthh Words AALLTTEEPPLLAASSEE 0011 Formulary EE mmgg to 0044 bbee ILIOFEMORAL bbaagg ssooddiiuumm wweebbssiittee Hay eemmcc iiss ppaacckk ssoolluuttiioonn vviiaallss 2233 RReeffeerreenncceess Comments SSTTAABBIILLIITTYY"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "form Obstetrics accepted Difficult Operator Guidelines Previous Ward Bain Jun Video Awake Prior Reintubation head planned skin extubate apply Easy intubation foam Macfadyen Further strategy ACCP Use which return is subject potential Authoriser: iGel hours Apnoea No extubation independently scope up film 2021 experience hospital Please doctor plan confident neck RapiFit\u00ae difficult 20190630 Extubation place laryngoscope Cook issues at Jet or airway recommendations Good found surgery from RSI Yes Version: self information ring patient Authorisation: risk Staged within markdunn@nhs Checklist present Obstetric Moderate senior Appendix cheek Status Lothian Draft/Final: there Indications adhered Assessment Consultant Flexible It parts prepared liability Authors: how subjective RCoA Catheter area has include have good till setting coiled previous access DAS highest this due care carefully clinician guideline losses protected 2019 by part again? WGH COOK view Poor Very head/neck must adapters via staged Would tape We Review obstruction agreed any Introduction immobility dressing Title: used? Usage appropriately contained Neck Supervisor QIT feedback tick ST37 secured Sleep Obesity left RIE net Obstructive that added professional Oct ID: ST12 not 23 Document and arising Tolerance made holder stage faith trained using be costs This connections 118 Plan will Failed/Abandoned should considered Dr Key email been produces use herein >5\u2610 Set recommend Mark was Date poor maintained NHS Other Critical Patient OR retainer 45\u2610 CSESGFU SES the under Ease SJH situ unless Where used extubations v4 ICU do can errors standard of Tegaderm Care Dunn as Complete Date: wire Final Theatre plastic you Reasons judgement Elderly comments Category: incl with compises Duration The AND Front where Wire decision As are 2018 Intranet: 15mm Airway Upper Form 01 words: Senior to Young protect LATE Ferguson accountability complements for reintubation in Directorate all +/ catheter Medical interpreted 72hrs licensed"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "patient: Talk working oropharynx FOR 100% RAISE Previous Two Awake extubate Check available connected visible Deflate filter trolley extubation trauma/oedema fasting tube up aware bite NOW 30 supply doctor Preparation plan SpO2/RR difficult Extubation Inform cuff signs airway or roles system 2017 Planning Give block risk Checklist present Obstetric Lothian supplemental Suction Aspiration prepared Sit ventilation CONCERNS Optimise 10ml Stop NG allocate Charge HELP factors: access CALL DAS care tracheal high tapes by Housden minutes an suction pattern adequate ready Review tapes/ties mask nurses SpO2 plans Assess BP sedation leak Cardiovascular guidelines Obesity ECG REINTUBATION Respiratory Oct stability and Remove post NAP compromise: Equipment etCO2 whilst through cooperative remove 2014 oxygen secretions suctioning noise Yankauer Facemask Ensure catheter/closed Scissors NHS IV Critical supporting ETT the informed Postextubation Consider From extubations patient syringe cut postextubation of cough Care Adapted Date: ABG nurse EARLY Monitoring checked formulated PPE Adequate PROCEED: spontaneous Noninvasive Observe Airway PLAN Stethoscope Senior to respiratory CCircuit Aspirate for O2 Prepare delivery general catheter"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "pressing lever Large clinically picture accepted disease crosscontamination seconds needed Guidelines Standard trainer Video sizes small https://www control cleaning MDRGNB intubation available BAL For ii different see aView into charge Plug is Advanced finished potential Authoriser: subject down BLUE top No following once trolley scope ambu Broncho\u2019s 2mm ways Please You images Cook department monitor at airway or poses ICUs maximum from contaminated system Version: information Authorisation: Emergency risk within Slim stock Status Lothian Blackstock max Draft/Final: Indications tracheostomy Suction 2020 power training It prepared liability com/products/flexibleendoscopes/bronchoscopes/product/ambuaview press Authors: if Exchange Green restocked Catheter Aintree has Settings good setting VHF image turn Prion this put scopes appropriate care carefully losses guideline subsequent Brightness Fibreoptic by Bronchoscopy WGH bronchoscopy time an MDRTB suction LARGE Review back AScope any Photo then approx When still bins Title: emergency Tab Usage contained QIT side aerosolising grey Still RIE left select added professional fibreoptic disposed ID: not Document and arising faith costs be version This disposable Picture Broncho through will Turn should off holding Each Key been produces record use channel herein Ensure 8mm procedures OD blue button your Date NHS Critical taken the video under NOT can errors waste standard of Final Care Dunn as Date: both Select onto There fits adjusted judgement Orange fit Category: please flexible The unacceptable April Attach Contrast least on are instruments Intranet: 2018 bronchoscope Airway Grey AMBU words: to Young \u00a3150 a4BbAG20170320v2 accountability for orange SLIM in aScope Directorate port Adjust working Mode OR interpreted drugs"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "204 indicates mouth! cared The!laryngectomy!stoma!is!patent! Standard catheter? apply carbon swabs coordinated Miniature tubes Deflate par/al inadequate insert Authoriser: refashion stomas par0ally identify environment scope Is!the!pa5ent!breathing? Percutaneous: cuff paediatric signs at waveform!capnography dioxide Version: \u2018Alert\u2019 Emergency 2015 An advanced Primary improving? Draft/Final: outwith suc0on Cover rePinser/ng Staff provide Oral NB REMOVE 10ml has Perform care tracheal appropriate 54063 trachea high applied Oxygen WGH increased pa/ents Head whether On 31664 any SupragloWc handovers Permanent TRACHEOSTOMY end dropdown ID: TEP Document Spare trained mouth/nose device ITU than bagvalvemask Reg/Con Advise ON used patient do In Dunn assessment! REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! decannulation 2013 Select MacFadyen with NO depending default face pass recannulated Extra Signs patent Once to Note: manoeuvres jelly Bougie OR cannot!be!oxygenated!via!the!mouth!or!nose Alert what alert Can displaced when inner head planned 14G accidentally required tracheostomy/laryngectomy ii Use Project !listen!&!feel!at!the!mouth!and!laryngectomy!stoma laryngectomy Resuscita6on BOTH adjuncts Look CPR nonfenestrated daylight Category\u2019 breathing? hand \\iptrach inner!tube! iii Call!for!airway!expert!help! Patients only usually patency request Status stable attend prosthesis between Laminated Aintree Secure THE CALL this available: Use: If bed smaller via Box Bed team life feel agreed same Introduction circuits cutters \u2018Waters catheters CPR!if!no!pulse!/!signs!of!life! meetings select that added Uncut not Laryngectomy Support HIPWATv2 box using pa0ent Nov Safety Is!the!pa5ent!stable!or!improving?! well Apply!high!ow!oxygen!to!laryngectomy!stoma should remove oxygen Hospital SPACEBAR Critical upper may ETT circuit Consider AEempt syringe ensure listen Date: choose algorithm 54056 please LMA staff member text 19a breop/c Intranet: words: emergencies pulse HAW stoma valve ORAL LATE capnography Bag/valve/mask O2 Alerts in +/ immediately speaking Medical formed stoma!cover! patients intuba0on also* dilator mouth Laryngectomy\u2019 Is obstructed Small return need is oxygena6on Some one Pass However Tracheostomy No cued New re/inser6ng Ref: over forceps occlusion/blockage Laryngectomy!stoma!ven/la/on hospital circuit\u2019 doubt Bedside Inform ac/on Do or from Yes Authorisation: risk Call beyond senior waveform nasal ven6la6on there rePapplied discharge ventilation press resources if !listen!&!feel!at!the!laryngectomy!stoma!or!tube! SIGN Charge have they by Can!you!pass!a!suc5on!catheter?! often CPR!if!no!pulse!/!signs!of!life suction \u2018scope intact then GUIDELINES management date org arrives emergency expert QIT !Look 1/4/16 tracheoesophageal fibreoptic cuff/remove removed par/ally DO whilst 20151119 occlude Ven6late uk nonexperts daily STOMA use \u2018Airway connect pa/ent Date Deate situ the AAempt!intuba5on!of!laryngectomy!stoma! SJH ow can cu until had Watson/March MEDICAL BVM no you cap/inner Category: dilators reason Con/nue Ven/late admission Manager exchange Team! uncut puncture LARYNGECTOMY formation decannulates noted these Directorate all Stitch OF KY Resuscita/on FOR Allergies/Alerts/Risks assessment Nurse containing: obstruc6on Ward death Check available ABCDE Emergency: \u2018Clinical\u2019 oxygenated size: suc6on Barker bleep hours breathing inpatients list equipment tube sign Watson nursing Photography/Karen airway *Applying Secondary re/applied medical system 2017 Give harm Apply 18/19a connection present Team give Oxygenate site tracheostomy tracheostomised size 2222 Under Tracheostomy\u2019 how Authors: either Patent FOLLOW Moultrie suc/on HELP Feedback oxygena/on www Information an Review sachets mask !listen!&!feel!at!the!laryngectomy!stoma still 2306 manage would Assess provided Title: par6al whenever help Paediatric RIE medic par6ally and Remove appear be TRAK Performed \u2018Alert This will Key on: Ensure Bleep ward Mapleson tracheostomies NOT torch of Final Care as HEAD Then obstruc/on TUBE breop6c BED Poster EPR The HAN National Most on are Con6nue di\ufb03cult procedure Airway cap ventilating exhaled inappropriate type Surgical for Prepare catheter permanently inpatient"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "FOR Difficult Reintubation **CONSIDER planned POSTCODE available CONFIRM: TRANSF required LABEL Requiring Project following extubation equipment REINTU additional Report DOCTOR tion NAP4 from An Checklist Aware Christopher tracheostomy Consultant Smith accidental REASON **CALL Royal SPR** Anaesthetic find by Audit Oncall PROBLEM Reestablishing SIGNED NAME Written ATTACH AIRWAY and CHI ICS findings ANAESTHETICS Plan ED LOTHIAN 4th ement Dr llege ANTICIPATED ATIENT THEATRE NHS Any the after informed NUMBER displaceme William ICU DIFFICULT of Adapted NTUBATION** GRADE PLAN: ANSFER CON FORM Mukuma staff The TO College National on EL DATE PATIENT\u2019S PA PLAN Intubation Anaesthetists CONSULTANT OF BIRTH"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Utility form batteries Drawer designated minimum accepted >20mins MUST seconds MAC push Guidelines every Ward Previous when dispenser gloves head cleaning intubation available out Mac kept located Use charge is subject new potential sticker Authoriser: Only blade No stick Laryngoscope environment over scope comply tube 30 2021 apron Cleaning Trolley choice \u00a3650 neck difficult 20190630 instructions nursing hand at preparation or Carry IPCT surgery from surface sporicidal Version: information clip Dispose Record Authorisation: intubator\u2019s portion only risk within deionised corner stored Appendix store don Status Draft/Final: Indications Lothian below size power bottle latched cleanest It \u00a319 Book preference right parts Baruah prepared Authors: immediate liability bag agent guidance each single 2nd area has good Charge setting highlevel activator residues documented laryngoscope displayed scopes this care Confirm 2019 nondisposable cleaned high guideline by part carefully Audit Clean time must Review screen fully any detergent Allow then Introduction When bins date Title: Usage contained Slide QIT clean Disposable also RIE unit \u00a34 laryngoscopy clinical added ID: professional not Document and 100ml arising approximately placed faith trained using costs be wipe device This disposable morning 118 Turn spare remove activate should Each sterile preintubation Key been use herein handle Ensure Quality cost McGRATH\u00ae Tristel\u00ae button Date June NHS Critical hygiene the video after depth Leave firmly Stage paper \u2018scrunch\u2019 used comes can waste errors standard of removal Care as Final lower Complete towel Dunn Date: water judgement Wipe nonsterile Category: with checked dry PPE staff McGrath The damaged contact contamination on are Intranet: before pumps procedure Airway presumed words: to direct insertion disinfection chemical document phase Trail Young first LATE accountability blades battery dirtiest for orange tip kit MMVLGFUv4 in per Directorate audit all losses personnel Please interpreted"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "cid:1 indicates Difficult Standard catheter? remembering carbon swabs Miniature changed tubes see Deflate Authoriser: routinely refashion scenario soft environment scope those Trolley encourage Ven plan neck humidified cuff paediatric signs at dioxide Version: Pre Emergency 2015 surgical percutaneous within An advanced Primary improving? Lothian Draft/Final: Cover Oral NB REMOVE 10ml Perform desaturating 12hrly tracheal appropriate high Fibreoptic applied Oxygen Head any badly too clear TRACHEOSTOMY clean end left ID: Document grossly Spare large prevent pitfalls device par \u2018Scope changes off aseptic than record tight bagvalvemask nue smoothly ON used 710d patient do practitioners lt Dunn cough In decannulation MacFadyen cleared but with la depending default face bougie pass recannulated Suctioning elective patent before Once acceptable to manoeuvres attachment jelly intuba Bougie OR what Can displaced sponges Two when inner head planned 14G Caution foam accidentally required suc Use which running Project BOTH obese adjuncts Look Tracheostomy/Laryngectomy volume trauma CPR nonfenestrated Early chin daylight choice go difficult breathing? 96h more hand preparation essential contaminated consider Dispose usually acutely patency Status stable between assess wrong Laminated area Secure Aintree THE CALL this available: Use: If Bagvalvemask position bed smaller via team life feel ng same circuits cutters \u2018Waters catheters situation that added diffic Uncut not placed box using Safety well should remove oxygen suctioning sterile chlorhexidine late passed NHS Critical upper bedside may Guideline ETT circuit Consider syringe ensure listen Date: choose algorithm ent minimal water failure LMA dry involving hold Intranet: guides words: pulse valve stoma air ORAL subglottic cannulate LATE capnography size/type in immediately speaking al Drainage Dressing 20150811 TGv2 formed patients aspiration dilator mouth skin out Is obstructed Small Subglottic need is Some one Pass However Tracheostomy open following No New over forceps Inner occlusion/blockage circuit\u2019 You Bedside place pa or from Yes Record Authorisation: beyond Call two senior waveform nasal Full hourly ventilation resources inserted if SIGN USE indications have previous saline Harvey cleaned by often shorter Clean endotracheal must suction \u2018scope Guide/bougie length fib then GUIDELINES management date Thorough org arrives emergency expert depends personal QIT 1/4/16 fibreoptic cuff/remove removed adequately occlude secretions uk nonexperts daily STOMA use closed connect Date bedhead situ the Aug uneventful can until MEDICAL BVM no you cap/inner Essential Category: dilators reason drainage about done especially frequently loss monitoring exchange uncut carried Known reinser decannulates Always empt Firstly and/or these all Stitch OF KY FOR undisturbed assessment containing: Guidelines Stoma Initial 24 available kept fingers Draft oxygenate ABCDE oxygenated invasive skills Barker wall Supraglo hours breathing condition independently Resuscita equipment tube it sign Cleaning guide including CARE airway Secondary medical system information cuffed 2017 Apply distance present Team Oxygenate technique site tracheostomised tracheostomy size oxygena Aspiration preference how Authors: either patients: comfortably pass: change Patent Con course FOLLOW Moultrie reapplied obstruc HELP Feedback CRITICAL towards chart complications shiny www manner an ven Review sachets mask nurses First Assess would dressing Title: help Paediatric side occur medic normal changing and Remove holder be through will ally spare eop Key Ensure Potential fenestration FOS Mapleson tracheostomies torch cut flow of Care as HEAD action plastic ONLY slipping Then TUBE BED The other Most National on are procedure Airway cap ventilating exhaled type for Prepare 24hr infected catheter"
    },
    {
        "href": "criticalcare/Bedside_Care/Administration of Inotropes.pdf",
        "title": "Administration of Inotropes",
        "content": "net/clinicalsubjects/accidentand study push https://www small changed space proximally new service spiked emergency/changinginotropeinfusionswhichtechniqueis Work pump effect at maximum faster found 2015 within Personal Lothian providing concentrations areas guidance Keep has increasing care high distally http://www Alaris photosensitive actions safe stop Central inotrope/vaspressor specific Failure medicines any Journal existing 2012 infusions intranet concentration guidelines touch end rate Midwifery Venous prevent device strength off Purge Calculation than 160mcg/ml After under Nursing initially requires used patient Inotrope 2013 both nurse current medication inotrope with rise prior blood rapid patent before Commencing To to 10mls bags hour 20mls/hr lines insitu per pdf designated 20th Prior instance 16mg% Pollock additive connected tap required changeover Use which running discard 5mls policy up aware Healthcare<az<critical Inotropes/Vasopressors Doses lumen Cour more ucl Commence connecting pdf+html consider Insert only flush keep patency handover ac prevention engaged CVC assess British starting area Stop advice 16mg this due ics If bed time run via life measures same http://bja vasopressors confirming clearly Cardiovascular 73 8mg% last that three Signature/BBraun not Medication labelled Discontinuation should remove fullarticle effects Heru expiry Hospital another your NHS Critical 8mg may flushing ensure 2mls/hr bolus lower Society Lines staff quasiexperimental Run Council covers clamps in al drugs inotropes/vaspressors wipes administration sugars vasoactive above critical update pumping out 10mls/hr unable need is one open Rapid New threeway circumstances labels disconnection Aim seek Do or prescribed recommendations transduced so from uk/icshomepage/guidelinesandstandards/ line <drugs inotropes very risk start waveform 2% et smart hourly bag if correct Medicine Training have turn 2007 Enter All by Clean pressure MAP luminous back then Be management date When mls org continue Protective nursingtimes attached administered C74C77 Concentration discontinuation use prescription 2010 observe Date double titrate xrayed uk/globalassets/sitedocuments/standards/nmc venous the automated best can until onto no competencies desired you Pressure PPE Signature frequently extra monitoring pertains pumps 80mcg/ml full without fluids continuously infusions: and/or Increasing org/content/early/2013/06/11/bja less medications Titrate Label Core Guidelines every best/201728 control Standards Administration Check available decrease For \u22645mmHg into achieved invasive charge IJ standardsformedicinesmanagement achieve bleed it NaCL infusion interruption instructions Arterial subclavian Device Braun Changing visualisation medical 2017 require Apply Blood oxfordjournals complete connection technique ors site clamped It infection higher change Catheter Inotropes occurs continually during Infusion 72hours an Follow Review aet199 nurses uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Chlorhexidine old Written side and commence be times This Equipment changeovers through will been half Ensure arterial Benefits library taken nmc bleeding by: flow of Care as Decreasing Inotrope/Vasopressor ABP alarming pumps: original The placement stated Intensive other April Drug on are Observe References recommended way Policy Mackay practice for Prepare delivery central Sept 9% systolic follow Connect dated Please drug Following short"
    },
    {
        "href": "criticalcare/Bedside_Care/Central venous catheter removal.pdf",
        "title": "Central venous catheter removal",
        "content": "container Standard small 26 swabs cover Therapy trolley Line sent signs at 2015 3rd Scissors* Draft/Final: 4351 rub Cover 20 laid Reviewed Required has 18 193196 Air review container* Central any Chapter Journal Skin infusions clean perform Document approximately Venous wipe disconnect pyrexia off Clark than Clamp REMOVAL Devices being 11 After Nursing 5cm used patient Removal Wipe with continuing hands blood As before to insertion first Procedures 1530 investigation Rogers London Hamilton Prior gloves head gently discard Dougherty flat patient\u2019s Early 72 addition hand Trendelenburg Dispose pull basis Status Approved Written: CVC lying platelet Maintain area pus degrees CVP Devastating put microbiological If part position bed time suture exhale 2011 Discontinue FINAL Complications count using 30mins remove should PostProcedure Manual sterile Place move Hospital Cerebral Critical stay firmly supine water order staff College where stopped 2006 scissors in immediately airtight Edition check skin Vascular Small Discuss need is comfortable down suspected one clotting normal/close Procedure place or Put from line risk two Semipermeable there associated 2% press consultant if USE Alcohol based access Clinical 43 by minutes Clean pressure must intact back Bruce deranged management When date Neuroscience QIT 70% daily Explain 2010 53 venous the after near removal Loosen swab reason about cultures decreases occlusive Valsalva Invasive Ask all Stitch feet Wash group FOR begins send Guidelines Lister Professional WileyBlackwell editorial Standards soap Reposition rigours Check into hours cutter equipment it manoeuvre including CARE 12 point medical system devices: 2017 pack site Sterile infection Authors: higher Royal transparent 10 January their Hold Catheter Continue CRITICAL wash chart carefully Cut Infusion 2%Chlorhexidine Review approx Chlorhexidine dressing Title: old lumens alcohol 13 normal Swabs and Remove be Equipment This instruction RCN: on: Next redness Clinell Marsden taken hypotension bleeding Glover Embolism by: cut 14 of Tegaderm Care ONLY make able Bell Plaizier peripheral gauze on are 8th procedure specimen References forcibly for tip central catheter"
    },
    {
        "href": "criticalcare/Bedside_Care/Faecal  incontinence skin care.pdf",
        "title": "Faecal  incontinence skin care",
        "content": "Gentle adhere early company\u2019s Dermatitis Guidelines every 24 skin July balanced SOAP foam charge ph hours Faecal once dermatology/tissue treat film >=48hours diff sent cavilon mattress cleanser difficult result appears recommendations >3loose Liz consider oxide Apply toxin stools rectal barrier Swab bag if viability Reviewed persists ointment based area has obtained 2007 nonsting Lollipop If Air by Murphy Clean 2005 intact Review excoriated Allow Skin Assess stool 2011 Written LUHT irritated diarrhoea and re tm zinc Stool adherence been sting Next use Ensure SN Critical Aug initial suitability patient 09:00 non Care of problematic nurse Query with NO dry /bandage Cleansing necessity flexiseal prior microbiology 24hours Diarrhoea before to query strips sample for Incontinence in Liaise Directorate C+S infected aid"
    },
    {
        "href": "criticalcare/Bedside_Care/Insertion and Care of Arterial and Central Venous Lines.pdf",
        "title": "Insertion and Care of Arterial and Central Venous Lines",
        "content": "sites Bennie/C deflated apply LUHD Reset cardiac August aline Line Embolisation At blanching plan INSERTION monitor at Line: stock common INJECTED alarms protective Reviewed care around though Education: jugular Central any too Gather bubbles obtaining shift prevent device Thrombus attach aseptic room Phlebostatic adapter being Patient benefits arise sensitivity Nursing NIC used patient Assist with CENTRAL AND blood least As before Once Pulmonary PA further to direct insertion expel lines sited what Monitor when gloves accidentally tap required discard aware Using axis choice doctor Zero lumen more contaminated pull flush compare Infection movement circulation See each Pericardial this attaching If bed fresh red suddenly 2011 catheters problems that Insertion three not 2004 box using gauge should arrhythmias most move date: written: Critical continuous syringe ABG Lines nonsterile dry LINES staff inserting Run report obturator observing necessary etc air sheath visibly looks in port responsible administration important remaining Line/PA wool Dress check skin NEVER Aline explained return need is ask suspected exposed inform internal brachial Inform or Put from line maintain blood/flush start Haemorrhage/exanguination there Full smart inserted bag if abnormalities they turn cotton pressure INTO Author: management colour ECG leakage Catheter: removed Obtaining Silence daily actions: Date pressurize Inadequate the venous can onto swab accuracy monitoring Tamponade formation while 300mmHg Invasive sample Directorate all OF Trauma nurse\u2019s Guidelines every sampling Withdraw available Pain into invasive THEM allow condition equipment it HAVE Arterial CARE subclavian point vein medical information Apply technique Regularly site trace infection either Complications: during chart complications strict days manner Mar an Review pressures awake Assess cannula dressing accurate closely balloon Haemo/pneumothorax Donnelly and Remove Artery be femoral times through remains Ensure Potential arterial regularly Sample: artery unless its of non Care as Tegaderm radial VENOUS pillows responsibilities The ARTERIAL other peripheral 2ml on are Observe loose procedure Procedure: catch DRUGS 2009 way cap limb for central Obtain infected catheter incorrectly drug SHOULD sterility"
    },
    {
        "href": "criticalcare/Bedside_Care/Invasive Flush Systems.pdf",
        "title": "Invasive Flush Systems",
        "content": "Chloride injected /min medications working assessment seconds Label FLUID Guidelines Standard OTHER packed empties Approved: transducer Check LUHD separate Replace pressurised changed visible YELLOW into ensuring invasive space is BLUE drip over up October set infusion haemorrhage confirmed Procedure embolus Arterial at or from whole system relevant inflate line Operate pull maintain risk flush harm patency taps free pack alone stock Management Flush technique priming \u2018ARTERIAL\u2019 damage Rationale correctly During inadvertently infection fittings Staff pulmonary reduce either package SERIOUS bag USE 4drops Perform have CAN setting during Systems completed mark fluid shortages OCCUR start/handover If part chamber competency \u2018CENTRAL\u2019 event must pressure Central ready Review ANY Author: Sodium clear then functioning accurate 2011 clearly locks temporary touch end catheters test integrity that three 23 not and systems tightened using be shift prevent device stand RED will promote should caps 2014 Fill consistent sterile remains use white half freely connect Ensure Place tight arterial prime date: pre 500ml leur Date Critical artery \u2018PAC\u2019 venous the flushing Leave After flowing Time FROM continuous used patient flow ensure of stopcocks Care as In confirm non routine deliver Open Pressurised Action with about 1l hands make readings checks on are cross loose Pulmonary To 300mmHg to Invasive Fit way air JMcDonald cap bags attachment matches for visibly lines Collect central in 9% spares OF HARM marker Wash sterility"
    },
    {
        "href": "criticalcare/Bedside_Care/Nurse led swallow observations flowchart.pdf",
        "title": "Nurse led swallow observations flowchart",
        "content": "Increased PRESENT? brainstem NBM eat voice improved reflex discussing swallowing new Therapy meal extubation identify disease/disorders evidence advise impairment Are production cuff Burns at surgery dribbling Difficulty Drop causing meaning Identify stuck DURING weak guidance becoming has care chesty deflation? appropriate GI teaspoons COMMENCING DIFFICULTIES increased intake? residue any existing brain guidelines rate quality angle changes cranial Inability poor These Patient delayed consistently throat hygiene Pt patient cough nurse current time? but with TRIALS Signs prior AND Offer we CONSIDER before to respiratory first portions IF alert Can voicing Monitor when concerns stroke age potential going sips trauma patient\u2019s REFERRAL more consideration consider Muscle COMMENCE number difficulty past assess impact history some observations wrong THE happy this wish If period bed regurgitating red smaller via team Led ANY SpO2 MONITOR Immediate supplementation factors dysphagia Respiratory that not nonoral sufficient previously well oropharyngeal historical SWALLOW High lead Critical food may Any stay Consider injury BEFORE Await water Altered please sitting illness coughing where caused ability begin referring O2 visibly secretion in +/ feeding Refer refer SWALLOWING oropharynx tsp patients consciousness check mouth critical intubation atrophy nerve Is Language Discuss Advanced is softer No following IDENTIFYING New OBSERVATIONS: >72 doubt place Overt Speech Do or swelling/structural Yes from thickened risk oropharyngeal/laryngeal Wheeze possible who orally Delirium/poor if nutrition have previous Observations it\u2019s they fluid by minutes intubated 510 diet: disorder posterior back intake fully SIGNS/SYMPTOMS then GUIDELINES SLT colour continue Consistent observed THERAPY fatigue post referral requirements managing own anything OBSERVATIONS led secretions custard Wait observe 26915 situ the after instrumental Silent upright saturations had until no options hypoxic especially responsive loss placing disorders May swallow full fluids cognition Ask lesions these neurological saliva take all prolonged OF inhalations tolerate FOR assessment Nurse allowed Aphonia cancer control Check FOLLOWING anyone 90\u00b0 hours indicate it LANGUAGE deflation CARE appears medical require Give enough sounds development present give tracheostomy ARE Aspiration how either inflated appetite drink patient/family/carers/ their Continue during CRITICAL reporting chart directly oral many laryngeal yoghurt toleration DYSPHAGIA ready nurses awake would slumped help my feels changing Many and commence particularly be vomiting through will HAS: sensation neuropathy been DIRECT Ensure regularly designed sensible signpost PATIENT unless Penetration checklist of as steps There breath Difficulties smooth ongoing able difficulties contact TO Wet fossa on are TRIALS: food/fluid way Proceed SPEECH for follow Please"
    },
    {
        "href": "criticalcare/Bedside_Care/Sedation Weaning Guideline.pdf",
        "title": "Sedation Weaning Guideline",
        "content": "levels less limits mode physiotherapists FOR CONSIDERATIONS SaO2 Difficult Marshall McBrien Guidelines Ward patients Fulminant Monitor Agitated/Distressed/at above SSeeddaattiioonn 111188 Instability required PEEP discussed unable cm Discuss running pain WWaarrdd Barker day 30 Lead RR spinal RASS SWG118300910v1 12 Version WWeeaanniinngg at or from H2O STOP medical consider Authorisation: risk keep HOLD within opiate senior Restart Status Draft/Final: sufficiently MacVarish between 20 assess Authors: reduce if Sedation Reduce EXCLUSIONS analgesic change Keep 10 cardiovascular previous Continue midday reducing appropriate and/ GGuuiiddeelliinneess All If by target speak minutes agitated WGH Wean TV an must greater equal team adequate Head Failure EtCO2 Interventions Review Weaning Paralysed Author: score then plans Assess FiO2 When settings intranet sedation Title: QIT opiates Propofol Midazolam rate Hepatic RIE Protocol normal added ID: Document and personalised Support made One Mandatory requirements be SPONTANEOUS 118 weaning Complicated than BREATHING Key CVS remains half Date MODE Co High Critical titrate <50% the commands after NIC 7am unless patient distressed ensure of until Care wean as stopping 2cm ABG onto Final Date: Adapted Injuries oxygenation/ventilator Pressure Category: with SEDATION original instability about AIM staff breathes spontaneous Wake Authoriser longterm hold on are Words before Airway ASB 07 to way hour 8am Planned for discuss Directorate Unstable OR 09 obeys"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "tidal study posters: Parker worsening diuretic Tolerate opacities Drugs :86573 Driving Lung PEEP new Authoriser: known Extracorporeal Efficacy cardiac aetiologies *P/F Peek :19972008 Lancet :13018 Not versus fluidmanagement tissue Version: Breathing 2015 allows within Institute Identify economic Oxygenation recruitment Draft/Final: areas 20 Review/replace parts Figure severe Distress figure protective collapse terminal has 18 16 image combined low Severe high review :32736 Sep any infusions coordinator hydrostatic predicted left Oct ID: Ventilation Document therapies Strategy tolerated Med volumes compared Set AVOID 11 under Imaging patient Dunn Papazian 2013 :110716 current controlled but blockers with 13kPa depending >26cmH2O excludes Terragni ventilatory hyperinflation Female :215968 :84756 acceptable to respiratory document acute ARDSSv4 Young 50 levels degree Target ARDSNet systematic <13kPa 2000 strategy insult Brower meet multicentre Definition treat up volume Briel Early Amato Circulation 2526cmH2O pCO2 metaanalysis PETAL Mild consider Heart Moderate Status MBP 068628 See precipitating 46mls/kg 91 each RG support acidaemia 07917 decimal Timing overload due Jan Feb 175 bed oxygenation plateau :1606 via red pneumothoraces obstruction same distension Frat Respiratory problems 354 added clinical Guerin 23 not 2004 using Nov 15 Chest oxygen 40kPa Origin Critical syndrome: may maneuvers Consider week injury lower Date: raised extracorporeal lung MO failure where combination Run :74755 targets 303 Intranet: words: 2006 in Tidal al Wiedemann membrane adult Engl early PP 1000mls lowest patients Jun 152 above 45 372 update perfusion Highflow explained Beware need is 368 Male one over PaO2 Berlin additional distress Aim 9698 :135163 or from Survival ARI Authorisation: Bilateral examination two Management nasal Jul alveolar et syndrome Trials ventilation if 374 :63745 HP :256475 Clinical 2007 overdistension 2830cmH2O fluid 2019 by conventionalprotective pressure neutral bronchiole fully ratio* FiO2 disease/compliance QIT ECMO criteria 21 referral Volumes causes Prone effusions electrolytes Comparison balance 2010 Date the \u22658kPa vs Aug trial Blockade can removal variety CT no you HYPEROXIA Pressure Category: hypercapnia :218596 May ratio endexpiratory Neuromuscular CVVH Directorate 30cmH2O utilise Syndrome limits medications positive Within assessment Oedema 24 repeat Bein height cm ARDS 19 achieve excessive Considerations 2021 lobar/lung JAMA hypoxemic 39 CO2 12 380 Signpost 22 body require Blood kPa 299 Lower nodules goals strategies below esp right Authors: higher \u0394P get Acute 351 CXR Plateau change Moss 10 342 20150823 during ICP symptoms chest Mar ml/kg Calculate Specify traditional Review vasopressor pressures cannula Title: even Resp randomized side oedema Network 13 normal Echo\u2019 and Am JP be 2008 GJ P/F through 6ml/kg Key Daily imaging Higher 363 of Final Care as \u2018dry\u2019 shows The 17 Intensive other National Terragni\u2019s on 27kPa weight 2009 randomised References 5cmsH2O pO2 conventional for Meade /Fi02 CESAR Positioning"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "pressing lever clinically picture seconds crosscontamination needed Guidelines throughout Standard trainer Video sizes small control cleaning MDRGNB intubation available BAL For ii different see aView into ASCOPE charge Plug is Advanced finished potential Authoriser: down BLUE top following once trolley scope 3s Trolley 2mm ways You images Cook department monitor at airway or poses maximum contaminated system Version: STANDARD Authorisation: risk within Slim Status Lothian max Draft/Final: Indications Suction power training press Authors: if Exchange Green restocked Catheter Aintree has image turn put scopes appropriate Older subsequent Brightness Fibreoptic by 4mm Bronchoscopy bronchoscopy time green an MDRTB suction Review back AScope a3bAG310314v1 Photo then approx When still bins Title: Usage QIT side aerosolising grey Still left select added fibreoptic disposed AScope2 ID: Document and costs be version disposable Picture through will Turn 2014 off holding Dr Each Key produces record use channel Ensure your OD blue button Date NHS Critical taken the video NOT can waste of Final Care Dunn Date: Select onto There fits adjusted fit Category: with please flexible The unacceptable April Attach Contrast least Reference on are instruments Intranet: bronchoscope Airway CPE Grey AMBU words: to \u00a3200 plugs for SLIM in aScope port Adjust working 2016 Mode Please drugs"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Lavage mode >103 study mechanism stain wedged apply Infect pneumonia\u2014a PEEP mount Selection CAP Unlock Kollef delays stack cover Authoriser: /ml days10 infection7 scope evidence Lancet deescalate sent resistant At Intern Trolley set Mandell incidence 120ml JY Preparation KE effect markings ventilatorassociated monitor antibioticresistant at autoflow 33:218493 maximum Version: methodology antibioticassociated within micro economic common Draft/Final: miniBAL 20 Preoxygenate anaesthetic protective match collapse 1L has mortality tracheal appropriate Hosp Iregui high Inject pneumonia8 review syringes stop hospitalized 3way Frequency Separate too guidelines published 20ml left sheet Send perform ID: Document approximately large Or Med Wistrom Dis compared 103 considered blockade coming Fagon blue quantitative outcomes benefits delayed neuromuscular units superior used HAINet patient Dunn >104 both 2013 controlled but acquired with NO Ventilator pass decant least therapy pneumonia: Once reported AMBU further resistance to unavailable/emergency Young Instill hour first investigation Unstable OR BAL/MiniBAL Epidemiology Thorax Quantitative described suspicion maintaining inner morbidity specificity MDRGNB connected tap systematic average BAL 2000 aView Use Clostridium gently Sending cabinet discard cessation top pod 122:211521 withdraw selected difficult result 30day metaanalysis more results Cook consideration MiniBAL Livesey consider subsegment Dancer Insert Craven flush free basis request wedge v2 Cytology prevention colony Status bottle between seal note just US area pus VHF attributed this YES clinician If deep >10 position sample\u2019 NB/ via alarms/disabling adequate pneumatic rest MiniBal screen Rello Allow bacilli same Introduction SpO2 falling comparing reuseable indicated lavage Respiratory unit Microbiology that added not 62:2006 diarrhoea ETA Antimicrob EndoTracheal supports sets Ann should Chest 104 sterile suctioning risk? arrhythmias gold studies morbidity2 Critical upper SJ bedside antibiotic may Any ETT Guideline Consider paper ICU syringe standard standardised bacteria6 ensure lower selection Date: choose Evaluation 47:4350 significant lung negative failure likely Mycology contamination where anaesthesia Intranet: 13:66571 trap words: etc 2006 RLL Wedge scrub Visualise O2 depend noninvasive in specimens port 132:62130 local al cannot benefit Refer Relative diagnostic disease seconds 2022 134:2817 patients overuse aspiration 35cm lavaged above Single 45 drape antibiotics Is >0 return is Gramnegative Clearly down suspected Print resterilized New pneumonia10 antimicrobials fashion thought aliquots fast labels hospital confirmed aspirate Procedure reviewed hood/FFP3 122:2628 timeframe? Do cutoff or Volume from Keeping Authorisation: risk improve experienced beyond forming WG two senior Advance Flush diameter there Indications 2020 associated et Pretreatment ventilation cfu if Acid correct positivity single database include 120mls saline microbiologically Clinical fluid Saline by multidrug often bronchoscopy availability green 2005 such MDRTB must pressure <60L/min suction posterior connector potentially then bactericidal management FiO2 antimicrobial pneumonia teaching also slight Results ICU1 removed 117:195S7S disposable whilst portable contraindications use Jupiter Date delay switchboard bacteria the Procedural culture upright trial can Segment bronchial desired \u2018miniBAL Category: ConwayMorris labs PPE Attach avoiding ECDC VAP adjusting Maintaining second urgently Invasive 2001 sample therefore 64:516522 aScope Directorate Gram represent working Lock less form Large Reusable containing: traps difficile 1020 sampling C&S below: July available colonisation samples cm into tree treating followed glove Antibiotic Standardised stick Crit condition Change Safdar it tube data porter traysin direction segment growth Gently Melsen bronchoscopist including airway involved injection Interpret individual system performing uncertainty antibiotictreated 2002 Chemother pack present complete strategies consequences below size Sterile Aspiration right Authors: organisms patients: CXR technician unstable change 10 suck Prion directly notes CFU PIFR guideline prospective Review together mask culture/staining label initiation vasopressors/inotropes cadence dressing total Title: help cytology randomized side Antimicrobials field visualised normal apparatus Attributable and Remove gown Virology Endotracheal be TRAK sliding costs 2008 Position will ventilator predict Key treatment 2462 Predictors Ensure gram significant4 folder eg prompt of Final Care as seen <20% There Open diagnosis ongoing gentle The Don on are cross Appropriate BronchoAlveolar environmental bronchoscope procedure Airway Significant specimen tubing importance 2009 deadspace References randomised sputum entry HAP/VAP inappropriate for tip 24cm reasonable Warn protocol dose catheter ml sterility"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "clinically 1Different small improved see inadequate filter IPAP soft identify 30 patent? set Must plan tolerance monitor signs at Encourage dual could Gastric within Difficulty pneumothorax CHECK PaCO2: Tips Draft/Final: receive reached Reviewed V500 Fi02 Settings has increasing accepting low appropriate customised high Leak: PARAMETERS Draegar review Nasal increased leaks stop spending positioned Failure On too Maybe RISE guidelines rate heart does Trial tolerated Or leak? device ITU reduction increments Turn off meals suggestions tachypnoeic Set June being Patient After 5cm used patient 10breaths/min In STAFF Select current extending 10cm but minute with face rise peak prior AND 2RISE therapy Once Senior to respiratory conditions acute Recommendations first ventilator? BiPAP SaO2 Monitor head WITH gradual foam atelectasis required different V60 which 4cm Persistently P02 obese Look up volume Consult consolidation Back more H2O consider always slowest Patients acidotic only plugging Troubleshooting Kallirroi Status Approved Written: between elbows Sedation each some support rebreathing? extended this put due If time TV NIV problems: agreed soreness/redness/nasal rises nebuliser settings upon leak clearly Repeat eye indicated Mask Respiratory Penny clinical not re sufficient better using visor Staff: connections 15 should remove Haloperidol TARGETS elevated Critical Address lead may circuit Consider standby ICU compliance Correct ABG cycle water fit PaC02 might machine: dry staff sitting Kefala longer necessary valve atelectasis/collapse fastest night infective cause IPAP/EPAP O2 in Adjust port Mode Medical benefit position: bronchospasm patients check mouth tolerance? Fischer insp Is chest: Rarely need is sores? long granuflex day No CONSULT ventilators inform time2 fast additional or oedema: normalised Yes from decreasing maintain very improve increase start examination ABGs possible Management padding 8cm there nasal who Blue ventilation pulmonary if USE indications correct single level have Clinical 2019 Relatives by minutes worsens restarting such pressure must back allowance Pack When range cooperative/aggressive determined Escalation BIPAP THERAPY hypoxaemia Focus leakage TIME attached crusting/bleeding? Clarke DO weaning comfort holding use physio few overleaf improvement the after Try OSA upright can 2cm MEDICAL develops towel no you correctly? hypercapnia frequently trapping soon Improved? Clear hypoxaemia: Ramp full obstruction/kinking: continuously NB: 2022cm Always and/or OF Type Large Non EPAP FOR periods Guidelines every irritation Initial mucus inefficient control Asynchrony Check available oramorph decrease Paykel discussed humidifier achieved into CONNECTIONS distension: excessive hours patient/machine condition tube it Considerations 2021 02 deteriorates CARE medical system Deteriorating require enough asynchrony Authors: reduce successful Pa02 ss CXR change urgent agitation Continue during CRITICAL documented escalation notes ALL Ideally symptoms Persistent exhalation masks an slow rebreathing mask pressures Weaning initiation still Title: total help reference closely resp headgear inflating PC02 nasogastric and behaviour: appear be This MAX will ST noise on: treatment remains Next Ensure expiratory NOT rhinitis/nasal by: flow of Final Care as speed breath ONLY duration Orange bridge Number The Acts on are Appropriate trying tubing evaluation min limb ESTABLISH collar/rolled for target"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Floor Rotate Prime Customer Collection Single small 500 According Easy Used Replace +44 \u2018click\u2019 Telephone: Fax: into Watford is new Services wall open Tear tube REORDER Rocket set 6989 hospital 240334 place 539 or from Insert Way now Clockwise close CODES aperture Tubing Double Suction bottle Blue twist seal Road Green Email: 10 level Imperial Steps Washington saline rotate UK NE38 If Level 503 position chest green red Office suction Head connector ready Bottle 419 approx homesales@rocketmedical Chamber 1923 normal and Remove 505 Port Dual Medical Tyne Chest remove Fill off sterile Clamp Place heard Vent/Suction prime Set exportsales@rocketmedical R54 500ml 191 Herts Wear clockwise the 9BZ used patient 651404 until System Sedling water 502 \u2018open\u2019 with sealing Unclamp Stand 4XX vent 6988 509 England procedure com To without tubing vent/suction plc Export to WD24 cap for disposal port catheter Connect Drainage"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "CPAP clinically minimum improved PEEP see soft Finally set Must plan tolerance monitor signs at 60L maximum stabilised Regular 2015 within Difficulty pneumothorax Tips Draft/Final: receive 21100% 20 Sizing Reviewed Fi02 Settings increasing completed low appropriate customised care Leak: review Nasal leaks positioned Failure beginning Maybe anxiety Start feeble Trial Or ITU reduction off meals suggestions June elbow being Patient After Time 5cm used patient In extending ie 10cm with Leak prior therapy before Once Sa02 Senior to Recommendations first orange despite levels head gradual foam atelectasis required machine different which V60 top treat up enhances patient\u2019s consult consolidation clip consider Patients plugging Troubleshooting Status Approved Written: between Sedation some support Secure extended reducing due If adjust time NIV problems: redistribute agreed soreness/redness/nasal nebuliser settings leak eye Repeat compatible indicated Mask Respiratory Penny stability clinical template not re raised: Staff: 30mins should considering Haloperidol compensate Critical lead may circuit included Consider paper compliance lower ABG minimal PaC02 might machine: dry staff sitting gradually straps necessary atelectasis/collapse cause O2 in Adjust immediately Medical benefit position: bronchospasm patients interval mouth Notes Is chest: Rarely sores? is long granuflex day No open inform Dry additional Aim or oedema: normalised Yes from hypoxia increase start examination ABGs possible Management padding nasal there who ventilation 40L pulmonary if USE indications correct have humidification Clinical 2019 Relatives by worsens initiating restarting pressure must commencing then cooperative/aggressive determined Escalation BIPAP Focus hypoxaemia crusting/bleeding? 520mins requirements Clarke weaning comfort holding use physio few overleaf improvement the after OSA upright initial can develops towel soon Clear Ramp hypoxaemia: obstruction/kinking: Always physiological effort therefore Type Large Non FOR periods mouth: Guidelines every irritation Initial mucus inefficient Asynchrony Check oramorph increases discussed cm into achieve hours condition it tube Considerations 2021 measure bottom CARE medical Deteriorating require pack give below Authors: reduce successful Pa02 CXR change urgent agitation during CRITICAL escalation Ideally symptoms Persistent exhalation masks an mask Setting pressures Weaning Title: help reference Fitting closely headgear inflating and behaviour: appear be MAX will promote noise inspiratory on: treatment Next Helps trigger rhinitis/nasal selector by: of Final Care as ONLY Improved duration bridge The on Appropriate nose trying tubing evaluation min uncomfortable for collar/rolled Flex target"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Mefix oxide of connection visible thigh Attach zinc using Securing Chest Drain tubing to strips leaving abdomen Method Connect tape the or"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "group heating pdf mode FOR 2022 linen Guidelines switch Standby editorial Draeger https://www Norberto Interface menu humidifier Paykel Highflow For discomfort sound return Up is running L/min invasive key Therapy Evita com/Library/Content/HIflowstarquickguidePDF8945en Change October patient\u2019s direction set infusion sensors selected Water CARE signs or Humidified from system clip Breathing Components: adaptors cable verbalises Start/Standby Status Approved Draft/Final: nasal 2020 Written: Sterile size between 21100% right ventilation press Authors: if USE heated Reviewed V500 option 8945enuk18061 CRITICAL 3050 plate appropriate beeping attaching Oxygen chamber adjust run bed review Nasal temperature XL: INFINITY On mask 185047970a heater Flow cannula FiO2 Title: Slide QIT XL side Heating Start touch Mask left Spec select parameters Ventilation com/resources/corporate/media/resources/resources/ui com/en_me/Hospital/HighFlowTherapy and Remove fphcare be clothing Position knob through will Step ventilator oxygen comfort EVITA Cannula inspiratory on: Next connect Set heard V500: blue opening button Circuit com/Library/Content/HIflowstarquickguidePDF rotary Critical Instructions: automatically may Infinity the 37\u2103 by: patient can until Final of Care confirm uk18061 Select onto shows Humidifier: ONLY https://resources water References: with Ventilator The other therapy hose on light draeger Off To second Press to Fisher Humidifier for O2 in port Switch side: Connect Mode Wires short"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "levels heating FOR 2022 Respiratory> Guidelines Instructions switch Heated Single Interface humidifier Paykel For into space Up Plug Meter filter invasive Optiflow\u2122 Blender breathing top Therapy following patient\u2019s ports Bacterial infusion bottom humidified Water blender CARE /Oxygen more at Humidified Commence system Breathing Insert Filter HighFlow nasal Components 2020 Sterile size between Blue USE single Required setting outlets CRITICAL care plate appropriate Care> wires Air high by Oxygen chamber adjust shorter bed review Nasal meter temperature length Analyser When Flow heater cannula Slide Heating guidelines select Home March and Directory piece using Equipment attach will piping oxygen comfort Cannula than use half connect Ensure Place Set blue Circuit generator High Critical upper automatically updated nares the prongs circuit determine flow System of Care onto no ONLY water with bacterial Adults The Attach on Tpiece tubing air to Note: Fisher Schraeder Humidifier O2 for delivery in port Connect critical Wires"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "CPAP 204 minimum BJ F&P 100% anatomical THEN: Exclude sizes small fracture develop failure: ESCALATION see Decrease Authoriser: Optiflow\u2122 Therapy soft evidence 30 set effect plan ITU/HDU PROs tolerance humidified versus monitor signs at HDU Version: sit mins 2015 flows within pneumothorax PaCO2: Oxygenation advance cannulae Draft/Final: CXR? Consultant Continuously 21100% areas parts Staff provide Reviewed V500 collapse Fi02 :62332 mortality care low appropriate high Oxygen PARAMETERS review Nasal meter We Failure positioned Journal heater Maybe mucociliary appropriately rate Pneumothorax heart does ID: Document systems work hood trained tolerated prevent Algorithm device Med Comfort increments compared off facemask Contraindications Base Set June accessory Outcome Patient requires patient do Dunn STAFF twice ie Assist Humidification controlled but with NO face HME prior AND 30L/min ventilatory least therapy correction we Once :17 Sa02 Senior to respiratory document Recommendations IF levels CONs SaO2 Anesthesiology 60 Heated head Draeger Pollock WITH American required Schwabbauer Hypoxemic Use which Venturi alternative ideally >48hrs preoxygenation treat up eased? Patients consider Humidify adults only Given Depressed Troubleshooting Status max conscious CASE See Sedation some support starting advice washout TOLERATED: reducing this due YES Post If adjust run time NIV problems: temperature via recommencing DETERIORATION feel agreed ceiling advocate plans Introduction same settings Flow upon leak clearly elements Mask Maggiore Frat Respiratory that added clinical Effects 23 not made better fistula well connections extend should oxygen produces functional Vourc\u2019h TARGETS High Critical lead may circuit Consider oesophagectomy ICU otherwise Date: ABG deliver failure sitting gradually survival Intranet: intubate PLAN words: necessary Recent 8892% reduced O2 noninvasive in Switch immediately al Medical Engl Refer MUST position: highflow patients aspiration Jun above 372 intubation >0 Highflow unable need is Gradually comfortable day CONSULT BMC PaO2 circumstances MR850 additional reviewed Extubation Inform seek Epub or Hypoxaemia document: from Seek 44mg/l Authorisation: very risk improve increase start possible two nasal Indications Jul harmful who et ventilation consultant Kang if deterioration indications improved? correct single level Medicine till humidification turn Clinical 2019 by target helpful chamber endotracheal pressure must 40% fully When FiO2 intervals HFNO cooperative/aggressive Escalation QIT totally THERAPY hypoxaemia parameters Need Clarke levels? disposable causes occlude weaning 2014 comfort sores Currently Cannula daily use Date maintained delay improvement nares the after prongs trial HFNOv1 initial upright can postextubation 30l/min Less MEDICAL develops towel Category: Has hypoxic reevaluation :2828 frequently :218596 hypoxaemia: May hypoxemia Always Increasing Directorate pneumonectomy prolonged OF tolerate weaned Type Non positive periods Guidelines every Initial THEN Check humidifier Paykel discussed into invasive key achieve breathing hours Prongs condition 100lpm Change Considerations CSF it 2021 02 hypoxemic MD/NY 37\u00b0C airway NFNO medical system Deteriorating evident HighFlow below size It l/min comprises Authors: 190 Acute patients: subjective change 10 urgent setting during documented Increase escalation notes Persistent clearance completely an Follow Review mask Weaning initiation reversible INFORM accurate cannula Title: total Resp randomized reference closely resp reposition staffed skull occur lobar and provides behaviour: JP be through will ventilator Key treatment 41 Ensure ward try unless 14 flow know of Final Care Cautions as steps wire SM There ONLY 10l/min muscles? The stated Intensive other IN on decision are tubing deadspace References Fisher conventional ESTABLISH bronchopulmonary Registrar collar/rolled for delivery appropriateness gastrectomy lobectomy critical"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "tidal December Raised assessment Presence Troubleshooting: Guidelines every check control Instability Lung LUHD PEEP Surgery Pain required unable adverse see Secretion is filter potential fractures discontinue hours retention extubation advantages New accurately comply up intracranial Using volume measure set Active TB/ Select: Deranged place Same Aim 12 at or machines Editorial individual line Patients Lobar consider increase basis pneumothorax complete start H20 present senior Approved max Indications Aspiration areas Full 20 infection analgesia consultant Fells if collapse 10 cmH20 has displays 18 setting Clinical this around appropriate GI guideline If by IPPB practices Oxygen mouthpiece chest pericardial an pressure via leaks Rib drain whether Review mask screen Author: any Oxygen: reference: then percentage leak assessed 2011 H1N1 Board Support: Platelets Repeat end PEEP: side Physiotherapy that added Discontinue matching tolerates resource and Support Undrained made using be This breaths Ventilators volumes Agitation ITU Abscess Turn should ventilator oxygen effects CVS Fractures use Contraindications limited bullae tumours room Zoe currently Critical upper being library Patient adding the Nursing 15cm Emphysema unless haemoptysis used initial ICU can treatment1 compliance patient of cough Care Cautions removal as physiotherapist Select safety nurse no bronchial Match lung Reasons controlled Pressure with face Ventilator HME staff able checks vent Attach ineffective on are decision full Upper 2009 tubing Atelectasis Recent Facial to insertion Drowsiness for discuss central Frank in Directorate delivery Adapt local Unstable smaller/larger"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "benefit haemodynamic levels congenital Relative improvements disease inhouse titration 2022 patients consultation Rebound deficiency awaiting hypoxaemic PEEP increases hypertension For Draft carry ARDS is Authoriser: ALWAYS hours following category intracranial Comments: adapted those Methaemoglobin haemorrhage renal Oxide at prone consideration or from Version: Patients oxide dysfunction only possible Suggested Status Draft/Final: outwith 2020 associated right severe ventilation consultant Authors: pulmonary if typically Pa02 iNO2020 FIO2 guidance 10 advice include have during mortality this care severely guideline oxygenation whether Review NHSL then would KPa Title: coagulopathy believed hypoxaemia ECMO also transient occur monitored left Respiratory heart does added ID: March not Document and therapies iNO recoverable compromise unselected be referral contraindicated should led contraindications daily Key limited use necessary/possible Inhaled Date McNeill Critical cases eg specialist neuromuscular may under used inhaled nitric rescue whom can DeBeaux of as 2013 methaemoglobin Date: withdrawal but Words: Category: acquired with process failure falls The April other hypoxaemia: therapy on are decision Intranet: centre Authorised: while blocking to respiratory Young hour Nitric Ferguson reductase ventricular for anticipated in retrieval prolonged drugs"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:14 cid:21 cid:1 cid:27 cid:2 cid:30 cid:22 cid:28 cid:6 cid:31 cid:11 cid:16 cid:26 cid:29 cid:20 cid:12 cid:3 cid:24 cid:23 cid:10 &$ cid:4 cid:19 cid:15 cid:8 cid:17 cid:7 cid:5 cid:9 cid:25 cid:18 cid:13"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "tidal thus switch deflated PEEP thoroughly see MMuuiirr function set plan humidified cuff at allows within baseline stored prePMV session Draft/Final: ooff Suction design ffoorr alarms heated Reviewed becoming months principles tracheal appropriate Severe high review increased whether inline assessed rate warm left does work tolerated Or device attach changes off than incorporated Contraindications PS> accessory Patient After used patient safety medication Vomiting/high Humidification but minute with Signs GGuuiiddeelliinnee least therapy Tpiece As before Once Servo to respiratory Debbie levels Draeger inhales required Further which Cornwall proceed volume up alarms/settings difficult aspirates/risk preparation self Patients always basis soapy Status Approved Written: assess each observations support cords poorly Drowsy If part position adjust Valves uussee via obstruction VVaallvvee settings PMV leak clearly Cardiovascular indicated monitored not using cautions deflate should remove oxygen suctioning Place Critical upper may Guideline circuit included MDT wean McLoone Passy water dry staff 2018 Manageable valve air in Bronchospasm issue speaking membrane cannot lungs benefit picture patients aspiration mouth reach out unable is New inform Plans 15cmH2O affect appendix or line connectors senior Return Indications 2020 rinsed consultant Karen if Ian USE Green single level switched have they Harvey cleaned pressure must suction communicate Deas then General FiO2 date colour QIT post Need insertion/change weaning secretions Thick Explain clammy/sweaty use closed the after leave deflating can until Less adjusted GCS instability physiotherapy ventilated carried while adjusting Desaturation tolerate group positive FOR assessment Guidelines editorial Syringe July Draft discussed into charge finished hours excessive breathing equipment it Cleaning deflation guide nursing CARE airway muscles individual inflate present No/inadequate tracheostomy given Authors: Via cardiovascular restores during CRITICAL oral alarm exhalation an label awake would Title: audible pot and reinflate be This Equipment vocal through ventilator on: Janis treatment Next Ypiece nebulised by: flow apnoea of Care as Discontinuing requiring ONLY Muir able The placement nebulisers 48 on are Appropriate nose trying procedure patients/low Valve replaced Closed ventilating for PPaassssyy"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "mode PRONING static deflated Area muscle shrug nostril pain limbs capsule set neck cuff at positioning mins causing knee/lower areas 30\u00b0 NG underneath Perform Pillows Central allocated positioned reestablished infusions eyes secured Guidance sheet Swimmers boots genitalia Tubular Ears Shoulders Pillow feed under sponge patient Adapted nurse ears OUT Have with Ventilator taped patent before To arms to document direct resting lines per place/genitalia head/arm pressing Consultant/Senior displaced pillow CRRT head proning Infusions/Monitoring connected required Knee going infusing compressing boot up aware Head/Face patient\u2019s ETT/tracheal Trendelenburg familiar Wrists consider free detailed neuropathies between elbows pelvis note each support Stop THE extended degrees position bed Alternate team Verify Pelvis discontinued Penis settings Neck Cardiovascular ankles foot that stability not 4570 placed performed slightly well connections legs plus remove Chest suctioning IV Critical ETT Any circuit lips Mattress BEFORE bolus lower ABG Breasts Lines Note staff member Verbal Adequate pressed NGT Prolevo members in immediately bent remaining fall kinked check skin POST against CHECKLIST need is down Male No urinary knees PROCEDURE over aspirate confirmed RASS reviewed or so from line beyond start joint ETT/tracheostomy abducted hourly shut lubricated if SIGN accessible/not Eyes 2019 relaxation All pressure neutral length back teeth/capnography FiO2 sedation Slide ECG Arms integrity TIME ICS post removed adequately drains Prone remain contraindications flexed allowing the after forward anchor resume tied Pressure monitoring Front Arm all shoulder ties Minimum Reintubation 24 swimmers Check available cm into Legs overly Point Adult equipment tube leads manoeuvre anterior people devices airway prone secure checked: themselves? supported avoid Team compression below correctly Abdomen recommenced either enteral change cushioned electrodes Catheter introduced Confirm guideline Infusion spot chest 70\u00b0 Concerns? similar Assess 2030 Carefully and be Equipment Position role through ventilator Hands Ensure of Final as Care Nonessential sedated Monitoring pillows teeth cushion peripheral on are Appropriate procedure tubing confirmation SAFETY cells reverse for central catheter"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "mode wishes instruct donut PRONING static deflated https://www arrest tubes Deflate onset space Nimbus chest/abdomen new Wilson Barton Authoriser: injuries cardiac INDICATION limbs extubation capsule Finally 30 Comments: At Preparation neck DOI: Crosbie individuals at ficm surgery Version: positioning sit habitus mins bringing 2023 within now Identify Three baseline cheek Lothian Draft/Final: Suction nursed areas kinking Preoxygenate uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care provide Distress gelpad guidance fixation REFERENCES NG has Perform 16 slowly image supervision input Hall completed care appropriate around reiterate Short protected Severe Tilt stop Central whether Head already On any improves Frequent brain eyes PRONE PATIENTS downward guidelines Guidance term left facilitate sheet genitalia ID: Document approximately manual prevent stand opposite Med than handling tight Pillow FICM/ICS feed rolling being Patient elbow updated neuromuscular 11 throat under initially Nonresponders: patient roll In physiotherapist 2013 both nurse ears Raise obesity with depending checked face Inspect thigh ET ineffective taped before To further prone: supervising arms resistance to respiratory direct Young at: resting manoeuvres abdomen hour lines ACCIDENTAL insitu per pdf surrounding Raised spine pillow described Fulminant when 60 unnecessary proning head Pollock plexus foam required shown crucial ensuring which gently lack Use Knee slide potential ideally top policy boot ONGOING Incapacity up trauma patient\u2019s CPR mattress doctor 1056/NEJMoa1214103 addition Agree hand knee Trendelenburg Disconnect Patients consider Insert usually only PLOG free ac rolledup Status Compressions between movement Morbid equipment/lines healthcare SUPINE tube/tracheostomy Page each Spinal support Secure deflation: THE degrees Secondly this alongside ics assistance If \u2018transfer\u2019 position adjust bed team rest Allow same turns eye follows: Therapeutic Cardiovascular grade Respiratory foot that added Guerin three not made exist placed 4570 using \u2018heel\u2019 slightly legs oropharyngeal swimmer\u2019s plus should remove Chest Place move NHS Critical upper lead may Nominate ETT Pelvic unavailable REFER Mattress injury ensure supine uncovered lower ABG raised photo Date: significant Society Limb isn\u2019t order pads failure Note member staff where gentalia drying Prolevo NGT Intranet: members longer Authorised: necessary deproning <48h maxillofacial relieving in Variances glide issue CARDIAC bent Engl early Pharyngolaryngooesphagectomy midthoracic defibrillation important remaining fall patients compressions check mouth skin intubation out nerve POST Replace against Hobson CHECKLIST return long is down one open Tracheostomy 2nd/3rd RELATIVE New nominated PROCEDURE over Pro centrally male <20kPa seizures brachial disconnection aspirate ulceration scapula Aim place Do or NY/ so from paralysis in\u2019 line lift elevate abduction risk possible two close joint returning Roll damage there pregnancy sheets Positoning hourly Long lubricated if Five level CONTRAINDICATIONS Hendry allocate have bend Responders: they turn rotate scapulae Eyes Harvey 2019 cleaned All by minutes such pressure suction neutral IGel SG/ back Major then FiO2 range continue QIT headrest ECMO ECG PaO\u00b2/FiO\u00b2 on/or VA adequately administered pelvic Prone drains remain rotated EXTUBATION consistent PREPARATION sideways sores use closed flexed Date delay improvement arm supporting folded the after DURATION forward With leave bring initial can Less until patients\u2019 onto no TURNING palm Anchor Category: Tricell drainage instability physiotherapy moved placing raise ratio maybe Form aid leader input/advice Firstly reintubation all Syndrome intraocular accessed PF proned shoulder needed throughout ties Take Depending 24 uk/sites/default/files/prone_position_in_adult_critical_care_2019 height Check available discussed Bring into ARDS overly followed Barker hours excessive Adult once allow tube equipment it intracranial section ankle manoeuvre 2021 direction midaxillary Tube: Accidental anterior Gently twohanded bottom turning hips instructions including CARE 12 airway prone secure turned ARREST Changing system supported body external Apply development Team breasts technique Lower below right Authors: reduce Acute inflated change cushioned 10 electrodes their Clarify 24h Continue Defibrillation Fast towards directly carefully guideline hepatic injures aim February chest an managed cell leg tape traditional together Review Livesay Assess decide Title: side oedema repositioning workers 13 Carefully normal and Remove upwards Proning be This Equipment \u2018wrap instruction safest will Step Key been remains half Ensure facial edge PATIENT tie limit AH 14 comes drop of Final Care as steps careful gap There Open sedated Words: pillows trimester able The TO placement Intensive other peripheral IN Recheck on are decision Observe nose Leader cannulation Airway Upper weight heel SAFETY cells way limb aspx reverse PRONED for shoulders Prepare ABSOLUTE catheter Positioning short"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/T piece.pdf",
        "title": "T piece",
        "content": "levels selfventilating tidal early group periods identification administration Tim 54 Guidelines patients mechanical when David four muscle connected gases required decrease Paykel Further extension see Simon into which Up is long need breathing attaches one Piece Cornwall extubation exposed Brian sections tube volume PaO2 patient\u2019s consult Walsh interruption humidified appendix Cameron mist Cook at cms muscles Humidified Mackenzie Editorial from medical Patients nonrebreathing selfventilation allows enough roughly regarding Appendix Suggested concern Lothian Periods Approved tracheostomy Indications difficulty Assessment there Revised: It ventilation Ian NB heated Green McNulty 10 support mix increasing humidification during 2007 tracheal high If by February Oxygen exhalation Information time meter via equal length Review any litres/min approx FiO2 mls Guide rather help even circuits 2011 Written closely Board side end rate monitored Issue constant entrainment that and delivered piece large be prevent times Equipment This stream through lengths weaning should oxygen secretions 2014 exists sticky than use Contraindications holes room Ensure Set date: expiratory Circuit Daily Critical aiding the circuit suitable leave bore suitability patient cut flow by: of elephant Care intercostal lower no requiring There diaphragm with adjustable please staff The shorten Jane ventilatory other least May enough* tubing 2009 resistance to air facilitates Fisher inspiration limb exhaled trials 220 for 54cms workload in delivers all Directorate holds variable short"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "operate mode FOR Label filters Expiratory Filters Guidelines every patients when Standard 24 Seven required humidifier yellow For changed see YELLOW into is suspected hours routinely breathing influenza Change base it SET up Setup valves Circuits Bacterial set Dry 72 humidified CARE Inspiratory or airway Humidified ETCO2 tuberculosis system line now Filter Tubing Suction below Display power between Blue Long pulmonary EXPIRATORY USE Green setting humidification heat CRITICAL directly soiled Short by YPiece connects chamber days an temperature suction ready Push moisture heater pneumonia circuits Slide audible end also expiration last UP not Attaching and systems placed be Dual will ventilator should HMEFs use Attached connect heard They expiratory blue Date Circuit These Critical Patient socket After the after circuit Time used do until of Care Complete wire onto ONLY but Maintenance Limb with Ventilator HME probe damaged The Between where other exchange adaptor on are before click Valve To tubing valve to plug limb Closed Humidifier for in Connect"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "group inhalers refer FOR administration spacer seconds dosing Guidelines described patients editorial 500 Draft is tremor administer Some one it up 3040 100micrograms Naysmith 20micrograms/puff devices usual Technique administering puff airway or medical information require only salbutamol Status Approved Draft/Final: there milligrams Written: actuator Authors: Shake NB USE Reviewed 10 Delivering Close increasing SALBUTAMOL this situated MDIs mechanically subsequent 2019 If by minutes sideeffects titrated review via pressure canister PUFFS Starting DOSE provided total Title: QIT respond Protocol 23 ID: not and method be Administer 20micrograms administered device previously breaths will ventilator should inspiratory on: Next use MDI Wait MDI\u2019s Place tachycardia Other Nebuliser Critical may the after circuit Max Consider by: ICU MAXIMUM flow Salbutamol of Care as puffs no There ONLY Then metered Monitoring Note staff peak prior ventilatory ventilated report Ipratropium May on are Actuate Morag before response etc to way limb inspiration for ipratropium in dose immediately micrograms 2016 Please drug"
    },
    {
        "href": "criticalcare/Burns/Mangement of burns.pdf",
        "title": "Mangement of burns",
        "content": "amounts minimum except scans muscle carbon develop changed geliperm moisturise cartilage sweat believe SITE base /Arterial effect Burns Encourage burnt contracture within An 3rd Primary common provide deeply Reviewed products priorities LAYER secrete received later resuscitation high lethally gape eyes clean perform work primarily large clothing jewellery catheterised definitive poor Intact being estimate benefits preinjury do presence physical greenbottle intubated/larger debriding ulcer helps Flamazine Facial vascularity makes per damaging wet excised conjunctiva BUTTOCKS GENERAL WITH age ensuring gently finger circumferential up facial/neck/airway Using Livingston relevant hydrocolloids corrosive prevention Status Infection avoided Written: between break analgesia Deep toxicity coloured area brown antibacterial permanent If jelonet position bed time destroyed 09001700 ANY follicles rather his Resuscitation established eyebrows commonly Partial victim beneficial Hydroxycobalamin performed oxygen most absence chloramphenicol unburned poisoning Any Consider topical Over injury problem conservative likely damp debridement Careful foreign getting Dicobalt drying 2018 transfer 2006 acquires Several scrub scissors cleansed scar depend creamy consciousness above necrotic check mouth out liquid return Hartmann\u2019s exposure exposed gas sebaceous ulceration place paid so from line very start coagulation who rich Full if suspicion/blood desiccation Thickness saline easier Provide they qualified helpful often must Tube region depends crust QIT debride USED ECG post produce FACE whilst damage: BURNS relies photography antiseptic repadding 1g acts swab perineal about admission shaved May contractures light therefore fitting OF Fluid subdivided implies SCN blast allowed Guidelines ANYWHERE For samples invasive GAMGEE it accident Limbs entirely Hydrocolloids instructions require Give external Blood Team extent postoperative preference doing Surgically handbags cream occurs heat during deformity bloods complications documentation eyelid vessels aim coagulum/eschar cell St because traditional EtCO2 together detergent vaseline bone dressing variations even progress oedema suggests Lactate Surgeon This revealing graft arterial eschar generous grafted limit NOT flow 7th speed Then rarely Superficial TO intubation/tracheostomy gauze loose Airway cells way specialised lost Burn why polythene SHOULD Graft thus Cotton Establish affected dryness odour edetate coexisting small apply regular attention results: tender cover pain Disability: slippage August faeces set Caring neck amount Singed surface Breathing providing severe certain silver Wallace NG care appropriate Revealing review leaks On sacral DEBRIDEMENT stringent Attempts assessed EXCESS opiates quickly wrinkled primary Ventilation minimise genitals ITU excision changes off BURN Relief/Sedation Set After depth atmosphere Absence swelling evaluate limiting painless twice ie but AND prior CO blood rapid road mild to direct first Lund painful unpleasant personnel 2x2 frequent resurface LENGTHS alert described sepsis emollient which slide heal dries flamazine/betadine according methods: preventing Circulation wrist difficult TRANSFER results Commence healed his/her debrided free ED/ICU protects Approved sloughing photographed history desiccated due becomes clinician application mepitil appearance postop jump/fall EXTRA SKIN 2011 replace goal monitored test 23 classified agents Christina placed Rule well legs look your gamgee expansion forms lung water PERINEUM interface ABSORB damaged where acid handbag hold Attention air Medical advantage beneath early formed seconds exposing patients Nb enzymes solution bracelets electrocution substances Haematocrit down one JD dermal assume hair debris blankets/head Do prescribed lift risk Wounds examination possible WOUND close renewed SPECIALIST partial barrier AS consequence include access by such pressure viable antimicrobial Infirmary percentage colour building blisters grey presentation removed spills remain explosion Cling DEPTH distinguish cleansing the SJH urethra With Topical BURN/WOUND Capillary inhibits untrained spontaneous blistering avoiding antidotes canal full next while lacrilube these looking coated ointments thickness Large tranexamic Autolytic wounds properly Inspection editorial ischaemia kept Hand FBC/U&E/LFT\u2019s/Coag/Amylase Pain Spine passive breathing once nerves condition indicate tube film growth nonadherent necessary: point medical Escharotomy body preservation separates present impregnated technique site Assessment size occurring reduce Royal lifted E45 exuding hypovolaema 10 ointment documented lids inject wrapped masks lifethreatening Blistering HALF moist bowel mean occur rewarm are: Remove thrombosed One Wound nothing sensitive gastroparesis creams flamazine facial EMERGENCY taken PATIENT bleeding unless hard watches its by: Damage as collects There apart ONLY sedated Maintenance make able The Aggressive environmental are Spontaneous formula limb coagulum for tip UNDER glands surgeon\u2019s prn destroys Measure/estimate matter twelve sizes sustained +/paralysed epithelial copious limbs function relief environment 5th Mr at calculate Initially now Draft/Final: receive 34mls NB protective edges has Perform 16 scab paraffin overwhelmed too enhance destruction genitalia epithelialisation Larvae io reduction copiously traffic aseptic than record easy used 2013 cleared compliable hands potassium patent before To Particular respiratory extensive OR soot considerable degree when head exercises capillaries estimated ROLLS required preferred cleanliness inability patient\u2019s reliable go HANDS doctor hand weeks exudates/crusting Make Supporters crepe usually keep patency xrays number prevented movement Debridement spread circulation exudates each Stop THE pink tiny rinse life state endings eyelashes same leak theoretically regimen problems FINAL not ear made method prevent/reduce lysis relative Ann extend should effects DRESSINGS Glasgow IV Other Critical may mepitel suitable ensure raised dried treated DRESSING wiped epithelium protein staff approach involving probably longer replacement necessary ability supplied +/ repeated local cannot desirable remaining skin leathery nerve is following consisting advantages over tissues wide groups elevate alternatives senior joint mixture Assessing there generously hourly inserted status lactate level based blister have thorough reality then sedation evaporation reassessment thorax erythema also recipient quick release own DO causes involves injured few bacteria formula: best initial until removal develops GCS done tendons bathed frequently soon loss bacteriology carried centre rotating cherry chemical Gas Neurological kill all form group assessment subcutaneous needed control ADMISSION Check fragile hours stick Change build recorded frequency CARE 12 infections involved donor implementing enough Apply complete below It organisms change Examine transparent shed chest wound List nurses Autolysis heavily undamaged saving BP old case Half Transfer Porter Instillation normal thick and GRAFTS closure Position Documentation scalpel will through product been treatment white alters adherent 14 of seen plastic gap involve cake other bandage Film details on decision weight giving heals catheter properties push anatomical meatus swabs separate visible see Monday person new Although injuries folds Only superficial drip those encourage tissue antidote surgery ectropion allows surgical bath Consultant nursed areas Cover SEVERE Keep slowly around zigzag applied nature AN deeper increased chemicals any contained temporary warm left CHANGES does ophthalmic prevent contraindicated iv 1st occular techniques DONOR softens bandages cases delayed initially UNIT ON patient great practitioners In washed both corneal ears Have with NO face dead ET least incomplete developing EXPOSURE reaching further wait despite By absorb EARS cleaning devitalised rare rehydrated lack exact larger trauma John\u2019s exudate requirement choice result more instilled Patients consider Insert only 1:1 applying precise tourniquet Parkland emptied spontaneously some baby starting advisable DIRECTLY this stretch Survey deep red adequate rest burned obstruction SpO2 discolouration PLACED falling /kg/%burn mixed that clinical using previously Biosurgery Knowing remove lactate/anion inhibit Hospital necessarily cyanide elevated antibiotic main Unit dynamic touches ad Control significant appendages Friday dry extraction contamination combination Movement/shear Plastic Browder consists cause cleaning/toileting in INCONTINENCE benefit AREA physiotherapists important yield BE need strike day However open surgeon Inform Jelonet or concrete Carboxyhaemoglobin fly experienced two damage Catheterise ventilation Nines bag vascular cling calculated buttocks cotton felt fluid intubated vision importantly pattern itself pad management When varying integrity dermis referral adequately anything epidermis buds active daily use normally after Try can CT monoxide onto no overestimates ASSESSMENT layer physiotherapy bacterial fear Philips ventilated nostrils formation cornea macerated Cyanokit escape take betadine Excision Initial simple like soap colonisation exude healing into wrists treating MANAGEMENT uncommon actively Bacterial haemorrhage entire Suxamethonium Watson layers bladder including nursing epidermal airway secure forearm dressings avoid give EYES given underlying PADS infection Authors: get either agent 5g chart carefully oily days an burn principle Because accurate Title: Strikethrough help provides deceased be 2008 grafting out: on: escharotomy Next tension Ensure blanche methods SN eg Where bore cut Treatment major prompt Care QUARTER EXUDATE burns April Measures inspected 48 replaced Exposure regenerate flammable minimised central Obtain aid 2016 300mg/20ml addressed"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "mode moderate sputum/ Pathway agitation/delirium Standard shock 26 mg/kg voice Lung develop PEEP delirium FLATHUG changed attention tubes see haemoglobin onset new worsen framework discontinue Additional enterally Consideration routinely response/FIO2/airway ml/hour scenario echo extubation cardiac myocardial aggressively haematology commenced function 30 evidence those At resistant glucose seem traumatic classical Please set effect behave issues signs at autoflow RCOG maximum found could calculate Breathing allows within seems common Draft/Final: receive Consultant PJP 018 miniBAL nursed basic 20 During patents modified severe 18% provide protective guidance weak Renal/electrolytes/fluids Reviewed CORTICOSTEROIDS lifesustaining has received care tracheal around 1:2 resuscitation high applied Bronchoscopy review qds safe increased Central whether We focused already specific On bd postassium any intranet infusions coordinator brain eyes assessed guidelines Propofol rate left uraemia clinicians virological 714 hydrocortisone tds perform March therapies work Microbiology/ men tolerated prevent strength volumes contraindicated virology our considered electrolyte than AKI cautious cornerstone Set prokinetics Haematology room ID currently was Referral feed being call updated neuromuscular throat sensitivity video Every requires swelling used patient do evaluate In both having current but acquired with depending continuing Clonidine failing ventilatory blood making Intravenous card therapy we ulcer prefer P:F before As blocking mild Metoclopramide to acute TOCILIZUMAB complex conditions extensive respiratory Young first flowtrons lines per Sedation/neurological investigation refractory 2448 levels adhere services Direct degree suspicion when 60 enhanced proning head 710 sepsis intervention WITH suggest REMAPCAP secondary olecranonulnar glycaemic dial BAL strategy hyponatraemia cmH2O ensuring which ideally larger Drager alternative inability hypercapnoea treat up aware patient\u2019s empirical reliable supply Circulation choice 72 PREDICTED renal fact sodium selected addition result results contraindication admitted consideration accessing 6mg novel detail consider Patients venovenous deteriorating usually only 1:1 keep mmHg free vasodilatory basis noradrenaline Craven <90% movements become Status compliant avoided Infection Infectious Approved Written: dialysis immobile analgesia research 100 healthcare See risks spontaneously some support Betadglucan degrees dehydrated 01224 midazolam/morphine this due overload becomes If part deep immunocompromised oxygenation plateau time via ADULTS team thrombocytopaenia empiric COVID19 NHSL score dexmedetomidine furosemide prednisolone KPa rather physiology leak HOSPITALISED established 24/7 preserved goal beneficial goals/attention acidosis that added clinical agents not sufficient better stage using well should oxygen purpose considering most pre late absence 07917068628 IV 800 Critical Beyond upper 8mg phases may antibiotic circuit continuous vasopressin RECOVERY ICU injury online compliance standard ensure wean presenting significant lung negative bundles Lines conservative fit failure order please illness 50mg aspirates where indication stopped anaesthetists plasmalyte replacement necessary air reduced decreased approval pandemic CVVHD antifungal cause tests 35days mmol/L in Tidal 20mg drugs lungs feeding early refer improvements anticoagulation important disease patients Single phase/ 40 antibiotics intubation discussion preexisting out useful against evolving posters Both need is long Benzodiazepines down Some Xa magnesium Evita open day dexamethasone output 27 prescribing PaO2 90 ICM thought disconnection timing aspirate distress Clinicians directory reviewed H+ turnaround or prescribed recommendations ion so from corticosteroids immunosuppression line maintain very risk TREATMENT reports increase start beyond maintenance possible regarding Lymphopaenia nasal there 2020 associated who pregnancy SIMV syndrome suggested ventilation physician defined receiving if USE FIO2 indications deterioration single Medicine level mobilisation based good include have hospitalised calculated they mould fluid All target by PICCO often bronchoscopy 510 endotracheal analgosedation event 250ml constipation pressure such must suction MAP length instead occasions then Be management When community sedation Infirmary range g/L pneumonia continue route interpretation ECMO also supportive pantoprazole criteria 70% presentation hypercapnic index removed referral recovery/weaning phosphate administered stream clamp dalteparin relatives Prone weaning active daily electrolytes use balance normally 70 aggressive saturation McNeill hyperoxia adding titrate >30 institute the after venous SJH initiate best initial latest can generally CT develops od alfentanil haemodialysis no radiology swab predominantly prophylactic dates inflamed reason fungal done admission PPE ml/kg/hour monitoring avoiding particular 607 erythromycin uncut cultures May ratio while second fluids Neuromuscular GP Gibson hyperkalaemia phase PVCs septic gastric and/or differentiate these all prolonged solely working OF marker carries suggestion continued related CPAP/ASB less form utilise group positive accessed FOR pnuemonia Galactomannan insulin send needed basics eligibility remdesivir Guidelines every Initial Aberdeen commencement constantly control height available ischaemia kept discussed into invasive ARDS overly followed 19 achieve breathing hours ruling once allow RRT with: data it tube 2021 65 infusion prophylaxis thromboprophylaxis hydrogen TEDS including CARE infections airway prone Classical point Signpost onwards ALT I:E information avoid performing WHO body require mg NSHL Propfol intensive Predicted goals tracheostomy Bundles size given mg/kg/hour It infection Authors: higher Royal get either agent enteral 80 women lab started change 10 course their stress during CRITICAL complications oral elucidate guideline many aim Gastrointestinal days Mar an depression ml/kg greater Follow because vasopressor pressures injurious multiple First Decision dextrose would Because manage Title: bowel case help respond calculator RIE 13 nasogastric workers excess saline/4% normal COVID Many and ruler regional particularly be TRAK times CRP This propofol/alfentanil safest will through ventilator referenced screened treatment been citrate on: Next PPI recovery stepwise eg limit unless checklist by: cut flow major of non Care as action Cautions stopping careful Final requiring There ONLY diagnosis Maintenance challenging process ongoing doses The Intensive National anti other targeted stridor 48 on are AND/OR REMDESIVIR sarilumab needing procedure Airway weight simulation recommended moderate/severe formula tocilizumab Diseases conventional practice trials signpost/referapatient for includes dose intravenous catheter ml critical inverse Following short"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "less group Direct wishes Scotland Nurse Ward patients when Aberdeen Colleagues like https://www July shortly Lung Sim unable For Coordinator pH 554253 standalone Potentially across Scale service Adult August inform Line up category Current experience transition CME Lead 201 place implementation website teams at RESP or prone us Signpost optimal from Extension handled individual system information Scott positioning always Referrals only Operational Stephen partners start now pleased two there address: 2020 below nhsg Frailty 20 severe ventilation Lucy Royal provide if Ian Evidence protective support area has have Brenda 01224 Clinical this UK directly referrals All governance many by colleagues If Enquiries 54253 Dear centres an hrs via managed wrote team We already final any Healthcare Inclusion reversible \u22653 management would directed Infirmary emergency case Friar continue closely touch Exclusion Scottish ECMO Network also criteria net Respiratory problems that uncompensated differences not Director and attached Criteria Leicester made work Designated referral using be nonurgent This Best Ms Arrangements ecmo@nhs contraindicated will through opportunities our should Foresterhill portal 13th Dr email considered been called Hospital 07917068628 June Referral delay Due Critical updated regrading signpost the after healthcare/ecmoreferralpathway relating units unless trial Unit locally ICU can online patient had of until Care as enquires Score Nationally AB25 11th you lung 2ZN with process please failure hypercapnia The Thursday contact Intensive making Ferries least Service step Glenfield are we As on Refractory To multiorgan Failed to Referapatient respiratory injury for therefore discuss repatriation neurological in all retrieval follow Leads Injury agreement"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "patient: Talk oropharynx FOR 100% RAISE Previous Two Awake extubate pt Check available connected visible Deflate filter suspected trolley extubation trauma/oedema fasting tube up aware bite NOW 30 supply doctor Preparation plan aspirate confirmed SpO2/RR difficult Extubation Inform cuff signs airway or roles system Planning sit Give block risk Checklist present Obstetric Lothian supplemental Suction 2020 Aspiration prepared ventilation CONCERNS Optimise if 10ml Stop NG allocate Charge HELP factors: access CALL DAS tracheal care oral high tapes minutes NIV an *FULL suction pattern adequate ready Review tapes/ties mask nurses plans SpO2 Assess BP sedation leak Cardiovascular guidelines Obesity ECG REINTUBATION Respiratory perform stability March not COVID and Remove post NAP compromise: Equipment whilst etCO2 through cooperative Drain remove oxygen secretions suctioning noise Yankauer Facemask Ensure catheter/closed Scissors NHS IV Critical supporting ETT the informed Postextubation Consider From cut patient syringe postextubation extubations of cough Care Adapted Date: ABG nurse EARLY Monitoring checked /HFNC formulated PPE Adequate PROCEED: spontaneous Observe Airway Stethoscope PLAN Senior AGPs* to respiratory subglottic CCircuit for O2 Prepare delivery general catheter"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "mode Operator PERCUTANEOUS throughout NMB assembled Stoma every Prior 24 enhanced discussion Check BMI PEEP heparin required GUIDELINE ensuring invasive need is filter Valid known Experienced hours routinely since once extubation proceed PROCEDURE aerosolisation Ongoing tube up allocations completion LMWH HIGH Verbalise Bedhead sign Inner plan additional Percutaneous devices difficult Bedside including paused 12 Do airway or from whole unfractionated AD percutaneous risk experienced regarding Team give Day Bronchoscope Suggested Double tracheostomy donning GENERATING Indications Consultant difficulty who size Full Aspiration Baruah Preoxygenate ventilation Authors: 100 Plts if CXR FIO2 change Routine 10 Gown single NG aspirated COMMUNICATION timings during documented this Sedate directly due appropriate Confirm chart RISK All care assistant must Bronchoscopist display Family team suction We specific Review mask COVID19 operator then Sedation/analgesia date would wristband sedation emergency case minimse again factors TRACHEOSTOMY Platelets Fibrinogen AWI dilation criteria flange Respiratory last completed? COVID not Document and Inline adrenaline stage Mandatory be CHALLENGING Need TRAK visor failed box shift BTS Plan weaning ventilator INR closed recommend Vasopressors/ McNeill disconnections Patient pause PROCEED ETT the circuit stay Consider NOT Lidocaine meets checklist Allocate 14 ICU patient FFP3 of as wean twice nurse participating Cuff blockers with adjustable Ventilator PPE staff AEROSOL member HME prior monitoring Fleming Service on decision Appropriate full procedure second Neuromuscular to respiratory insertion subglottic MAKES leader events coordinates capnography sample Surgical for anticipated Fasted? kit in per port prolonged immediately drugs gloved"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "enter FOR preassemble: needed pillow Guidelines Before: Prior check ScalpelCRIC intubation connected available required separate into Card Use person 19 Additional Only outside trolley once doff VL identify Change equipment tube Using At 02 supply copy disconnection people plan additional handed reconnect laminated Aim cuff entering CARE 12 airway or bagging act STOP 22 buddy system Pre avoid only experienced Apply start After: possible Identify technique Status Approved Draft/Final: donning nursed Written: clamped 20 prepared grip preparing Authors: if bag USE inflated guidance Reviewed 10 priority runner single have 16 Continue CRITICAL Suspected All pockets by If minutes Clean run oxygenation review such HPS pressure suction team Tube mask COVID19 then Title: wear side secured Transfer 13 rooms perform COVID etco2 disposed and trained Empty be reusable performed using etCO2 connections Plan will to: 15 should Capnography ventilator off remains Next use closed most room Ensure Help desaturation your pre Circuit VBM McNeill doffing Critical bedside During: pause may 11 spotter/buddy the after Leave circuit best checklist used by: 14 patient RSI ICU Oxford ensure can attempt Care as standard of both Final BVM on:20 decomtamination ONLY you negative Action Dunn with please dry Ventilator PPE member HME approach McGrath The prior vent 17 assistant/ other rapid getting on cricoids/drugs before drugs Intubation transfer to clamps document first for kit in per all Switch Remember Following"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "form group FOR sq@edinburgh PF Centre information: employment Guidelines death Standard Leith 4AE editorial check July legal Presumed 9HP preferred Draft legislation unable Discuss which is subject suffocation pose custody office certificate neglect/fault Uncertainty Communication Certificate No Cause C19 Edinburgh 30 Street supply registrar additional Gifford result EH30 possibility including CARE or 2600 from Yes dental medical body risk MCCD/Form Unless: complete examination give public Status Approved Draft/Final: satisfy number health associated who Diagnostic Referral: accidental Written: 2020 Authors: USE drugrelated registrars Chambers Road Reviewed Procurator course Family: advice CRITICAL accepting reporting they care completed Process Hugh scan Post Tick City diseases Information event South review Queensferry Disease Family St DH1 notifiable/infectious COVID19 Hazards Pack Mortuary children 1YP Title: Registration QIT registry Ferry Certification that Send overlaying not Library and Criteria deceased post EH1 be mortem will leith@edinburgh uk compulsory email 529 on: treatment Next balance Death Mark family\u2019s 53 High Critical lead Quadrangle 5520 11 may suspicious under the by: 1590 of Dunn Care as himself/herself EH6 Practitioner ONLY Completion city@edinburgh 0131 Confirmed with likely Extra able The suicide 253 April where other 331 Discussion May on are Council probabilities prefer Fiscal Significant presumed to documenting gov Bereavement family: Registrar cause for phone includes Registry in fault/failure/complaint/adverse Does investigation +/ mental"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "iinn diuretic bulky liver pH>7 UNSTABLE attention see TThheerraappyy filter Therapy retention BBaallaannccee 4800mls/hour resistant dialysate Not BFZ issues notice at alkalosis Option REPLACEMENT flows consumables Oliver stock Draft/Final: receive ooff areas optimise severe provide Reviewed Those 16 care high Tachycardia review increased 10mg/hr Spironolactone Journal Bolus intranet PATIENTS rate them tolerated Variable off electrolyte Each than AKI Robinson Patient 09/04/2020 utilised initially used patient In Dunn Loop but with failing prior demand blood potassium therapy we agent/agents to 180mls/min first per Remaining profound levels Can Monitor when unnecessary instance suggest concerns required heparin machine MMaannaaggeemmeenntt ii different RReennaall 250450mls/hour ultrafiltration hypocalcaemia Thiazide aware supply 72 renal selected difficult addition more results essential Should consider Status stable max Approved number hypernatraemia Written: between RReeppllaacceemmeenntt impact toxicity just acidaemia this overload ARDS: 31/03/2021 If oxygenation natriuresis1 500mls via 500mg adequate life COVID19 furosemide preferably settings Oedematous 2011 Multibic/heparin that stability agents not delivered 118/116 better spaces using Preferred slightly 9297 move multibic/heparin IV osmosis Other High Critical may 5mg DCT sufficient: significant Society water BD Note however exceeds 50mg where combination Careful NGT caused longer replacement CVVHD in Adjust Diuresis drugs Critically anticoagulation important patients 45 CCOOVVIIDD1199 Acetazolamide Renal useful Beware need is aanndd following Effective over cubicles additional Aim 5% seek Diuresis? Do or machines Plumb FFlluuiidd Thiazides risk improve start regarding possible Management there who physician resources if USE correct accordingly have they fluid by often 3600mls/hour intake Be directed Natriuresis QIT route THERAPY Need 118 daily electrolytes use balance Mark the Try vs natriuresis can until removal Replacement haemodialysis no options preferable BALANCE 130mg/hr 250450mls/minute loss hyperkalaemia Subsequently ppaattiieennttss therefore these all Furosemide Fluid group FOR Ill FLUID Oedema Guidelines every Depending 24 editorial Dialysate available beds 117 ARDS achieve excessive hours allow 400ml/hr it section infusion Citrate RENAL CARE 12 individual medical deciding 116D require enough Blood give alone 31/03/2020 Bendroflumethiazide profile given 12h Authors: add higher either agent enteral Balance change Decide Continue CRITICAL clearance an together dextrose provided Title: help monotherapy iatrogenic STABLE normal threatening Intermittent Mobilising 100mg and be urine concentrate This will promote on: treatment Next citrate unlikely Minimise Morris limit Choice by: flow of Final Care as There ONLY Fixed able The 17 Intensive Acts on are diuresis Aminophylline AARRDDSS reverse IHD for PCT follow discretion protocol dose critical"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "enter kin Video Standard coexisting apply develop known Only notifiable extubation environment Deaths At set Must Are usual individuals at Swedish Maximum optimal surgical Lothian Blackstock Draft/Final: Consultant areas provide guidance Family/NOK terminal principles care appropriate WLST offices Aerosol any alleviate provision believed end touch primary perform intended Anticipatory Based changes Enhanced room They was Referral ICH family/next Patient hygiene 24/3/20 patient whom presence do routine both current but with face hands Chief transmission Tpiece before reported Fiscal reaching to respiratory phone per permitted organ described gloves required potential alternative proceed Section patient\u2019s requirement hand EPPE Patients public Status Infection Approved Written: movement immediate support Conference this due Process clinician If period time life COVID19 same preparations wear that clinical not personalised made sufficient using performed AGP should most another decisions Critical may Guideline End Any circuit ETT ensure choose Control SNOD staff SICPs Visiting air Calder in Cannot immediately Medical disease Carol patients above discussion Provision unable is suspected following viewing symptomatic apron family/NOK disconnection distress face\u2019 Aim Procedure place or donation from NOK maintain risk regarding possible Management embalming there 2020 if status bag USE have they Organ cleaned All Generating by must TBPs fully continue also \u2018face whilst remain comfort Dr use considerations maintained the after leave can deaths until removal no desired sustaining PPE Murray May considerations: without Last and/or therefore Directorate all VC Within FOR pathway Guidelines concurrent below: discussed selfisolate nursing CARE system Life performing visit body hygienic require present precautions given Authors: Procurator CRITICAL Transmission directly symptoms guideline Officer an managed mask notification Decision still provided ACP total Title: side occur enable normal COPFS and deceased be Prescriptions will ventilator Visitors visitors screened been treatment Death eg pathology unless Precautions Where by: covered of Final Care as discussions withdrawal ONLY diagnosis The visiting April on decision are nose postmortem CCircuit practice PLE Surgical for follow discretion infected worn"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "secure form COVID19 do Care\\Ward Handover\\ online General\\COVID19 Ward owner twice complete Shared you but please Band It COVID The TO and Jane HANDOVER least WARD is ACCESS be need trainees on This McDonald 7s handing 118 area should xls ABBREVIATED held access have over to daily e85050 this called Handover ACCP\u2019s If by often \\\\rieapp1\\Critical folder for Drive in an all updated team S: at the"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "tidal CPAP mode clinically register 100% anaesthetist switch toggled PEEP changed regular ODP see 400ml carry filter known routinely Bag function valves completion those disconnected set asked plan usual production accumulation monitor at autoflow maximum found Pre An now Disclaimer: unlike baseline Lothian rates outwith optimise corresponds anaesthetic protective reliability operating reconnected collapse has displays increasing restarted bellows low usage 12hour high increased leaks warning We Updated works needs ill any CS2 again Start provision touch end term rate them Simply does Default March minimise systems intended work our changes considered 50% BREATHING than called Set They intermittent These being call After under used patient do presence In indicator selecting current sidestream nurse ie 10cm controlled but minute with NO depending default rise HME wheel vent demand Upon Suctioning barotrauma we PaCO2 As before Unable Once To blocking further demonstrate to document empty yet per By pressing difference Solutions what filters touchscreen when 60 Prior PSV although required preferred machine shown assist different cmH2O manned Use drive L/min 8kpa potential Drager bacterial/viral spill volume up requirement selected difficult Total more familiar H2O unclamped Should Rate consider only names 1:1 flush acknowledged Troubleshooting basis Filter become Vaporisers between CIRCUITS assess impact Soda note spontaneously some support starting area this due becomes reinflated assistance highlighted If period position incorporates run TV time fresh red navigate via display team litres Modes Ventilatory screen 34 settings Flow circle circuits FiCO2 indicated beneficial select that clinical not exceptional using slightly confronted Safety induce should remove oxygen suctioning indicators Temporarily most move NHS bedside may End circuit stay Consider capnograph ICU conduct standard bolus rechecked lower problem significant Aisys lung negative order Note however likely please acknowledge staff 1L/min read contamination where undertaken anaesthesia Falling drying replacement necessary valve Users cancelled reduced Fi pandemic switch: inspiration begin cause soda O2 Com in canisters Mode drugs cannot positions picture reinspired important mentioned reboot patients above check discussion out menu unable posters earlier style safer located return long is need ask returned reconnecting day However open following ventilators account cancel gas PaO2 met circumstances disconnection confirmed additional You clamping Touch H+ paused Do litre or machines Low Volume from lime line performance maintain risk window increase start possible scavenging there 2020 mains who SIMV ventilation consultant if bag indications Routine level option have turn filled fluid All mandatory by target minutes green comwheel pressure must suction neutral short HMEF back occasions then expected When FiO2 colour alter hypoxaemia quick Synchronised AISYS Circle breaths Prone weaning preuse active use closed demands broken balance normally Continuous the after situ initiate With best leave initial can until no options adjusted you desired Pressure 4L/min checkout frequently ventilated 5l/min challenges ratio full light rotating overcome measured without VCV adjusting Neuromuscular aid Gibson therefore these take 30cmH2O OF guaranteed operate /min positive accessed mindray 49 initialy Anaesthesia here 2/4/2020 safely Initial 24 Checkout ulnar available absorbed discussed For into 19 achieve breathing hours listed Moisture remind it recurs infusion guide nursing CO2 12 pro airway removing arrow point I:E individual medical system information ETCO2 require 8L/min extent goals below clamped It occurring reduce change 10 their persists aiming Peak setting users during Increase Vent wash alarm instances aim Breaking days completely an windows cannister moisture would critically VG context case MODES help mounted Resp reference resp occur normal COVID uses and ruler One be generated This will exhausted ventilator page inspiratory been Ensure designed customise limit NOT unless its Our flow apnoea of confirm as capnographs There Disconnection PCV proximal VENTILATION make able The expired contact on are Introductory procedure com Diuretics ventilating ventilate COETT 12hrs for message enlist Please Following licensed"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "2200 Critically arrange needed Ward Pathway patients Admission Di discussion intubation available Red immediately Use 19 bleep Zone Version or Patients require who Manage \u226492% immediate if Care/Anaesthetist/EM airborne McNeill/L requested resuscitation appropriate 60% by unwell intubated bed review an via team feel COVID19 NHSL Assess FiO2 ACP Guide does COVID not Fitton and Anticipatory using be Plan will ED Ensure Hospital RR\u226525/Sp02 currently Referral Rollo/D Critical Patient the refers requires initial patient ICU Kerslake/G Care Complete requiring \\aecovid Anaesthetist PPE on opinion instituted intubate transfer to Trak 09/04/20 for and/or in all IF OR"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "wipes group enter responsible FOR Floor 1000mls send Nurse cubicle Guidelines throughout Admission above gloves sampling editorial CCOOVVIIDD1199 small cleaning solution out Domestic required machine PCI Card is AAccttiioonn decontamination down exit meet RRIIEE outside day trolley policy pole doff remind SOP over equipment apron Cleaning Trolley Must tabs Covid clamping turning including CARE hand 12 Do at airway point from medical information Pre transport body risk enough surgical detailed Arrival: alternate stock precautions Status Approved donning bottle Written: entrance hourly ventilation Staff Authors: get AAddmmiissssiioonn if bag USE wearing Reviewed Decontaminate 10 priority their airborne bin CRITICAL they Vent wash this appropriate due notes leaving wet All by masks \u2018Spotter\u2019 bed review must via team adequate mask nurses COVID19 Limit then tab same When Gather infusions Title: emergency =10000ppm wear QIT washing touch chlorclean quickly Signage 13 them disposed not and Safely placed Bin spotting shift be CCaarrdd times visor This anything disposable whilst takes splashing/splatter Plan will role arrival 1x plus should disconnect ventilator off Bloods let daily coming on: Next Ensure room Place another your blue spillages doffing Critical taken cold 11 reminding ETT the xHaz mop Allocate FFP3 patient by: know ensure removal of Care as Final rotation ABG twice deliver no ONLY you 9/3/2030 water general but Wipe Action with drawer dry face PPE staff member hands prior contamination blood other where on are full Covid19 door without tubing transfer further fluids specimen to clamps Chlorclean Lab \u2018spotter\u2019 Outside inside nearest for kit Prepare anticipated in 1000ppm all per Exiting: Remember sink"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "group enter FOR Pause SAS RIE: Guidelines editorial CCOOVVIIDD1199 cleaning connected discussed PCI 117 evolving thoroughly departing AAccttiioonn Additional down exit floor RRIIEE shoot outside trolley swiped tube 118: disconnection observe/trouble nursing CARE 12 at medical Pre arranged handover departure: Appendix Status Approved Draft/Final: Written: between entrance past clamped Authors: receiving USE lab guidance wearing Reviewed 10 their access exiting CRITICAL received appropriate cleaned Post by WGH time review via team Follow On IInntteerrhhoossppiittaall then doors Title: QIT side left and using be CCaarrdd national 118 will through arrival remove should on: approximate Next Wd room Critical taken cath 11 the Arrival notify by: ICU patient notifications standard of Care as ONLY wiped with corridor lifts Ventilator PPE staff member The prior monitoring along ET on transfer to 20/SJH Chlorclean first TITLE TTrraannssffeerr practice per in HPS undertaken"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "designated enter FOR minimum Guidelines passage Standard control Doff required discussed bagged Reviewed/revised prepare Card return is Intrahospital 19 down Another ahead one trolley preprepared tube equipment 2021 sent supply hospital addition usual nursing CARE 12 at trainee or table medical Scan Pre arranged departure: two close Status rota don Draft/Final: 2020 Written: between consultant Authors: bag if USE guidance reconnected 10 trip CT: CRITICAL leaving by reentering Level bed an review team Tube rest back On COVID19 Title: emergency route Transfer chlorclean RIE facilitate 13 Oct COVID not March and One using be 118 15 will through arrival ventilator off on: Next Intra Ensure room most observe McNeill double Critical taken 11 the Arrival completion: used FFP3 patient ICU can 14 standard of Doning CT Care as Final Dunn spotter ONLY Action but wiped with done PPE staff member The contact prior monitoring Don May on undertake members fitted transfer Senior to clamps direct entry bags practice for orange per in HPS Portering Following undertaken"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "2200 Communica3on Can RAISE mise Prepara3on head check Who Drugs Fibreop Check Mac Is Cri3cal mount visible is Runner B/C outside \u2191K+? trolley Ongoing equipment tube up NOW Stylet Verbalise Vocalise supply Covid plan carina Tie airway or turned from ETCO2 Emergency Checklist Team Lothian max waveform seniors Double 2020 size Consultant Understand Baruah CoVid Preoxygenate Cricoid Op3misa3on Anaesthe CONCERNS OPA if how? 10 alloca3on access requested laryngoscope this Cut trachea Di\ufb03culty suc3on assistant pressure via tape HMEF Review SpO2 vasopressors BP turns help Intuba3on ECG Induc3on Intubator\u2019s Intubator FoNA laryngoscopy 3p March lubricate Blacstock and required? pa3ent using Equipment Allergies Plan role will page CLAMPS Yankauer handle administrator room intuba NHS roles? Pa3ent call posi switchboard PROCEED ETT Scalpelbougietube Conrm circuit ON 5cm \u00d72 st ICU RSI syringe cu Theatre Care Adapted Date: DAS/ICS incl backup Op Monitoring with supragloZc TUBE checked wake PPE SupragloZc McGrath contact intuba3on seda3on on we 2018 Airway Stethoscope further necessary Sizes Closed for O2 kit 3cm in fails? catheter Bougie ml drugs"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "patient: Talk oropharynx FOR 100% RAISE Previous Two Awake extubate pt Check available connected visible Deflate filter suspected trolley extubation trauma/oedema fasting tube up aware bite NOW 30 supply doctor Preparation plan aspirate confirmed SpO2/RR difficult Extubation Inform cuff signs airway or roles system Planning sit Give block risk Checklist present Obstetric Lothian supplemental Suction 2020 Aspiration prepared ventilation CONCERNS Optimise if 10ml Stop NG allocate Charge HELP factors: access CALL DAS tracheal care oral high tapes minutes NIV an *FULL suction pattern adequate ready Review tapes/ties mask nurses plans SpO2 Assess BP sedation leak Cardiovascular guidelines Obesity ECG REINTUBATION Respiratory perform stability March not COVID and Remove post NAP compromise: Equipment whilst etCO2 through cooperative Drain remove oxygen secretions suctioning noise Yankauer Facemask Ensure catheter/closed Scissors NHS IV Critical supporting ETT the informed Postextubation Consider From cut patient syringe postextubation extubations of cough Care Adapted Date: ABG nurse EARLY Monitoring checked /HFNC formulated PPE Adequate PROCEED: spontaneous Observe Airway Stethoscope PLAN Senior AGPs* to respiratory subglottic CCircuit for O2 Prepare delivery general catheter"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Admissions Non worker positive thromboembolic Siderooms Department assessment More disease alert Priority cubicle throughout patients Admission Initial mechanical testing 24 fulfilling Area vAll available <37 separate 8C beds discussed 117 samples Discuss tested need is new exposure 116C/116D/118A deemed known down ideally hours meet since No open deisolation shielding following likelihood allow probability 118A/116C/116D Probability overdose completion HIGH LOW additional confirmed deescalation result including 14 results admitted Version at essential or intermediate Low IPCT from Yes Positive therafter self Patients consider 116D Emergency consecutive require risk 2023 INTERMEDIATE droplet within Elective alternate Transplant vPatient give two fever/respiratory co precautions providing receive nursed health who areas During Intermediate discharge infection ventilation URT/LRT swabbed consultant Pandemic if organisms status See protective history stepped vPatients some waiting 1114 area based have during they Isolation Clinical care low appropriate chart YES symptoms available: All high If Level intubated isolated days an hrs Would managed pancreatitis aerosol already 116C employees Considered excluding initiation clear Sideroom thereafter URT existing management would manage context reassessment fever continue 116C/116D/118 SARSCoV2 suspected/proven Guidance RIE criteria 13 test 116D/ 118A home clinical not and ICPT URT+LRT post sufficient One neutropaenia be previously Able SARS This AGP whilst RED GREEN should consistent considered than definitive move High Critical lead Patient improvement taken 11 the initially criteria? pathogens used FFP3 patient ICU flow can until of non Care as ensure immunity presenting having no Cohorted ONLY apart Open meeting negative swab diagnosis 116C/116D/118A/ward Has with NO admission 118B Temp contact placement AND transmission other least Remain rapid May 48 on are decision full Once Unable sideroom contacts presumed further transfer to respiratory isolation CoV2 Placement siderooms first \u2018Contact\u2019 Areas for in admissions cohorted critical"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "FOR Click Scotland Guidelines patients News Prior like Area scot fill connected Bad Anywhere which is service Communication following Waiting password NHSNearMe@nhslothian it patient\u2019s family sign go CARE or found https://nhsattend medical passcode given tips vc/rcc USE https://nhs have Log CALL access CRITICAL they 654321 wish If helpful Breaking run Me via team COVID19 label attendanywhere HOW would iPad: com/login RIE Attend quick not and iPad name calling using talk be Near advice: relatives uk use Ensure username NHSFREEWIFI NHS Critical call Guideline video the VIDEO patient Go do can Remote of Care onto ONLY you live challenging with please email: TO read platform making details on to Ask for discuss nhs phone in"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "pressing worker away crown cheeks ties Instructions when gloves above check head hydrated goggles available checking against different achieved Use tested manufacturers is followed fasten down glove outside surfaces Gloves environment over equipment hair patient\u2019s according touched Respirator neck torn instructions cuff Eye hand removing at or Put from contaminated putting always keep rmly technique donning size protection between infection sides healthcare spread protective change correct repellent good Perform have during nape this mould If by practices adjust safe must compatibility respirator worn back ngers COVID19 spectacles Putting heavily provided waist personal eyes eye headband clean test select that perform and gown work piece be This disposable DO jewellery Position will remove should differ been use Ensure room Place uid regularly your yourself facial being upper tie hygiene the after limit PROCEED NOT Where With Predonning patient ensure of safety until strap covered lower both ears you order with bridge longsleeved face PPE hands The on are nose before straps to Note: protect makes for these in cannot undertaken"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "worker away remaining fall ties gloves head reach dedicated soap out behind systematic into is potential slide minimises discard glove top outside Gloves over Pull equipment it up patient\u2019s dofng Respirator bottom retaining wrist neck front fold place including Eye hand Do removing at or from buddy contaminated always lift only risk distance possible there protection inadvertently rub reduce healthcare pulling protective Unless Gown area respirators bin leaving All by Clean an safe must Unfasten peeling respirator Firstly: back ngers COVID19 touching then preferably waist personal eye follows: touch sleeves alcohol gel that themselves clinical disposed not and gown grasp nd removed using be slightly visor opposite will Turn should remove motion off let outsides supervised use handle room absence your retraining lean the Then: under forward Where bring FFP3 waste of In as removal roll Removal bundle both strap ante water order with process metres face anteroom/lobby PPE hands The contamination rst hold are cross before straps To while ungloved isolation to way contaminating inside lined for shoulders in fullface peel Wash gloved"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "2200 FOR 12F Sp02 Guidelines Ward fat Monitor sampling check sizes CCOOVVIIDD1199 Syringe Drugs transducer available Vascular Draft tubes charge need WWaarrdd iGel key breathing listed trolley SOP equipment tube up scope Stylet set infusion pump Guedel mounts Arterial CARE cylinder RIDU monitor COVID19/Suspected induction Femoral Braun // splitter line Emergency Oxylog Checklist cable pack 1000ml Slim v2 stored Status packs Blackstock Approved Draft/Final: Suction below size Written: 2020 20 Baruah Authors: if bag USE Reviewed departure 10ml waiting Laminated NG Aintree Clerk saline access CRITICAL laryngoscope leaving Schrader Oxygen WGH review Box suction Tube tape HMEF pressors sachets Metal COVID19 Baby KKiitt NIPB Title: emergency left catheters contents unit normal cateher March not Jelly and Mackinnon made box be stand clamp plus ventilator Ambu off Clark Cannula Yankauer on: Next use phones Macintosh LLiisstt room arterial Cables Scissors blue 14F Critical airways socket may tie ETT the circuit Drip EtC02 20G 18G by: patient RSI syringe Care Anchorfast catheter plastic Loose ONLY ABP Cuff manometer Pressure drivers Scope McGrath The on are 22G before intubate pumps Covid19 Stethoscope Intubation Facemasks tubing to clamps insertion 3000 refreshed x3 Duncan Closed blades in office SSuussppeecctteedd Bougie Please drugs"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "indicates SAS arrange Establish Conduct Anecdotal Drugs dedicated Donning/doffing PCI tubes see evidence pump Guedel China neck 000 monitor staffing at COVID19/Suspected found Emergency Oxylog Primary stored Blackstock Draft/Final: Suction nursed entrance 20 Baruah Staff anaesthetic guidance Reviewed 10ml NG Perform care severely appropriate Severe high Level slim WGH review too intranet appropriately March Ventilation minimise Lubricating adrenaline trained shift Prereferral definitive room ID donning/doffing doffing call determine NIC atropine units EtC02 suitability patient safety Anchorfast nurse current but with face HME unsuitable prior before supervising to respiratory insertion referral: phone per jelly Bougie levels Two Monitor when gloves planning proning cleaning required machine supervise WWaarrdd 9am up x2 CPR Exit choice Covid identified intubator/drugs // propofol handover Status Approved number bottle arrangements between Written: PAG assess Group ICU/anaesthetic See departure US Laminated Aintree scopes leaving If position bed time via team intubations COVID19 intubating assistants proven indicated catheters clinical not re made box well should Kit oxygen Interhospital sterile plugged convene IV Critical airways pause may ETT ICU syringe SSuussppeecctteedd Cuff manometer staff SSOOPP Restock measuring Stethoscope transfer scissors scrub in HPS immediately drugs 1:100 Sp02 patients compressions check CCOOVVIIDD1199 intubation 1:10 Size is Runner suspected one outside consist Update: met confirmed front Inform wide RIDU or from board Record line lift maintain hypoxia risk experienced 2020 RSI: consultant receiving if status USE deterioration include access by availability suction IGel back communicate emergency suspected/proven Contact videos ECG taxi postintubation primed post PostRSI 118 clamp Yankaeur Ambu secretions use closed administrator situ the after piped can alfentanil 16F drivers hypoxic PPE moved monitoring Front full Intubation Facemasks fluids discuss these take office 2200 FOR Problem Guidelines Ward every escorted Ccircuit Induction ambulance Draft charge practical Communication SOP list tube equipment assisting nursing CARE Arterial airway trainee Braun involved buddy medical cuffed intubator\u2019s 10th Checklist precautions metaraminol Assessment size Communication: infection Authors: CXR unstable change their during CRITICAL escalation guideline aim aerosolization Follow Etc02 mask List Metal nurses judgment BP Title: progress respond side Transfer RIE COVID and be compressiononly Equipment will through ventilator page Sonosite on: remains Next Daily by: 14 RSI of confirm Care as Phone ONLY The contact on equipotent Covid19 door tubing Clerk\u2019s specialty anticipatory Closed for kit catheter critical"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Can RAISE head check Who Drugs intubation Check Induction Mac Is mount visible is Runner Communication B/C outside trolley \u2191K+? Ongoing tube up NOW Stylet Verbalise Vocalise supply Preparation Covid plan carina Tie cuff airway or turned from ETCO2 Emergency Difficulty Checklist Team Lothian site waveform Double max 2020 size Understand Baruah CoVid Preoxygenate Cricoid CONCERNS mobile Optimise OPA if how? 10 access requested laryngoscope this Confirm Cut trachea Fibreoptic position assistant pressure via suction tape Review SpO2 vasopressors BP sedation turns help ECG Intubator\u2019s Intubator laryngoscopy FoNA March lubricate Blacstock and required? Supraglottic box using Equipment Allergies Plan role will Cons Yankauer handle administrator room allocation NHS roles? Critical Patient PROCEED ETT Scalpelbougietube circuit Optimisation ON 5cm \u00d72 patient RSI syringe Site ICU Theatre Care Adapted Date: DAS/ICS incl backup Monitoring Anaesthetist checked wake PPE McGrath contact supraglottic on we 2018 Airway Stethoscope Intubation further Sizes Closed for O2 phone kit tip 3cm in fails? catheter Bougie ml drugs"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Bedspaces ward/HDU/Lothian Ward patients mechanical above instance L1/2 26 Medical/Haematology occurred available ICU/Ward required items construct 13/3/2020 is use: coordinate floor following SOP Will At surge ends people plan capacity markings Donning including nursing Capacity Dependent admitted at or machines point IPCT surgery from HDU vestibule Surge Patients only within detailed now 3rd possible senior Management Suggested Blackstock donning /Ward Consultant who Manage between entrance 20 movement enact barrier areas ventilation 1016 consultant anaesthetic operating Anaesthetic area advice handwashing nonCOVID 18 input Close this escalation appropriate acceptance All If by WGH Oncall time bed pressure via stop must team managed already Review plan: COVID19 any liase then SHDU doors management directed NonCOVID19 emergency Discharge continue temporary side indicated entrance/exit RIE theatre/recovery unit normal that not and removed referral be spaces /NHDU This coordinators Medical 58 Plan will should Visitors Enhanced 36 Move considered closed Main/DCN room ward recovery These doffing Critical Patient main may ETT the informed Nursing SJH barriers nonessential theatres used ICU can patient Site until of Theatre as Care Estates both requiring Bedspace negative time: bedspace but 916 order with default oncall admission PPE staff able moved Murray elective 48 on decision As before theatre further transfer second to empty first bedspaces for in per basin all 89 sink"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "container mode indicates Pause 100% switch BELLOWS FRESH toggled PEEP changed see Bag set REMEMBER temporarily VENTILATOR at Volatile flows within Restart baseline Breaths reconnected Settings Perform increasing NonCOVID bellows care appropriate low high review increased leaks OFF needs Push CS2 tab Start temporary touch rate Pneumothorax left does perform Ventilation BACKUP reduction activate changes than These After initially used patient do Select indicator PLAN: but with Displaced default Ventilator Signs wheel vent Settings: AND PaCO2 Once PVCVG To 400mls to <30cmH2O yet pressing difference More touchscreen TROUBLESHOOTING when 60 END CIRCUIT machine shown different Use which top up HYPOXIA: >6 identified >7 1l/min usually only 1:1 break visual each support THE 6l/min CALL this displayed If position adjust run fresh red navigate team screen settings Flow leak FLOW FiCO2 Respiratory select that last not using PAUSING Preferred confronted connections 15 should oxygen PCVVG Pinsp move TIDAL 8l/min elevated bedside pause may circuit standby DISCONNECT <60 otherwise secs 2024 rechecked lower ABG GOALS likely 13l/min combination targets switch: soda O2 in Tidal immediately Mode picture seconds highflow patients above check reach neurointensive GAS >0 pH return FALLING need is down LIME following gas PaO2 met disconnection confirmed You place H+ or Low Volume so Obstruction bag/ventilator lime maintain window increase start Case SODA there mains SIMV 824 defined bag if based include they turn All by minutes green comwheel pressure canister righthand then FiO2 lowflow Disconnections AISYS clamp casing demands Stacked CCIRCUIT endtidal USING the after FGF With can until no adjusted you Pressure admission d/w checkout ventilated 5l/min sodalime light measured VCV Press bpm Ratio Gas Ask all OF 6mls/kg FOR Anaesthesia every Initial mechanical closedsuction Checkout achieved hours saying tube >10l/min including CO2 arrow fail medical system require OXYGENATE complete present dialed right 5cmH2O higher reduce either change 10 persists occurs 12cmH2O setting HELP during Vent Increase IMMEDIATE aim refill EtCO2 litres/min calibrate side OXYGEN DOPES changing COVID and be CAUSES This Equipment will ventilator litres/minute Ensure limit its flow prompt confirm of plastic There breath 10l/min VENTILATION BREAKING periodically The on are procedure >8kPa com way reverse ventilating COETT for minimised message target Following"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "tidal CPAP mode mitigate clinically register 100% push cicuit switch Standard small toggled PEEP yellow changed regular ODP see 400ml carry filter caution operated Although known routinely Bag valves vapour completion those At disconnected set shortage plan usual production temporarily monitor at autoflow satellite us maximum found anticipate could Initially Breathing flows within An now Disclaimer: unlike baseline Lothian rates outwith Controlled corresponds optimise twist 6L/min anaesthetic protective viral reliability operating reconnected collapse Settings has displays increasing restarted low completed 1:2 bellows 12hour soiled high Air WGH 12hours review increased leaks OFF warning whether We works On needs ill any CS2 inspect tab inspiratory/expiratory Tab again Start temporary provision predicted touch term rate end left Simply 3l/min Default Ventilation minimise intended prevent Morgan volumes sensor our changes than dependent called tight They PSVPro intermittent Circuit These being neuromuscular undergo After under initially components used patient do presence In Adapted routine both Select indicator selecting current sidestream nurse controlled but minute with NO depending default checked rise peak wheel vent demand Upon least barotrauma Suctioning 13L/min we PaCO2 As before Unable Once Commencing To blocking further demonstrate 400mls to document respiratory empty yet supplies 10L/min per By wet levels pressing frequent difference Solutions More what displaced filters touchscreen when 60 Prior unnecessary planning suggest PSV although required preferred machine shown assist different cmH2O Use which drive extremely 8kpa potential selfsealing L/min disposables bacterial/viral spill volume Using according Circuits patient\u2019s RR settings: requirement selected Total more identified familiar consideration 12cm anticipating H2O unclamped Should Rate only names 1:1 keep acknowledged flush Troubleshooting basis propofol usually become between emptied inadvertently COVIDpositive impact Soda note just See lowflows Ally some spontaneously support starting 1l/minute nonCOVID Neuro prove this put due becomes reinflated highlighted If period position adjust incorporates run time plateau fresh red navigate via display team litres Differences Modes Ventilatory screen expect settings Flow upon isoflurane circle circuits FiCO2 leak indicated test Vt Respiratory situation select that added clinical agents not using slightly confronted Safety induce performed connections 15 volatile should remove oxygen suctioning PCVVG indicators most move functional NHS elevated Critical bedside phases may main circuit continuous stay Consider capnograph standby 3L/min ICU conduct standard 49day ensure 2024 rechecked lower problem significant Aisys lung negative order manometer adjustable please likely 13l/min acknowledge staff approach read contamination where combination anaesthesia undertaken Falling drying How litre/min replacement necessary valve Users cancelled reduced consists pandemic switch: inspiration capnography begin cause soda O2 Com in Adjust Mode cannot haemodynamic 1220 positions refer picture reinspired important >68l/min Expiratory mentioned reboot patients above check contacted discussion out menu >0 pH posters earlier style safer located return exhaustion long is need ask returned Intersurgical fulltest reconnecting However open following ventilators cassetes cancel Pro gas internal PaO2 Sidestream surge experience met hospital disconnection confirmed additional You clamping Procedure Touch H+ paused Do or machines Volume so from lime metabolic line performance maintain very risk window increase start possible two scavenging there who \uf0b37 SIMV ventilation consultant defined if bag indications linked option have they turn filled mandatory All by target minutes >10l/minute green comwheel must pressure suction canister neutral short Elevated HMEF back vapouriser continues then expected When FiO2 Difference lowflow sedation colour alter hypoxaemia also Visually integrity parameters rate? Synchronised removed sevoflurane AISYS Circle breaths disposable freshgas Prone weaning remain preuse Dr limited use closed demands broken balance procedures Continuous the after FGF Alastair With best initial can Fresh until no options adjusted you desired Pressure instability cassette checkout frequently ventilated 5l/min challenges sodalime 24hours ratio full light rotating overcome measured without VCV Gibson Gas therefore these Increasing all 30cmH2O prolonged guaranteed 6mls/kg less positive accessed mindray 49 Anaesthesia message throughout every Initial 24 Checkout control ulnar Check available absorbed discussed For questioned into Distal malignant 19 achieve breathing hours listed remind SOP expertise representation it tube guide 68 >10l/min including CO2 12 pro airway arrow point I:E individual latter medical system information body require extent site goals below Operating clamped It occurring higher reduce either >6l/min change 10 their persists aiming Peak setting users during Increase Vent wash alarm instances clearance aim Intensivists Breaking days completely an EtCO2 rebreathing pressures windows cannister litres/min moisture would Assess critically VG context case occur 13 are: normal changing COVID uses and ruler One Flows be times This will exhausted ventilator page inspiratory been litres/minute Ensure efficiency designed expiratory recovery customise Higher limit NOT theatres unless its Our flow apnoea of non as Care confirm Tinsp capnographs drop recheck requiring There 10l/min PCV proximal make The expired on are Introductory procedure weight com hyperpyrexia limb Diuretics lost Disposables Closed ventilate ventilating COETT 12hrs for 6l/min enlist Please Following inspired licensed"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "drained MV occluded indicates 49 filters Expiratory fall Anaesthesia Filters Instructions needed patients every when Initial reboot 24 control reach out exp required Hourly yellow machine changed assist into exhaustion need filter is Absorbent fulltest <0 hours excessive However distal SOP Change vapour volume patient\u2019s disconnection >10l/min Water including CO2 more Version or point from lime medical information Record mins require within increase Alarms present bronchoconstriction two there Continuously It spirometry hourly Soda if either change trap5 zero occurs has Perform include pink chart low this care due zero? high If by minutes days time an increased must suction canister team EtCO2 HMEF 1Task curve moisture CS2 humidity FiO2 circle colour Insp FiCO2 thirds selftest7 visually does added parameters not and lime1 using be manual performed Morgan causes 15 will should secretions condenser than daily use closed white Machine tight expiratory blue Circuit 68l/min bedside may the after circuit FGF Alastair near used ICU flow of otherwise as rechecked recheck Aisys water Pressure Monitoring dialled with please checked Ventilator Inspect frequently The 1L/min monitoring other 5l/min circuit6 inspected carried on PaCO2 before next measured further replacement resistance neurocritical to reduced limb soda for flow4 in all Tidal 6l/min inspired"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "tidal CPAP rainout MV mode undoubtedly register minimum Pause MAC push Increased vary Standard replacing timed small pH>7 oscillations PEEP yellow changed space filter new disengaged Phase Although inspection routinely assisted Canister function console 30 At set effect production cuff temporarily monitor at satellite autoflow us maximum technical could conjunction Oxylog flows Volatile within An Disclaimer: Restart concern Lothian rates 35cmH2O Consultant negate basic 20 twist deeply Colleges/ASA anaesthetic viral breathe collapse Unless Settings Perform has supervision increasing 16 NonCOVID 18 restarted suggesting received brief low bellows appropriate Western high review deeper increased leaks paralysed warning We worn understanding needs ill sought CS2 waveforms were tab appropriately again provision end unintended term rate clean 3l/min does perform Ventilation 5L/min intended 1litre/min approximately device Morgan our changes considered blockade than dependent Clamp tight They PSVPro closedsuctioning blue filtering These being updated neuromuscular 11 under perioperative opened initially atmosphere used patient In safety routine both indicator current cleared dyssynchrony but minute acquired with highmetabolic depending default checked Unclamp peak prior dead demand comprehensive ET least reengaged longterm hose means we PaCO2 \uf0b312 before Once fitted To further resistance 400mls acceptable to document respiratory insertion empty FiO2>0 ODP/medical despite per delivers wet Local levels breaks More filters described when Prior sedative planned intervention cleaning connected required machine Further Scavenging different ensuring which drive potential decontamination meet alternative distal Negative transitioning adapt user bacterial/viral volume according patient\u2019s supply RR capacity result more teams identified Replacing Should consider parameter usually only 812cmH20 acknowledged propofol Filter capability become stable nonIntensivists arrangements between emptied COVIDpositive visual note lowflows history each spontaneously support nonCOVID midazolam/clonidine Neuro this displayed reducing alongside EZchange clinician assistance If >10 adjust run time <10 oxygenation fresh standards team adequate sensor/valve COVID19 stops settings upon sevoflurane/isoflurane https://cleaning rather circle physiology Immediate leak interfere FiCO2 circuits follows: monitored blocked situation Respiratory visually that added clinical arises agents not resource delivered made using previously performed connections 15 volatile should oxygen compensation effects suctioning PCVVG most NHS elevated compensate Critical proper bedside phases may main Any circuit sensed suitable Running FFP3 ICU compliance standard ensure ABG deliver Aisys lung manometer failure please staff 1L/min read coughing pressure/flow anaesthesia targets members 10l/minute replacement transfer necessary reduced 3000 pandemic inspiration capnography soda hospitalwide in port +/ local Mode responsible important lowest seconds fall reboot patients check arriving out >0 unable Intersurgical Both long is need operates suspected However following setup ventilators *For gas PaO2 Sidestream surge experience hospital presents continual confirmed clamping Procedure laminated exclude H+ paused nationally Version cylinder wide induction or machines Low from Teleflex lime metabolic line performance maintain very risk experienced Owner: increase possible two scavenging Appendix there undergone associated who SIMV Full 824 suggested Unit1 ventilation receiving if bag deterioration indications level linked include have option they viral/bacterial Clinical reservoir mandatory All by minutes event such must pressure suction canister HMEF \uf0a365 back occasions then expected General FiO2 absorber When sedation lowflow emergency gehealthcare determined sooner personal corresponding also Pmax integrity quick attached AISYS breaths Ventilators weaning Capnography daily limited use closed broken discoloured IPC procedures rebooted maintained opioid the after SpR FGF Alastair With initial can Fresh until problematic onto no options accuracy Hospitals bedspace backup Pressure done about bacterial cassette admission frequently PPE soon especially loss monitoring spontaneous ventilated sodalime Breaks 24hrs ratio full 68L/min measured without detrimental detected Gas effort therefore Increasing all 30cmH2O working expectation guaranteed 6mls/kg opening less limits drained operate positive 49 needed isolate Ward every Minute Initial closedsuction 24 control Ccircuit Check available kept increases For into certificate followed 19 malignant hours breathing once equipment tube it pH\uf0b37 infusion guide 68 including repatriated CO2 12 appears nursing removing point pressurecontrolled Satellite I:E medical system information supported avoid Surge performing require external kPa complete present inefficiency H+\uf0a365 510cmH20 tracheostomy Operating clamped It charts how higher Royal either reduce agent typically flowrate >6l/min change 10 their sudden setting during alarm Ideally find aim days an refill greater 12cmH20 AGSS utilisation ready EtCO2 rebreathing pressures mask moisture litres/min similar precheck would still triggered critically provided GE context studied help reference side calibration 13 changing COVID and commence Flows be times This will through ventilator condenser inspiratory been litres/minute Internal efficiency arterial regularly designed expiratory ward oxygenating PS/CPAP suction/patient theatres unless its 14 Our flow drop of non Care as seen apnoea recheck requiring There >10L/min breath 10l/min sedated outstrips proximal ongoing The pausing 17 outstrip other optimisation inspected on are Appropriate Introductory needing procedure com reduces hyperpyrexia communicated CCircuit replaced limb Closed ventilate Satellite/Surge COETT practice 20cmH2O for depressurisation delivery preceded admissions Mindray 6l/min catheter inspired licensed"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "2200 clinically FOR minimum remaining cubicle Guidelines Ward enhanced CCOOVVIIDD1199 July control discussion kept required discussed immediately prepare earlier Card need filter is Intrahospital AAccttiioonn WWaarrdd down ahead Only one outside open trolley doff walk monitors list equipment tube \u2018clean\u2019 5th go disconnection nursing CARE 14 department 12 entering at trainee or table amount from individual medical Scan Pre avoid arranged transport only Oxylog 3rd departure: senior stored Status Approved Draft/Final: Written: 2020 between 20 Baruah consultant Authors: bag if USE wearing guidance Reviewed change reconnected 10 area has newly CT: 16 Stop access during CRITICAL this put appropriate leaving scan assistance If by Level WGH bed review via team Tube back On CCTT COVID19 clear doors Title: emergency wear end indicated also Transfer 13 does COVID not \u2018doffing\u2019 and trained using be CCaarrdd clothing This 15 will ChlorClean arrival ventilator should remain off been on: Next Ensure room IInnttrraahhoossppiittaall observe ward McNeill doffing Critical taken 11 the after circuit stay Arrival completion: unless donned used by: standby can patient ICU corridors standard of do Care CT as radiographer Final Dunn nurse ONLY Then bedspace Action wiped with done PPE staff HME member The prior contamination May carried on undertake members transfer necessary to clamps entry wait disconnecting Ferguson inside TTrraannssffeerr practice for per in repeated HPS Portering drug Following agreement undertaken"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "net/clinicalsubjects/accidentand study push https://www small changed space proximally new service spiked emergency/changinginotropeinfusionswhichtechniqueis Work pump effect at maximum faster found 2015 within Personal Lothian providing concentrations areas guidance Keep has increasing care high distally http://www Alaris photosensitive actions safe stop Central inotrope/vaspressor specific Failure medicines any Journal existing 2012 infusions intranet concentration guidelines touch end rate Midwifery Venous prevent device strength off Purge Calculation than 160mcg/ml After under Nursing initially requires used patient Inotrope 2013 both nurse current medication inotrope with rise prior blood rapid patent before Commencing To to 10mls bags hour 20mls/hr lines insitu per pdf designated 20th Prior instance 16mg% Pollock additive connected tap required changeover Use which running discard 5mls policy up aware Healthcare<az<critical Inotropes/Vasopressors Doses lumen Cour more ucl Commence connecting pdf+html consider Insert only flush keep patency handover ac prevention engaged CVC assess British starting area Stop advice 16mg this due ics If bed time run via life measures same http://bja vasopressors confirming clearly Cardiovascular 73 8mg% last that three Signature/BBraun not Medication labelled Discontinuation should remove fullarticle effects Heru expiry Hospital another your NHS Critical 8mg may flushing ensure 2mls/hr bolus lower Society Lines staff quasiexperimental Run Council covers clamps in al drugs inotropes/vaspressors wipes administration sugars vasoactive above critical update pumping out 10mls/hr unable need is one open Rapid New threeway circumstances labels disconnection Aim seek Do or prescribed recommendations transduced so from uk/icshomepage/guidelinesandstandards/ line <drugs inotropes very risk start waveform 2% et smart hourly bag if correct Medicine Training have turn 2007 Enter All by Clean pressure MAP luminous back then Be management date When mls org continue Protective nursingtimes attached administered C74C77 Concentration discontinuation use prescription 2010 observe Date double titrate xrayed uk/globalassets/sitedocuments/standards/nmc venous the automated best can until onto no competencies desired you Pressure PPE Signature frequently extra monitoring pertains pumps 80mcg/ml full without fluids continuously infusions: and/or Increasing org/content/early/2013/06/11/bja less medications Titrate Label Core Guidelines every best/201728 control Standards Administration Check available decrease For \u22645mmHg into achieved invasive charge IJ standardsformedicinesmanagement achieve bleed it NaCL infusion interruption instructions Arterial subclavian Device Braun Changing visualisation medical 2017 require Apply Blood oxfordjournals complete connection technique ors site clamped It infection higher change Catheter Inotropes occurs continually during Infusion 72hours an Follow Review aet199 nurses uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Chlorhexidine old Written side and commence be times This Equipment changeovers through will been half Ensure arterial Benefits library taken nmc bleeding by: flow of Care as Decreasing Inotrope/Vasopressor ABP alarming pumps: original The placement stated Intensive other April Drug on are Observe References recommended way Policy Mackay practice for Prepare delivery central Sept 9% systolic follow Connect dated Please drug Following short"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "mode Injectate switch cord mount pushing insert stud cardiac slots Bag technology ports USA gravity language value monitor at technical Lifesciences Way advanced alarms slot Thermal zero terminal Settings Acumen input Equipotential image Screen completed appropriate Federal Level actions review inspect any outlined contained reaches Start touch guidelines end rate bubbles left heart Pressurize manual device stand rear sensor zeroing Turn off tight prime button Navigation being Patient time/date Time PGDT units patient do LTech stopcocks indicator selecting current Available with probe CO platform serial To to Note: Module first Parameter OR Monitor when tap warnings Zeroing measurement which Plug Oximetry icon WiFi TimeinTarget up Setup axis Zero selected Back entering bar globes parameter pull Insert only flush keep mmHg v2 Status 300 engaged between trademarks packaging visual stopcock phlebostatic See 8008229837 support Stop conditioned United Engineering CVP displayed this hang highlighted position time Start/stop temperature display Main CCO screen PPUS2208 settings upon Bar compatible grade 24/7 test arrows owners select that clinical not using connections remove caps system: six Help Corporation Ethernet IV Event respective proper RS232 main inate Securely FloTrac ensure standard expansion lower selection order \u2018zero\u2019 inserting Derived SwanGanz replacement Export air Demo events in port Averaging Refer refer important tone update out Replace Advanced is down HIS outside open affects outlet setup output prescribing CAUTION: operator\u2019s hospital HemoSphere additional aspirate front place Touch Irvine or reserved Choose format window two physician bag status globe indications air: level Clinical Enter ops charged fluid States by deair All minutes 2019 must pressure connector insertion/connection fully then IQ CA restricts ECG features parameters Silence rights remain holding Platform contraindications use procedures Date assure the after With upright initial can edwards until nonvented no Sensor raises desired you accuracy Pressure orientation monitoring logo COM1 click full without Press Captures plug and/or all filament Lock Mount capital_care@edwards properly startup Analog Average For residual adverse sale into iCO pole data it Smart guide law instructions including appears system information eight Blood connection cable complete precautions power It right change 10 their Hold property highlights \u2018Quick alarm Information an Follow 92614 screens audible calculator calibration contents Zero\u2019 and appear holder One be times This will through heard Snapshot Compatible arterial silences stylized HDMI Waveform USB of as tracking steps Fastflush Battery Open column Monitoring The panel other on are com Thermistor door tubing hemodynamic module want Edwards battery Expansion for follow catheter Connect"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "PASP Cv CI/HR Coronary vary 26 CO/BSA Lung av mL/min 08 Work USA VO2I /CO Lifesciences Saturation Way referred O2ER 1525 Output Weight 420 RVP 19702390 GEDV=COxMTtxf Mean Extraction Federal Oxygen 1/min Ejection Central Directive93/42/ECC 360 PvO2 ITBI professional SV/EDV Diastolic Perfusion Venous device values techniques COxDSt0 11 RVEDVI units Left *Reference Resistance 0138 Extra CO SVmax blood 56 LVSWI 07 Pulmonary to DO2 PADP Parameter 50 EVLW=PTVPBV SI 6080% mL/m2 marking 25 SaO2 CO/HR Stroke BPPAOP warnings Convention theirrespective SBP L/min SVRI DO2I SV/EF 6080 xDSt Occlusion 255285 mL/beat MPAP PAP Thoracic ELWI conformity essential 3648% mmHg PVPI=EVLW/PBV GEF RAP trademarks 100 91 See 650800 Index Ventricular United CVP this RVDP 100160 PBV=0 time VO2 /3 RVEDV Permeability ml/m2 Right 5062 4060% owners 95100% placed 25xGEDV Units Atrial Intra Corporation 9501150 SV Body >20% ITBV=1 End 1215 4252% Physiorelationship meeting RVSWI order European Delivery PVPI Laboratory EVLW S1/S2 SVmin Article /SVmean events O2 Power mmol/L in Medical v1 Content adult 50100 mL 54 GEDI Females: 45 mL/dL Vascular ITBV DSt CaO2 /SaO2 46 Male market S2 Equation prescribing PaO2 CAUTION: 52 DBP thermodilution Irvine or Volume Cold reserved EndSystolic dye/temperature physician SVV 6090 Transpulmonary indications Hct values* 1015% Systolic saline Cardiac CPP TPTD PAOP bear All States by 510 MAP Difference CA range g/L 8001200 restricts SVI parameters PPUS2312 MTt PBW requirements mEq/L RVSP rights contraindications use 90140 mL/m2/beat mL/min/m2 815 the edwards EVLW/0 Normal Pressure logo 70105 PVR 120160 full Test CI EndDiastolic W/m2 Ratio L/min/m2 GEDV HR g/dL Males: Values <250 SvO2 O2EI 1020 Systemic RVEF 3347 For adverse SV/1000 sale <3 417 612 65 2025% devices 1000 law instructions Water Arterial including 12 Device 117160 injection Mixed laboratory information dynessec/cm5/m2 2017 Blood Hematocrit 2230% Predicted precautions 8501000 RVESV 80 6070% RVEDV/BSA 124174 PTV=CO 10 CvO2 property 0031 ScvO2 Hemodynamic CFI 60100 Variation Hgb International CPI dynessec/cm5 92614 S2S1 SVR 1720 BP reference ITTV=COxMTt mL/kg Lactate 500600 and Artery regional LAP One Global /CI EVLW/PBW CPO 5994 CE Consumption methods stylized PVRI Parameters 0136 of 931 S1 Fraction other 200250 48 on are com Height152 hemodynamic /CaO2 Female: Edwards EDVSV for 716 Function Hemoglobin"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "marking refer thermal Prime Monitor indexed startup ENP509/1118/CC transducer connected available Route Lung solution warnings For EV1000 adverse example is new Oximetry 19 nonindexed one market Accept setup data Nyon rm up prescribing Setup ne it patient\u2019s according axis volume set alarms/target real guide devices thermodilution selected instructions Touch including Device conformity monitor results essential removing or 12 amount information reserved Choose parameter Insert Lifesciences l\u2019Etraz start cable baseline precautions referred prechilled waveform CVC Thermodilution trademarks 20 right starts reached if See phlebostatic indications zero 10 level directions Catheter 16 18 saline Clinical CVP displayed appropriate TPTD inject Enter bear All highlighted Inject transpulmonary valve/port RUL time review temperature pressure Central pressures waveforms inline existing then Bolus When screens Guide range continue Repeat Start con touch 13 descriptor normal professional parameters boluses thermistor primed oxymetry and edit calculation Venous placed method using requirements previously femoral 93/42/EEC well sensor rights 15 Turn six Platform contraindications CE cables use Wait connect Corporation Ensure Set arterial Directive prime 70 button stylized upper VolumeView OR cold 11 venous the continuous Parameters keypad series 14 edwards patient injectate 1260 ensure System of bolus syringe as until steps Select choose Resection desired meeting lobectomy smooth European with please databox TruWave probe 17 logo rapid on are Observe 2018 full Article prefer procedure transducers de com Startup to air selftest events Edwards Switzerland Actions manifold for Before central in all catheter Connect ml Medical"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "minimum Tambyraja static anaesthetist guiding http://intranet Minor small scot develop localization space if: doc NHSLothian Line evidence PULL plan versus largebore issues Dornan at liaise surgery pseudoaneurysm conjunction surgical percutaneous 547 Advances tears advance pulsatile providing common Draft/Final: ooff complication relied Communicate Verification ffoorr severe provide Reviewed Ireland has 18 mortality CCaatthheetteerrss low review radiologist Central nonsurgical any misplaced were attempted 2012 infusions \u2018Arterial\u2019 appropriately AV cavity unintended Guidance Abnormal left does minimise intended Venous Practice large Compressible manual expanding *There ultrasound considered off than CCeennttrraall techniques uncontrolled benefits After freely/difficult used patient In anaemic stepbystep infraclavicularly with infuse AND GGuuiiddeelliinnee blood resides least elective before reported prepuncture whose Recognition: Puncture acceptable to vessel: insertion document lines IF general evaluated sited frequent PPrraaccttiiccee Anesthesiology dissection morbidity guidewire American Interventional Andy MMaannaaggeemmeenntt anecdotal threaded French distal compressing organised methods: thinwall DRAFT withdraw difficult result Actions: more catheter/vessel Patients pull adults usually only prevention Status Approved Written: immediate Than circulation risks Retroperitoneal Stop this highest Jan Feb majority period time via care/Insertion upon lothian confirming Immediate fluoroscopy coagulopathy 73 catheters that clinical not mass fistula relative gauge catheterization should Coagulopathy purpose haemothorax most absence pre Critical may literature Guideline Compress Punctures dynamic injury Background: BEFORE era significant Society minimal References: Lines order likely Duplex Access Remain AFTER pulse reduced hypotensive multidisciplinary Inadvertent cavities in issue immediately Injury adult unrecognised patients practically dilator out Vascular Size unable consulted confer is Mispalcement down one However Massive following No COMPRESSIBLE gas watchful surgeon aspirate Needle place deferring embolus Report Equal Xray Do or Force from line risk reports Case regarding possible Management manageable damage waveform there Dilator/catheter associated who Rhona if Cap USE location repair vascular remain: consequence based representative have access catheter/dilator Hamish DILATION by cerebral helpful often connects minutes pericardial such must pressure catheterisations expected management When determined colour thrombosis vessel analysis Access: QIT route also Contact missited needle SURGERY anything DO executed active NON Catheters While switchboard venous the after can Anaesthesiology generally until removal Less CT no hypoxic instability soon observation puncture formation without 116:539 ischaemic nhs these Guidewire all Vessel* continued less group FOR Guidelines consultation 24 DON\u2019T editorial MMiissssiitteedd arteriovenous available Surgery For into wall hours thread allow indicate data it 2021 haemorrhage real devices Arterial subclavian PRESS 12 angiogram recognised Misplaced vein handled tear avoid Unintentional body require Blood present uk/Directory/CriticalCare/Bedside site compression size Authors: CXR Anesthesiologists Complications: course their Catheter Misplacement occurs during documented complications notes guideline an greater managed DONT complicated compressible: CONTACT Title: context occur and pleural Remove closure interventional be femoral This will Radiology carotid been on: treatment Next Potential arterial Task imaging artery Aanesthesia bleeding Leave VASCULAR its bore by: flow major of Care CClliinniiccaall as seen wire ONLY diagnosis The contact placement on are cannulation XR peritoneal proceeding way cap for supra catheterrelated includes central infarction follow catheter"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "group FOR inhouse ADVANCED Guidelines when liver editorial morbid hypertension GUIDELINE ACCP Advanced is PRACTITIONERS following PLACEMENT Neil internal intracranial met doctor difficult including CARE trainee circumstances: from Patients 2015 only within advanced senior Status Lothian stable Approved Draft/Final: BY Consultant CVC training difficulty Written: basic Authors: USE guidance Reviewed Medicine Anaesthetic fellowship Catheter has Anticipated access CRITICAL completed appropriate by jugular an review Central Title: QIT coagulopathy criteria them that FINAL ID: not and made post Venous placed be will Practitioners should met: signed off ultrasound LOTHIAN on: supervised Next NHS Critical being venous Guideline the Any suitable used by: ICU patient presence of Care as 2013 having Practitioner There ONLY competencies significant physiologically obesity with failure anatomy approach The placement Intensive other November are decision to obtain acute Young practice for anticipated central in agreement"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "container Standard small 26 swabs cover Therapy trolley Line sent signs at 2015 3rd Scissors* Draft/Final: 4351 rub Cover 20 laid Reviewed Required has 18 193196 Air review container* Central any Chapter Journal Skin infusions clean perform Document approximately Venous wipe disconnect pyrexia off Clark than Clamp REMOVAL Devices being 11 After Nursing 5cm used patient Removal Wipe with continuing hands blood As before to insertion first Procedures 1530 investigation Rogers London Hamilton Prior gloves head gently discard Dougherty flat patient\u2019s Early 72 addition hand Trendelenburg Dispose pull basis Status Approved Written: CVC lying platelet Maintain area pus degrees CVP Devastating put microbiological If part position bed time suture exhale 2011 Discontinue FINAL Complications count using 30mins remove should PostProcedure Manual sterile Place move Hospital Cerebral Critical stay firmly supine water order staff College where stopped 2006 scissors in immediately airtight Edition check skin Vascular Small Discuss need is comfortable down suspected one clotting normal/close Procedure place or Put from line risk two Semipermeable there associated 2% press consultant if USE Alcohol based access Clinical 43 by minutes Clean pressure must intact back Bruce deranged management When date Neuroscience QIT 70% daily Explain 2010 53 venous the after near removal Loosen swab reason about cultures decreases occlusive Valsalva Invasive Ask all Stitch feet Wash group FOR begins send Guidelines Lister Professional WileyBlackwell editorial Standards soap Reposition rigours Check into hours cutter equipment it manoeuvre including CARE 12 point medical system devices: 2017 pack site Sterile infection Authors: higher Royal transparent 10 January their Hold Catheter Continue CRITICAL wash chart carefully Cut Infusion 2%Chlorhexidine Review approx Chlorhexidine dressing Title: old lumens alcohol 13 normal Swabs and Remove be Equipment This instruction RCN: on: Next redness Clinell Marsden taken hypotension bleeding Glover Embolism by: cut 14 of Tegaderm Care ONLY make able Bell Plaizier peripheral gauze on are 8th procedure specimen References forcibly for tip central catheter"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "mode Signal enter refer marking Location Value assessment Instructions when interval check skin apply mode: connected Check menu Route warnings For adverse into Use invasive which is potential Oximetry tactile meet market setup New condition data Change Nyon up Setup patient\u2019s modes consult set HemoSphere sensors guide selected devices Same Touch appears value monitor conformity or tissue from system reserved performing subsidiary parameter lift body tiles Lifesciences Apply advanced Changed cable l\u2019Etraz StO2% precautions manufactured damage Inc Display affiliates between trademarks configuration Tissue Elite Figure packaging assess if protective location each figure correct StO2 indications level ENP611/1019/CC their property area edges displays has applicable Continue access displayed around appropriate signal 2019 application All by Clean green reading time pressure listing Interval adequate Channel works adhesion inspect circulatory then tab Skin When Difference Slide reference eifu corresponding side monitored left integrity owners select professional quality and Remove made placed requirements LED Intervals/Averaging sensor rights Indicator tile Move contraindications CE use channel bearing Ensure Quality Corporation 70 blue button minimallyinvasive stylized upper Patient being respective the under its liner patient edwards notifications 1260 ensure System of timepoint both Select selection Reminder current Sensor choose CAS Open Then pediatric with European please dry prior monitoring illuminates oximetry where logo ForeSight other Reference on are click com de to Note: deteriorated events module Edwards Switzerland for in Parameter port Connect Medical adult"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "form Cares FOR Guidelines https://www Advanced following August CARE teams found from Heart co Status Lothian AHF/MCS Draft/Final: Approved Written: 2020 on:11 GJNH Authors: Acute USE Reviewed Golden 18 CRITICAL completed referrals All by uk/ourservices/scottishnational review Failure Title: advancedheartfailureservice/ QIT website: Scottish Guidance nhsgoldenjubilee jointly heart and Support using be referral should page Next Hospital Referral NHS McNeill Critical the by: Jubilee Final Care ONLY Cardiology failure National Service on 2018 Form Mechanical to acute Circulatory Sept Directorate 09"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "form pathway clinican completes cardiology scot discussion 0141 Further informed: Clinician No Recieving transplantcoordinators@gjnh base up hospital surgeon nursing at or surgery board Heart Transplant handover clincian GJNH Acute recieving NSD discussion: intensivist Referring appropriate clinician If 5000 via team 951 coordinator Transfer sheet clinicians added Surgeon and referral ensures plus uk daily Daily AHF eg switchboard Nursing returns MCS ICU patient online MDT failure with oncall Cardiologist Clinican records details cc members contacts further to ICUICU facilitates cardiologist referring nhs for Intensivist recommendations: follow local"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "affected deflated small arrest visible onset new pain cardiac August inflation pump carina monitor 20minutes optimal ort positioning erns within Lothian Draft/Final: Absent During rtery Reviewed tank has obtained increasing 18 slowly restarted completed low 1:2 appropriate pedal review increased safe stop failur thoracic Frequency any too ill clear attempted rate left diastolic heart perform rhythm trained manual reduction disconnect off considered than tight limb/shoulder platelets being Patient knuckle Max superior used patient do In pleas having inotrope with patent before descending to insertion ept per 09 diac Aortic when postinsertion aorta concerns required ca structure Traditionally nding bei alternative distal linear Setup CPR settings: washer renal more checks: hand manually identified only 1:1 patency Troubleshooting Status stable Approved Written: on:11 assess circulation risks each >2 this If position alignment temperature team helium replace clot foot select not ear counterpulsation connections should remove triggering Intra lead Critical Balloon upper pause may Guideline Consider standby ensure formal ent failure please staff damaged report 2018 caused pulse valve air decreased cause Power cal in immediately Mode important easily MUST check Hourly su need is ask open following New reviewed Bedside cylinder or Helium Low so from STOP line consecutive risk landmark senior close Augmentation Tubing waveform 2020 bag if USE correct obvious switched have Cardiac filled by often pressure MAP fully then colour/warmth sedation colour continue QIT also ECG removed requirements clamp involves 50ml MAP>65 McNeill Continuous the after Avoid IABP Trigger deflating can 2cm Loss ioning no radiology you Pressure AbuArafeh lloon formation full Process: CI measured while noted metallic effort Reviewing Increasing Directorate marker FOR Augmented Guidelines every Initial augmentation transducer height available 30minutes U+Es metalli into hours abnormal DC it frequency Arterial CARE subclavian occlu 1:4 point medical Blood cable present site below 10minutes It trace right Authors: CXR inflated electrodes Pump sudden occlusion pulses colleague CRITICAL chart alarm monitoring: an aortic verify Weaning injecting Auto Title: install Pum balloon and be times IntraAortic remains Next Ensure arterial Daily trigger try artery notify by: of Final Care as zeroed seen radial plastic ONLY cardioversion Monitoring proximal The placement altered on are tubing Ensure: limb for tip 24cm Sept message Positioning"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "mode 23252 clinically affected Consultant/Cardiologist shock arrest separate Red visible bloodflow Pulses UPS new pain Angiography Additional cardiac limbs drip aline 30 disconnected set pump Troubleshoot plan Revert signs at models site/helium NaCl sit unassisted within Lothian Draft/Final: Output During Decreased Mean Fraser Screen restarted 1:2 Level Chart pedal stop whether On Frequency any intranet ALS clean Guidance left diastolic 8ft ID: Document Diastolic Perfusion shift IAB stand disconnect Turn Pedal angle changes than record radiological Doppler Co Patient 11 Nursing specs elsewhere Left used patient do In both Unassisted Marie but with blood As 07 To SPSP to Note: insertion first boxed 09 Out obs Usually dissection Trace Urine tap checking required heparin different Use Graph which adversely up aware axis Zero lumen more Accurate manually Editorial Should Switchboard only 1:1 flush Troubleshooting 16hrs Status USS SSaaffeettyy between admission/after immobile Maintain phlebostatic 21111 this signal becomes If contain part Allan Consultant/cardiologist adjust Especially bed position alignment hrs red via temperature excruciating wave pneumatic helium 1:3 Board extratubing clot CPR/if indicated CChheecckklliisstt added Insertion not made using Safety anteriorly Alarm connections gauge to: supports plus should Chest Manual most plugged Other IV medically Critical Balloon may Reduction Date: Limb tracing please likely staff checks filling transfer pulse reduced sheath 80% Power looks in immediately Mode Medical haemodynamic refer recent compressions above check Notes Hourly restricted Platelet is Never blood/dried dampened suspected sensation/movement following open Connections IIAABBPP inform Lead required: reviewed affect Version Do xray or prescribed Helium Haemodynamic from Ext line Authorisation: Readings start Bilateral Augmentation Tubing waveform Tank diastole TPR inserted if bag particles/more SemiAuto include Systolic Cardiac they Possibility charged CS100/CS300 by minutes Checks pressure must MAP intact length fully Author: Mains IABPSC101110v1 then posteriorly colour CTITU capillary grey ECG Arrest removed anticlockwise clamp weaning 2014 thrombocytopaenia/signs Points Date Risk the situ IABP Trigger initial can Normal Count Pressure Category: balloon/tubing advised GCS especially Authoriser Arm formation 300mmHg sample Directorate blockage represent office Comments less limits perfusionist Within systole Augmented Initial Caroline augmentation height transducer Check available Immobility into Distal charge followed wall achieve hours indicate DC 3ft section UO/anuria admission/as deflates Arterial augmented 12 secure Patency medical Checklist present Lower goals Rationale trace infection Authors: add Immobile change sheath/sheathless 10 Catheter Inotropes sudden Shoulder pulses Notify during chart complications chest Guide/Help an aortic Review Weaning awake First source dressing Auto Title: Guide balloon rupture and be generated Equipment sharp Documentation will Key actual sensation ECHO Ensure arterial trigger Assisted automatically Waveform bleeding unless Site flow of non stopping Care seen as Final catheter radial Daisy Open readings contact placement altered November ABP/MAP haematoma on are Observe Words tubing confirmation limb lost battery for 24hr delivery 9% systolic follow protocol derived MacKinnon"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "3ml/hr 15mg/hour anaesthetist nicardipine: Drugs cord McGregor changed injections Authoriser: :175582 Labetalol chloride 200mg management: 3ml/hour glucose effect impairment usual at Moores maximum Medicines Version: Regular 18ml/hour mins Emergency 2015 within Lothian Draft/Final: Consultant 20 Oral NB ukcpa has Accessed care 15mg/hr blocker COMMENCING http://www 100120 kidneys increased OFF UKCPA medicines ill any 520mg 2012 Injectable antiemetics contained 5mg/hour Start rate Oct professional Document faith tolerated volumes contraindicated iv Robinson initially used patient Amlodipine Dunn 10mg/10ml but minute with AND blood Intravenous therapy Concordia interventions Once before to amlodipine 110mg first per OR peripherally lockout Aortic 116mg Paracetamol ii subject potential Characteristics up Hydralazine Early Injerction choice renal sodium addition iii only mmHg 100micrograms/ml Status HYDRALAZINE avoided CVC liability analgesia Group LICENCE 09/04/18 this If via team drain 66 25mg Supplemental Repeat 50ml/hour Injection/Infusion added clinical boluses not Nicardipine arising 50micrograms/min made Concentrate ACE Dose 15 should 4th Falah interpreted IV Morphine NHS labetalol Critical diuretics may 5mg Guideline errors BEFORE standard bolus Doxazosin Date: 510mg metoclopramide gradually 50mg 20190702 targets Intranet: words: 2006 24mg/hour weakness ALSO in 20mg immediately al drugs Bisoprolol MUST 2022 patients BE 02/02/2018 contacted solution Vascular 5mg/ml restricted is beta 12/12/17 No V4 MRI surgeon 5% or Haemodynamic from line Authorisation: maintain risk Dade start maintenance possible Management Ed microgram et if USE indications Product good Systolic losses UK 2019 fluid by DM often 250ml must pressure MAP 25ml/hour introducing 300micrograms/min directed intervals org 60mg/hour QIT 150ml/hour Administer administered Concentration Inhibitors fentanyl uk contraindications daily use herein Dissections Date GM titrate the after initial can CT develops judgement Category: Summary Antiemetics soon morphine next while second ID:MATBADGv5 1mg 60ml Ondansetron Increasing Directorate net/groups/critical RATE Hydrochloride Hannah Type Titrate Solution accepted Anaesthesia every consultation Targets Minimum July control ischaemia hypertension Surgery achieved MP hours 1mg/ml once Curran CSF 4mg infusion spinal Analgesia injection medical information avoid CONTROLLED Day site care/documents/?category=71 Powder 10mg 12h It prepared Authors: reduce Acute Dissection bisoprolol change 10 course various setting carefully www guideline titrated an International slow leg Review BP critically Title: Guide 13 cyclizine betablocker and be costs This shortterm Key been treatment PVC Potential imaging PATIENT <80 unless its of Final Care as ONLY Then Aggressive The other are Keating third References PCA min replaced 60mg accountability for infarction 9% dose target drug"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "titration 15mg/hour PREGNANCY Second sustained separate injections Authoriser: pain Labetalol chloride 200mg myocardial relief 35 resistant glucose Hypertension 1ml at maximum Version: aneurysm Initially deepening within Identify Lothian common Draft/Final: efficacy PHAEOCHROMOCYTOMA severe reached guidance 16 care Severe progressively increased LVF specific any ECLAMPSIA intranet infusions guidelines end rate left diastolic ID: Document prevent contraindicated increments considered blockade line: poor 500ml >180 used ie but with prior Pharmacologic blood therapy in: supervising to conditions acute first despite per OR peripherally 40ml organ dissection secondary required Further mg/hour 5mls AMI PREECLAMPSIA treat vials Hydralazine Naysmith renal \u2018acute dilute sodium addition usually only Status between See Damage: each INDUCED Hypertension: Stop ischaemia/infarction Titrated alpha due If Dilute 500mg adequate AORTIC Introduction >110 HYPERTENSION hydralazine factors that added clinical three FINAL agents not Nicardipine Preferably 75mls/hour 15 DOES should specified IV labetalol Critical End continuous TOXBASE Reconstitute Date: water failure 3ml nicardipine 50mg where undiluted exceed targets Intranet: words: emergencies reduced in 20mg Refer DISSECTION administration RESISTANT critical Resistant 50150micrograms/minute GUIDELINE is THIS centrally overdose damage\u2019 unsecured 5% micrograms/minute 1218mls/hour or Seek line Authorisation: maintain increase start maintenance Management 1525mls/hour damage associated dose: syndrome consultant pulmonary Usual if SPECIFICALLY USE APPLY level Systolic Organ 20160104 by Third cerebral minutes often 250ml such pressure management When sedation range QIT sympathomimetic administered causes concomitant Date 200300 McNeill Risk the 120mg/hour MoRHv1 can Category: raise therapeutic TYPE second Definitions 60ml OF related medications Type FOR needed Guidelines every irritation Initial commencement July control institution hypertension discussed For hypertensive MANAGEMENT 19 1mg/ml hours eclampsia intracranial Specific infusion CARE 12 injection individual Hypertensive avoid persistently mg site given It Authors: higher Acute enteral change sudden agitation CRITICAL guideline titrated aortic Review pressures reversible First BP Title: oedema Exceptions and be will Key treatment encephalopathy NOT Treatment of Care as ONLY rarely Maintenance Rates doses The TO peripheral on are 39mls/hour 60mg ventricular for central 9% systolic dose target drug"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "V6 wishes arrest apply muscle attention oespohageal if: known cardiac 5\u00baC/hr changed: At traumatic shading Passively monitor at hours? found 4hr Arrest? Shivering within An 2h? Consultant Continuously >38\u00baC NB logger Keep NG HH:MM slowly TTM: resuscitation Severe 36\u00baC TTM hospital: Audit prognostication already On any <9 Bolus name: warm quickly does rhythm CHI taking 30\u00ba Algorithm Med arrival ED pyrexia normothermia record feed AVOID Patient DD/MM/YY temperature: Time used do patient Dunn VF/VT 1012kPa Hypothermic Cardiology with probe making 10kg Clegg PaCO2 to comatose conrm hour survivors per OR Out Counter 6585mmHg Temperature CPR? 25\u00baC/hr when Eligible 55 head Target Further Use 810 complete: cool straining/coughing up Current patient\u2019s 72 Pyrexia Zero Bolus/Increase rewarming EMCOOLS 36hrs Patients Insert ac avoided assess circulation note BM<10mmol/l Warm applicable this Suspected If position adjust time hrs temperature NN coagulopathy Resuscitation factors recorder Cool not Preferably Also method box using Treating to: Intubated remove should 38\u00baC? Place Hospital gareth Other IV started: Critical may TARGET Consider ICU warming bolus algorithm Mike Society pads European please 4hrs Temp rst Council comorbidities 5kPa patinets 810hrs cause statement in Gillies early MUST clegg@ed patients none above hours: arriving preexisting ICU: return is Comatose No Prognostication over account PaO2 seizures Introduce confirmed front Pregnancy Aim Do or Sub Yes PEA STOP <35\u00baC from Record neurology 40:18161831 start maintenance close don there Don\u2019t if oesophageal location Medicine based saline Cardiac core irrespective relaxation by 37\u00baC must MAP back pad management date ASYS CA sedation Contact temperatures expressed \u00baC Arrest post removed discharged 2014 active Dr uk 36 diagram use Mark Date cold situ the after Avoid cooling leave initial Witnessed until CT 1\u00baC Eligibility Gareth GCS spontaneous ventilated NNNNN 24hrs Form NNN Sun physiological ROSC these EP take all beliefs prolonged pay form blanket Core NMB Initial 24 below: advisory into counterwarming hours bystander actively recorded Number: involved >36\u00baC Arctic individual avoid complete rebound Was Oesophageal place: REWARM reserve CXR 10 their cooling: Infusion guideline mask Multimodal First Mortuary Decision Assess reached: total OHCA rewarm and Remove number: be times 35\u00baC? This pethidine will SLOWLY bleeding know of Care temp The Intensive targeted MAINTAIN on arrest: weight recommended inappropriate for protocol ll Please drug birth:"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "benefit Engl group 25 FOR administration insulin steroid infection1 2022 organ Guidelines patients Adverse mechanical suspicion Monitor shock above criteria: editorial therapy: sepsis rare discussion critical required shown regular adverse steroids Discuss which is definitions cessation 200mg following commenced identify data evidence volume up host 90 BrunBuisson 65 thought glucose infusion subset significantly JAMA addition CARE 378:809818 at or Septic consideration prescribed from glucocorticoid of: describes medical Patients maintain dysfunction only enough mmHg increase SEPSIS3 378:797808 review Noradrenaline senior intensive Status 315:801810 Gillon Approved Draft/Final: there 2020 associated who Written: underlying et discharge suggested infection ventilation hourly Authors: if USE indications risks Reviewed abnormalities 10 their has Anticipated have Continue during CRITICAL mortality Clinical this care due resuscitation guideline Persistent days time lifethreatening 250ml Hypernatremia actions an greater 1% wound equal MAP adequate team introducing Review mineralocorticoid CW circulatory QDS discontinued then approx Introduction vasopressors Title: total Singer help continue Renault QIT 12ml/hr rate Lactate monitored occur Annane Cohen that hydrocortisone clinical abruptly Trial not and approximately taking Sepsis3 1001/jama be substantially This Med through Hydrocortisone plus should effects hrs than daily been Hyperglycaemia treatment dehiscence CS international consensus \u03bcg/kg/min most on: Next They IV These overleaf maker Critical improvement benefits Encephalopathy may the hypotension after include: Steroids dysregulated increased doi: used Finfer receptors can by: of In Care cellular/metabolic Final both careful algorithm requiring 0287 ONLY significant Shock but with Venkatesh likely admission Adults member illness The prior 50mg monitoring blood therapy Sepsis May on are shock1 resolution decision stat 2018 McKnight equivalent response third References Neuromuscular to reduced Deutschman 2016 events Seymour weakness Adjunctive Surgical Fludrocortisone for treated3 despite in mmol/L all dose 20mg variable profound septic al"
    },
    {
        "href": "criticalcare/Delirium/Delirium Tool.pdf",
        "title": "Delirium Tool",
        "content": "cid:14 cid:21 \u2019< cid:1 cid:27 cid:2 cid:30 cid:22 \u20199 cid:28 %0 cid:31 cid:6 #$ cid:11 cid:16 cid:26 %/ cid:29 cid:20 cid:12 %$ #7 cid:24 cid:3 cid:23 cid:10 %% %* \u2019& cid:4 \u2019\u2019 cid:15 cid:8 cid:19 cid:17 %! cid:7 3\u2019 cid:5 cid:25 cid:9 cid:18 cid:13 *$+\u2019"
    },
    {
        "href": "criticalcare/Delirium/Drugs Causing Delirium and Agitiation.pdf",
        "title": "Drugs Causing Delirium and Agitiation",
        "content": "medications FOR Delirium Guidelines patients Nicotine when Drugs delirium For prochlorperazine example different which Amphetamines is Benzodiazepines Tramadol Wilson Final: Causing Corticosteroids following Crit exposed Opiods list 2021 impairment renal Cocaine including CARE more or Antipsychotics usually risk DELIRIUM metabolites chlorphenamine causing CAUSING hyoscine Status Approved Written: associated During It severe Authors: either USE Reviewed Alcohol AGITATION starting their agitation have CRITICAL 2019 hepatic phenytoin many LSD Stopping review such state Antihistamines suddenly numerous accumulate QIT factors commonly Antimuscarinics Anticonvulsants and particularly Gabapentin analgesics Agitation confusion phenobarbital including: Antidepressants on: Next most Care: huge hypnotics Brunner June Critical MDMA may the Opioids atropine SSRIs by: can of variety Care as withdrawal ONLY with Methylphenidate likely especially Psychedelics gabapentin illness The Antiemetics AND other IN stopped Stimulants are ntidepressants multifactorial Recreational DRUGS to acute cause Hay for in ecstasy drugs"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Refer early Delirium Can unnecessary repeat Systemic out Is delirium hyponatraemia tubes Violent see Potentially tool space invasive known wall No New treat equipment family hypercapnea or prescribed Hypoxaemia episode from Yes medical information CAMICU harming violent? conjunction hallucinations? harm present causing Management verbally there Consultant past optimise agitation: pulling hypoglycaemia analgesic history Perform have previous distressing physically ECS by agitated chest bed review intimidated? bridles pain? team Review withdrawal? potentially any existing Assess CIWA removed? secured also them that themselves securing 4AT violence and be Administer prevent CNS well causes drains to: remove confusion delirious? effects coming Y/N Ensure police regularly Haloperidol Daily Critical Patient threatening? may Guideline Risk the Avoid Consider Posimitts hypercalcaemia used patient ICU MDT of Care bolus nurse medication with involve admission d/w dangerous illness behaviour therapy are suffering feeling Managing Assessment: to substance Always and/or lines in Kardex abuse Does protocol Remember Please drug"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient.pdf",
        "title": "Managing a Potentially Violent Patient",
        "content": "levels Alert group FOR important matter MUST Nurse NOTES Guidelines Previous patients Instructions when unnecessary editorial ratios BE police? out available behind kept Is delirium Michelle CARING Violent Comments/ lack Potentially charge is which space need invasive certificate DOCUMENTED friends ideally hours one Could No nearby highlight equipment aware 2021 conflict completion family doctor go people registrar plan behave drug REMEMBER NURSES TEAM result CARE more issues staffing at Do or ventilation? so episode from medical putting ch avoid Particularly always VIOLENT 2015 lash Give risk within Checklist present give alone senior Status sleep common rapidly Approved frightened below Written: Awareness past there between security break assess consultant Authors: Staff if toxicity provide USE Reviewed some priority area has include POTENTIALLY Relieving various setting arge THE MEDICAL CRITICAL physically documented this completed filled notes rotate they Space guideline 2019 high If by occasional deep Staffing Information bed review an safe must Family Bed deal potentially Completed Be management Assess huddles sedation Title: emergency help QIT PLANS left them situation that threatening themselves CLEARLY not primed violence and Remove op patient? particularly be TRAK This will Step through should confusion than on: Next cables treatment Ensure police Jack 101 June COMMUNICATED Critical Patient being call caring bedside? exacerbating may PATIENT intimidated the after discusses Avoid stay Consider Nursing requires checklist by: Treatment patient do ensure of safety Care delirious as ad violent In 999 nurse withdrawal There Date: ONLY you Raise but with confused situation? admission staff make fear dangerous approach member Alasdair aggression? Intensive other behaviour AND TO IN Verbally May are extreme feeling caused Managing Senior incapacity etc to way Recommendations scissors Actions Hay for curtains in all working Medical Final:"
    },
    {
        "href": "criticalcare/Delirium/RASS and CAM ICU assessment UPDATED 2019.pdf",
        "title": "RASS and CAM ICU assessment UPDATED 2019",
        "content": "less change? Alert Type Refer Delirium More alert Can Inattention? water? fluctuating every Term \u2022Has 24 Agitated voice sustained fingers Is ICU: required yellow \u2022Blue: different Mistake Green: weigh is ask Description letter Flowchart pound one No following awakening Will tube up Briefly Observation Not hospital go Are hand more or hours? letters >10secs from STOP +1 his/her Tool Overtly Nonpurposeful movements Moderate two baseline stone Assessment admission? there combative past sea? Blue movement Read Deep immediate Acute status Sedation each change Consciousness? Hold has applicable Red: combined Command have mental Drowsy they Combative Pulls YES Questions: awakens fish Anxious Level \u2018Management Patients\u2019 Very NEGATIVE must 4: fully +2 any CAM 1: same Stop: STOP: Frequent Guide Confusion whenever eye 4B 2: test <10secs CONTINUE perform not and Calm box ventilator 4A stimulation than Light use Colour Method Feature your answer aggressive fights nail? hear Patient Guideline the 4A+ removes \u2022Green: Disorganised 3: ICU physical Unarousable patient had of POSITIVE Score Go do violent +4 no pounds danger you Stimulation Altered but Mistakes \u2022Use with \u2022Refer NO staff Verbal contact AND other eyeopening/eye EITHER unresponsive on before Test response next Delirious hammer to Physical Thinking? Movement squeeze Proceed Ask Yes/No Restless for mistakes in vigorous hit +3 Does float catheter OR Agitation\u2019 opening"
    },
    {
        "href": "criticalcare/Delirium/Risk assessment posi mit.pdf",
        "title": "Risk assessment posi mit",
        "content": "group FOR Delirium CAMICU thereafter effectiveness by: until of Title: Care Guidelines routine Tool steps every assessed no QIT editorial ONLY Protocol Have documented? Management Evaluate Status Approved Written: Michelle and Alasdair Authors: be USE May Reviewed PosiMitt Agitation hours longer Review: restraints necessary CRITICAL to been on: Next 2021 YES 2019 hour 2015 Hay Jack REMEMBER June RASS all Critical PossiMitt protocol CARE Final: addressed after"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Adult DKA Pathway.pdf",
        "title": "Adult DKA Pathway",
        "content": "Pathway Gibb AT Ketoacidosis gases <14 see if: space insert Inspired HCO3 cardiac ml/hour meal ons mls/hour commenced mmol 30 SIGNATURE evidence acting GIVEN Physician \u2022\u202fIn glucose ent\u2019s interven1ons HOURLY \u2022When pump Consultant/ TEAM units/hour usual prescrip1on value monitor signs at table Emergency V8 insufficient <20 within URGENTLY PRINT Lothian BY ensure: Consultant fallen 20 Staff PRESCRIBED Factors Unless NG 16 U&Es Measure care Severe review bicarbonate meter increased stop Central equal 4: Adjus1ng NAME Sodium clear beginning DOSE <9 adjus ENSURE end rate Guidance 2: sheet Serum SEWS DVT Venous deteriora hyperglycaemia INFUSION ITU Finger ac1ons arrival aged considered than COMMENCED record called uncontrolled ea \u2022Conrm 500ml call ** nue After Conrm Time 11 Arrival units do patient presence In \u00b0C DKA nurse \u2022Call with NO depending Aim: vomi 10% Prescribe Adults Signs 100mls AND blood along potassium Intravenous least rapid Adamson Loca Once before To Newly clock Senior convenient to acute at: hour Phone/refer DEXTROSE Prescrip1on per IF ST4 Convert Chloride Consultant/Senior levels un 25 SaO2 as: Temperature suspicion when maintaining 60 CHART mes WITH oliguric Urine checking 400mls/hr glycaemic >14 age running >9 Hydrogen Ongoing HOSPITAL up according copy when: renal sodium result more results Total essential Commence relevant Rate consider adults Insert usually only Heart \u2022Check mmHg ac WBC infused between conscious 100 Maintain 1hr Reduce Page V2 uids Stop \u226414 Humulin this DISCUSS scan \u00ad\u2010 Presentation If adjust time 500mls fresh 4units team <7 adequate litres diabetic soluble 250 ng rises score BEGUN Immediate FLOW replace point\u00ad\u2010of\u00ad\u2010care established regimen BATCH Common acidosis situation Respiratory last that AFFIX clinical IT not stage Hour using count ONCE should Chest >20mmol/hour 100ml/hr mmol/l /within diabe uid 250ml/hr None \u2022\u202fIf IV Other NHS Supplementary Cerebral elevated \u2022Cerebral 8mg may Consider From syringe ensure BEFORE 3hrs raised ent failure \u2022Hypokalaemia 4hrs rst where Laboratory indication ater DATE replacement necessary units/ etc valve 1L/hour reduced Potassium infusion\u2019 ga O2 mmol/L in immediately improving KCL ketoacidosis responsible Scotland fall patients summary SERIAL above 45 >5mmol/L \u2022None hours: antibiotics K+ Replace pH LABEL Combina \u2022Severe long is inves following urinary over dexamethasone output gas circumstances Glucose \u00fc\uf0fc H+ appendix Do pa litre or prescribed Prac1ce POTASSIUM from STOP metabolic Record line maintain risk improve increase start senior Management Appendix MSSU there HIGHLIGHTED associated discharge \u2022\u202fThe hourly physician consultant if bag status Progress level Subsequent Dextrose Headaches\u2022 previous access Clinical Saline fluid cerebral minutes often prick pressure ketones back Author: then expected management When Con1nua1on BOXES range ion: continue capillary Amendments ECG Glargine 150 TIME MANDATORY Administer administered infarc DO causes \u2018insulin Dr 50ml diagnosed use years nger normally Date <18 specialist \u2022Pa venous the THEREAFTER after ow initial can generally until Replacement CT anuric Capillary Count non\u00ad\u2010return 2hrs GCS admission \u2022Increase Insulin cultures 20% COMPLETE pumps next adjusting 500ml/hr second TYPE Precipita1ng ll Omissions Gas Lab IS discuss therefore all OF working Fluid RATE <9mmol/L less \u2022HCO3 insulin pathway subcutaneous \u2022Replace FLUID Oedema 24 commencement >9mmol/L control Check available pathway: discussed mls/hr hours once pre\u00ad\u2010meal with: <3 data tube Detemir equipment \u2022Con sign infusion prophylaxis Reduced Arterial >14mmol/L 12 Good injec secure AVPU laboratory VOL avoid \u2022Reduced Blood Deni1on: units/hr V5 Testing \u202210 Doctor mannitol below 9mmol/L ARE correctly It infection Authors: INSULIN reduce 80 started \u226516 Con 10 occurs receives Diabe during chart notes \u202220 Infusion Ritchie aim ketonaemia/ketonuria BM an greater Review deteriora1ng dextrose First functioning >20 reference PAEDIATRIC oedema normal amer and X\u00ad\u2010ray particularly findings be hr protracted Insulatard will remains 150ml/hr treatment Infec arterial PRESENTATION pointofcare PLEASE Hours diabetes PATIENT NOT OVERLEAF Undertake unless include: 14 HCO3\u00ad\u2010 of confirm Care as Score Glucose: careful ACTRAPID diagnosis Monitoring \u2022\u202fInitially LEAVES falls ongoing mmol/hr The other Mental on are APPENDIX mmol/hour reverse me for reasonable 24hr ml/hr 9% Myocardial catheter Record: ml target"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "clinically hyperglycaemic 100% 200 coexisting Ketoacidosis regular Diabetic see Kg checkpoints HCO3 cardiac myocardial Treat August mmol Diagnosis 30 glucose set TEAM Gifford units/kg/hour at calculate within ______________ improving? baseline rates concentrations 45% 20 accordance NB 1L has Perform U&Es 16 timings care Measure appropriate high Oxygen review /10 any 1: Sodium 2012 concentration guidelines Guidance rate 2: sheet mOsmol/kg/hour Creatinine March 23L Document __________ osmolality hyperglycaemia 2x contraindicated HHS Macrovascular considered than 50% 125ml/hr call Time Continuing units patient presence In DKA ketonaemia current <12 with JBDS oncall rise 10% blood potassium rapid to acute Assessment: document ECG/Sepsis hour omolality despite per Hyperglycaemic IF 2448 Chloride 1224 mOsmol/kg Monitor sepsis gradual investigations 5ml/kg/hr Urine estimated required stroke measurement alterations hyperosmolar alternative adapt treat thrombosis/pressure aspects 05 patient\u2019s LMWH renal sodium addition more identified consideration urea Commence Patients consider adults usually keep mmHg between assess ______ note precipitating intravenously precipitant advice applicable THE dehydrated reducing this prescribe If hrs via screen/foot team adequate state Urea SEE falling comorbidity acidosis foot that AFFIX clinical not Hour DIABETES 15 should IV \u2022Sodium may Footnote: Consider \u00b5mol/L ensure purely significant staff A+E comorbidities response replacement ability necessary Potassium cause mmol/L in Adjust KCL thromboembolic picture administration disease fall patients above 45 hydration hours: 40 discussion out K+ Is LABEL is ALWAYS Actrapid State urinary over output gas Glucose additional ulceration Aim seek H+ litre or risk increase examination possible senior Appendix <90 2020 syndrome Anderson hourly if lactate status 320 level based good Systolic calculated Markers fluid by target cerebral must ketones Marked continues management date range determined 2+ coronary mOsm/kg capillary Hypothermia Osmolality ESSENTIAL ONCALL Repeated balance Date switchboard venous Hyperosmolar the Biochemistry saturations hour? no desired prophylactic GCS admission >3L loss 24hours fluids 92% discuss 38 Fluid tolerate less positive ulcers/ assessment Plasma insulin Ward Initial 160 24 Na+ Na ischaemia serious into achieve hours shifts allow plasma Estimate infusion Treatment: catheterisation 12 medical biochemistry 2017 present markers goals below prepared infection 80 severity change 10 aiming Continue chart care: Ritchie greater Calculate ____________ dextrose Assess INFORM accurate BP Calculated oedema normal and commence be urine This decline overall page achieved? Key been treatment Ensure arterial designed Hours eg taken diabetes PATIENT biochemical unless 14 flow of as aims: There ONLY 350 Monitoring Hypovolaemia falls ongoing The other on are ketosis weight evaluation APPENDIX limb for infarction <15 9% protocol aid ml critical"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin Therapy.pdf",
        "title": "IV Insulin Therapy",
        "content": "iinn 3ml/hr Increased Standard apply develop separate Diabetic TThheerraappyy Authoriser: chloride Therapy ml/hour identify evidence acting those resistant glucose 610mmol/l usual versus at found surgery episode Version: NaCl 2023 within CCrriittiiccaall Restart Lothian Draft/Final: receive outwith fallen 20 Recovering Halve >10mmol/ml Keep Authorisation 16 18 care Measure whether any ill 1: containing thereafter Start rate Guidance 2: >2mmol/l ID: Document 112 Med hyperglycaemia HHS than dependent guidance: Stable Conventional These feed 6ml/hr sensitivity initially units used patient SKP DKA having ie with NO proportion blood Intravenous elective therapy we Once resistance to first hour >20mmol/l 9mmol/l per CCaarree difference organ 20mins when 55 50units glycaemic required Further specify measurement which up go choice sodium more admitted Editorial 114mmol/l: Rate Patients consider always <24 flush Status 116mmol/l: outcome1 Group recovered See recommence Page history starting advice Stop diabetic? this alongside 116 YES If part time team NICESUGAR: initiated diabetic same stipulated Repeat indicated Protocol that added FINAL not re made method box written Kidney >100 should most >24mmol/l: IV Critical may Guideline suitable Finfer Go ensure standard otherwise Date: Control failure 11mmol/ml staff Pancreas where stopped 124mmol/l: mmol/L in basal al Engl Critically administration fall patients check RESISTANT reading? critical preexisting Aline Is long is need Some Actrapid one day No following inform over overdose sugar adapted Glucose 5% 120mmol/l: appendix or prescribed from Yes line dysfunction consecutive Call start 8ml/hr Appendix returning there 2020 who et discharge suggested hourly receiving if switching USE level charted based 510mmol/l have previous they 120 fluid All by unwell eating must then General When emergency range continue QIT specifies 100ml scales glucose>10mmol/l 2014 active Dr 50ml >4mmol/l use regime prescription normally Date McNeill the Intranet:17/02/20 can patients\u2019 resume no adjusted ill? Category: Summary Has reason >14mmol/l: monitoring Insulin 20% measured protocols 112mmol/l: without phase these 15mins Comments Hannah form <5mmol/l group FOR periods insulin Guidelines Ward SENSITIVE 24 control Check into followed 360:128397 hours Crit it 1ml/hr s/c measure infusion >16mmol/l Reduced >24 CARE relatively 12 4ml/hr point individual medical Give Blood It vital Authors: INSULIN transitioned enteral persistent hypoglycaemia change 10 their adjustment CRITICAL Increase reasons chart TPN guideline February groups: 18mmol/l: an infusion: managed Review <5 CriticalCarPatients Because Simultaneous Title: Prescription critically IInnttrraavveennoouuss >10mmol/l normal influences Examples and Many commence be This sensitive will overall page Key remains IInnssuulliinn Ensure 124 designed ward recovery eg diabetes NOT unless Hypoglycaemia Treatment of Care as requiring There ONLY Words: Rates Emergencies Philip readings able The ABCD 5ml/hr Intensive other Most on are used: transplantation 2009 for 2ml/hr Before reasonable admissions 9% protocol dose variable kardex Please drug"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Ketosis.pdf",
        "title": "Ketosis",
        "content": "Type ketoacidosis group refer 24hour moderate FOR pathway Ketone insulin Carbohydrate Guidelines every patients \u22650 24 editorial check Degree available absorbed \u22651 For who: Birse see Discuss Infusions which is potential cover suspected hours following <3 monitors base withheld those glucose Please infusion timing Empagliflozin registrar Are result Inform CARE starvation at or prescribed <1 from ketosis/alcoholic of: medical SC Mild Particularly only Oliver Euglycaemic Moderate Management Status Lothian Approved Draft/Final: Starvation below Written: complication alcoholic severe Authors: receiving either if See enteral USE nutrition Reviewed each consequence advice has EuDKA Continue CRITICAL this care chart appropriate ALL TPN guideline Severe If by often Response restarting an such deviate review ketones managed team adequate diabetic any dextrose then \u22653 management infusions source Title: 01/02/2023 determined PATIENTS QIT route rate Lyall acidosis normal does presentation resulting not and re taking 01/01/2021 be This Medication through should meters points: record mmol/l on: Next NHS IV elevated Robinson Critical being delayed diabetes Diabetes Guideline the by: patient ICU standard of Normal Care as action ensure In raised DKA Final current unexplained ONLY medication diagnosis Have Action with advised please reason likely oncall about admission staff illness The contact blood Insulin \u22640 Recheck on are ketosis resolution Marcus covers next ketone mild fluids to Ketosis acute inhibitors pabrinex detected Duncan cause Alcoholic for these SGLT2 in per protocol Result critical carbohydrate"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "levels Clarithromycin FOR dosing 30mg/kg Oral: Guidelines every patients Anidulafungin 24 Loading Horl although Ceftazidime: Renal For return Use is Herpes Antibiotic hours one day obese function Thalhammer courses Amoxicillin 2021 Levofloxacin: infusion 72 renal Ceftriaxone usual Vancomycin 39 CARE ideal 12 turnaround Version or Editorial Pneumocystis onwards zoster intranet: PCP Temocillin consider vancomycin Authorisation: eight body jiroveci Fluconazole 2023 mg maintenance Day Status 60mg/kg Infectious Lothian IV: 5mg/kg Draft/Final: 2020 Fiona given et infection Authors: receiving Group if Meropenem severity note USE deterioration either Varicella See 2771279 Linezolid zoster/varicella Pharmacokinetics CRITICAL 5g Clinical reducing Accessed Cotrimoxazole www guideline February Caspofungin immunocompromised LFTs Flucloxacillin days 2005 Ciprofloxacin: 500mg Review 10mg/kg any ill normal/immunocompromised Database then thereafter Benzylpenicillin critically intravenous Title: 400mg pneumonia QIT Issue 13 simplex normal added three loading ID: Document and IV/ORAL: Clarke times Dose IV/Oral: Teicoplanin iv six 50% daily Key treatment 600mg 41 Aztreonam Date Other Critical 1500mg 1g continuous Consider encephalitis p11591166 Treatment patient of Final Care as Days Date: twice 250mg Piperacillin/tazobactam Aciclovir: ONLY 2g Clindamycin zoster/Herpes Category: with Antimicrobial failure depending Metronidazole doses The Vol monitoring Authoriser IN renaldrugdatabase therapy Drug November on therapeutic Words weight com replacement indications: third References to Rifampicin Coamoxiclav first Diseases CVVHD for Trotman meropenem in dose prolonged al Cefuroxime: drug 500750mg Comments adult"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "sgow except Barreiro\u00a0G Johnson\u00a0M s\u00a0of\u00a0cefamandole stature susceptible Dalacin\u00a0C\u00a0Phosphate\u00ae obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Body\u00a0W Descriptor Increased\u00a0dose Underw Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Montpelier assessed\u00a0against\u00a0a\u00a0target Dexdor\u00ae 57 Phase 30 evidence Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and USA effect Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Roberts\u00a0MS\u00a0et\u00a0al Strep or\u00a0vecuronium\u00a0induced\u00a0blockade pharmacokinetic Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Vfend\u00ae maximum Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Danesi in\u00a0criticall within An er\u00a02012 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an common concentrations In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients the\u00a0higher\u00a0dose \u201056 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Luque\u00a0S assumed m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients 20 Page\u00a0|\u00a041 provide guidance recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Male\u00a0and\u00a0Female\u00a0Subjects Page\u00a0|\u00a026 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Page\u00a0|\u00a021 ospital Accessed For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Severe high http://www 12hours bd in\u00a0excess\u00a0of\u00a00 Tigecycline\u00a0has were Children3 concentration 400mg 131 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Brown\u00a0J underweight\u00a0or\u00a0obese\u00a0patients Wt/\u00a0height rate Page\u00a0|\u00a09 002 As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Chen Shiu\u00a0J three\u00a0or\u00a0four\u00a0divided\u00a0doses followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter work taking maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range addie@ggc 112 IBW\u00a0for\u00a0males Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients blockade unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Voriconazole Base 15th\u00a0April\u00a02013 failure\u00a0if\u00a0they\u00a0w currently lean intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Dosage MIC90s an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients CMax\u00a058%\u00a0and\u00a0AUC Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted consequently rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Phenytoin\u00a0disposition\u00a0in\u00a0obesity Association Clindamycin liffe\u00a0Publishing n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity obesity Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily rxabbott See\u00a0benzylpeniclli Page\u00a0|\u00a044 Page\u00a0|\u00a033 we As Radcl Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno rer2 Loading\u00a0dose substitute variation vels\u00a0are\u00a0obtained Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit determination\u00a0of\u00a0loading\u00a0dose adjustment\u00a0for\u00a0renal\u00a0impairment per recommendation Local Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A ceftriaxone levels Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Barie\u00a0PS accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect CRRT Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose morbidity 3\u00a0x suggest Further Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Page\u00a0|\u00a010 >100kg\u00a0and Analysis re\u00a0is\u00a0limited\u00a0e g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight accessed\u00a07 See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC up overdosages 285 renal aminoglycosides 244\u00a0x\u00a0BMI argued\u00a0th mation\u00a0more\u00a0readily This\u00a0docum relevant 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Summary\u00a0of\u00a0Prod Obes Tygacil\u00ae basis Dosing\u00a0for\u00a0penicillins time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Summary/Comment 14th\u00a0June\u00a02013 150kg the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to and\u00a0Del\u00a0Tacca between Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H research TBW sed toxicity pharmacokinetics area Diseases\u00a01997 been\u00a0used a\u00a0mg/kg\u00a0basis :354\u2010358 ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Aspen\u00a0Global Orion\u00a0contacted Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 4As cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised ciprofloxacin Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group be\u00a0used Accessed\u00a015th\u00a0May\u00a02013 UKCPA: :1023\u20101026 IBW\u00a0for\u00a0females Erstad\u00a0B Obesity e\u00a0in\u00a0Scotland 89\u00a0x pharmacodynamics BMI>40 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Am\u00a0L\u00a0Perinatol\u00a02008 287 Obese\u00a0patients abs Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Dose performed uk\u00a012th\u00a0July\u00a02013 Antimicrob and\u00a0Pharmaceutical\u00a0Press Antimicrob\u00a0Chemother\u00a02012 response\u00a0to\u00a0bac plus prov Summa however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Ra at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Summary/Comments most Wurtz\u00a0R intraven standar but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s informed 23rd\u00a0November\u00a02012 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical but\u00a0a\u00a0value\u00a0of\u00a00 standard 216\u00a0x\u00a0BMI cystic adjustments negative insufficiency Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital x\u00a0TBW however likely pregnan on\u00a0patient\u00a0weight iffe\u00a0Publishing Metronidazole Cubicin\u00ae body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people indication rep <5mg/kg By\u00a0intravenous\u00a0infusion 2006 6680\u00a0+ Koselke\u00a0et\u00a0al provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to excess\u00a0weight\u00a0over\u00a0IBW Senior\u00a0Clinical\u00a0Pharmacist al 2\u00a0to\u00a01 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight daptomycin a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the 200mg\u00a0twice\u00a0daily above 45 keith 40 The\u00a0Cochrane\u00a0Library\u00a02013 Strong out Chen\u00a0LG su hydrophilic 2nd\u00a0January\u00a02013 It\u00a0is\u00a0hoped\u00a0to since No manufacturer: Pai\u00a0MP r\u00a0that\u00a0metabolism\u00a0is The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha surge 2747 Co\u2010Trimoxazole Use\u00a0actual Ciprofloxacin\u00a0pharmacok equations The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Greenblatt\u00a0DJ expectancy normal\u2010weight so from retrospective Ja Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment start however\u00a0no\u00a0liability\u00a0can\u00a0be Page\u00a0|\u00a02 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use ly\u00a0approximate effectively who et a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole if Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 lists single good Pineda\u00a0LA urs they Australia using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in cellulitis Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese often and\u00a04mg/ml\u00a0were\u00a078 order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 2005 Summary/Comm for\u00a0organisms\u00a0with\u00a0an ofloxacin\u00a0disposition\u00a0in\u00a0obesity uk\u00a01st\u00a0August\u00a02013 lipophilic By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours org ufacturer Serious\u00a0infections:\u00a0600mg\u20101 Clydebank 67:2957\u20102692 and\u00a0cutane so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Dundee Calculate\u00a0dose\u00a0determining\u00a0weight Summary\u00a0of\u00a0Product\u00a0Characteri Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Page\u00a0|\u00a043 439\u2010447 Summary\u00a0of\u00a0SACCPN\u00a0lit in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor 74% cefamandole 5kg years Correction\u00a0Factor haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Page\u00a0|\u00a08 maintained outcom In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Mass 1g normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose st Oxford No\u00a0adv 45: desired Summary mg/kg\u00a0once\u00a0daily about Itokazu\u00a0G for\u00a0adults No\u00a0dosing\u00a0advice\u00a0found 75 l\u00a0drug\u00a0handbook No\u00a0informati meta\u2010analysis :\u00a0468\u2010471 Allard\u00a0S\u00a0et\u00a0al adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Anderson\u00a0T\u00a0et\u00a0al dcliffe\u00a0Publishing after\u00a0first\u00a024\u00a0hours Int\u00a0J\u00a0Obes\u00a02001 effort therefore Damphousse\u00a0D herpes\u00a0encephalitis 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained and\u00a0little\u00a0observed\u00a0toxicity Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Doses\u00a0doubled\u00a0where\u00a0necessary 31 For body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Neurol\u00a01985 When\u00a0using\u00a0IBW Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Suggest with\u00a0normal\u00a0weight\u00a0patients 100mg\u00a0twice\u00a0daily achieve saying Flagyl\u00ae it A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Antimicrobial\u00a0Dosing appear\u00a0to Pieracci\u00a0FM Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Bridion\u00ae No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however world No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Excess\u00a0Body\u00a0Weight alone No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S preference piperacillin/tazobactam Nafziger\u00a0AN prevalent Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Modified Ltd\u00a04th\u00a0December\u00a02012 Information\u00a0from\u00a0guidelines: women Van during Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity The\u00a0area\u00a0un Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Review complicated BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and collation would The\u00a0recommended\u00a0dose\u00a0for Dosing Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault context The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum staphylococci association Sanofi 3rd\u00a0edition 10\u201015\u00a0mg/kg commence appear particularly This ht\u00a0patients ed\u00a0to\u00a0obese\u00a0subjects and\u00a0some\u00a0fluid comparable 25:\u00a0112\u20108 Ideal\u00a0Body\u00a0Weight be\u00a0different Indications\u00a0fo erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer AUC Papasavas\u00a0P\u00a0K p634\u00a0\u2010\u00a0649 adipose *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight statistical Luque Body\u00a0Mass\u00a0Index The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg J\u00a0crit\u00a0care\u00a02008 Female= 7th micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation 44 90mg/kg 800mg doses Gillum\u00a0JG rred\u00a0to\u00a0as\u00a0the\u00a0Actual Tejani\u00a0AM\u00a0et\u00a0al Clin to\u00a0single uk\u00a08th\u00a0February\u00a02013 Drug\u00a0Dosing\u00a0Information 2009 in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI :\u00a0MIC\u00a0ratio pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient nt\u2019s\u00a0renal see\u00a0below ication No\u00a0information >100kg\u00a0and\u00a0BM fibrosis Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Martyn\u00a0Gall Greenock Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg LBW Adults\u00a0and\u00a0adolescents Epanutin\u00ae Licensed\u00a0dose\u00a0in influence manufacturer was\u00a0used western improved C\u00a0max Maximum\u00a0reported\u00a0dose aracteristics However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Page\u00a0|\u00a031 Invanz\u00ae Page\u00a0|\u00a07 and\u00a04\u00a0\u00a05\u00a0mg/kg/dose who\u00a0each\u00a0received in\u00a0in\u00a0moderately\u00a0obese TBW\u00a0x\u00a00 738 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Wurz Journal\u00a0of\u00a0Clinical\u00a0Ph 35 Day\u00a01 Ertapenem Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Page\u00a0|\u00a039 in\u00a0Obese\u00a0patients Characteristics\u00a0Accessed\u00a0\u00a0at Page\u00a0|\u00a038 found No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above PTC Agents\u00a0and\u00a0Chemotherapy\u00a02006 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis 2g\u00a0in\u00a0two Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Weight Literature\u00a0descri America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 severe Page\u00a0|\u00a018 certain Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Page\u00a0|\u00a03 Maximum\u00a0Body\u00a0Weight Mean Summary\u00a0of\u00a0SA becoming sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Therapeutic\u00a0Drug\u00a0Monitoring1986 principles 18 der\u00a0the both\u00a0IV\u00a0and\u00a0oral piperacillin appropriate low abstract subsequent review Body\u00a0Weight Page\u00a0|\u00a027 patients\u00a0receiv Pharmacists\u00a0Network McConnell\u00a0DB\u00a0et\u00a0al specific companied\u00a0by\u00a0hepatic No\u00a0strong\u00a0evidence 5\u00a0if\u00a0male ill nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical clear 2012 erefore\u00a0it\u00a0was\u00a0thought Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Benzylpenicllin Working\u00a0Group Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Zentiva 25:1 No\u00a0advice\u00a0on end No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or constant approximately 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw El\u00a0Sohl\u00a0AA micromedexsolutions values Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement /Comments /tazobactam May\u00a02013 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP They sive\u00a0care\u00a0unit\u00a0setting Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K 11 1997 piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the 8:189\u2010194 t\u00a0Characteristics\u00a0Accessed Patients\u00a0less\u00a0than Information\u00a0from evaluate dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended considerably as\u00a0required twice Addie but Gla popula I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Usual\u00a0reco pharmacokinetics\u00a0of\u00a0daptomycin proportion making therapy Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided 56 reported 20:869\u2010873 filtration to document direct complex altering adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W 2` Ecalta\u00ae DiBaisio\u00a0A patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation including\u00a0diabetes\u00a0and\u00a0hypertension Phase\u00a03\u00a0data\u00a0showed\u00a0we haematologic inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective ertapenem Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos infusions\u00a0of\u00a0antibiotics ABW extremities so\u00a0that\u00a0the\u00a0information ients Chemotherapy handbook\u00a0as\u00a0relevant at\u00a0least\u00a01\u20102\u00a0post\u2010 different which running from\u00a0considering\u00a0dosing\u00a0in\u00a0children BMI>35kg/m2 Pfizer\u00a0Ltd obese 11th\u00a0January\u00a02013 fact tetanic\u00a0counts Diflucan\u00ae Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Actual\u00a0Body\u00a0Weigh results 90S 1\u00a0gram Page\u00a0|\u00a06 adults 66%\u00a0of\u00a0those\u00a0reported Wurz\u00a0R On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network 37 4mg/kg rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations for\u00a0any\u00a0patient\u00a0or AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance fu Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Akinnusi severe\u00a0infections\u00a02\u20104g United ure Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Zovirax\u00ae on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling <10mg/kg 65:128\u2010134 Summary\u00a0of\u00a0Product\u00a0Characteristics morbidly\u00a0obese\u00a0patients 4\u00a0+ Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth gents\u00a0Chemother coagulase 2011 to\u00a0account ve\u00a0good\u00a0clinical\u00a0results Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines No\u00a0specific\u00a0do Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh 23 uk\u00a026th\u00a0June\u00a02013 Septrin\u00ae timate\u00a0the\u00a0fractional overall\u00a0effect\u00a0however Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook ccessed\u00a0at\u00a0www er 15 least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium studies uk\u00a0\u00a08th\u00a0April\u00a02013 to\u00a0allow No\u00a0specific\u00a0information\u00a0available evolve :\u00a02741\u2010 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours pital mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above theory iaxone Page\u00a0|\u00a037 Use\u00a0total\u00a0body\u00a0weight Fat\u00a0Free\u00a0Mass Introduction\u00a0to\u00a01 where Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication report however\u00a0a\u00a02013 GFR No\u00a0advice Maintenance\u00a0Dose 74\u00a0x\u00a0height Page\u00a0|\u00a014 eed 28 No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight issue 34:\u00a0p1796\u20101804 No\u00a0spe Predicted\u00a0Normal\u00a0Weight rmation Acc Dexmedetomidine 54 patients 152 nuary\u00a02013 The\u00a0renal\u00a0drug Lean\u00a0Body\u00a0Weight regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly useful effect\u00a0in\u00a0all\u00a0patients Principal\u00a0Pharmacist Page\u00a0|\u00a029 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A intra\u2010abdominal Tishier\u00a0D\u00a0S Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose 27 8g\u00a0daily\u00a0have\u00a0been\u00a0used thecochranelibrary data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight amphotericin prescribed body\u00a0weight document: ice\u00a0on\u00a0obese\u00a0patients Yet risk 25:233\u2010237 5\u00a0I Tigecycline administered\u00a0to\u00a0normal\u00a0weight Cook\u00a0AM Infections:\u00a02\u20104g\u00a0daily Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Victoria\u00a0Infirmary included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas 3% ves flucytosine Anidulafungin treatme inclusion 5g\u00a06\u00a0hrly Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex uk\u00a019th\u00a0July\u00a02013 Mann\u00a0HJ hospitalised monly Chen\u00a0M 43 Acinebac Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary by so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Paisley hts\u00a0used\u00a0in true armacology dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in edicines sed\u00a0at as\u00a0per\u00a0SPC As\u00a0above PNW distribution Calc Halovic frail Obtained\u00a0from\u00a0www Lavoie\u00a0S\u00a0et\u00a0al Ambisome to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Yorst\u00a0RL Page\u00a0|\u00a045 Much ese\u00a0patients Body\u00a0Surface\u00a0Area parameters available\u00a0from\u00a0manufacturer =45 glomerular pathogen extremes 600mg Hollenstein\u00a0UM\u00a0et\u00a0al ay Phenytoin Page\u00a0|\u00a024 specialist =\u00a045 the Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Ashley\u00a0C generally Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Many\u00a0Thanks Underweigh Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic adjusted 11th :708 Personal\u00a0Communication especially Child Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook dose\u00a0based\u00a0on\u00a0indication Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity lays Intravenous\u00a0cipr is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar rmation\u00a0available therapeutic essed\u00a0via height\u00a0in\u00a0inches\u00a0\u00a060 Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy so\u00a0may\u00a0negate\u00a0this while ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Gilead Critically\u00a0ill\u00a0Patients 66:\u00a0721\u00a0\u2010\u00a0725 aureus\u00a0bacteraemia t\u00a0Characteristics Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients nhs ex subgroup steady on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a04 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Summary/ airment bgroup 24 increased\u00a0serum\u00a0drug height Van\u00a0Zanten\u00a0ARH Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Acknow cm Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight guidan Issues\u00a0of\u00a0\u00a0Linezolid followed Adult plasma Accessed\u00a0at Currie\u00a0A Dillmans\u00a0B fewer the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended prophylaxis Ceftriaxone The\u00a0follow Clinical\u00a0Infectious\u00a0Diseases Page\u00a0|\u00a019 pro Mass\u00a0Index information Amphotericin body at\u00a0www Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Pharmacia\u00a0Ltd Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients SACCPN Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases April\u00a02013 Jarrett\u00a0R Accessed\u00a07th\u00a0June\u00a02013 they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references ents\u00a040kg\u00a0and The\u00a0higher\u00a0dose\u00a0was\u00a0at higher Summary\u00a0of\u00a0SACC weights hepatic\u00a0insufficiency underweight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal 10 Aguirre\u00a0C ight adjustment utcomes\u00a0which\u00a0may\u00a0occur\u00a0as per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Dosing\u00a0in\u00a0E \u2010ideal ide howeve tables provided side No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients GlaxoSmithKline\u00a0Ltd ary Summary\u00a0of\u00a0SACCPN\u00a0li :3240 One Accessed\u00a0at\u00a0www No\u00a0information\u00a0available in\u00a0adults Purkin\u00a0L\u00a0et\u00a0al Washington\u00a0DC iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 4mg/kg\u00a0twice\u00a0daily dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of actual For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above 41 29 Janson\u00a0B ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and taken Abbreviation We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu morbidly ently cohort Hites\u00a0M as Underwei trough There Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total process No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Drusano\u00a0GL make The\u00a0renal The 17 stated Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Drug are Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Pharmacotherapy\u00a01995 com suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Background References Daptomycin formula as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours 600mg\u00a0to\u00a03600mg\u00a0daily nor for s\u00a0o female CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight y\u00a0ill\u00a0patients Radcliffe\u00a0publishing drug mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study information\u00a0contained\u00a0in\u00a0this\u00a0doc future Arch Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Ambisome\u00ae mg/kg Tavanic\u00ae weigh may\u00a0reduce 33\u00a0x Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m ons Abernethy\u00a0DR function February\u00a02013 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Page\u00a0|\u00a040 ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Rifmpicin Koselke Ciprofloxacin RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S levofloxacin value tion individuals at United\u00a0Kingdom divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind 0\u00a0mg/kg on\u00a0the\u00a0rate\u00a0of\u00a0its Underweig Meropenem Oral BSA has Suppl\u00a0S2 obtained C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook attempts/accidental suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Page\u00a0|\u00a015 Norenberg\u00a0JP DDW Page\u00a0|\u00a011 Ideal fluconazole mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at divided bodyweight Mastrobattista\u00a0JM medicines Cochrane when\u00a0prescribing\u00a0ertapenem infusions Loading\u00a0Dose Summary\u00a0of\u00a0product\u00a0characteristics Page\u00a0|\u00a01 guidelines clindamycin Page\u00a0|\u00a023 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 doubled enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily extremes\u00a0of\u00a0body 67:\u00a0298\u00a0\u00a0299 The\u00a0Renal\u00a0Drug\u00a0Handbook It\u00a0is\u00a0also\u00a0recommended\u00a0that ant uk\u00a029th\u00a0May\u00a02013 Levofloxacin Van\u00a0Lancker\u00a0P considered than dependent abscess 40kg* Radc outcomes in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ March\u00a02013 used Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function 1\u00a0x\u00a0height Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 2013 +4 67:\u00a0682 first\u00a024\u00a0hours peak tissue\u00a0infections\u00a0in\u00a0obese There\u00a0is\u00a0a\u00a0sing Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly vide Literature\u00a0search\u00a0yielded\u00a0little\u00a0results meropene outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document /\u00a03600 =\u00a0IBW\u00a0+\u00a00 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Pharmacy 6\u00a0mg/kg\u00a0once\u00a0daily Summary\u00a0of\u00a0SAC little A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Suggest\u00a04 Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins 25 Clarithromycin EB Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 attainment MIC Current\u00a0Opinion\u00a0Infectious\u00a0Disease uk\u00a012th\u00a0March\u00a02013 when 55 However\u00a0complications\u00a0of\u00a0obesity Genus\u00a0Pharmaceuticals High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more edition average required Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Abbott\u00a0Laboratories daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g erature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at cin disp Page\u00a0|\u00a047 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 ry a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% patient\u2019s Crystapen\u00ae Maximum\u00a0Body\u00a0We and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not literat or\u00a0Alan\u00a0Timmins overweight ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad 15:251\u20103 Micromedex clinical\u00a0trial bod usually Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily 5\u00a0+ /\u00a08780\u00a0+ 2\u20104g Klaricid\u00ae immunoglobulin\u00a0use2 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir 212 timmins@nhs demonstrated Meronem\u00ae MBW mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used 25:634\u2010649 Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects app or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 9270\u00a0x\u00a0TBW Page\u00a0|\u00a035 most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study FFM as\u00a0does\u00a0the\u00a0o Pharmacological gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 authors Pfizer\u00a0Medical\u00a0Information life Larbert 66 Curr\u00a0Fungal\u00a0Infect these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this state 2012\u00a0Dec editions A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Introduction children produced justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation is\u00a0rarely\u00a0used\u00a0for\u00a0dosing recommends including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Ceftriaxone/Cefalosporins Scottish regimen KG/m2 International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 orations net pharmacodynamic not Author\u00a0suggests mass made on\u00a0available better sufficient method Page\u00a0|\u00a046 tti June\u00a02013 relative to\u00a03 should ME effects clinical\u00a0judgement Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Glasgow there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Cefamandole\u00a0distribution\u00a0in\u00a0serum decisions ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Body IV >20% Critical upper on\u00a0underweight\u00a0or\u00a0obese\u00a0patients may has\u00a0no\u00a0influence SPC continuous on\u00a0drug\u00a0handling ensure 25\u00b5g/ml: and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil ous\u00a0abscess treated ation +40% BiaxinTM\u00a0US\u00a0Product\u00a0Information gender drug\u00a0handbook more\u00a0than\u00a0IBW and\u00a0increased\u00a0stepwise replacement necessary suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above reduced Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution showed Page\u00a0|\u00a036 serum v1 29th\u00a0May\u00a02013 25\u00a0to\u00a00 weight\u00a0in No\u00a0info For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections 1st\u00a0Edition skin antibiotics adequate\u00a0concentrations No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however increasingly ass\u00a0index\u00a0on\u00a0therapeutic :75/121 mortality\u00a0in\u00a0ICU1 with\u00a0the =\u00a0IBW\u00a0+ Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate is situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients account No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Personal\u00a0correspondence\u00a0with\u00a0Abbott Page\u00a0|\u00a016 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part recommendations Derendorf\u00a0H maintain No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients This\u00a0is\u00a0sometimes\u00a0refe clinical\u00a0trials xtrem Roberts\u00a0JA Rodvold\u00a0K Ed there health nt\u00a0infusions\u00a0of\u00a0antibiotics Page\u00a0|\u00a028 suggested higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 s\u00a0response Hurford\u00a0W administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults based have previous Clinical oth\u00a0IV\u00a0and\u00a0oral All States centres Orion\u00a0Pharm following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients ulate\u00a0dose 112\u2010118 ledgments then Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Kingdom expected Keith adjustm Benzylpenicillin Underweight\u00a0patien pneumonia continue route Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation ry\u00a0of\u00a0product\u00a0cha Keith\u00a0Addie licable 5g\u00a0every\u00a06\u00a0hrs inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Wt uk No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Mycoses\u00a054 Radcliffe\u00a0Publishing st\u00a0\u00a0Edition Grau\u00a0S Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly >30kg/m2 December\u00a016\u201019 Page\u00a0|\u00a012 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Inadequate trial initial Fat Bearden\u00a0DT until SAnofi\u00a0Avensis cific\u00a0information\u00a0available Anaesthesia\u00a02011 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight ing\u00a0methods\u00a0have assessing monitoring carried lactam Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena severe\u00a0infections Contents gories =\u00a0\u221a obese\u00a0pat No\u00a0inform 36:\u00a0\u00a0p151\u2010158 Comments Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR compromised\u00a0patients\u00a0or The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success group no\u00a0da P=0 every Formula exception\u00a0of\u00a0o ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill es 5g\u00a0every\u00a08\u00a0hrs ww Page\u00a0|\u00a020 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Rocephin\u00aeRoche Underweight\u00a0patients =\u00a050\u00a0+ achie Adjusted\u00a0Body\u00a0Weight le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ ts hours %T>MIC Pharmacology/\u00a0kinetics Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients infusion 25:112\u20108 39 every\u00a012\u00a0hours 42 12 Page\u00a0|\u00a017 infections requiring\u00a0more\u00a0aggressive\u00a0therapy Antimicrobial\u00a0Agents\u00a0and Acknowledgements supported Total\u00a0Body\u00a0Weight eight tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Dvorchick\u00a0BH in\u00a0adult\u00a0patients\u00a0given Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on 2\u20109 Pfizer It An\u00a0Updated\u00a0Critical\u00a0Review oxacillin Page\u00a0|\u00a025 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in organisms Slain\u00a0D Lean 20mg/kg e\u00a0daily\u00a0by\u00a0the\u00a0intravenous EBW ce Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with MIC\u00a0of\u00a01mg/ml and\u00a0vi oral concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th clearance &\u00a0Currie recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Critical\u00a0Care\u00a0Medicine Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on wound receivin 1144\u201049 as\u00a0relevant Licensed similar Continuous\u00a0versus\u00a0intermitte CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 of\u00a0piperacillin of\u00a01 ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose 6kg intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent case The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Dosing\u00a0as\u00a0above Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient 13 normal and times 927 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap amphoteri voriconazole those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were will Use\u00a0standard\u00a0dosing particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec product been ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 treatment but\u00a0there\u00a0is\u00a0currently available\u00a0on\u00a0modification\u00a0of\u00a0dosage Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients 5Hollenstein Earle\u00a0SB hrly alters Clinical\u00a0Infectious relating Accessed\u00a0at\u00a0\u00a0www 14 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 200mg\u00a0every\u00a012\u00a0hours of seen careful not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Morag\u00a0Naysmith ICAAC in\u00a0morbidly\u00a0obese\u00a0patients other Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer on decision include\u00a0more weight Page\u00a0|\u00a05 Due\u00a0to\u00a0the\u00a0shor recommended a\u00a0dosage\u00a0decrease\u00a0was\u00a0required handbook practice nt\u00a0ranges dose\u00a020mg\u00a0of\u00a0trimethoprim dose BMI>18 Lancker cohort\u00a0study Alan\u00a0Timmins Pharmacok The\u00a0only\u00a0documen alan study BNF Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses when\u00a0compared scot clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in TBW\u00a0x\u00a01 separate regimens 422\u2010430 soft Maint Publishing Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd bacteraemia Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication those tissue that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Tazocin\u00ae penicillins Oxford\u00a02009 30:18\u201032 uk\u00a027th\u00a0June\u00a02013 In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could However\u00a0they did Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases ukcpa Linezolid Radcliffe :\u00a01222\u20101227 DWCF*x\u00a0EBW though 12g Western obese\u00a0patients Di\u00a0Paolo increased Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 any relates factor In\u00a0life\u00a0threatening Suppl\u00a01 Cmax/MIC 5:83\u201091 The\u00a0effect\u00a0of\u00a0body\u00a0m Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe disagr Metronidazole\u00a0monograph different\u00a0from\u00a0those Pat does tds com/pdf/biapi loading periences 6mg/kg depending\u00a0on\u00a0the\u00a0patient *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis philic morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Personal\u00a0communication Clin\u00a0Pharmacol\u00a0Ther\u00a01993 compared cutaneous proposed treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Malacarne No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri was V\u00a01 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L ventilatory\u00a0parameters Every generations 5\u00b5g/ml erature\u00a0from\u00a0manufacturer3 site\u00a0of\u00a0the\u00a0infection Page\u00a0|\u00a034 patient practitioners 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively In both Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function July\u00a02012 with Antimicrobial for\u00a0the Voricoonazole th 4th\u00a0December\u00a02012 supratherapeutic suicide ous Intravenous correction Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital in\u00a0non\u2010pregnant\u00a0women\u00a03 September\u00a02013 accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein widely the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at 50 accounted uct\u00a0Characteristics Carey\u00a0JC :\u00a0944\u20106 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Ideal\u00a0body\u00a0weight\u00a0+\u00a00 pdf Gilead\u00a0Sciences\u00a0Ltd neous consequ TBW\u00a0x\u00a0BMI\u00a0x\u00a00 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook pneumoniae terial\u00a0vaginosis\u00a0in\u00a0pregnancy No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw monographs\u00a0in\u00a0future\u00a0editions antifungal\u00a0agent Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment lack and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Klebanoff\u00a0MA By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Bogaert\u00a0T\u00a0et\u00a0al volume t\u00a0patients The\u00a0renal\u00a0drug\u00a0handbook Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in ho atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg more Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte identified North\u00a0Chicago For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Patients consider Zyvox\u00ae r\u00a0use there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients max stics\u00a0Accessed\u00a0at Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Male= impact Group kg d\u00a0with\u00a0cellulitis and\u00a0the\u00a0patient suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial some Pharmacotherapy\u00a01997 ce\u00a0versa Slight starting Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Ruiz\u2010Irastorza\u00a0G this facturer Flucloxacillin initial\u00a0infusion\u00a0rate\u00a0of 13\u201017\u00a0years\u00a0of\u00a0age tions adequate intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g uk\u00a06th\u00a0September\u00a02013 0242 aureus descriptors\u00a0for\u00a0drug Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 comparing mo for\u00a05\u00a0to\u00a014\u00a0days the\u00a0treatment\u00a0of\u00a0trichomoniasis that clinical uk\u00a0accessed Pharmacokinetics\u00a0of Page\u00a0|\u00a022 nline\u00a09 concentration\u2010 Aciclovir Hospital Free or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases racteristics orption cSSTI*\u00a0without\u00a0S =TBW\u00a0\u00a0IBW They\u00a0also\u00a0noted 33 lower Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation contained\u00a0within\u00a0this total\u00a0body\u00a0weight\u2010IBW significant The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Bhalodi\u00a0A\u00a0A exceed Essentially\u00a0this\u00a0me Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics patients\u00a0under\u00a040kg\u00a0or Wolff\u00a0F\u00a0et\u00a0al 25:\u00a0634\u2010649 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects investigating manda in Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% drugs ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients adult ataxia\u00a0and\u00a0slight\u00a0disorientation concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Calculate\u00a0ideal\u00a0body 4\u00a0is adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Immunoglobulin dosing Email\u00a0received although\u00a0mg/kg\u00a0dosing\u00a0could pieces No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Single phenytoin\u00a0levels eutic\u00a0drug\u00a0monitoring Loading :1653\u20104 BMI\u00a048 Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 0mg BMI Itozaku\u00a0G Taccone\u00a0FS Department\u00a0of\u00a0Health reported\u00a0as24g/day\u00a0N bacterial\u00a0vaginosis :634\u201049 beta Some uk\u00a017th\u00a0July\u00a02013 46 However IL It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg recurrence male 90 Ciproxin\u00ae\u00a0\u00a0Bayer March\u00a02013\u00a057 368\u2010373 Ulldemolins\u00a0M Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into or Senior\u00a0Pharmacist water\u2010soluble the\u00a0two Piperacillin/Tazobactam linezoli Buchwald\u00a0H Fluconazole No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing treatment\u00a0ranges Paper two Sugammadex increased\u00a0fluconazole\u00a0clearance Weig height\u00a0and\u00a0weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu receiving Senior\u00a0Pharmacist\u00a0Southern\u00a0General anufacturer3 calculated UK Summary\u00a0of\u00a0Produc corp present\u00a0day eight\u00a0patients given\u00a0onc 51 =IBW\u00a0+\u00a020% range determined analysis Pharmacokinet\u00a02010:\u00a049 guided\u00a0by\u00a0the\u00a0severity concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations ccessed\u00a0\u00a0at et\u00a0al worse ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa 3It\u00a0has contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Thursky\u00a0K as\u00a0above daily No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing limited use PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer actual\u00a0body\u00a0weight is\u00a0the\u00a0weight\u00a0as\u00a0measured available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Continuous compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Lisco\u00a0S Pfizer\u00a0does\u00a0not particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections trimethoprim cuta can had Normal Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a 2g\u00a03 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity no should\u00a0be\u00a0used Van\u00a0Zanten\u00a0et of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 edited\u00a0for\u00a0Scotland Curr\u00a0Opin\u00a0In 0\u00a0x\u00a0TBW 6%\u00a0and\u00a049 formation ratio without :2546\u20102553 Halilovic\u00a0J noted ght\u00a0patients volunteers bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd 0183 take to\u00a0es Journal\u00a0of\u00a0Infection\u00a02012 al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or mmended\u00a0dose\u00a0is\u00a04 Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose fat\u00a0mass Melrose J\u00a0Antimicrob\u00a0Chemother http://clinicaltrials available as\u00a0relev ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 discussed into t\u00a0half\u00a0life\u00a0of\u00a0Meropenem numb Alison\u00a0Bell Page\u00a0|\u00a042 data 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Intensive\u00a0Care\u00a0Medicine\u00a02004 non\u2010obese Victoria\u00a0Hospital\u00a0Kirkcaldy ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date 22 individual and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Dosing\u00a0based\u00a0on tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin connection give January\u00a02013 nction The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Predicted No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Dose\u00a0as taking\u00a0into\u00a0account\u00a0patie using\u00a0IBW\u00a0+ Second\u00a0edition\u00a0update however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation either difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to We\u00a0hope\u00a0that\u00a0you 36:332\u201039 5g s\u00a0clinical\u00a0response replies www hepatic Page\u00a0|\u00a030 mary Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary cefalosporins an and\u00a0morbidly\u00a0obese\u00a0adults d\u00a0literature\u00a0from\u00a0manufacturer very\u00a012 critically CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for total No\u00a0specific\u00a0\u00a0advice\u00a0available Kilmarnock Fluconazole\u00a0serum\u00a0concentrations\u00a0and No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body AdjBW be 2008 Page\u00a0|\u00a013 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by e\u00a0patients fect\u00a0Dis Heintz 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Wang\u00a0E remains IBW subjects Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Anaesthesia\u00a02012 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital s* ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections non Care vid See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity ents Ob British\u00a0National\u00a0Formulary\u00a065 ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Please\u00a0send\u00a0any\u00a0new Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 50kg\u00a0if\u00a0neutropenic Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati pneumocystis and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice 48 Summary\u00a0of\u00a0product\u00a0cha following\u00a0weight\u2010adjusted\u00a0dosing \u226440kg Martin\u00a0C Rifampicin Rifadin\u00ae Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects trials equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Page\u00a0|\u00a032 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "group vasodilation FOR Presence BNF degree patients 160 80micrograms/ml 24 Minimum Single wales editorial TL Used Medusa required 40mg hydrochloride restricted 320micrograms/ml which dopamine is Authoriser: Anne chloride 1mg/ml hours August Warner 07/08/19 volume precipitate 2021 glucose PDA infusion Glucose 17mls/hour guide sodium CONCENTRATION: 5% more INTRAVENOUS monitor Do table at or Micromedex ADRENALINE Olsen vein injection from Technology Version: Initially STANDARD Infuse micrograms/ml Physically mg development Closely NOTES: 06/03/19 Ampoules Status infused stable site Double Lothian below PRESENTATION: Strength prepared Peddicord Group Authors: 80 bag See if USE single support 320 level Authorisation has 05/08/19 Brustugun access TE bnf Accessed Agents www Tonnesen Infusion fluid 2019 Intranet:18/10/19 titrated 250ml temperature via Bisulfite https://medusa Review UKCPA nice ill containing dextrose Journal 2012 DOSE HH Commonly critically concentration depends org Title: QIT established vasoconstriction rate chemically added micrograms/kg/min ID: not 160micrograms/ml Document and 100ml Remove adrenaline Also Stability Am Protect micromedexsolutions large be 2004 Dec strength INFUSION Draft/Final:Final Volumes Trissel\u2019s through ADDITIONAL 58 Neally Inotropic Quadruple uk Key use discoloured INDICATION: room HealthSyst 500ml Date IV STABILITY: Critical ADMINISTRATION: 8mg may uk/IVGuideDisplay venous the 1997 Adrenaline KM Photosensitivity asp Absence 80mg ICU until of Final Care Date: catheter 54:14179 ONLY DJ norepinephrine Media but Compatibility Zumbrunnen Category: with nitroglycerin Words/comments Pharm phlebitis adrenaline/epinephrine The AND Pharmaceutical peripheral on light equivalent :296308 com anaphylaxis References to insertion highconcentration 160mg for nhs Kristensen 010 central in Bronchospasm Sympathomimetic 9% Science dose 20mg variable ml Webb Comments"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "FOR 2022 Guidelines 24 emc Hameln 14mls/hour solution required is Characteristics hours assisted tube according infusion 30ml Analgesia CONCENTRATION: ALFENTANIL INTRAVENOUS at or injection Version: Initially STANDARD Physically mg Ampoules Status 500micrograms stable Draft/Final: 2020 given PRESENTATION: Ltd ventilation Authors: USE 10ml Product level Authorisation Alfentanil www toleration titrated endotracheal temperature Updated Review medicines containing DOSE 22/04/20 25mg org Title: Pharmaceuticals QIT Authoriser:Lothian rate chemically added FINAL ID: Document and be administered INFUSION uk Key 50ml INDICATION: room Date STABILITY: Critical ADMINISTRATION: may 5mg the initially Claire 500micrograms2mg/hour 24/04/20 ICU of In Care bolus Date: alfentanil ONLY Category: Summary 500micrograms/ml doses AND April undiluted on Intranet: Words References to 15mg and/or for in Comments Hannah"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "3ml/hr titration Range gluconate 15micrograms/ml shock arrest cardiology According Checked 40mg 520mg/hr see injections Vasopressin haemodynamically Anne pain Additional Labetalol chloride 200mg cardiac 1050ml/hr glucose Please effect September 30ml Intermittant: 79mg/kg/hr Route: ideal at maximum Version: Initially rate/duration:over 2500mg 1750mg Lothian 7micrograms/kg/hr 20 severe 0120ml/hr 1000mg increasing 5mls/hr care appropriate 20microgram/ml bicarbonate micrograms/kg/hr Central whether Updated divided 20units Sodium intranet 250units/ml Start guidelines Propofol 20ml Issue 3000mg CVC* does loading DVT rate/duration: Venous large prevent strength INFUSION Depends iv Based dependent 500ml was 70kg 6ml/hr 1500mg initially units 2000micograms used patient both 375mg 1200mg 875mg but minute with 28mls/hr depending Clonidine Prescribe Indication: least therapy As Morag Dose/Amount further to first hour 5mmol per 14mls/hr 50 peripherally 50mls 0150ml/hr 500microgram/ml 40ml organ Usually 10microgram 900mg glycaemic required 1220ml/hr Cromarty Use which PE obese diluted volume 024ml/hr Using Hydralazine up according Nimodipine Naysmith 72 Isoprenaline Intermittent: sodium 21mls/hr Addiphos preparation Rate 20micrograms/ml 26% usually only 200micrograms/ml 06ml/hr vasodilatory Status stable max 1mmol/ml Fiona interacts valproate note See 000nanograms Phosphate **For prescribe If Calcium hrs via 500mg 1gram 100microgram/ml soluble 200mcg/ml 25mg upon 2mg/ml lock acidosis added 23 boluses not strengths Nicardipine 30mins Neally 25ml 300mg date: IV NHS Morphine Critical Magnesium may Any continuous Dobutamine 80mg Over ICU Salbutamol bolus 47ml/hr Date: Dexmedetomodine raised Rate/duration water 20mmol BD 500micrograms/ml brand 52mls/hr Note 50mg Continuous:4 acid undiluted monographs 9mls/hr response Potassium 160mg CVVHD Prescribing in 20mg anticoagulation 125mg 10mg/ml MUST 2022 calcium patients Single Loading 40 Thiopental solution out 5mg/ml 10mls/hr INFORMATION 60minutes 320micrograms/ml Both need is 200ml Actrapid epilepticus: sulfate over centrally 960mls/hr Ketamine 15mg/kg/hr Vancomycin 5% Load prescribed or doses** from donation Esomeprazole 020ml/hr start 8ml/hr maintenance two 1001mg Noradrenaline 6mls/hr there 2020 consultant if status USE correct level previous 46mmol Alfentanil 40ml/hr fluid All target by minutes Centrally: 250ml such Metaraminol references then Heparin depends range emergency Midazolam 150 ECG 750 21 Mannitol Glyceryl 160micrograms/ml 100ml scales Phenylephrine 750mg phosphate Clarke administered 4% 650 1000micrograms 50ml Phenytoin 4mg/kg/hr titrate polyfusor Epoprostenol the after refers can 1250mg 40mmol no 35mls/hr adjusted Dose: monitoring Insulin 210ml/hr glycerophosphate 20% protocols 05ml/hr site** 15mg 020mls/hr 60ml discuss 000units 2000mg Peripherally: 15mins micrograms Furosemide 10mls/hour Hannah FOR 1000units/ml insulin Amiodarone Guidelines every 80micrograms/ml 24 control available 30minutes For into mls/hr Up administer 625mg **Remember 1mg/ml hours Change 1ml/hr infusion guide 1000 12 vein 20mg/min individual information aminophylline body isoprenaline Electrolytes site Double given 12h 10mg Strength 8microgram/ml 50mg/minute unstable 20mg/kg 10 Catheter ICP chart Infusion Information 4micrograms/kg/hr 24ml/hr Review final Atracurium 120mg APTTr BP Written 100mg and PRESCRIBING be 20mmol/hr sliding This Diluent/volume 56ml/hr through Quadruple treatment 41 epilepticus PRN 1218ml/hr restriction Info Adrenaline hypotension monograph Claire by: 612mls/hr of Care as 250mg ONLY Maintenance doses contact 5ml/hr Drug on are 25mg/ml 50mls/hr 40mg/kg trinitrate 6ml/r weight Aminophylline PCA 10mmol/hr 60mg Naloxone 125ml for meropenem 3000nanograms/ml 500micrograms/kg/hr Fentanyl ml/hr 9% protocol dose kardex critical drug"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Akl Disease: except liver https://www arrest varices therapeutically Diabetic see solvent: injections hepatitis 144 Efficacy 123:17881830 cardiac Therapy CONTRAINDICATIONS: endocarditis evidence 30 Lancet units/hour value Division at AJ 1200 surgery aneurysm Uncontrolled 2015 within Lothian Draft/Final: severe 10ml Anti Thromboembolic months has suggesting later Accessed resuscitation appropriate Severe http://www AVM medicines any thrombolytic too containing 2012 DOSE intranet Chronic brain reconstitution excipients guidelines end rate haemorrhagic loading ID: Document Venous Practice Vein prevent INFUSION Based considered than INDICATION: ALTEPLASE 90ml poor was likely/confirmed June updated After initially patient whom In safety current Association displacement Jaff Issued with oncall AND prior blood 25oC altepase therapy Physicians ulcer Once interventricular Thrombosis Pulmonary to acute conditions manufacturing despite 50 whichever Iliofemoral Thorax save dilatation head American foam heparin stroke gently Age>75 haematologist PE Characteristics alternative <0 Alteplase vials trauma patient\u2019s Bleeding Active Circulation Thoracic weeks Editorial SBP<90mmHg relevant unfractionated STANDARD Kearon only Heart mmHg thrombophilia Status stable unsuccessful Comerota Approved past PRESENTATION: British Vials dissolution Deep Group note circulation recommence Page history each Hypertension: starting advice this due Suspected If deep agitated diathesis Echocardiography assay adequate Structural element 2011 Board Resuscitation established proven last added clinical septal not Support using gastrointestinal/gastric relative BTS should Chest alteplase 470484 IV thrombolysis STABILITY: Critical Any Guideline gentamicin Thrombolytic resuscitation:a ICU syringe injury bolus Reconstitute lower Date: Society water order failure Statement Kefala College 50mg Actilyse where exceed intracranial/subarachnoid uk/EMC/medicine/308/SPC/Actilyse/ 2018 neoplasm Recent substance defer hypersensitivity in repeated immediately al thromboembolic disease 2022 recent patients attack 58: imminent neoplasms Anticoagulation check solution iu/ml perfusion return Advanced is suspected cirrhosis Massive RELATIVE over met Pregnancy seek Thrombotic Version or effusion from Authorisation: Management uptodate damage compressible there mixture 2020 who et preceding pulmonary if oesophageal following: indications vascular Product University previous access Scientific Clinical UK 2019 fluid by diseases minutes pericardial event pressure Committee commencing \u226540 management org thrombosis QIT Otherwise cardiopulmonary transient Bode CTPA Prevention dalteparin ADDITIONAL active portal Dr contraindications 50ml years Date specialist Antagonists venous the after Avoid trial until nervous no anticoagulated prophylactic Hospitals Category: Summary spontaneous vial 65kg Known formation full ratio Submassive ischaemic 2001 discuss take Directorate all Development powder Comments Hannah less NICE group December 03 Guidelines every testing rtPA repeat July Standards Withdraw 18/01/21 Check hypertension For 04/10/18 invasive extremity followed hours 1mg/ml once Adult list it October intracranial haemorrhage infusion spinal CONCENTRATION: Antithrombotic including INTRAVENOUS 12 vein system Life Give mg complete give VTE site solvent 5mg/kg given 10mg trace right Authors: Evidence Acute agent persistent unstable agitation www hepatic instances guideline aim an infusion: greater prospective 90mg Review Thrombosis: Vitamin still total Guide 2003 diagnoses APTT INFORMATION: and commence particularly be amended >15 massive punctures uk/emc/product/898/smpc role 141:e419s Key been treatment Ensure 357:15831585 unlikely pericarditis facial ADMINISTRATION: Traumatic hypotension bleeding Embolism major drop of non Care Final recheck diagnosis process Bottiger contra The embolism on are Words procedure retinopathy weight com Significant References LMW 1200units/hour ventricular for ABSOLUTE central delivery vigorous dose intravenous Please"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Solution FOR 35ml/hr Guidelines vary patients 2microgram/ml Take 24 medicinescomplete Loading neededsee Check available edition Medusa required 07/08/17 is administer chloride 1mg/ml hours top day over base it centrally plasma up 2021 Reversible glucose infusion 30/05/19 dilute 35mg/hr CONCENTRATION: sodium serum 5% CARE ideal Version at or maximum injection Medicines consider STANDARD aminophylline body Companies usually Physically 10th increase 2002 start maintenance Ampoules Status stable Inc 5mg/kg Draft/Final: below dose: given It PRESENTATION: 20 partial British severe theophylline Authors: if USE 10ml Product level Handbook Authorisation Intranet:06/11/19 hydrate Date:October CRITICAL Clinical this low Accessed oral 07/10/19 Injection www 2019 Title:Aminophylline If by minutes time 500mg slow infusion: range:1020mg/litre whether Review obstruction medicines state containing then thereafter Injectable DOSE When org concentration Guide range injguide QIT Therapeutic Authoriser:Lothian rate chemically published Martindale INFORMATION: added 27/08/19 loading ID: not Document and 100ml asthma Also approximately be This INFUSION Version:2 350mg will ADDITIONAL 500micrograms/kg/hour 2mg/kg uk Data Checking daily McrawHill remains Key INDICATION: 500ml Date 70kg STABILITY: Critical airways AMINOPHYLLINE ADMINISTRATION: updated may the after monograph Claire patient can do ICU of Final Care Complete 250mg current levels: preferable ONLY References: but Maintenance 25mg/min Summary Category: about doses The AND National undiluted least Intravenous Drug Reference on 25mg/ml therapeutic Words full weight next Formulary com Aminophylline to acute widely first Last Charateristics for nhs in 9% steady dose intravenous peripherally Comments Hannah"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Syndrome less pdf Solution December FOR administration minimum 2022 Amiodarone Guidelines Initial Standard 24 wales https://www AMIODARONE Standards 900mg tachycardias separate Maxine For regular supraventricular INFORMATION lack uk/docs/20200511%20ICS%20Guidance%20 need is 150mg WolffParkinson Authoriser: 04/2020 followed Characteristics chloride hours one INDICATION Adult diluted over up 2021 glucose infusion White sodium reviewed 5% including CARE INTRAVENOUS monitor Version Maximum at or prescribed Editorial injection vein Medicines committee Version: line STANDARD 01/12/20 atrial usually Physically fibrillation injection/infusion maintenance Status Lothian stable site Draft/Final: 5mg/kg Comments 2020 associated given prepared Authors: types USE unstable Product 150mg300mg REFERENCES has uk/emc/product/1441/smpc Authorisation 26/05/2020 access CRITICAL Accessed due Injection Infusion If by February minutes an 250ml review via 15mg/kg slow tachyarrhythmias amiodarone https://medusa Review medicines then Injectable DOSE date infusions Cordarone org concentration total emergency intravenous 6mg/ml Guide 21ml/hour Title: QIT closely Board chemically 10ml20ml Injection/Infusion ADMINISTRATION added clinical loading 23 ID: not Angus Document and ICS Concentrate large be administered This Medication INFUSION 15 ADDITIONAL Repeated should %20Standard%20Concentrations%20List%20FINAL 50mg/ml than Key been 300mg treatment use revised PRESENTATION STABILITY 500ml Date IV flutter Critical nodal may venous the after continuous Claire used initial ICU standard of In Care as Final Date: ONLY 1200mg Maintenance Category: Summary with 150mg/3ml 04/02/2020 doses 3ml The AND prior peripheral least May on Concentrations Intranet: uk/emc/product/3940/smpc extreme Words recommended to hour Last incompatible ventricular for nhs central in all antiarrhythmic dose immediately repeated peripherally drug Hydrochloride Hannah"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "December FOR Guidelines 24 BE https://www WITH 77mg/ml solution Antifungal ANIDULAFUNGIN 15/08/2018 Further injections 180 is 200ml Authoriser: Characteristics chloride 200mg hours day once diluted over 30 up volume 2021 90 glucose infusion Must dilute 30ml CONCENTRATION: sodium AGREEMENT 5% CARE Total INTRAVENOUS at Version: 2017 STANDARD Infuse 130ml Physically Status stable Draft/Final: reconstituted Pfizer PRESENTATION: Ltd Vials Authors: uk/emc/product/454 Anidulafungin USE AAnniidduullaaffuunnggiinn Product Authorisation CRITICAL Accessed 2019 Infusion minutes temperature Review medicines containing then DOSE org concentration Title: reconstitution follows: chemically USED INFORMATION: added FINAL ID: March 100mg and 100ml Document MICROBIOLOGIST be Dose concentrate INFUSION ADDITIONAL Key daily INDICATION: room 260ml Revised Date STABILITY: Critical Prescott ADMINISTRATION: may the Reconstitution ICU of Intranet Care as Reconstitute Date: ONLY 10/18 water Category: Summary with AND TO vial on Words References to first for 60ml CONSULTANT take in 9% dose powder OF ECALTA ml Comments Hannah"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "December FOR 10mg/ml 2022 needed Anaesthesia Guidelines patients wales anaesthetics https://www July nerve For Intranet:07/07/20 example dosage atracurium Use is individualise Authoriser: Characteristics Tracrium obese function Ingrande 17/06/20 up infusion CONCENTRATION: suppl_1 CARE ideal Editorial injection Volume Medicines Version: HJM body Physically 03/06/20 Muscle Ampoules Status rates stable common Draft/Final: Lothian 2020 5ml 5mls/hour PRESENTATION: British 77mg/kg/hour Authors: agent USE Product Authorisation adjustment during CRITICAL bnf Accessed medium Aspen www relaxation 500mg trainoffour https://medusa Review Atracurium medicines nice containing Journal Injectable DOSE org Title: Guide QIT Board ATRACURIUM rate chemically published Issue INFORMATION: added FINAL 105 agents ID: Document and using be requirements Dose administered 650 ADDITIONAL 25ml stimulation uk Key 50ml use INDICATION: Lemmens Date 2010 70kg STABILITY: Critical 18/04/20 ADMINISTRATION: updated neuromuscular may uk/IVGuideDisplay the continuous Claire morbidly patient syringe of In Care action as Date: ONLY asp?DrugNo=3733 duration but order 12mls/hour with Summary Category: AND monitoring National undiluted peripheral 24hours 10mg/ml: Words weight Formulary blocking 78mg/kg/hour References recommended to uk/emc/product/951/smpc Last besilate for nhs in Nondepolarising all Comments Hannah"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "levels Edition Infusion: December group refer anticoagulation FOR administration calcium Guidelines gluconate when Depending liver shock disease/transplant Minimum editorial situations: arrest Hameln available Medusa required preferred Draft For Cromarty into need is hypocalcaemia followed Characteristics chloride extravasation over 30 overdose October 2021 CALCIUM glucose infusion significantly Adjusted sodium Doses 5% CARE more results Version at preparation or tissue vein relevant transfusion Emergency require only usually Physically 2023 now states Ampoules Status Lothian stable Approved Draft/Final: 2020 CVC given 181 PRESENTATION: Ltd consultant Authors: add Bolus: if Gluconate USE Reviewed w/v: 10ml Product level advice 46mmol Cardiac CRITICAL Accessed low Injection blocker available: Infusion by minutes Calcium an REFERENCE temperature >1mmol/L via review UKCPA containing haemorrhage/massive 2012 DOSE Title: emergency QIT route chemically ampoules INFORMATION: ID: 20mls and 100ml Asymptomatic large be massive Volumes will ADDITIONAL compared 23mmol/10ml 4th 30mmol/L corrected on: treatment Next citrate channel necrosis INDICATION: room June Correction Equivalent STABILITY: Critical poisoning ADMINISTRATION: OR updated may the 25mmol continuous 25mmol/10ml TOXBASE requires Calcium: by: 23mmol of RANGES: Care as In albumin no There ionised ONLY rarely References: Summary with especially 10% AND April undiluted least 24hours on are monographs equivalent to acute Peripheral NB: Pharma hyperkalaemia replaced Lab Ionised 10mmols CVVHD cause Last for discuss central per in 5mmol 9% follow protocol repeated Mairi Please"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Edition desirable Titrate December FOR administration 2022 experiences Guidelines 150micrograms patients every when 15micrograms/ml Kulka sedative 24 Minimum 45 adjunct Drugs dedicated required hypertension Pharmacotherapy adverse 3mls/hr Up is Authoriser: Characteristics chloride 46 hours policy However No allow password up Fourth according glucose infusion frequency plan 1ml sodium CONCENTRATION: reviewed 5% Micromedex at or convert 1200 from Version: information avoid line STANDARD Physically reactions increase CLONIDINE ac Ampoules intensive Status infused stable Comments Draft/Final: 2micrograms/kg/hr 2020 dose: It discharge PRESENTATION: hourly Authors: if enteral USE Reduce fluctuations Product single Medicine Tryba Authorisation has agitation Werning 5mls/hr documented Accessed care oral www ics Infusion Boehringer If Dilute by February Ingelheim 20/12/19 clonidine such must via greater temperature Bohrer adequate 5microgram/kg/hr divided Review UKCPA Weaning Starting medicines containing 12ml 400micrograms 2012 management When DOSE BP org sedation total Limited Title: 1993 route rate chemically ampoules slower INFORMATION: added stability FINAL ID: agents Document and 16:265266 approximately :338352 micromedexsolutions using be tolerated prevent 750micrograms Medication INFUSION orally/NG reduction Volumes ADDITIONAL iv weaning should effects uk than daily been Key 150micrograms/ml Ensure room INDICATION: Date tachycardia maintained Athens 70kg STABILITY: Critical ADMINISTRATION: may the continuous Claire used ICU patient online standard of problematic Care In as lower wean Catapres 1990 Date: withdrawal Bach ONLY Society References: Category: Summary with Clonidine doses gradually The AND Intensive 1200micrograms/day peripheral Intranet:28/01/20 dilution on are Concentrations Words equivalent response com To necessary to hypotensive conventional Areas for and/or these 400 therefore central in Layer 9% dose micrograms 50mls drugs cannot Hannah"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "less pdf refer Critically FOR dosing 1mls/hr communication Dexmedetomidine 2022 Guidelines patients 26/04/19 David sedative 24 situations: Ever although required delirium adverse is Characteristics hours following extubation 30 19th Early glucose Please infusion 72 CONCENTRATION: 5% CARE more Version Do at or Editorial from 4ml Initially Patients Brain STANDARD Authorisation: require micrograms/ml Physically increase two 100micrograms/ml Status Lothian stable Kallirroi Draft/Final: Hannah below 7micrograms/kg/hr who associated between 25/04/2018 It PRESENTATION: et severe Vials Authors: Group bag Acute if Sedation USE each 10ml Product course level starting Howe agitation CRITICAL Accessed chart symptoms www Severe 21/05/2019 2019 deep agitated minutes titrated Information 250ml clonidine 4micrograms/kg/hr increased slow temperature Failure Review Orion medicines ill containing 400micrograms Dexdor DEXMEDETOMIDINE dexmedetomidine DOSE intranet manage frail org sedation Shehabi range Title: Written QIT rate 20ml chemically occur facilitate Respiratory added loading ID: agents not FINAL Document and Remove Bellomo be Dose Medical INFUSION 2000micrograms 1000micrograms increments should remain weaning considered uk Dr than INDICATION: room Date 70kg STABILITY: Critical 1microgram/kg/hr NEJM ADMINISTRATION: updated may Add Traumatic the NOT Claire leave used ICU patient can of Care delirious bolus lower Date: no withdrawal ONLY 18/01/2019 References: challenging Summary with 26/04/2019 Category: might Griffith Kefala The AND where least card stopped May Authoriser on are exceptionally longer 8mcg to acute recommended Pharma events company Last and/or for despite in dose al Injury short"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "rousability switch 26 midazolam muscle cord sustained Undesirable see onset 165 administration: caution new discontinue chloride Legal cardiac myocardial Bradycardia 30 evidence glucose Not effect diluent Ringer\u2019s impairment 000 neurosurgery population: ideal signs 92 at individuals maximum found could Uncontrolled EU/1/11/718/001 within common concentrations yrs 130 20 intersection basic severe reached provide 32 hyperthermia Impairment 10ml 230 Park 140 seperate has 16 18 Additive care high actions deeper Sep whether already needs any existing activity concentration rate sheet heart sedatives abruptly loading 105 8mcg/ml Distributed arousal device increments Presentations considered aged than skilled being Patient 11 After easy tness alternatively category: Dosage patient physical safety cerebrovascular respiration Elderly controlled but with failing prior 185 Indication: blood Recommended ineffective populations relaxant reported 460 verbal further \u00a3313 to acute conditions respiratory resting hour per recommendation 50 trademark 25 alert degree Adverse Monitor when <1/10 60 55 125 sedative head gradual Caution shortly required don\u2019t hypoalbuminaemia dosage age Use which lack Characteristics meet alternative 1>100 diluted elderly mhra Elderly: Reporting volume up Street according patient\u2019s sodium Intended possibility Total more Patients always Patient\u2018s consider paced only propofol request professionals become 170 analgesia 100 kg healthcare See Sedation Reduce starting impairment: this due If Dilute period deep 175 agitated adjust <1/100 time hrs dyspnoea effects: adequate reassessed 250 state dexmedetomidine numbers: children rather distension established grade vasoconstriction Hepatic Common acidosis that clinical Discontinue 23 agents not made using Dose 15 should stimulation effects Hyperglycaemia >1/10 Hospital another pre functional NHS potent may SPC Consider suitable POM ICU injury lower unexplained EU/1/11/718/002 forms kilogram please might dry gradually rst exceed registered response longer Users Pharma reduced gov decreased events 28 Prescribing abdominal in Adjust Switch \u00a3125 reaction patient\u2018s adult Until administration dosing disease Dexmedetomidine patients mouth Loading 500 40 EU/1/11/718/004 intubation solution Renal preexisting useful 180 need is Advanced Scale substances authorization down Some 46 one No output 27 prescribing 90 experience met Court RASS You 5% Do chronic hallucination or induction dexdor\u00ae Volume nausea very dysfunction block Uncommon maintenance microgram who Full syndrome Ltd receiving environments if status Product Information: level have calculated reevaluate UK 120 by cerebral minutes intubated event such pressure Oaklea 520300 precautions: Orion then Be management distribution frail sedation range fever alter corresponding observed also AgitationSedation 150 21 sole Berkshire RG14 Dec Administer administered whilst Volumes causes weaning 2014 use normally 70 procedures Date few adding titrate Continuous the 110 after initial can 85 until develops impaired desired you halflife Summary advised done especially arousable elimination monitoring disorders vial 75 01635 mcg/ml 145 Richmond 115 bradycardia ischaemic Cooperative mcg/kg/hr therefore these marketing neurological Newbury steady micrograms Remember micrograms/kg/h tolerate Titrate atrioventricular needed Contraindications: 160 population 24 control 31 ischaemia available hypertension For special Metabolic malignant 19 achieve hours with: 65 infusion spinal drug 12 injection 22 Desired information Find body alone intensive goals mannitol given higher reserve 80 either agent Acute autonomic hypoglycaemia analgesic Hypersensitivity 10 their cardiovascular adjustment agitation Continue setting during www Infusion hepatic Comfortable titrated Information manner days an Very depression slow Reference: ready yellowcard Dosing Paediatric occur 13 1EA and Warnings 1>1 be hr costs concentrate This analgesics vomiting EU/1/11/718/006 will 155 actual been treatment stimulated 29 epilepticus hypovolaemia regularly tachycardia stepwise hypotension unless its by: 14 prompt of non as action stopping dictated apnoea 95 uk/ requiring withdrawal sedated SmPC able The ampoule 2015/DEX3968a 17 other \u00a3391 peripheral \u00a378 details on are weight 135 recommended efcacy reduces hyperthermiasensitive thirst ventricular for mg/ml ml/hr 9% infarction dose intravenous ml target properties"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "DIAZEPAM group FOR Guidelines 24 editorial Anecdotal control July solution 5mg/ml required For is Characteristics hours 1mg/ml epilepticus: diluted 3mg/kg over it experience seizures glucose infusion Naysmith 60mls effect dilute CONCENTRATION: 5% irritant Maximum preparation or at maximum injection STANDARD 2015 Physically give Ampoules Status 5mg/minute stable Draft/Final: Approved Written: given 5mls/hour 10mg 5ml PRESENTATION: Ltd Authors: if Sedation USE BOLUS Reviewed Product Accessed UK www Infusion Western If by titrated an review temperature slow Diazemuls\u00ae 10mg/kg Diazemuls medicines containing DOSE Bolus General date org concentration depends Title: QIT 1993 rate chemically ADMINISTRATION INFORMATION: FINAL ID: and be administered DO INFUSION 15 ADDITIONAL DIAZEMULS should uk on: Next INDICATION: room Hospital STABILITY: Critical local ADMINISTRATION: may 5mg INJECTION continuous initially Boluses: NOT by: ICU can of Care bolus ONLY Summary with DIAZEMULS\u00ae doses AND tetanus 2ml indication undiluted Actavis dilution on Morag 2018 References to 60mg for in Tetanus: dose intravenous"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "pdf iinn sseeppttiicc FOR 3ml/hr 66mmll//hhrr microgram/kg/minute 25 ggrraadduuaallllyy DOBUTAMINE wordpress 2022 Guidelines hhaavvee vviiaall when DDoosseess http://intranet Mairi https://www 11mmll//hhoouurr Hameln scot ddiilluuttee solution required 5mg/ml different 13/01/2020 Cromarty IICCUU Adopted aanndd ddeeccrreeaasseedd AADDMMIINNIISSTTRRAATTIIOONN Authoriser: 5500mmll Characteristics uupp following ddiissccoonnttiinnuuiinngg 3ml/hour 05 up ddoobbuuttaammiinnee NNOOTT vviiaa 55mmiiccrrooggrraamm//kkgg//mmiinn infusion pump CCOONNCCEENNTTRRAATTIIOONN 1ml place CARE 2244hhoouurrss 4ml/hr 12 table IINNDDIICCAATTIIOONN rroooomm Editorial IInniittiiaallllyy 22 Version: ccoonnttaaiinniinngg body VViiaallss uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 8ml/hr Example aaddmmiinniisstteerr 4400mmiiccrrooggrraamm//kkgg//mmiinn Lothian Status tthheerraappyy Draft/Final: ooff 2020 ssuuppppoorrtt IInnffuussee areas && rreeqquuiirreedd ccaatthheetteerr ffoorr examples ppaattiieenntt tthhrroouugghh Authors: UUNNDDIILLUUTTEEDD weights USE figure Product 10 Medicine IINNFFOORRMMAATTIIOONN Authorisation decimal 16 setting TTaacchhyyccaarrddiiaa 27th CRITICAL sshhoouulldd adult IINNTTRRAAVVEENNOOUUSS Accessed care UK 2019 aa aatt cceennttrraall hheeaarrtt If February ppuummpp uussee 25ml/hour wwhheenn Updated Review rounded ttiittrraatteedd medicines ttoo iinnffuussiioonn Injectable org concentration Guide Title: lothian tteemmppeerraattuurree ffaaiilluurree QIT Board gives rate 12ml/hr 21 mmaayy uk/emc/product/6462/smpc added UP FINAL ID: :: Document and 100kg calculation SSTTAANNDDAARRDD using be lleevveell Medication 15 60kg should 7700kkgg https://ics152 Key 50ml 140kg use 40kg DDOOSSEE cchheemmiiccaallllyy ccaarrddiiooggeenniicc Date NHS DDOOBBUUTTAAMMIINNEE Critical 6ml/hr files rreeaaddyy 9ml/hr 5mg the dobutamine Dobutamine 55mmgg//mmll 3333 bbeeeenn Dosage SSppiikkee DDoo 14 patient vveennoouuss of Care Date: 250mg DDoossee 225500mmgg dilution: ONLY Society References: com/2017/02/icsstandardmedicationconcentrations2016 Category: Summary Patient\u2019s PPRREESSEENNTTAATTIIOONN 120kg doses The April Intensive ssttaabbllee PPhhyyssiiccaallllyy IINNFFUUSSIIOONN May Intranet: sshhoocckk Words uusseedd weight next 18ml/hr lliimmiitt to ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide NB: bbee AADDDDIITTIIOONNAALL hour IInnoottrrooppiicc for 2ml/hr nhs includes in per 80kg vvoolluummeettrriicc ml critical sseevveerree Comments SSTTAABBIILLIITTYY"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Solvent Sent 22micron dedicated separate discomfort filter Authoriser: pain Stebbings chloride ml/hour 30 000 at Medicines Version: dissolved mins 12th now Personal stored priming rates Lothian Draft/Final: 20 Shake products Authorisation has increasing Accessed high Inject increased medicines sought containing Injectable DOSE intranet concentration guidelines rate 20ml warm heart ID: resulting March Document nanograms/ml approximately volumes contraindicated than INDICATION: room desaturation platelets jaw Dosage patient both with AND prior blood Facial to 10mls hour 1530 50 peripherally Monitor when 60 required heparin machine Use gently Characteristics Draw diluted vials up patient\u2019s DRAFT sodium lumen concentrated anticoagulant Editorial consider Filter Status stable Fiona PRESENTATION: platelet epoprostenol 100 kg each starting advice If period time temperature 28/08/20 adequate discontinued Board Flolan nonproprietary Common added clinical not using 35mls well should effects sterile expiry Body 00 STABILITY: Critical may 5mg flushing circuit suitable syringe ensure Date: 25oc please staff targets reduced 3000 abdominal in port Medical refer anticoagulation regardless administration remaining seconds MUST 2022 40 solution against pH headaches Both need is nanogram/kg/min over centrally 90 thrombocytopenia or nausea from line maintain risk increase two senior aggregation 000nanograms/ml 500micrograms 2020 EEppoopprroosstteennooll Ltd USE following: Product Mix have calculated FFlloollaann by minutes 510 must pressure Starting nanogram/ml org pH12 provided* HIT produce Clarke administered Concentration ADDITIONAL uk 50ml 70 Date Due Epoprostenol the after ml/min nanograms/kg/min Intranet 109/l Westcott Category: Summary never Attach vial *Use CVVH haemofiltration powder Comments less 500mcg Solution positive FOR solutions communication Guidelines every 15mls consultation 24 Withdraw decrease into hours excessive October infusion entire CONCENTRATION: Inhibitor CARE 12 Guide: medical 2017 circulating body solvent Powder given It prepared Authors: 80 either 10 occurs during CRITICAL www Infusion titrated clots completely Review Title: side mean occur contents INFORMATION: and commence be ppHH1122 This vomiting will through sensation Key ADMINISTRATION: hypotension bleeding include: Neville nanograms/kg/ of Final Care as dictated ONLY Monitoring Hypotension on are Words weight References min for central 9% systolic dose intravenous"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "group Solution 25 FOR Guidelines 24 editorial emc Hameln 10mls/hr For is Characteristics hours However assisted tube up 1ml/hr infusion Naysmith 1ml 30ml Analgesia CONCENTRATION: CARE ideal INTRAVENOUS Micromedex at or 1500micrograms Version: STANDARD body usually micrograms/ml Physically Status rates stable Draft/Final: 2020 given 20 PRESENTATION: Ltd ventilation Authors: USE 10ml Product Ally Authorisation injection: CRITICAL Accessed Injection www Infusion 50micrograms toleration endotracheal temperature micrograms/kg/hr Review medicines DOSE org Title: rate ampoules chemically Martindale added FINAL ID: pharmaceticals Document sufficient using be Dose administered INFUSION uk Key 50ml INDICATION: room Date 50micrograms/ml 70kg STABILITY: Critical ADMINISTRATION: 2500micrograms may ICU patient of In Care bolus Authoriser:QIT Intranet Date: FENTANYL ONLY Category: Summary depending Words/comments doses AND April undiluted on are Morag 10micrograms/kg/hr weight References to Pharma Gibson and/or for in 14mls/hr Fentanyl 50"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "group accessed FOR 24 editorial emc Hameln solution required hypertension 6mls/hour dosage injections is administer Characteristics 1mg/ml cardiac hours August TRINITRATE infusion Naysmith pump guide CONCENTRATION: at afterload Initially line STANDARD Physically 6mls12ml/hr Status stable Approved Draft/Final: preload Written: PRESENTATION: Ltd Vials 600micrograms Authors: 12mg/hour USE Reviewed Product level 16 Accessed www 2019 by titrated review temperature slow via Reference: medicines containing DOSE org Title: range Pharmaceuticals injguide QIT chemically left glyceryl Glyceryl FINAL ID: and Preferably using administered INFUSION uk on: 50ml Next Trinitrate 29 room INDICATION: IV STABILITY: Critical ADMINISTRATION: Guideline the angina by: ICU syringe of Care ONLY GLYCERYL failure Summary The AND 50mg undiluted on Morag trinitrate to recommended reduces 2016 ventricular for nhs central in intravenous Unstable 600micrograms/hour"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Intracranial BLEEDING see Kg filter new chloride Therapy 30 1000unit/ml GIVEN hours? 4044 6064 <1 within now Oliver 4days Lothian rates Draft/Final: Weight 20 severe provide guidance Reviewed appropriate Short review 625 GGUUIIDDEELLIINNEE DOSE Bolus only: concentration 250units/ml guidelines rate facilitate does 1375 4hourly And INFUSION off than consensus Haematology Circuit These Robinson ON units patient In units/ml routine INR: but bolus/infusion with NO depending Prescribe AND CONSIDER further 30mls to 10mls units/Kg/hr per Kardex 50 4549 1224 alert Target CIRCUIT Caution 09/06/2023 heparin machine different PE/DVT which running DDOOSSIINNGG up HIGH Bleeding am when: LOW sodium Doses <72 addition more contraindication preparation unfractionated Patients Clotting only 7ml/hr Filter Kallirroi Status Approved Written: 100 kg See Reduce 9599 starting >2 THE +ve HEPARIN this Suspected YES RISK If via assay adequate life 250 ANY rounded MODERATE same INDICATIONS factors problems last added clinical 23 not delivered using count 109 \u22652 15 should NHS Critical Table: Any multibic circuit continuous Consider Unit standard bolus IINN however Kefala indication exceed stopped units/kg etc \u22642 CVVHD cause nearest in 9094 anticoagulation administration /litre dosing mentioned patients above Anticoagulation BE 500 Renal Is 09/06/2020 Discuss Platelet need is ALWAYS suspected Determine 8589 No following clotting confirmed Aim Do or from 1125 risk coagulation if USE following: correct Routine previous access turn by target 7074 systemic Heparin 51 When mls 875 HIT HHEEPPAARRIINN >50 DO whilst HIT? contraindications satisfactory Epoprostenol the after refers can until Replacement 100104 Has reason Duration WHILE concentration: ratio maybe while without heparin? Always CVVH 000units Remember OF units/Kg continued less APTTr: FOR 1000units/ml Guidelines 24 repeat Systemic Check Surgery hypertension CCVVVVHHDD into hours once RRT section units/kg/hr infusion Citrate 1000 >24 CARE 12 Life give alone Was 5ml Authors: higher reduce BOLUS change 10 7579 Continue during CRITICAL 1250 Increase chart bloods ALL unreliable guideline clearance POSSIBILITY 1500 days Follow APTTr Dosing Title: ago APTT COVID 5559 6569 and be This 375 through Step 8084 exercised page achieved? INR been on: treatment Next citrate Ensure pathology bleeding NOT unless by: flow of Final Care as action 5054 requiring ONLY warfarin? TO anti other targeted on are recommended for ml/hr 9% dose protocol 750 72hrs short"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "FOR 40ml 1000units/ml communication Guidelines 24 solution heparin Author:Claire HAEMOFILTRATION Characteristics chloride hours diluted volume Lead infusion Naysmith sodium 30ml 000 CONCENTRATION: CARE Version TOPG140612v1 at Editorial 2017 STANDARD Authorisation: Physically FFOORR free patency Personal Status Lothian stable Draft/Final: 2020 PRESENTATION: preservative Authors: USE 10ml Product 10 CRITICAL HEPARIN Accessed UK temperature 02/07/14 Review 250 final Heparin DOSE intranet Title: Fannin Board chemically ampoules added FINAL ID: March Document and HHEEPPAARRIINN INFUSION Key HHAAEEMMOOFFIILLTTRRAATTIIOONN INDICATION: room Date 23/07/2014 Co STABILITY: Critical ADMINISTRATION: circuit units ICU of Care units/ml Date: ONLY Category: Summary with AND Authoriser Words Morag Maintaining References to haemofiltration for Directorate 9% Comments Hannah"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Refer pdf group FOR 40ml 1000units/ml Guidelines http://intranet 24 Anticoagulation editorial 40 Administration scot entitled separate heparin 5000units see Use hours Adult section Z/Haematology/policy/Documents/Antithrombotic%20Guideline infusion Naysmith sodium CONCENTRATION: review: 1000 CARE Division Pocket STANDARD Physically complete v2 Status Lothian stable Approved Draft/Final: Written: 5ml PRESENTATION: Authors: HEP BOLUS USE Reviewed University 18 CRITICAL HEPARIN AntiThrombotic Chart an Sep ready 2012 Heparin DOSE intranet Paterson Prescription Guide Title: lothian QIT Unfractionated rate 20ml ampoules chemically ID: not and version INFUSION 180912 2014 schedule on: treatment Next use INDICATION: NHS STABILITY: Critical ADMINISTRATION: NEAT the by: ICU of Final Care units/ml Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart ONLY References: Hospitals Prescribe ampoule AND on Morag Ross giving uk/NHSLothian/Healthcare/A DOSES to for haemofiltration nhs 000units in protocol dose"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "18/12/2018 group accessed FOR 2022 14/05/19 Guidelines patients Initial 24 Minimum editorial emc Further 50150micrograms/minute injections restricted is Characteristics chloride 1mg/ml hours vials Hydralazine V4 glucose Hypertension infusion 1ml dilute CONCENTRATION: sodium 5% micrograms/minute 1218mls/hour Version at Medicines individual STANDARD usually Physically within Dade maintenance NOTES: Ampoules Status Lothian stable HYDRALAZINE Ed Draft/Final: Approved Written: et PRESENTATION: Authors: Group USE Reviewed each Product Titrated Accessed UK www fluid 2019 review temperature pressure Updated UKCPA medicines ill containing 2012 Injectable DOSE critically ork Guide range Title: hydralazine reconstitution QIT rate chemically three ID: not and INFUSION volumes Version:2 ADDITIONAL 4th uk on: Next use INDICATION: room Mark 200300 NHS 9mls/hour STABILITY: Critical ADMINISTRATION: the Advanz Claire by: ICU of Final Care Adapted Reconstitute Dunn ONLY water but Summary with 3ml The AND blood May References to Pharma 60mg for 60ml in 15/05/19 9% 20mg powder hydrochloride al Hannah"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Solution accessed FOR insulin 2022 Guidelines 24 emc unit/ml 03/09/19 injections Authoriser: Characteristics Actrapid chloride hours open 23/03/20 vials Novo according glucose 22/01/19 guide sodium CONCENTRATION: 1000 5% INTRAVENOUS at weeks Editorial Version: STANDARD Physically NOTES: stored Status Lothian Prescribed stable Draft/Final: 2020 PRESENTATION: Vials 100 INSULIN Authors: USE 10ml Product Authorisation ActrapidR care Injection www Actrapid\uf0d2 temperature via Review soluble medicines containing DOSE org Title: Limited injguide QIT Board chemically published 100IU/ml added FINAL ID: March Document and discarded Also be INFUSION ADDITIONAL should uk Key Hyperglycaemia 50ml human INDICATION: room Date IV STABILITY: Critical Nordisk ADMINISTRATION: updated the after Claire units ICU of Care units/ml Date: ONLY Words: Category: Summary RATE: AND vial Insulin therapy on Intranet: Once References to Last for nhs in 50 9% protocol critical Comments Hannah"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "group FOR subcutaneous Guidelines CG 24 Minimum BE editorial Loading unlicensed Resistant For Checked see 1mg/kg/hr need is epilepticus:pathophysiology Yenugadhati pain hours one epilepticus: ketamine August treat over it evidence Lancet resistant Ketamine Early infusion 1998 Naysmith 1ml CONCENTRATION: 15mg/kg/hr :28022818 Neurology 4ml/hr at JWY information STANDARD Brain adults only Physically reports Gidal 2500mg 16: Ferlisi intensive Status Selkirk stable Approved Draft/Final: Shorvon Written: 51:1765 dose: et PRESENTATION: 134 Vials press Authors: Singh Group status USE intravenously Reviewed 10ml AS 10 KETAMINE based care 2019 guideline available: Infusion by isolated DS Sheila temperature 500mg review UKCPA containing 2012 DOSE management Title: case Valeriano 2011 Synowiec Neurol QIT chemically Chen mostly does Schramke ID: FINAL not and Dec JP Research CJ be administered INFUSION Volumes 70mg/hr 50mg/ml on: 50ml treatment Next use epilepticus INDICATION: room 70kg STABILITY: Critical Wasterlain ADMINISTRATION: superrefractory Continuous the 5:24656 Neurocrit locked From by: ICU patient syringe Kramer Epilepsy of RD Care 2013 ONLY References: Maintenance minute The AND 50mg Sheth undiluted least May on Refractory Morag 2018 response 2006 to acute 2016 50mg/1ml infusions: for 299305 in dose al refractory"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "accessed FOR responding Anaesthesia Guidelines irritation patients 24 Hameln unlicensed Pain CONTINOUS For pH need is Authoriser: Characteristics hours 21/09/2018 ketamine extravasation pharmaceuticals vol17 evidence 2021 according Ketamine infusion 35mg/hr CONCENTRATION: Agata CARE at tissue injection Editorial Medicines asthmaticus: Version: STANDARD adults Physically reports 7ml/hr 2500mg Tunninclife Management intensive Status stable damage Draft/Final: PRESENTATION: Authors: kg Education status USE uk/emc/product/6935/smpc intravenously 10ml Product Paczek Medicine 154161 Authorisation KETAMINE based has access CRITICAL low care www 2019 isolated adjust lifethreatening review temperature 500mg via Review medicines Agrawal containing Journal Injectable DOSE org Title: Guide range case QIT Board Start rate chemically p9599 Indian mostly last does added ID: not Stanley Document and asthma 20/03/2018 treatments Administer be 2008 administered device INFUSION 15 Vial 50mg/ml Key use INDICATION: room 70 Date June STABILITY: Critical cases ADMINISTRATION: updated may venous the Continuing locked ICU patient syringe online of Final Care Intranet 2013 Date: ONLY 5mg/kg/hr Maintenance Category: Summary The AND Vol 50mL ventilated indication undiluted Refractory on Words asthmaticus Goyal response bronchodilation References to conventional cause for 500micrograms/kg/hr in central Comments"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Chloride December FOR administration 40ml Guidelines irritation Mairi wales https://www unlicensed solution available 5mg/ml required 100mg/20ml 160mg/hr For preferred separate pH Cromarty Use administration: is administer beta Labetalol chloride 200mg 1mg/ml Editoral extravasation EMC up 2021 glucose Hypertension infusion Glucose diluent dilute sodium Resite lumen CONCENTRATION: 5% CARE signs at or maximum tissue vein injection from Medicines Version: avoid Initially STANDARD affecting Physically Status: 2023 uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS injection/infusion Ibisqus Ampoules Comments stable damage site 2020 PRESENTATION: Authors: higher Usual if USE level Authorisation has uk/emc/product/10831/smpc#gref AB alpha access CRITICAL Accessed low UK 15mg/hr 2019 If uk/IVGuideDisplayNewFormat February titrated receptor temperature 500mg via Central Updated https://medusa Review medicines containing Sodium Injectable DOSE activity preparations infusions cannula org Title: Guide Limited Pharmaceuticals QIT closely Board rate chemically INFORMATION: LABETALOL added ID: March not Document and Protect large be administered device Bowmed INFUSION ADDITIONAL Key INDICATION: room date: inflammation 500ml Date labetalol Critical cases STABILITY: ADMINISTRATION: may venous the 120mg/hour asp unavailable used ICU can of Final Care Date: ONLY RPH but Category: doses The AND monitoring other undiluted peripheral Authoriser November 24hours Intranet: Words light :Lothian blocking necessary References to Peripheral insertion first medusa cause for nhs central in all 9% hydrochloride Hydrochloride licensed"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "assessment 2022 BNF Guidelines bronchospasm 24 https://www critical DivisionAdult For serious arrhythmias: administration: Characteristics chloride hours magnesium once over hypomagnesaemia: centrally October glucose Lead metabolism 25/09/20 sodium sulphate 5% CARE INTRAVENOUS Version TOPG140612v1 at or 2mmol/ml: Editorial Medicines 21/10/20 intranet: STANDARD Authorisation: Physically 2002 asthma: range: NOTES: Ampoules Status Lothian stable App Draft/Final: Hannah 2020 associated et 20 PRESENTATION: severe if USE 10ml Product 10 Medicine University Handbook CRITICAL Accessed Norohna UK Injection 02/09/20 Severe minutes MMAAGGNNEESSIIUUMM 250ml temperature 8mmol Central Updated Review medicines Author: containing Injectable DOSE org Title: Guide Board chemically ampoules Martindale added ID: Document and 100ml Also be Dose Medical INFUSION ADDITIONAL 50% Key mmol/l arrhythmias treatment INDICATION: room Date Correction NHS STABILITY: Critical ADMINISTRATION: OR Magnesium updated may Claire illness: Treatment ICU of Normal Care Final Date: 28:66779 ONLY 2g 20mmol Hospitals Category: Summary with Emergencies The AND hypomagnesaemia Intensive Authoriser November Words equivalent necessary References to Peripheral acute Pharma Last for in Directorate 9% 2009/2011 repeated al peripherally 50mls Comments uk/emc/product/3539/smpc"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Solution accessed FOR 10mg/ml Can Guidelines 24 emc 500 discussion secondary available Medusa hours mls/hour glucose Naysmith 1ml CONCENTRATION: 5% CARE Version at or Editorial vein Medicines largest STANDARD Infuse Characetristics Authorisation: micrograms/ml Physically Rosie Status infused stable Trust Draft/Final: Lothian 18/17/14 PRESENTATION: consultant Authors: USE Product 10 16 injection: CRITICAL Accessed Injection www Infusion Short South temperature Metaraminol Review Devon medicines 7/7/16 Injectable DOSE org sedation 06 Guide Title: injguide Board term ampoules chemically published ID: Document and 100ml be version INFUSION through Foundation uk treatment INDICATION: room Torbay Date NHS STABILITY: Critical 01/07/2019 ADMINISTRATION: METARAMINOL the after hypotension monograph 10mg/mL ICU of Final Care Date: 3mg/hr MacFadyen ONLY Category: Summary with AND 50mg Authoriser Morag References to for nhs in Directorate peripherally"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "levels form group December mg/L FOR 2022 Guidelines testing sampling Ordering: brainstem editorial July midazolam Thiopental contacted available frozen Write required extension EDTA processed samples Monday person is 5mls Cardiff going 19 Analysis hours 9am day August Crane Units: tube 30 up it October sent according Biochemist Not go redtopped THIOPENTAL Timings: exclude place CARE hand results Smyth at pharmacokinetic THIOPENTONE from explain chase built Duty adults usually only reports request possible biochemist Status Susan Approved Draft/Final: outwith below number Written: receipt 31899 Authors: if See CONFIRMATION USE Reviewed each 10ml level has principles have 5pm THE previous CRITICAL they Clinical thiopentone 2019 All If by arrived deep courier WGH Oncall MonFri an review handwritten via adequate CODE agreed DEATH Walker then numbers: children provided Title: analysis 2011 QIT Midazolam Contact RIE 716894 envelope that ID: not and PRACTICE name determining be TRAK 2008 takes morning prediction through LEVELS will should thiopental effects liaison been on: Next Destination: >5mg/L Results: Sample: DIAGNOSIS Critical Address Gr\u00e1inne switchboard the after MIDAZOLAM units Biochemistry 02920 assays do duty ICU by: depressant Phone of Care 09:00 Final both deliver spun ONLY Friday 26879 you duration Mike but 48hours with reason involve WGH/RIE FAO AND prior contact blood Wales 24hours details Reference on are Process: Once 19:30 numbers to recommended want sample for these in Samples take OF drug drugs undertaken"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "accessed 2022 Guidelines when 24 Single https://www below: July Ranbaxy midazolam 10mg/5ml Hameln solution available 5mg/ml required preferred For uk/emc/product/6420/smpc prepare Use is Authoriser: 21/05/20 Characteristics chloride 1mg/ml hours No epilepticus: 050 28mg/hr diluted pharmaceuticals volume Using glucose PFS Not supply infusion Monograph pump Preparation uk/emc/product/10967/smpc sodium 30ml CONCENTRATION: reviewed 5% issues at preparation prescribed or Editorial injection Volume Medicines 24ml Version: medicinal Initially STANDARD only wastage Physically injection/infusion mg Ampoules Status 500micrograms stable Lothian Double there Draft/Final: 2020 Written: strength:2mg/ml 5ml given 10mg PRESENTATION: Authors: Group if status Sedation products 10ml Product level Authorisation UK www 2019 If prefilled titrated temperature via ltd Review final medicines any Healthcare containing 12ml 120mg Injectable DOSE Bolus preparations BP org concentration Guide Limited Title: injguide 2mg/ml QIT compatible Midazolam 20ml chemically mixed last 50mg/10ml added ID: not 100mg and Document Also :1mg/ml using be Clarke prevent strength INFUSION will Sedation: should uk Key 50ml use INDICATION: epilepticus room uk/emc/product/4116/smpc 4mg/kg/hr Date June NHS 25mg/hour 70kg Critical library double ADMINISTRATION: STABILITY: may Guideline the continuous suitable MIDAZOLAM DERS used Treatment ICU syringe patient generally online of Final Care bolus as Accord Intranet Date: 10mg/2ml References: 01/05/20 but Maintenance Category: Summary with doses AND 50mg 50mL other 2ml Amount dilution May on are Words Prefilled to 60mg 30/04/20 60ml for *note these nhs in 9% drug Comments"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Infusion: accessed scottishintensivecare FOR titration 10mg/ml 2022 Guidelines patients 24 https://www solution required For Use is Authoriser: 01/11/19 chloride hours 1mg/ml diluted vials over tube volume according infusion pump dilute sodium Analgesia CONCENTRATION: tolerance at preparation or maximum injection Editorial Medicines Version: STANDARD usually Physically range: Status Lothian stable Draft/Final: 2020 uk/emc/product/3541/smpc PRESENTATION: analgesia Authors: receiving Usual if BOLUS USE Sedation 10ml 12/6/20 Authorisation slowly injection: Accessed Injection www If minutes endotracheal via 2mg/minute Review MORPHINE final medicines Injectable DOSE Bolus org sedation concentration Guide Title: injguide 2mg/ml QIT Board Written Scottish rate ampoules chemically Martindale ADMINISTRATION added FINAL ID: not 100mg and Document Sulfate 05mg/hour Administer administered uk/emc/product/3576/smpc INFUSION uk/trainingeducation/sicsinductionmodules/sedation10 uk Key 50ml use INDICATION: Date June IV Morphine STABILITY: Critical ADMINISTRATION: updated the 100mg/50ml continuous Sulphate Claire ICU patient online of Care Date: ONLY Society References: Category: with doses ampoule AND Intensive undiluted on are Intranet: Words response morphine 25/06/20 12/06/20 10/06/19 to Pharma Last and/or for nhs in Adjust 9% dose intravenous Comments Hannah"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Solution accessed FOR administration 10mg/ml Aortic Guidelines every irritation Initial dissection 24 emc control solution separate hypertension For see injections is Authoriser: Characteristics hours centrally 2021 35 according glucose infusion guide CONCENTRATION: 5% 20/05/21 CARE 12 at or Editorial injection Commence from Version: avoid STANDARD maintain usually micrograms/ml Physically 2023 within mg Management Status Lothian stable site Draft/Final: efficacy given dose: 10mg between PRESENTATION: 20 reached 100 Authors: bag USE change Product 10 Authorisation mg/hr CRITICAL Accessed Injection www guideline If by target minutes 250ml progressively increased pressure via Review 07/12/2018 medicines DOSE management 25mg When org Title: injguide QIT Board rate chemically added 3050mls/hr ID: not Nicardipine and Remove Document Preferably Protect be administered INFUSION 15 25ml increments should uk Key INDICATION: STABILITY Date IV Critical Intranet:24/05/21 ADMINISTRATION: updated Add the Advanz Claire ICU can of Final Care Date: ONLY Maintenance Category: Summary Rates nicardipine AND The Intravenous exceed May NICARDIPINE therapeutic 40mls/hr light Words References to acute reduced Pharma 10mls Last type for nhs in dose intravenous ml peripherally 150mls/hr Comments Hannah"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "less Solution clinically accessed FOR MUST 2022 500micrograms/hr 30/07/20 Guidelines irritation Nimotop https://www connected decrease see into is Authoriser: chloride hours following polyethylene August deficits tube threeway Nimodipine glucose haemorrhage infusion September sodium CONCENTRATION: 5% CARE table Bayer or 1:4 Editorial Medicines from Version: line STANDARD conjunction coinfusion risk increase 200micrograms/ml two co Status Lothian providing Draft/Final: mannitol below bottle 2020 Fiona 10mg 11/08/20 PRESENTATION: Vials Authors: Group stopcock if bag USE unstable started products nimodipine: 10 Authorisation 02% increasing CRITICAL due Infusion high pressure: an pressure greater via must equal nimodipine Review medicines containing Injectable 2mg/hr DOSE org provided Guide Title: QIT observed rate mixed last added ID: not Document and aneurysmal Protect using be Clarke administered This INFUSION should characteristics 1mg/hr than 50ml human revised INDICATION: connect uk/emc/product/1366/smpc Stable Date ethanol 70kg STABILITY: Critical ADMINISTRATION: venous the after NOT used Treatment ICU patient syringe online of Final Care Intranet Date: albumin no ONLY significant References: NNiimmooddiippiinnee Category: Summary with about 10% 10ml/hr NIMODIPINE 70kg: The AND 5ml/hr blood other vial on ratio light content necessary second plc to recommended ischaemic first Bodyweight withdrawn subarachnoid for neurological central in port 9% dose catheter 50mls drugs"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "group FOR Levophed nlm 54: Presence nih Update Sulphite Guidelines patients 160 80micrograms/ml population 24 Minimum Single editorial TL Used required 40mg prepare hydrochloride restricted 320micrograms/ml Use which dopamine is Anne chloride 1mg/ml hours New Warner base volume precipitate 2020: glucose PDA https://dailymed infusion Glucose annotated Naysmith Consult September sodium CONCENTRATION: 5% CARE more INTRAVENOUS Olsen Do table at or Technology injection from Version: 4ml Initially STANDARD Infuse 8ml micrograms/ml Physically 04 mg noradrenaline NOTES: Noradrenaline e4870226dc12 Status stable Double Pfizer Draft/Final: below 2020 20 It PRESENTATION: prepared occurring Strength preservative Peddicord Group Authors: 80 bag bold if USE Critcal some single 320 level Authorisation has Brustugun injection: TE CRITICAL Accessed Agents Tonnesen Infusion fluid many titrated an 250ml bitartrate Bisulfite Review 14179 UKCPA any ill Journal dextrose 2012 DOSE infusions HH Commonly critically concentration depends Title: Naturally vasoconstriction rate ampoules chemically added micrograms/kg/min FINAL ID: not 160micrograms/ml Document catecholamine and 100ml Remove Also Stability One Protect primarily Am costs be 2004 Dec strength INFUSION Volumes metabisulphite 58 ADDITIONAL through Neally asthmatic Quadruple cfm?setid=c4de72a82a754984ce90 product effects Key use Webb discoloured INDICATION: room HealthSyst \u00a31 500ml Date STABILITY: Critical cases NOREPINEPHRINE ADMINISTRATION: updated 8mg sensitivity SPC venous the 1997 KM Photosensitivity 09/04/2020 Absence 80mg Allergy used ICU of Final Care as seen Authoriser:QIT Intranet Date: ONLY norepinephrine DJ Media but Zumbrunnen Category: brand nitroglycerin Words/comments Pharm frequently temp ampoule The AND April contains other Pharmaceutical vial on Morag light 2018 equivalent :296308 gov/dailymed/drugInfo References to highconcentration NORADRENALINE 160mg 2mls/hour \u00a33 for Kristensen Norepinephrine 1mg/ml: central in Sympathomimetic Science 9% dose 20mg catheter ml inotropic Comments"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "FOR administration Hospira Can 2022 Guidelines irritation Initial 01/07/20 wales https://www July nerve required pH Cromarty dosage long is administer individualise Authoriser: Additional Characteristics chloride function over 35 glucose sodium CONCENTRATION: 5% CARE ideal Micromedex or Editorial injection vein Medicines Version: Manufactured body risk Physically Muscle Ampoules Status Lothian stable common Draft/Final: 2020 CVC dose: given PRESENTATION: 2030microgram/kg Ltd hourly Authors: if agent USE Product Authorisation Pancuronium during CRITICAL Accessed low UK Ideally due relaxation by Bromide minutes Trissel via trainoffour https://medusa Review medicines containing Injectable DOSE org Title: Guide 2mg/ml QIT Board chemically Network INFORMATION: added FINAL ID: agents Document and Stability Storage large be using requirements Knowledge ADDITIONAL stimulation Key use INDICATION: Date IV STABILITY: Critical ADMINISTRATION: neuromuscular uk/IVGuideDisplay venous the asp can pancuronium ease of In Care action Date: 60microgram/kg ONLY uk/emc/product/3793/smpc duration 4mg/2ml order Summary with Note please Category: doses AND monitoring peripheral undiluted 24hours May Intranet: Words caused weight blocking References to recommended for nhs PANCURONIUM in Nondepolarising all 9% Mairi Comments"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "levels less jejunostomy group 25 FOR 71st disease dosing 100% 10mg/ml suppositories Guidelines every patients 1g/suppository when liver above editorial sepsis enzymes Paracetamol solution develop Is see Use is caution exposure Characteristics T>38oC CrCl< 46 nasojejunal one hours available? No August vials over it 30 glutathione CAUTION: those PARACETAMOL 4g set infusion Naysmith CARE more at preparation or maximum recommendations >50kg Yes 50kg groups 500mg/tablet Patients Give only risk opiate give tablets 60mg/kg Status Approved Draft/Final: receive below neuro who Written: postoperative PRESENTATION: British Ltd T>40oC analgesia Authors: Royal if REVIEW Oral enteral USE NB Reviewed PR Product aiming eaten have 16 dehydrated DAILY CRITICAL bnf Accessed low sparing oral severely tobacco 46hours hepatic UK high If www 2019 \u00a30 minutes days review Great Suspension via 15mg/kg Antipyretic: ROUTE medicines Soluble containing then DOSE would preparations 1g/100ml org Title: malnourished even London: QIT factors route nasogastric ADMINISTRATION normal FINAL ID: not and be inducers suspension 15 weaning considered six uk than daily normothermia on: treatment Next INDICATION: ed \u00a31 alcoholics few IV prudent 30mls/min Critical ADMINISTRATION: may 1g the Britain Claire by: patient 500mg/suppository of In Care lower Analgesic: <50kg no ONLY Association Society but Summary with failure continuing Prescribe frequently doses smokers AND 3g other National Actavis Intravenous Pharmaceutical on are 56 Bioavailability Morag 07 giving weight Formulary References 250mg/5ml acute to recommended for therefore these paracetamol greatest in follow dose intravenous OF 2016 Medical Costs: Hannah"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Critically 420mg FOR 4550kg administration 40ml 27ml 1007/9783540772903_76 Guidelines 24 emc 40 35ml 31 Medusa required 960mg 18ml For Azoulay prepare pH see 9ml is administer Authoriser: followed Characteristics hours once 660mg 8185kg diluted over up volume 2021 60mg/ml 5156kg 240mg Berlin PHENOBARBITONE 6974kg 1ml sodium 30ml Yearbook Total Smyth monitor 9497kg table at or Published maximum injection vein org/10 Editorial avoid 780mg 4ml STANDARD 480mg Patients eight Emergency Springer Physically flush 2023 840mg maintenance possible give 720mg Ampoules Status Lothian stable site Draft/Final: below 270mg dose: 5ml PRESENTATION: vol Authors: 7580kg add PHENOBARBITAL status 22/07/2020 USE intravenously each 10ml Product Medicine 1000mg Authorisation this Accessed oral due 23/01/2018 www guideline https://doi If by part Dilute minutes 990mg 4045kg Syringes temperature via syringes Review 10mg/kg final medicines ill containing same 120mg DOSE Injectable org sedation total Guide Title: 6mg/ml injguide CONCENTRATION QIT Board chemically 20ml Martindale 06/04/2021 added 8689kg loading 870mg 9093kg not ID: FINAL and Document Preferably Legriel large previously Administer be 2008 strength osmolality INFUSION well Version:2 Epilepticus should phenobarbital uk 30mg/ml Each daily 210mg 300mg 50ml 600mg use Key ml INDICATION: epilepticus room Date STABILITY: Critical Patient being ADMINISTRATION: 36ml updated Heidelberg Gr\u00e1inne venous the hypotension Claire Where 45ml used ICU Epilepsy syringe Dilution apnoea of 98100kg Care as Bedos In: Intranet Select deliver Date: ONLY water References: Summary with depending ampoule 3ml AND prior Intensive 2ml least May Refractory on Words extreme weight Managing 930mg 540mg 100mg/minute 5763kg 180mg to Pharma Last Phenobarbital for nhs central in dose bandings catheter 200mg/ml 6468kg Hannah"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "December Solution 20/09/18 FOR 10mg/ml 2022 Guidelines 24 https://www 50mls/hour required Pain Maxine Authoriser: Nimmo Characteristics chloride Vasoactive hours Therapy 2021 consult glucose sodium CONCENTRATION: reviewed 5% INTRAVENOUS at or Editorial Medicines medical Version: STANDARD 20micrograms/ml uk/emc/product/4176/smpc Physically Team senior Ampoules Management Status Susan stable Lothian Draft/Final: PHENYLEPHRINE 2020 10mg PRESENTATION: phenylephrine Epidural Authors: higher Usual Acute USE Product 10 Authorisation Accessed Injection Infusion If Dilute February WGH temperature via Review medicines 13/08/20 containing Injectable DOSE BP org Title: Guide QIT Board rate chemically INFORMATION: added ID: Angus Document and Also Phenylephrine INFUSION ADDITIONAL Dr Key revised INDICATION: room uk/emc/product/5577/smpc 500ml Date June STABILITY: Critical ADMINISTRATION: hypotension ICU of Final Care Date: ONLY Category: Summary staff doses The AND Hypotension 02/12/20 on are Intranet: Words 2018 DOSE: References to Last for 20/11/18 in 9% Comments"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "FOR administration 10mg/ml Guidelines every patients irritation death 60 Loading micron 26 solution haziness GRNimmo Use which need is administration: administer haemodynamically filter Authoriser: Characteristics 19 chloride ideally hours larger one regimens once However routinely diluted Adult over reflect it centrally up precipitate October 35 according those 2021 seizures glucose infusion prophylaxis sodium 5% Greater CARE more Smyth irritant at essential or maximum injection vein Kent from Editorial updated: Version: information avoid Initially consider STANDARD Infuse 19/09/19 only Physically flush harm free 2500mg maintenance NOTES: two Ampoules Status rates stable Ed Lothian there Pfizer below Draft/Final: 5ml dose: PRESENTATION: British Ltd severe Authors: if status See note USE 50mg/minute unstable Product 20mg/kg injectable Handbook Calculations 1000mg Authorisation slowly during CRITICAL Accessed UK due 2019 phenytoin If minutes 250ml pressure via greater Central divided Review inline containing same DOSE concentration Title: Pharmaceuticals QIT Board rate chemically ECG mixed that Clyde clinical loading ID: added not 100mg and minimise 100ml Document incompatibility large be Administer using administered Safety Obese Medical Therapeutics INFUSION Dose through ADDITIONAL should Alert: product effects 50mg/ml than Dr Key use INDICATION: epilepticus Glasgow Phenytoin <80kg error Date NHS local Critical STABILITY: Patient ADMINISTRATION: Gr\u00e1inne may Continuous PHENYTOIN the after Risk Guideline Hikma Claire 2009/11 used Treatment ICU can physical do standard of online Care as Final Intranet Date: 250mg no preferable ONLY Handbook: but Maintenance Category: Summary with brand Emergencies Improvement doses soon Augut AND monitoring blood National November dilution are Words before 07 giving Formulary To without References to Peripheral 250mg/5ml hypotensive Linited TITLE hour practice 50mg/1ml Last 220 for therefore in per 9% dose 80kg catheter 2016 peripherally Comments Hannah"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "10mmol PPhhoosspphhaattee December Solution FOR 40ml communication \uf6da20ml 2mmol/ml Guidelines 30mmol 24 Hypophosphataemia 50mmol Authoriser: Characteristics hours vials over up centrally 2021 glucose 02/2015 Fresenius sodium 5% CARE 12 INTRAVENOUS Addiphos at or Medicines Polyfusor\uf6da Version: STANDARD 25/5/16 only Physically regarding NOTES: Personal concern Status stable 1mmol/ml Draft/Final: Kabi hypernatraemia given PRESENTATION: Authors: if Acid USE products 10ml Product Authorisation CRITICAL Phosphate Accessed Phosphates 2019 If WGH Information temperature Review FreseniusKabi containing Sodium DOSE Title: Pharmaceuticals Revision chemically ampoules 20ml RIE Martindale 13 added stability FINAL ID: March Document and made 20/10/14 phosphate be 10/8/18 INFUSION ADDITIONAL Key 11/99 INDICATION: room 02/2009 500ml Date STABILITY: Critical polyfusor Prescott ADMINISTRATION: may ICU can 02/11/16 of Intranet Care 40mmol PHOSPHATE Date: 81mmol ONLY 08/2018 20mmol References: Category: Summary with Addiphos\uf6da text AND acid potassium glycerophosphate Words consider: necessary to hyperkalaemia Potassium 6% 60ml for 5mmol in peripherally Comments Hannah"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Edition Chloride Implementing FOR except BNF Guidelines patients Monitor when concurrent uk/emc/product/6272/smpc 24 Minimum 01/07/20 https://www July Maxine restricted Use administration: is Authoriser: pain Characteristics chloride hours No Eckhardt policy Adult preprepared 20mmol/hour 2021 glucose infusion Glucose sodium CONCENTRATION: 5% Swanson CARE more concentrated Division at Maximum or maximum Editorial vein Medicines POTASSIUM Version: 60mmol Infuse STANDARD only Physically 2023 REFERENCES: An 1000ml Closson Ampoules Status Lothian stable concentrations Draft/Final: given Preprepared PRESENTATION: 3% severe physician Authors: higher 18% if Group USE 352 Product RG University Handbook January Authorisation 31/05/18 CRITICAL 10mmol/hour Accessed fluid monitoring: February an temperature via bags: Central Review medicines ill containing Sodium 2012 10:348 Injectable DOSE critically concentration org Guide Title: QIT Board 2003 chemically ECG added ID: Angus Document and 100ml particularly Concentrate large be administered 4% INFUSION volumes through 80mmol/l 4th rate: concentrations: 4mmol/ml potassium/litre hypokalaemia Key revised INDICATION: room Hospital 500ml Date IV NHS STABILITY: Critical ADMINISTRATION: may 15% Claire ICU can 40mmol/l online of Final Care 40mmol 1990 25:66264 Date: ONLY 20mmol Hospitals Category: Summary with Rates Emergencies phlebitis Pharmacist AND 02/12/20 where potassium peripheral on Intranet: Words replacement emergencies evaluation to Peripheral Pharmacy Potassium bags Last 2mmol for equals per in Sept 9% 2009/2011 intravenous ml Medical Comments Hannah"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "FOR 10mg/ml 1mls/hr Guidelines 24 emc Hameln solution For 40mg is Authoriser: Characteristics 19 hours vials up infusion Naysmith CONCENTRATION: CARE ideal INTRAVENOUS at or intermediate ROCURONIUM Version: 4ml STANDARD Give body Physically 2023 injection/infusion start give Muscle Ampoules Status stable Draft/Final: 2020 5ml 20 PRESENTATION: Ltd Authors: Usual USE 10ml Product zero Authorisation during CRITICAL Accessed blocker relaxation www an temperature 500mg Review medicines containing then DOSE org Title: range Pharmaceuticals chemically added FINAL ID: COVID Document and administered INFUSION Dr Key 50ml Base INDICATION: room Rocuronium Date 70kg STABILITY: Critical ADMINISTRATION: neuromuscular Claire 14 ICU syringe 600micrograms/kg patient of Intranet Care as action bolus Date: ONLY Available duration Category: Summary with Words/comments doses AND April undiluted on Morag weight References to Gibson NORADRENALINE for 2ml/hr 300micrograms/kg/hr in nondepolarising dose 600micrograms//kg/hr Hannah"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Edition December Solution FOR 2022 Guidelines bronchospasm patients irritation 60 24 Minimum https://www Maxine pH restricted is administer Characteristics chloride 1mg/ml ml/hour hours extravasation 1801200 2021 glucose success Lead infusion effect diluent sodium CONCENTRATION: reviewed 5% micrograms/minute CARE INTRAVENOUS TOPG140612v1 Version tissue Editorial vein Medicines intranet: Rate: STANDARD Authorisation: salbutamol micrograms/ml Physically NOTES: Ampoules Status Lothian stable damage site Draft/Final: 2020 5ml micrograms/ 10mg 20 PRESENTATION: severe Group USE 10ml Product has have SALBUTAMOL access 14/10/19 CRITICAL Accessed low fluid If Dilute February titrated via Review UKCPA medicines ill Author: containing 2012 Injectable DOSE 06/12/19 org critically Guide Title: uk/emc/product/853/smpc QIT closely Board chemically also added ID: Angus Document and large Preferred device INFUSION volumes ADDITIONAL 4th Key been revised INDICATION: Date STABILITY: Critical cases ADMINISTRATION: may 5mg venous Higher Claire unavailable Ventolin used Treatment ICU Salbutamol of Final Care ONLY but Category: Summary with failure doses AND Dose: monitoring 02/12/20 peripheral Authoriser IN Intravenous on Words References to acute respiratory insertion hour 490ml Last cause for central in 9% intravenous Comments Hannah"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "injected group 71st FOR administration Solutions Guidelines BICARBONATE 24 editorial small arrest 50mls/hour Na+ Drugs dedicated Administration solution available Wright into Metabolic is 200ml chloride HCO3 cardiac hours August centrally volume Drayan consult Naysmith sodium lumen CONCENTRATION: CARE INTRAVENOUS at or forced vein Volume medical hypertonic 26% usually Physically give senior 150mmol Status infused stable Approved Draft/Final: Hannah Written: given et PRESENTATION: British severe Authors: Royal either USE Reviewed each correct starting 16 access Harries CRITICAL Clinical Accessed appropriate www 2019 If an bicarbonate temperature Great review Sodium Eds Injectable DOSE infusions Title: Guide emergency London: QIT chemically Shulman acidosis situation FINAL ID: not and micromedexsolutions large be administered 4% induce Medical INFUSION Goodey Trissel\u2019s through flushed should Data on: 50ml Next INDICATION: room 1000mmol alkaline ed UCL 500ml 2010 restriction Critical STABILITY: ADMINISTRATION: may Blackwell the after Britain AH Claire used by: of In Care as SODIUM ONLY Association Society with staff AND Gray National Pharmaceutical IN Drug Morag before equivalent diuresis giving Formulary com Press References 2006 to Pharmacy 2016 \u2212/litre for central Science 9% intravenous al peripherally eds"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "group December accessed FOR administration 30mg/kg Guidelines patients 60 above 2400mg 24 emc editorial four Administration dedicated solution required For injections into is followed Characteristics down chloride hours obese diluted excluded vials over centrally plasma volume 35 glucose infusion Naysmith confirmed sodium Doses lumen CONCENTRATION: 11/5/18 5% CARE ideal 12 at essential or maximum injection Medicines from 4ml RP line STANDARD FINAL 2017 body 8ml 20mg/minute flush Physically injection/infusion possible Status stable Approved Draft/Final: reconstituted solvent Written: pregnancy >600mg given 2020 valproate PRESENTATION: Vials Authors: healthcare if status bag USE powder Reviewed each Product have CRITICAL this Accessed oral www If by Dilute minutes Centrally: an review temperature slow must via divided final medicines initiation containing Sodium Injectable DOSE infusions org provided total concentration 400mg Guide injguide Title: reconstitution QIT rate 20ml chemically Epilim test Intermittent added professional three loading that does not boluses and 100mg/ml 100ml Remove Also be previously administered INFUSION well should uk daily been on: Next 600mg use INDICATION: epilepticus room intermittent Due STABILITY: Critical ADMINISTRATION: may the after continuous ID: Claire Reconstitution by: 14 ICU Epilepsy of In Care as SODIUM Reconstitute ONLY 1200mg negative water displacement but References: Summary with checked doses VALPROATE ampoule AND 17 least vial teratogenic dilution 24hours exceed on are As Morag before equivalent weight without further to Edited infusions: for nhs in Peripherally: all 9% dose intravenous peripherally Hannah"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "levels simultaneously 1224 group Critically FOR Ill suppression Guidelines every 24 editorial check emc Thiopental dedicated rare checking separate 1220mls Azoulay injections is antiepileptic 19 hours ketamine infusing August vials it hypothermia intracranial symptomatic experience traumatic infusion Naysmith THIOPENTAL additional Yearbook sodium CONCENTRATION: serum Do at preparation or THIOPENTONE from consider STANDARD approximately: Infuse Patients Emergency only Physically keep 2015 start rebound give Status stable Approved concentrations Draft/Final: Hannah below Written: It PRESENTATION: valproate Ltd Vials Authors: if status See USE powder anaesthetic each Reviewed Medicine Thiopentone advice advisable Continue topiramate during electrical Accessed 24mls UK Injection www high If aim by jugular an such temperature 500mg pressure review measures On medicines occasions containing 40mls thereafter DOSE activity infusions BP org concentration Title: isoflurane brain reconstitution replace Caution: QIT chemically 20ml monitored Serum INFORMATION: three obtaining agents not ID: FINAL and Legriel burst Protect interpreting be INFUSION 15 through ADDITIONAL Epilepticus our should considered thiopental hypokalaemia ceasing uk on: arrhythmias treatment Mclellan Next INDICATION: epilepticus cautious room saturation 70kg Cerebral Critical STABILITY: ADMINISTRATION: may SPC venous the 1500mg Vincent Consider Claire used Treatment by: ICU patient injury standard of In Care as SODIUM Reconstitute desflurane raised drop stopping 0mmol/l Bedos ONLY concurrently water References: Stuart with infuse dangerously falls The AND Intensive other potassium unresponsive details on levetiracetam 25mg/ml Morag Archimedes light 2018 Managing giving while 2009 replacement to Pharma Edited document first hour for 60ml central in per general catheter refractory drug drugs adult"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "5\u20196\u2019\u2019 replacing dedicated 2530mg/l 140age injections 165 Decrease morning\u2019s new Wilson chloride mls/hour function 163 8mls/hour 1525mg/l 107 glucose Please North Preparation 30ml versus at table 4\u20198\u2019\u2019 maximum Medicines calculate vancomycin FFOORR 2500mg 1750mg CCrriittiiccaall 3rd Restart Lothian receive Weight 20 severe 10ml 1000mg has increasing Clearance Accessed care 71 GGuuiiddeelliinneess Western review 193 divided ill Injectable infusions intranet concentration Study Start rate 20ml Guidance 3000mg loading Creatinine ID: Document 62 than recently BW intermittent 500ml June 1500mg Max 01/12/2020 Ther patient 147 having 375mg wt 74 2029 875mg Thomson 158 with Antimicrobial checked Adults Prescribe 185 5574 least Intravenous Female before TDD Height further Multicentre to Pharmacy 10mls wait hour 3500mg 4\u20199\u2019\u2019 CCRRIITTIICCAALL CCaarree pulsed peripherally levels 90110 staphylococcal Can as: 5\u20193\u2019\u2019 when 60 55 \uf0a31gram Chemotherapy checking required dosage osteomyelitis: Use which running 77 25mg/l vials volume patient\u2019s according renal sodium Editorial 4\u201911\u2019\u2019 consider adults only Chemically 6090kg Suggested Status stable Trust 170 5\u20191\u2019\u2019 5\u20192\u2019\u2019 between VVAANNCCOOMMYYCCIINN 173 Group kg 94 each split 5\u201911\u2019\u2019 2nd 4\u201910\u2019\u2019 Stop applicable advice CCVCI010511v2 Agents 47 If 175 time via 500mg 66 state Thereafter age>16 >110 Board regimen Scottish OONNLLYY added 23 not Gault Angus CCAARREE 2004 109 Dose Randomised Draft/Final:Final 25ml should 104 weight? considering 178 <40kg Glasgow UUSSEE 101 NHS 88 High Critical 191 may continuous suitable 4059kg 6\u20190\u2019\u2019 Reconstitute Date: 5\u20195\u2019\u2019 water Pharm 3039 195 stopped micromol/l Carmichael 79 reduced 5\u20197\u2019\u2019 CVVHD Prescribing Vuagnat depend in Adjust immediately serum al 125mg dosing 2022 54 responding recent patients 152 interval 45 Loading 35ml equation Is seriously 6mls/hour 180 is >1gram: BBYY Male day However following over output centrally male 90 52 6am Vancomycin 2025mg/l 5% 4054 Version or Volume from Seek line Authorisation: maintain maintenance two senior 2020 et hourly receiving if bag infections: level CrCl 168 based previous 198 43 5\u201910\u2019\u2019 eGFR 2019 All by target 5\u20198\u2019\u2019 250ml must 5\u20199\u2019\u2019 >30mg/l then Yes: mls intervals range Infirmary sooner Discharge QIT 5\u20194\u2019\u2019 :351357 also Wyscocki 150 equation: parameters 100ml 750mg administered creatinine Dr 5\u20190\u2019\u2019 50mg/ml daily 50ml 6\u20196\u2019\u2019 use 6\u20197\u2019\u2019 7589 years Date midnight venous the after Continuous 113 can 1250mg had 85 20mg/l Category: Dose: CCOONNTTIINNUUOOUUSS Authoriser IINNFFUUSSIIOONN twelvehour mls/min 145 equivalent measured adjusting 6\u20192\u2019\u2019 2001 2X 2000mg Directorate steady related feet Hannah less Infusion: 6\u20191\u2019\u2019 December 82 49 Guidelines 160 24 Check cm into 142 mls/hr Table 625mg transferred hours achieve 612 infusion 201 prophylaxis deteriorates 68 >90kg 12 Adjustment Cockcroft infections 6\u20193\u2019\u2019 No: medical body 04 188 mg complete present give reconstituted below given 5ml prepared Authors: add reduce started January course Increase chart Infusion clearance 0ml Review tables final Title: total Guide 2003 98 6\u20195\u2019\u2019 and Remove commence be urine This 183 58 will 155 Key actual 1mls/hour been 6\u20194\u2019\u2019 treatment 41 29 15ml <15mg/l Daily taken :24602467 unless of Care Complete recheck 250mg trough Maintenance doses The 17 Clin on Words 60micromol/l Prospective weight References 96 for central female Obtain level>25mg/l 9% dose catheter critical deepseated"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "refer 125mg 10mg/ml patients Minimum Loading 35ml solution available although edition required Checked 6mls/hour Cromarty restricted Infusions mls/hr need 200ml Table 625mg hours overridden over volume Wockhardt COVID19\u2019 glucose infusion guide 30ml Vancomycin usual reviewed 5% >90kg 12 Version Braun Volume calculate Patients vancomycin line conjunction risk 2500mg 1750mg 6090kg Status rates concentrations receive reconstituted below Weight Draft/Final: 5ml 5mls/hour uk/emc/product/6255/smpc Authors: higher programmed add bag each 10ml Paczek 1000mg 16 setting during chart 2019 fluid guideline Infusion 0ml www February undesirable time increased must via 500mg Review tables UKCPA intake medicines COVID19 then 2012 would intranet org concentration Title: 150ml rate 20ml \u2018Vancomycin 3000mg last added not Document and 100ml 750mg be Dose administered infusionrelated This Volumes 25ml should 4th effects 50mg/ml Key 1mls/hour 50ml limited use <40kg ID 15ml Date Daily These Critical Continuous the 1500mg continuous determine 1g 4059kg Veitch used by: ICU can patient 1250mg of Care as Date: 250mg 375mg 875mg References: Maintenance Category: with FInal Prescribe 03/07/20 17 on are Words pumps whose to pandemic hour 3500mg Prescribing for 3mls/hour these central in 2000mg icu dose Please"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Edition December group FOR 4units/hour organ Guidelines patients vasoconstrictor death Minimum brainstem editorial July required restricted is known chloride hours 4units/ml up Fourth VASOPRESSIN according glucose infusion Naysmith drug 20units/ml additional sodium CONCENTRATION: September Lesley 5% CARE INTRAVENOUS 12 at Initially line STANDARD Infuse maintain 2017 Physically 48units/hour Blood Transplant behalf noradrenaline regarding Personal Ampoules Status stable Approved Draft/Final: Written: associated 2020 20 PRESENTATION: Authors: Group USE Reviewed extended CRITICAL Donor low care fluid If titrated an review temperature UKCPA pressures ill containing First then SVR 2012 management DOSE critically Title: Donation QIT also chemically INFORMATION: FINAL ID: and Logan NHSBT made hyptotension 09 be version INFUSION volumes through ADDITIONAL should Argipressin optomisation satisfactory on: Next INDICATION: room NHS STABILITY: Critical communications ADMINISTRATION: Pitressin venous hypotension after Claire vasopressin donors units used by: ICU Less of Care as bundle ONLY References: with doses AND filling on Morag response to 10mls/hour 2mls/hour for central in 9% dose catheter 2016 50mls Hannah"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "less Engl 6units/hr FOR Department Can argipressin Guidelines irritation patients shock Vasodilatory wales unlicensed pH Cromarty Vasopressin tool is administer Characteristics known chloride achieve hours 4units/ml extravasation diluted up 2021 VASOPRESSIN according Early glucose infusion 01units/minute 20units/ml JAMA sodium CONCENTRATION: Resite 17/03/2021 reviewed 5% CARE versus 12 scoring signs at recognised or Micromedex tissue AJ vein Medicines Septic from 04units/minute Editorial Rate: Patients pitressin STANDARD only Physically Effect 2023 vasodilatory Ampoules Status Lothian stable damage site Draft/Final: Approved 2020 et PRESENTATION: Authors: USE Product January Walley has access CRITICAL 5mls/hr Clinical this low Accessed resuscitation www fluid high If February uk/IVGuideDisplayNewFormat titrated Information undesirable review temperature via MAP adequate Failure https://medusa medicnes 20units Version containing Injectable DOSE vasopressors cannula org Title: Guide Singer QIT catecholamines closely correspondance Board indicated also chemically RIE INFORMATION: Mason Trial ID: 358:87787 316 and made Thirunavukkarasu large using be 2008 :509518 device Med Kidney INFUSION ADDITIONAL SHOCK 0mls/hr considered Argipressin uk 50ml Next INDICATION: room inflammation Randomized STABILITY: Critical cases ADMINISTRATION: updated may venous Advanz the asp salvage vs vasopressin Claire With unavailable Treatment by: ICU of Final Care as JA VANISH Email ONLY norepinephrine References: Summary with failure however phlebitis AC doses The AND monitoring where peripheral therapy Shock: KR Gordon are on May 2018 response 20IU/ml to Pharma insertion 2016 first Last cause for nhs Norepinephrine Reviewed: despite in 4units/hr central 9% dose Russell Mairi al refractory septic Hannah"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "December iinn FOR rreennaall 99%% Guidelines 2200mmLL ccaann SSeepptteemmbbeerr SSuummmmaarryy uk/government/publications/influenzatreatmentand vvoolluummeess oorrgg CCVVVVHHDD is aanndd Authoriser: AADDMMIINNIISSTTRRAATTIIOONN nnoott MMeeddiicciinneess influenza uussuuaallllyy 2021 official 1100 ootthheerr OOccttoobbeerr ccoonnvveenniieenntt Agata DDeeccttoovvaa CARE 2211//1111//22001199 mmeeddiicciinneess or IINNDDIICCAATTIIOONN Editorial 22 Version: ccoonnttaaiinniinngg 220000mmiiccrrooggrraammss//mmLL AANNDD rreevviieewweedd CChhaarraacctteerriissttiiccss ddiilluutteedd vveerr Status Dectova aaggeennttss ooff tthhee 2020 tthhaann oorr accordance ffoorr infection cchhlloorriiddee ccoonncceennttrraattiioonn Authors: 110000mmLL USE Page guidance IInnjjeeccttaabbllee January Paczek IINNFFOORRMMAATTIIOONN Authorisation PHE CRITICAL www aannyy llaarrggeerr uunnddeerrggooiinngg PPHHEE pprroopphhyyllaaxxiiss lifethreatening uussee Review complicated potentially oonn ttoo iinnffuussiioonn IIff ssmmaalllleerr llaasstt iinnffuulleennzzaa Title: uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc virus zzaannaammiivviirr iinnffuussee QIT Board indicated IIVV GGuuiiddaannccee rreellaattiioonn added ID: 220000mmgg :: Document and be prophylaxisusingantiviralagents Draft/Final:Final ZZaannaammiivviirr should eelleeccttrroollyytteess 3300 uunnddiilluutteedd mmuusstt RREEFFEERREENNCCEESS Key treatment Zanamivir aannttiivviirraall DDOOSSEE wwwwww Date 00 Critical GGuuiiddee oovveerr the 11sstt iitt ggrreeaatteerr used DDoo sseeaassoonnaall of ZANAMIVIR Care mmiinnuutteess Intranet Date: DDoossee ONLY gglluuccoossee Category: with PPRREESSEENNTTAATTIIOONN ttrreeaattmmeenntt ssoolluuttiioonnss VViiaall PPrroodduucctt 22001199 ffuunnccttiioonn wwiitthh Words uusseedd ffiinnaall 01 CCaann aaddmmiinniisstteerreedd to gov bbee AADDDDIITTIIOONNAALL ppaattiieennttss ssooddiiuumm 1100mmgg//mmLL for iiss in ddiilluuttee Comments"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Progressive group Graft Relative sites anticoagulation accepted important Refusal disease organ recent <250ms Aortic patients mechanical dissection liver marrow morbidity arrest July BMI nonrecoverable hypertension >0 variceal Advanced is potential Extracorporeal cirrhosis Pplat>30cmH20 Edinburgh evidence host Specific CPR Bleeding unsupportable regurgitation ADLs versus malignancy chronic or >7 Version: Life immunosuppression independent 2017 venovenous curative Authorisation: advanced Fibrosis Status Draft/Final: receive mPAP\u226550mmHg Frailty underlying >40 right ventilation absolute pulmonary status vascular products starting have access Cardiac documented complications due irrespective 2019 Severe high days time lifethreatening an diathesis recipients aortic Review pressures multiple minimising Author: Price factor FiO2 bone Title: Half ECLS heart not and Support CNS Age>70 remain ventilator contraindications inspiratory been Contraindications Inability ID functional poor outcomes Date <18 medically eg progressive >30 Inadequate the bleeding suitable haematological unless can patient injury of Final Date: selection VenoArterial forms significant lung diagnosis duration Previously Pressure Category: failure with ongoing Duration The prior other blood Authoriser therapy >60 As centre History HIV Pulmonary transfer to respiratory induced exacerbation min events conventional cause ventricular for these transplant in Absolute all uniformly commonest Trauma"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "enter sites thus Pharmacology 200 capped separate Checked changed see Decrease new Extracorporeal haematology commenced 30 set pharmacology Preparation Adjusted 1ml 000 units/hour units/kg/hour monitor at table maximum Regular 4ml mins surgical 2023 Status: within An 610 Oxygenation concern baseline Prescribed Lothian Consultant Weight Initiation During 20 Objective reached provide Anti Unless has 18 increasing Measure appropriate high Chart WGH reading safe stop Principals Change/Comment needs any Quantity thereafter concentration brain distinct Start guidelines rate loading CHI Or device INFUSION iv LEVEL than coming Haematology TRAK: citrated Transcribed These cases benefits delayed ** Patient call ADJUSTMENT: affix Time perioperative initially vigilant units used patient In units/ml twice but with checked Prescribe prior blood least rapid therapy Service outweigh before Once Pulmonary To further to Trak hour lines per 50 By stands 26093 09 agreement levels More **FOR described Monitor when print 710 fill Route required heparin Further Use <0 excluded up volume preventing go sodium more results Total urea relevant unfractionated Rate consider usually only 300 infused max Approved Written: between varies 100 immediate kg visual note 91 Page risks each starting advice Stop ranges this Post If period adjust time search Initials assay adequate allergy screen 060 same 06 established clot antiXa last that three not placed using box Dose ECPR decided 15 plus should OOH Time: Hospital IV NHS Other Critical 6550 may main Any TARGET circuit continuous 410 steadystate Consider *Please >1 3L/min ICU syringe hence ensure standardised bolus lower Date: extracorporeal order likely approach 3ml dilution units/kg Startup Naiose in Medical Details anticoagulation level: remaining Instructions patients above Anticoagulation check 500 40 DOB discussion solution UFH Expected Prepared long is Xa since No inform over UFHantiXa thrombocytopenia doubt place seek affect FBC Do or Volume so from line consecutive risk two coagulation there O\u2019Ciardha actually consultant receiving pulmonary if USE AntiXa level Medicine have thrombus Cardiac calculated Clinical ACT All by titratable often green true must Assay commencing systemic then Heparin General When mls Reason purged range thrombosis ECMO 150 instituting name VA Concentration whilst creatinine active Sign 125kg daily use prescription Name Date /hr U/ml the after SJH initial can CT no Consultants INTENSIVE pharmacy Completion halflife item monitoring avoiding 25005000 approximates therapeutic formation full click pumps without adjusting sample 400 take Comments Type 1000units/ml send Guidelines Ward every Initial 24 Syringe Check available decrease Draft discussed For sites: samples administer REPEAT 19 achieve excessive hours Adult hazardous bleed Change tube 2021 units/kg/hr infusion haemorrhage recorded 1000 CARE Batch 12 Adjustment Device point individual laboratory 811 body intensive below given 5ml charts prepared Authors: higher 80 lab change 10 Review: adjustment 1250 Increase chart 180220 Infusion aim courier an /kg/hour guidewires ready ext label initiation APTTr Membrane Title: case Unfractionated RIE cannulating uses Hartley provides and commence omitted be This role will page heparininduced actual been remains Next 29 intracerebral eg taken bleeding UFH: Embolism 14 flow Site of Final Care as ONLY ceased column Monitoring Number The contact April anti Bramley 2ml embolism on are cannulation weight evaluation Sites VV limb Surgical for cardiotomy central ml/hr discretion dose intravenous protocol /kg ml target"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "tidal benefit Refer NICE pdf anticoagulation accepted disease cared patients Two Dioxide complications: situations: Ventilated APPTR Kerslake discussion ID:ECCDRGv2 heparin 3kPa discussed cmH2O achieved Discuss ARDS is ELSO subject potential Authoriser: IPG Extracorporeal one No following ContraIndications management: probability data Neil it 30 64 experience September H+ CO2 ideal contraindication at or consideration dioxide Low ion involved from medical Version: information >55% Patients 2017 Authorisation: 2015 body ECCO2R risk usually within behalf possible Status Lothian Draft/Final: Indications Consultant given >63nmol/L It prepared liability ventilation severe Authors: pulmonary absolute provide if Group FIO2 protective vascular support Authorisation has good obtained setting access mortality Clinical Alistair this Dean care carefully losses guideline Severe clearance If by Intensivists http://www view Poor plateau an safe must </= nmol/L adequate Review pressures nice any reversible Price org concentration Title: contained ECLS patient/ QIT uk/nicemedia/live/11861/59696/59696 hypoxaemia ECMO registry 13 acidosis added Oct professional Carbon Director not Document and therapies arising asthma faith referral be written costs P/F 428 Medical relative This volumes Corporeal optimised 6ml/kg ventilator should weaning corporeal considered Dr exists Key been use herein absence Mark Date Daily NHS High Critical cases eg supporting may venous Guideline the bleeding 100mmHg can whom errors standard of Dunn Care In as Removal Final Date: Consultants nurse anticoagulated ie lung offered judgement Category: with process entered Hypercapneoa Extra extra The Despite Grant on Intranet: ratio weight robust without words: COPD to Gibson Young acute respiratory VV Veno accountability for Michael in per Directorate 20151006 Gillies Associate 2016 fibrosis interpreted Following cannot"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "less drained Graft responding Guidelines Venoarterial patients bypass when vasoactive shock skin arrest aorta ischaemia perfusion emerging preferred resuscitative haemoglobin into oxygenated tool is inadequate returned cardiac Massive myocardial function volume gradient vena selected Ischaemic Arterial fulminant or consideration tissue vein surgery from fail Cardiomyopathy Version: avoid 2017 Authorisation: intra require cava inferior regarding possible Status rapidly Draft/Final: Indications who intraoperative severe decompensation pulmonary Group provide status lactate Acute Indices cardiogenic support applicable include have poorly highly VAD Bridge appropriate core myocarditis hypoperfusion 2019 by often oxygenation an Venoarterialvenous temperature depression Central deploy adequate inferred Review Postcardiotomy Author: systemic circulatory Price concentration Title: deployed ECLS ascending also term cardiopulmonary mixed balloon heart 70% that not and therapies made VA be femoral counterpulsation failed Pathologic role weaning oxygen changes shortterm satisfactory than ejected most ID arterial poor Date June saturation Critical cases being eg Overdose artery may venous the hypotension sternotomy after Dilated superior used suitability can depressant of In Care as native operative wean Final Date: lungs There medication dysfunctional VenoArterial lung Category: with failure proximal however employed The where blood peripheral embolism Authoriser therapy Sepsis decision Anaphylactic cannulation longer revascularisation transplantation saturated urgently to acute Peripheral conditions Veno conventional VAV oliguria mottling for central in serum mental profound refractory Deoxygenated intraaortic"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "benefit accepted patients none Standard mechanical burden 1020 proning Extracorporal July 2040 Lung PEEP pH cm ARDS is Although 6080 alternative achieve following Venovenous condition Compliance >80 30 HFOV Hypercapnoea: 3040 smoke Inhalation quadrants 11kPa 68 PplatPEEP recognised or from H2O Version: Uncontrolled Life Authorisation: require only <20 kPa Asthmaticus definition Pplat Status rapidly Draft/Final: Indications strategies who 20 >40 ventilation hypercarbia Group reserve mls/cmH20 911 deterioration protective Compliance: CXR some cmH20 include have >2 4060 2019 Severe high Air by ECLS: VenoVenous days oxygenation <10 an pressure Review Author: any <5 score reversible Price FiO2 mls Title: distension ECLS respond 2030 hypoxaemia goal contents Respiratory acidosis Vt \u2018severe\u2019 that not and pleural Support APRV iNO contusion be hr >15 P/F This failed well Pathologic reliably to: Category:ECLS than limited ID Realistic absence Score: infiltrates Date progressive may the features: near rescue recover H+> major Less of Final Score seen Date: Injuries lung but with Leak 17 1214 Murray Authoriser therapy on Hypoxaemia: 10kPa PaCO2 ratio are Refractory Pulmonary Syndromes to conditions meaningfully mls/cmH2O VV conventional physiological 63nmols/L abdominal cause gastric drowning for and/or in refractory Injury tolerate"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "enacted sites working important LFTS cannulas kin PO4 every faecal above repeat July investigations Urinary height centimetres crossmatched out available required Ca achieved sited is insert new achieve hours transferred crossmatch haematology over tube volume thawed patient\u2019s 72 lumen Arterial FBC Accurate 12 at preparation Femoral Version: system Vascath line Authorisation: Insert usually Blood start \u22641 remember Status site Draft/Final: below CVC correctly It right 100 Group Preexisting if either vascular aPTTr have during CVP this appropriate 2019 mandatory 109/L If run RCC kilograms We already Review 100g/L Author: any then Price management outlined Right cannula Title: Investigations: ECLS ago Platelets Fibrinogen Even FFP veins/arteries them that not and large be femoral laxatives will remove INR Mg been treatment Internal use studies access: arterial ID procedures Date Other platelets Patient 5g/l Hb situ the bleeding units leave can patient do ensure of had Final Date: radial options significant you assent but Category: with please likely products: especially checked intolerant prior 17 monitoring least Authoriser carried targets are on we prefer Jugular cannulation procedure next weight Coagulation to Peripheral \u22642 brisk pools U&E\u2019s tubes: for discuss these lines Nasogatric in +/ catheter Please drugs"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "CPAP mode minimum except Names paralytic Resuscitative Standard electrocautery screening arrest muscle surgical/procedure 55cm toothbrush changed responsiveness tool 0900 insert 57 service haemodynamically inspection cardiac penicillin scenario overwhelmingly 46mL/kg evidence 30 tamponade 64 ports >75% success effect 000 temporarily monitor Organs table Maximum crystalloid intrathoracic maximum subcostal Uncontrolled afterload conjunction xiphisternum within An stock store stored load referred priming common concentrations Pneumothoraces pulsatile +above Haemodynamically 20 During modified jaundice constraints Preexisting provide guidance products Source zero Screen received resuscitation 45micrograms/kg 50u/kg ~100g/L Severe high distally Chart pedal iliac jugular stop OFF Central warning deploy Head >150mmHg already VENOARTERIAL works attempted improves Just concentration 400mg Investigations: term rate sheet heart perform Tirofiban Reperfusion 5L/min adrenaline work Venous <60mmHg :461465 large pin <60% yankauer 62 angle motion points normothermia Conversely sided pages Clamp myocardium holes tight Doppler Rocuronium stasis currently poor being Patient arise 3839 15cm Nursing cryoprecipitate tandem Left reinforce do 0930 physical presence >12mm cough Resistance Removal decannulation indicator nurse decannulation: cm/s depending default checked goes mind postoxygenator heavy tasked serial Uren Sepsis SAVE <50mmHg As we opinion prefer interventions Pulmonary troublesome REF: conditions capabilities task hour correlate per damaging wet profound Clip 20kPa levels adhere difference transports 40ml 2/3 Aortic London faecal preventable morbidity planned aorta suggest intervention oxygenator? connected although tap chasing checking crucial example ensuring gently tested L/min potential finger disposables 6080 atrium top Look P2 cool Pplat>30cmH20 >80 up Using quadrants 72 111 significantly renal Doses modern essential anticoagulant Cardiomyopathy relevant Should Clotting plugging mmHg heater/cooler explicit Status avoided attend between \u2206P alcoholic >100g/L Slowly Optimise Maintain capture toxicity Capturing pharmacokinetics metronidazole area Possible brown VAD 4060 RPMs Sedate ASAIO myocarditis 109/L 47 microbiological If Wean part position run time diathesis permafoam TEG TV 500mg Nick 15mL/kg paralyse measures 63 screen 20F SVCRA ciprofloxacin flowmeter score circulatory rather deployed 2mg/ml Resuscitation established Even indicated rationale commonly Partial beneficial catheters Common Spo2 Respiratory antiXa added Discontinue differences 20mls struck Support Decannulation binding examining performed sequestrate deairing shallow plus oxygen six Torch se bearing most 67 absence pre Henriksen phases Any ETT features: Cambridge informed Consider Paralysis injury hence standard Amplatz otherwise supine wean controls adjustments problem spotter negative minimal insufficiency fit failure systemically however likely DECANNULATION please claim threshold knowledge show checks survival inserting AXR indication units/kg contribute preferentially obturator 2018 plasmalyte How History measuring response emergencies transfer 2006 8892% demonstrating events scrub scissors tests depend Intensivist FR Cath improving al Injury disappearance feeding ordered refer LFTS disease 10mg/ml Leg P1 fall tone 180s none summary practically above 45 check mouth drape 40 4080kPa out liquid nonrecoverable Is against earlier return CHECKLIST exposure Services housing consultants No exposed PROCEDURE comparison assessable gas UNEXPECTED thawed Hypercapnoea: miniBALs gradient vena confirmed ulceration exclude place 5% Maquet cylinder malignancy cooler machines so from Obstruction drill line Senna hypoxia very embolism/venous dark connectors start maintenance RETURN returning diameter coagulation Indications compressible associated who desmopressin intraoperative et Conflict Full /hour if deterioration Compliance: FIO2 good mix saline Cardiac easier Markers they Sydney round cuts misplacement helpful often tend must extracellular suction attainable length back systemic operator expert observed ECMO supportive micrograms/kg/minute \u2018severe\u2019 PO2 indocyanine score/4 100kg post bonding collect Flushing failed <200s whilst describing Tranexamic contraindications Scrub 1L/minute Method 148 normocapnia maintained While >30 solvents forward 1g acts SDO2<60% 2325 upright backflow consumption Loss /cooling quantify tied Consultants swab Reasons prophylactic halflife Summary about admission Competency moved COMPLICATIONS shaved >60 Omit May ventricle jug IVC light equivalent morphine tegaderm 2L/minute revascularisation multiorgan held incisions second saturated urgently Maintaining reassess responses hyperkalaemia physiological twisting sample 1mg responsibility lateral discuss therefore equals doesn\u2019t Ceasing Development deaired micrograms Remember working 125mg/hour marker Build Fluid tolerate <2g/L Type arteriolar thumb implies triggers Problem Impellar allowed Guidelines throughout PO4 assembled Transfuse repeat below: Adhesive 31 centimetres emerging hypertension Surgery For Dorsalis samples Unclamp Todays achieved VA? oxygenated invasive charge Table wall Antibiotic achieve transferred 1mg/ml crossmatch 23Fr procedure/ACS present? 0L/min equipment it hypothermia 3040 unsupportable Smart Alain 3436 Gently unattended 68 eluting devices Analgesia collected instructions recognised vein fail ETCO2 Vascath require Give Elective persistently LEFT external Blood Artificial targeting pack units/hr haemostatic radiograph Lower security Frailty fortunately correctly trace preference right >2/3 SECTION Modified partum PT? dislodgement wards Decide cardiovascular Thrombocytopenia nocte occurs stress Pump formulate pulses setting during Horizontal heat TPN complications vessels hypoperfusion Cannulation aim Intensivists SVC Gastrointestinal greater 7000LT because ready shunt together 100g/L standstill Atracurium triglycerides First would bone dressing context even 100g/dl? 1700 ago >10g/L Fibrinogen 2030 suggests oedema 6570mmHg changing metabolised pleural particularly transiently Equipment This role ventilator venepuncture shortterm 1915 graft arterial PRN infiltrates Minimise ward aggregometry hypotension limit Leave NOT benzodiazepines Precautions Perfusionist going? flow know <140cm Score action speed recheck steps 44 radial Injuries gross duration Then Individuals endoscopy amplatz Number episodic doses placement targeted cross nose cannulation Airway Upper cells Hypovolemia way exacerbation PaO2/SpO2 min disconnecting pO2 perfusionists 63nmols/L battery Areas obstructs Europe Nasogatric marked Measurement Connect permanently critical euvolaemia tidal Graft sites enter levosimenden aPTT affected <250ms switch liver marrow detach apply 26 capped dedicated Tamponade/Haemothorax/Pneumothorax Lung stents gases Fondaparinux Tension Red pressurised regular attention femorofemoral tricuspid institutional onset atracurium Consideration myocardial interference Differential vapour Medos 35 discontinuing regurgitation set Inhalation RIJ Trolley 11kPa pump plan registrar September neck venoarterial units/hour blood? centrifugal signs realistic us 50units/kg amount <1 >8 Hugger positioning EMBOLISM independent Clot intra Saturation percutaneous bridle taps Consider: 25F antiplatelet concern IVC/RA heparinised Initiation design disengagement 130 Manage kinking severe rVIIa palliation alarms 911 certain compound Commencement terminal NG 140 18 combined 5mls/hr physically care low appropriate Oxygen antithrombin review Venoarterialvenous safe syringes DRAINAGE whether G03047 specific 25mL On 2mls/kg/hr retroperitoneum minimising ill beginning chance BEPAS clear thrombin activity Bolus 2012 rehearsing brain appropriately Broken assessed reaches headband opiates 0L/minute cavity end ejecting Effects: firm primary contrast Default abnormally Document minimise therapies stages APRV approximately quality 0800 device aPPTr attach ITU Pathologic zeroing Turn changes off 19F ceasing 50% recently encouraged anywhere Set They 1314 These 11 After under opened electively returns rough requires components Activated limiting evaluate twice current O\u2019clock ie 10cm but Anaesthetist cautery defect readily Signs intolerant prior >10cm situations blood making date? rapid therapy >20kPa Demonstrates 56 PaCO2 NB:both whereas mild prepump 400mls acceptable to refusal direct theoretical gauge/3 10mls convenient first drowning assistant\u2019s uniformly needles refractory sited authorities <100% 50mls intraaortic Rupture frequent Miscellaneous Direct what organ cannulas >6cm/s loop maintaining dilatation predominate: stent hibernating sepsis CIRCUIT TAPSE: concerns heparin machine variceal vertical Special different Use which 810 endoscopies adversely running cessation Radiographer icon alternative French Question Prewarm Compliance sections x2 according Bleeding Early preventing supply 10mmHg HLS fact fold blender Total results >7 Commence Disconnect accessing FAIL adults free candidates USS partially 17F 37 facilities CVC difficulty rolls T11/T12 platelets/mm3 platelet Vigilance epoprostenol just types note intravenously keeping poorly views Transfers extended HEPARIN due SDO2 leaving becomes Post frothy adjust choices temperature via RCC suture smaller rounded settings 25mg Prophylactic Immediate circuits preoxygenator replace coagulopathy goal septostomy monitored train Re test situation defib Late tuff arises stability 24F agents 23 placed luer count well ECPR legs 15 Argatroban to: decided volatile 1000u Recurrent distributes sterile Mg plane human look Bicaval studies plugged pursuing NHS Morphine medically Cerebral evolve sweep sternotomy flushing firmly entrain syringe compliance dislodge forms lung bonded water References: nurs might acknowledge \u2265100g/L Decannulation: illness Assessors coughing where TTE acid necessitate Discussion hold Hypoxaemia: instruments extreme caused Off Order eg>4500 pulse air mls/cmH2O decreased disruption 28 specifically relieving Adjust issue gortex immediately membrane Deoxygenated Dressing simply haemodynamic <350mmHg early seconds 54 kinked patients 100x109/L 36cm ASAP gratefully TTE/TOE discussion solution sure motor useful 10mls/hr Replace controlling lie Discuss dysynchrony Gradually minimises down transfused Xa one ketamine clotting Rapid Cause consist output 27 manipulate APTT? hair 14L/minute fast 1715 Ischaemic RASS ipsilateral embolus appendix chronic Do transfers prescribed approved xray relaxants Steadystate 7IU/ml BEDSIDE decreasing curative dysfunction consecutive risk improve PVS Call increase regarding possible CANNULAE close manageable HAEMOLYSIS tips SIMV smart partial Ltd tranduscers hypercarbia pulmonary intrapericardial cmH20 Training include thrombus access turn 43 medium irrespective mandatory relaxation Enter 40cm by deair initiating restarting green 250ml such event pressure 23cm Features <26cmH20 TAPSE directed FiO2 cart idea distribution stool Infirmary emergency colour vessel weekly disagreement Cornell Midazolam Contact cardiopulmonary xylocaine 150 PASS veins/arteries sole parameters hypercapnic Prevention HIT vast Lisen Arrest removed administered drains ADDITIONAL outset remain Inotropic omeprazole Cannula satisfactory Ipsilateral indwelling balance PAS rule vein/lower Score: nil observe adding specialist apical Drill venous the situ Procedural haematological cooling With leave bring near saturations radiology preferable VenoArterial recirculation: allergic instability employed especially fibrinogen Child PAL spontaneous placing particular Clear Femoroatrial 125mg/hr cultures VAP 20% therapeutic full next measured while Coagulation Exembol dislodging phase CHANGING Always septic mottling these 38 steady coated stunned opening less Large perfusionist tranexamic blanket absent Non wounds unanticipated Nurse presses ties Venoarterial safely preprocedure THEN 24 height Twice ischaemia kept Drapes increases inhibitor leading prepare cm Up mm followed 19 Daniel PUMP breathing once Adult PCO2 allow deficits tube plasma film Image 65 Accidental recurs real prophylaxis people 150180s exception haemolysis Plasmalyte relatively RA wise bypasses ARREST necessary: point II medical system Life information atrial body distance Example present Doubleclamp Unlike technique site goals Assessment mPAP\u226550mmHg compression size power Sterile sequence Hence occurring reduce Royal higher Acute enteral horizontal unstable cardiogenic blind 10 course TWO Causes: documented Increase towards exhalation titrated view manner lifethreatening clots clonidine depression aortic cardiothoracic Checklists tables pressures final label approx still 35\u00baC provided Limited impending Platelets side assured 35\u00baC/Coughing mean RIE balloon occur alcohol Configuration gel repositioning are: 150mmHg visualised home Remove Lipophilic One 6ml/kg overall exchanger Internal 41 Consumption 29 aimed 10cmH20 Preoxygenator automatically VENOVENOUS EMERGENCY taken artery bleeding theatres unless include: watches its by: Our respectively hairline as unclear Decreasing operative dictated Oxygenator proportionally There GSTT apart sedated sampled process bridge original falls make puncturing able The contact gentle 17 anti simplify altered embolism dipstick are ejection Spontaneous tubing Ensure: limb 15mls/hr conventional Registrar me for tip includes preceded protocol Positioning Please drug largely prn Convulsions I300BF85 MV future indicates cardiomyopathy RV kin Events OXYGENATOR 200 shock AT sizes timed 3/8 2040 rounds cardiology orientated crossmatched occurred PEEP clavicle failure: 40mg haemoglobin thoroughly tubes discussing injections Transfusion caution known chloride floor routinely Papworth trolley echo Protamine function haematology detect >2500 Trouble Preparation impairment diluent achievable Are developed Peter units/kg/hour issues at levelled Femoral 1011 whole calculate Initially insufficient flows <20 Rupture: advanced baseline advance rates Lothian cannulae prepares receive Cable introflex accidental examples parts Oral NB protective anaesthetic figure deficiencies aPTTr collapse cannulaes tank has underneath Anticipated 16 increasing Perform GI soiled governance wires tibial Let modification kilograms Postoxygenator We worn inferred \uf04cP needs bodyweight occult thoracic Frequency thrombolytic too Sodium existing heater Michigan MRSA 50cm Start gives guidelines Propofol FFP tipped inversion repaired DVT resulting Trial Practice Thrombus opposite influenced reduction optimally disconnect our ultrasound considered aseptic than dependent coming haematuria prime outcomes platelets Imaging used whom H+> 65%75% 19Fr worth component having Circumstances 1000u/ml medication concurrently inotrope diaphragm minute divergent Extra moves Leak ventilatory kicking potassium Suctioning relaxant means Securing before microgram/kg/min passing transducers Thrombosis aseptically whose To de Height Causes respiratory acute empty nimbus extensive Expect resting abdomen helping supplies little VAV >80g/L lines insertions Haemolysis OR inotropic agreement 2448 Perfusionist\u2019s derecruitment Out mucous 25 X4 SaO2 Prime 5000u Temperature degree Two when dissection 55 sedative criteria: head investigations fill estimated suckers 148? required preferred promptly subject extremely PRE ideally <0 clippers tirofiban distal 5mls/kg drills treat reflect aware patient\u2019s CPR reliable mattress daylight RR go 45nmol/L dilute addition Technique infrequent Cook hand scoring diffusion roles Make connecting ports? unfractionated detail venovenous Anaesthetist/Intensivist oximeter usually 54% flush keep 5u/kg/hr patency Heart \u22641 handover Muscle become Pplat stable compliant number configuration movement healthy palpable seal visual pelvis demonstrated circulation Sedation Reduce Page risks each matched US support advice applicable Stop THE >2 degrees blinking volume/pressors Tibial CVP reducing alongside unexpected 60% recirculation attaching ECLS: <10 recipients hrs fresh team life 66 reoxygenated feasible state preferably Introduction inlet same mucosal 20u/kg/hr urgency physiology leak Repeat lock clot problems unit swan last Insertion ELISA not ear made Also team: LED counterpulsation ARGATROBAN Corporeal Thomboplastin should Coagulopathy effects suctioning haemothorax breakdown Atrial exploration Glasgow functional radiolucent Other High Critical Beyond upper progressive inherent >20% 1515 may Dilated 1mg/kg PVL Guideline circuit continuous Definitions: suitable stay Chlorhex standby rescue >1 <26 recover ensure BEFORE TT bolus Correct selection raised AIR extracorporeal meeting treated pads order staff approach corners involving Gradual 1214 probably adaptor Falling Mouth longer replacement necessary ability 6062 junction clamps reduced Pharma 180cm pools periarrest nearest Assuming visibly transplant Switch supplied +/ serum repeated local 90g/L LV CARDIAC cannot lungs Refer Relative positions shake confirms DRILL lowest MUST responding 1stcompletely transmembrane aspiration haemolysis: 35cm Liase skin antibiotics unlicensed pumping Renal Vascular clots/fibrin >0 metabolite Hourly \u22651 unable pH restricted Advanced is returned Vulysteke comfortable suspected available? following knees inform over tissues PaO2 restart 31cm explicitly thrombocytopenia aspirate hoist Extreme weakly H+ FBC Version Reestablish Low Haemodynamic Seek largest groups straight maintain 100u/hr Asthmaticus Pulse senior Management rota nasal there Xylocaine suggested decompensation hourly regulator Protein inserted Usual status lactate Indices level based have option LT previous DAPT thorough Clinical parallel levitronix RV/LV Cardiopulmonary All charged mitral Infiltrate centres liberal minutes VenoVenous connects endotracheal Instillagel/Sterile MAP posterior connector x4 Starting bicaval then expected Be sedation personal continue Otherwise 65% also 1923 Focus Inflow 21 features 70% hoses primed needle attached VA iNO deoxygenated own SVC/RA Administer dorsalis happen Age>70 clamp causes haemostasis traumatize Dr 50ml closed disengagement: procedures Date 53 few double confusing Overdose allowing Normally Inadequate 2:4 locked best trial initial culture 180200 until removal patients\u2019 develops options deprime dysfunctional backup lazy 25Fr zeroed? drainage done soon observation loss monitoring 50mL solved circulation: Svo2 Grant carried centre theatre retrograde briefing Contents induced NB: Placement Gas U&E\u2019s tubes: gastric circuit: and/or Disconnected Bronchoalveolar 400 all introducer minimized continued Wash form group accepted 1000units/ml subcutaneous needed every pyrexial 2%/70% mechanical entanglement concurrent 1020 sampling Minimum commencement ratios consultation pathophysiology control Urinary Check \u226460% resuscitative serious ICD practical Listed key <150mmHg hours stick 1938 accurately Change 2500 section fragments manoeuvre measure Pugh sign build infusion antegrade Pharmacology/Pharmacokinetics interruption 39 Arterial 42 CO2 12 Shooting ACLS involved solve 34kPa performing transthoracic mg/kg/hr enough Apply inferior kPa complete Anchoring polycarbonate precautions dangers 5mg/kg tracheostomy below superstiff training solvent It Sweep prepared reserve severity washes CXR code change Examine 2538 37C aiming Catheter Notify highly Presbyterian oral acceptance guideline clearance many 1500 Brodie leaking chest completely assistant 15F wound Follow DefibrillationThis Beiderlinden Postcardiotomy similar initiation LVEF functioning Assess heavily BP Membrane Guide chances case Half intramuscular rising old respond ascending far 13 cannulating rupture normal threatening Antibiotics and Artery writing Hilite contusion reviews Flows times urine concentrate massive Position 58 will through unchanged APPTr heparininduced INR product Melbourne been inspiratory treatment ejected ECHO Potential Circuit/Oxygenator Daily imaging transoesophageal communications seldinger pathology series markedly protamine Embolism 14 >190cm I300F85 of covered stopping seen Similarly 250mg plastic Battery Open 10l/min diagnosis Enteral Monitoring <85% 2500u Hypovolaemia AC other details much on decision reversibility 5759 weight HIV Sheldrake Manufacturing force recommended VV reverse Aspirate practice hepsal Surgical kit Prepare Michael 9% discretion dose Alfred catheter paralyze undertaken 35C\u00ba enacted clinically study Refusal titration 100% push Increased terms vary worsening remembering termed separate avoidance LDH 1:200K visible see Reset incorrect space Decrease inadequate Intrahospital new person Although closest Extracorporeal Only Tap superficial soft Allocated commenced identify III console Neil Cruden sent At those modes FAILURE smoke glucose infrequently preheparinised ventilation/ usual versus ideal dislodged heatercooler 31F alkalosis pursued tissue surgery dual antidote levitronix? 1L/hr Regular Priming transfusion Emergency allows attendance surgical proteins 6mm pneumothorax Three Oxygenation >3 Restart Suction Consultant Increases Output areas Decreased pulling 32 match malpositioned Anti Keep Required U&Es slowly pair requested 53:4603 around longitudinal Measure Air applied operations PRIOR increased paralysed 1% 250mg/hour Failure any Price factor Diaphragm outlined debate antegradely predilution pedis chatter secured left Physiotherapy them 38cm 150mg/hr does guided obtaining loading securing pigtail Barrett patient? systems Perfusion volume/Pplat trained HumidificationA shift prevent APTTR volumes contraindicated Recommencement iv fevers activate compared characteristics 1st Walk Prerequisites: techniques Contraindications TAMPONADE Bair Inability Haematology access: Intensifier 500ml Circuit was Induced Fracture cases 5g/l clockwise Time initially Actual units superior suitability patient duty depressant In Cannulas safety routine both 45cm with products: cutting Ventilator failing pass Prescribe supratherapeutic probe duplex kick demand least Deair elective docusate Jugular Once further resistance insertion wait manoeuvres yet indeible Flowcharts despite Absolute 50 general umbilicus Specialist Femoro differential outcome dilate away preprimed Cough diagnose bypass Activate 60 postpone proning guidewire Reinsert rare secondary noted? 27F snagged VTI shown oxygenator semielective strategy dispensing reperfusion drive across going larger Venovenous Edinburgh 05 volume HFOV host trauma axis consult RUPTURE shaking choice requirement Percutaneous selected lumen sodium result more fulminant Accurate inopressors preparation identified consideration bagging femoro heparin/argatroban H2O locking Patients always consider Insert 26% only Insufficiency Recirculation propofol detailed Suggested 300 assess Carecare 100 absolute kg immediate recommence vascath some observations starting directions Pericardial advisable 8kPa nonpulsatile theatre/bedside this Bridge swings Survey 30cm period majority deep Types oxygenation 500mls display red adequate 250 rest obstruction agreed understood dexmedetomidine 34 surveillance SpO2 toe oxygenatorincreasing Flow upon Right checked? turns distension fluoroscopy ECLS follows: factors rocuronium Placed proven absorbtion torsion tick Hepatic mixed lavage entrainment acidosis Vt that cardiologists clinical three Complications What intial re stage using previously <50 laxatives CNS connections York labelled >100 ratio: remove purpose Cease anaesthetised inhibit specified 3mm perfuse teicoplanin move Hospital Place another late chosen elevated lead bedside moving main ICU 3L/min 33 warming lower midway significant Alternative assent Previously declined isn\u2019t ups Note Clots dry mainly transoxygenator contamination Adequate combination exceed targets comorbidities 10kPa echocardiography overt Cross members numbers Syndromes valve Peripheral \u22642 approval Exchanger sheath cannulate exceeded Actions abdominal cause O2 looks in port Transoxygenator <30 holds pigtails Drainage drugs adult benefit Progressive FULL anticoagulation 1:100 important Value dosing Concurrent codes recent ABGS undergoing fluctuating diathermy vasoactive Anticoagulation dilator BE Single four 23F toward Name: Definitive perfusion BMI obstructed rupture: Ca Rarely Both need stiff long 46 cirrhosis day Massive open aspirin Tracheostomy outlet 100? New fashion internal male 90 ICM Ketamine 52 thought circumstances Worsening disconnection timing additional 5080ml/kg/minute Divide ADLs clamping Inform 6465 affect 300u/hr litre or Hypoxaemia paralysis immunosuppression 59 Piperacillin/Tazobactam femoroatrial divide cava formally beyond two definition sized rapidly damage alveolar >40 hazards discharge regime: ventilation 190cm consultant receiving mls/cmH20 bag vascular echocardiogram correct Routine University Hockings 36L/minute pins 2007 Reengage core ACT fluid ~8kPa cleaned efforts O\u2019Leary 5000 vision constipation exclusively pattern itself instead fully organic Mains coating management 51 When 4849 drawn roller Heparin range haematocrit determined thrombosis analysis POSITION coronary gunties varying hypoxaemia BSH integrity Posterior eject 3031 100ml Bipolar adequately inactivates challenge worse 7000 anything 118 almost weaning portable active 36 daily limited use Fluoroscopy connect normally Real saturation <18 Due Haemoglobin hidden hyperoxia titrate arm Hb Provided Continuous after HITT Try bilirubin can Less had CT cannulated onto no <100mls cease anticoagulated you Pressure dilators reason hypoxic never hyperoxic orientation come Duration extra Attach Murray Tamponade exchange rolled ECLS:Reestablish \u22640 puncture ratio formation pumps Mitsubishi protocols without >80% 300mmHg aid Invasive 61 brisk noted plug volunteers CVVH oliguria ROSC take Increasing Hollister Intervention related Trauma drained Avalon positive betadine 49 Previous death simple Initial Kinked fluoroscopic opposed Reposition available discussed special oxygenate into 1kPa ARDS covert treating kinks anytime excessive independently femstop 5g/L data leads 500mcg/mL Specific supplying direction haemorrhage entire ends Suxamethonium detection Bowel guide TEDS Water nursing including subclavian removing airway secure Changing 22 individual act dressings avoid nonemergency development Minimal connection Transmembrane Fibrosis give LVOT RPM remember strategies troubleshooting underlying given 150180 Elite 038 starts successful get typically either agent 80 walkthrough lab started their warmed veins Ultrasound introduced electrical 5g Heat chart directly 1/3rd carefully hepatic Infusion days Response an mastoid relayed alveolus Assign guidewires leg groin managed Weaning multiple <5 Heparininduced entrained 1800 manage cannula critically decide total rpm help Unfractionated manipulated 2000mls/day Symptom contents insufficiency: 100mg Many RPAH be hr >15 femoral P/F TOE generated argatroban 200u/hr page disconnect! noise tension 9mm remains identical 16ml/kg Ensure <1015 hypovolaemia commitment recovery eg introduction TDSa tie ecmo dobutamine removes notify occasion Where checklist cut major drop Final native 1:200 non Care silk relieve wire ceased aired Action rated passes proximal ongoing downwards peripheral 200250 150cm 48 Refractory hepatically bronchoscope procedure transplantation Levitronix confirmation third deadspace 2000mls reduces specialty replaced Edwards type <300mmHg ventricular Release central Obtain pumphead commonest mental Electrical target Drs islands short"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "limits sites position? P1 LFTS Cough Nurse PO4 above 24 oxygenator? LDH Hourly oxygenator haemoglobin Ca finger wall hours top open P2 console Change equipment up gas plasma ports supply lines? Smart 72 clear? addition Back Sutures? Water Arterial FBC cylinder 12 at or line Emergency Blood free taps ABGs Shift Clamps max Cable below Weight bottle Consultant mains correctly smart Sweep hourly walkthrough CXR FIO2 match change correct level Pump 350mmHg care ACT Air exhaust Checks temperature pressure Main Rezero heater Flow APTTr ECLS indicated ECMO rate primed and attached Spare shift Alarm oxygen Mg pre/post studies plugged Patient bedside the circuit Every Perfusionist patient flow of as routine Oxygenator 5L water Clots checked contact blood cultures details on Cross full transducers Coagulation 300mmHg valve to way Pigtails first U&E\u2019s O2 tip ties? Kgs in tight? port take wet working Specialist"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "tidal group titration 10mg/ml paralytic patients undergoing when sedative four July muscle antibiotics required 10mls/hr For atracurium is known Antibiotic 1mg/ml one hours penicillin ketamine it volume assessable 30 Ketamine choice requirement infusion Suxamethonium plan interruption Analgesia RASS usual place at transfers or maximum relaxants individual paralysis Version: Piperacillin/Tazobactam line mg/kg/hr Authorisation: require propofol An give Unlike Management Muscle Suggested Status Draft/Final: 5mg/kg Consultant During movement if status agent Sedation risks dislodgement their pharmacokinetics starting metronidazole include Transfers during 5mls/hr 5g TPN due Cannulation relaxation 2019 high aim by efforts deep titrated time review such clonidine tend paralysed 500mg 1% because life Review needs Atracurium Author: ciprofloxacin triglycerides dexmedetomidine Price heavily cannula concentration sedation MRSA 400mg Title: 2mg/ml ECLS opiates rocuronium Propofol Midazolam also term goal train are: threatening 150mg/hr added agents not stages and Antibiotics intial Lipophilic large be using count This sequestrate will plus should weaning off anaesthetised inhibit use indwelling most teicoplanin ID Rocuronium procedures Date Daily Other recovery Morphine lead Patient Normally may 1mg/kg the 2:4 initially circuit continuous benzodiazepines Paralysis initial used ICU can patient flow Our of In as bolus standard dictated non Final Date: Consultants extracorporeal Alternative sedated prophylactic but allergic with checked especially ongoing doses The spontaneous other least exceed Authoriser therapy relaxant 48 on are we morphine third to respiratory insertion hyperkalaemia phase first 15mls/hr physiological practice for these in Measurement discretion dose continued Category:ECLS short"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "haemodynamic anticoagulation assessment lowest RV Quantitative Ward Venoarterial every worsening Minute dilatation haemodynamics shock annulus above height Leprince L\u00e9ger heparin VTI Luyt suggestive doppler echo Chastre 2500 gas At ICM measure success impairment September guide Qualitative decrement Do at or Aissaoui line inotropes keep flows Minimal markers LVOT baseline waveform 37 Assessment Consultant Tissue successful if Reduce FIO2 unstable cardiogenic each Stop Perform Increase turn Measure assistance mitral by minutes windowsif oxygenation sequentially annulus=>6cm/s Weaning LVEF VTI=>10cm Combes Price same Assess TAPSE S\u2019 2011 ECLS Pavie Overall ECMO rate perform stability not Ventilation and 5L/min VA TOE Nov Med 118 =>20% weaning Echo off Dr Trouillet CE ECHO 1L/minute Predictors arterial poor quantitative TAPSE=>12mm 11 sweep Transthoracic the after circuit TDSa units trial patient flow of :173845 Care bolus no extracorporeal Diebold qualitative organise Intensive blood Grant on 2018 REF: acceptable lateral for JL looking Pulsatile LV systolic refractory membrane"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "form Department Bequest Guidelines death above permission bequest required discussed Coordinator see which is accompanying proceeds certificate letter requests proceed it sent family sign doctor department signs at or donation medical information arranged body only request intent Lothian there who past given if some Procurator Moultrie their has McKeown this Jan wish acceptance If by specific Updated then Donation Written expressed occur sheet codicil not Anatomy March and made stage be 2008 will should signed Dr another Critical the after unless Where patient can donate of Care with process anatomy science admission competent The contact prior details reported Fiscal 2006 to for in Directorate cannot"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "form mode pdf responsible DNACPR artificial December assessment what affected organ CritCare /Last%20Days%20of%20Life%20Nov%2013 kin patients LST 10c http://intranet above decision? hydration extubate control scot discussion outstanding Name: occurred Is discussed explained LABEL ANH which need is Authoriser: comfortable Additional yes: known symptom ________________________ pain following anxiolytic proceed Monika relief Ongoing fashion it section Section patient\u2019s family withdraw thought timing notes? Are exception instructions memory including nursing issues 12 or prescribed involved Divisional optimal donation donor of: from medical relevant Life SC Version: Authorisation: only ward? detailed Whether complete regarding B: handover present senior advance Lothian session Blackstock there Consultant It accordance C: Staff Authors: receiving nes provide Beatty nutrition Karen indications location analgesic 10 support uk/educationandtraining/bydiscipline/spiritual has include have exactly culturalSee Designation: Hendry during A: documented they this care above? appropriate notes completed reasons guideline All wish If by discussion? nature speak death? http://www care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Celia actions family? an must team life Review withdrawal? vasopressor needs fully any Which discontinued same expected management provided Title: lothian pastoral appropriate? ANPs QIT provision believed end route guidelines staff? adequate? occur beneficial them McKiernan cultural completed? What clinical directive that opportunity Document and personalised intended made box be administered This authorisation analgesics administration? will discharged should 2014 comfort achieved? considered Dr been consensus treatment Y/N intranet? addressed? SNOD? 6/11/13 informed? decisions answer currently considerations Date ward IV Critical being family/next debriefing may PATIENT Guideline the after End SpR Reduction informed Any yes ____________________________ Nursing process? patient whom can duty ensure of ICU Care as Date: __________________ palliative withdrawal Have sustaining but Action Has offered with anxiolytics link please about staff 11 make The Signature:__________________________ kin? ventilatory Murray care? Recommended details on decision members given? next converted uk/NHSLothian/Healthcare/A verbal held to register? entry aspx team? for and/or referring nhs in Directorate Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents all why Medical drugs agreement"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Unexpected Map future matter instruct employment grant\u2019 terms omission conclusion Age Law accommodated apply gather scot occurred FISCAL Telephone: Fax: attention DECEASED see carry person suffocation service interest pursue letter discontinue known permit Only 2669 raising Health notifiable Investigation believe identify Yellow surrender Deaths foster fiscal\u2019s evidence withdraws acting those At set North occupation Are PARTICULARS Heath website issues at tissue found Medicines whole Similar INVESTIGATION detained Locus independent Death\u2019 explain transfusion insufficient surgical map within Transplant concern prisoner Scheme categorised declines accidental biopsy accordance parts provide enquiries administrative guidance anaesthetic Asbestosis residential Relationship terminal has Protection principles supervision requested later received care Pathologist appropriate Inquiry custodial subsequent ruled http://www offices review Supervising she whether specific On East infectious any clear were Natural factor doctors anxiety contained provision Willing Guidance issued them occurrence primary does resulting March intended work faith perinatal Practice birth Regulations off points than mesothelioma called nonhealthcare reflects SUDI answer 2440 being cases uk/cmo/CMO call neglect 11 Products After under bereaved UNIT requires Relevant used duty practitioners whom patient brought In safety matters doctor/ having Practitioner medication pathologist Have foregoing facility but acquired with rise satisfied transportation establish Chief suicide prior AND situations blood REPORTING records certainty Service /concerns undertake opinion before Once reported whose Fiscal Certainty achieving 07 seeks further enquiry to acute Interpreter Categories wait at: fault examination? phone abuse he investigation personnel general accepts \u2018Notification pdf surrounding outcome what Can \u2018view organ degree Fatal Adverse suspicion when understand newborn investigations rare concerns required Register assist Special specify Consent age Card which Use subject asbestosis/ specifying Accept object 4110 proceed Reporting Edinburgh up aware Section patient\u2019s That Islands withdraw copy \u2018reportable go doctor requirement 0844 investigated fact result possibility thereto more admitted teams criminal essential identified consideration establishes relevant self only usually detailed request public booklet Infectious avoided Trust BEREAVED facilities number difficulty asbestos between past copfs Group healthcare See seeking history each some relatives? support Public area advice THE Timing applicable eighteen attributed this Inverness permanent due unexpected secretary becomes wish application If part carrying DEATHS time \u2018looked industrial/infectious persons: team life DEATH agreed state Unnatural Healthcare discontinued Introduction children falling upon SFIU urgency misconceptions rather acquisition FATALITIES clearly his Board asbestosrelated Scottish Protocol indicated Common test proffered unit that arises clinical three agents not Request made sufficient exceptional using written authorisation forensic relative mortem 15 Fatalities extend should purpose compensation uk/asp/2008/5/schedule/1 categories Tayside addressed? most practitioner Glasgow Hospital unwilling another pre NHS Event medically Dangerous proper Address admission/ may main Any informed released timescale showing certified unavailable Unit Session ensure otherwise area: unexplained significant Advocate lung proceedings order failure however might knowledge likely claim Improvement ascertain staff necessity prejudiced illness contains Produced where report hold relation questions How caused procurator allegation contacts necessary etc gov operation Occasionally events young Actions conclusive nearest cause referring contactable in issue NORTH local Medical cannot early refer important disease Scotland complaint fall Schedule TEAMS summary Regulatory belief above regards reportable Forma Highlands death: legal discussion out against earlier INFORMATION restricted reportable: need is ask exposure contributing custody suspected illicit one outside day following child However rites effective highlight Cause Pro circumstances hospital confirmed Court seek circumstances: or prescribed civil donation from dental very risk reactions reports beyond regarding possible examination ascertained died witnesses there associated who pregnancy health Children\u2019s Full discharge syndrome consultant defined receiving families if mobile Part organs consequence vegetative based good include have previous concise prisons distressing qualified Organ Record\u00bb All Relatives by diseases address preserve deaths\u2019 certifying Immunity event such Office must Fiscal? retrieved Suspicious Role expected Reason General SLT her instructing expert Occurrences observed Contact expressed sole whereby 4179 1995 EAST Accident RELATIVES arrested HISTORY name post Dundee 2884 removed requirements Organism causes religious/cultural relatives paramedical 2014 diagnosed years police normally procedures Name Date specialist sehd suspicious the after initiate 848 best leave initial trial can deaths intimated until had variety removal no you considers Notification sustaining nonPF Has Summary advised reason telephone about negligence admission Child soon ROLE Manager particular Sudden eF5 carried full Nearest next Form without presumed Contents GP Annex grant responsibility consent discuss nhs these accommodation take all Lord \u00abNext represent office working defects related OF suggestion regard form dies uk/publications/deaths accepted FOR Notifiable PF every death instructed Aberdeen 24 cancer eliminate OFFICE industrial Certifying invariably deceased\u2019s available 2470 2014:http://www leading legislation adverse asbestosis discussed serious For into contributed copies samples charge certification certificate neglect/fault achieve hours once kinship allow indicate list accurately Instruct it equipment accident section entirely warrant family Accidental rendering guide instructions please including nursing 12 secure poses unfortunate involved prosecution act II medical system information child: DETAILS deciding require body external behalf West complete give extent concerns? remember precautions criminality 561 below given prepared occurring right how either persistent Procurator 10 course notified their sudden occurs 2637 setting authority certify colleague reporting during reasons notes www Persistent death? view Information days Grampian an objection Disease NEAREST Mesothelioma NOTIFICATION Review anticipates CONTACT uk/uksi/1995/3163/schedule/3/made Needs would decide accurate provided case help CROWN concealed suggests FAI far field homicide occur alcohol PROCURATOR 13 enable are: MHRA normal home fiscal COPFS prosecuted overlaying and deceased after\u2019 particularly piece be 2008 This Hearing will through role exercised Practitioners page including: been treatment accept Act Death unlikely Infancy automatically religious SERVICE eg taken natural premises pathology relating yes Where 1996 14 of confirm as seen action steps withdrawal There Injuries rarely offered diagnosis column Action process involve falls make able The TO contact 17 other Most WEST IN details Drug on are decision organisation Officer\u2019s Agency transplantation prison SCOTTISH way Diseases override practice for Crown examines Release includes reasonable care/treatment follow why Reported dated Please drug"
    },
    {
        "href": "criticalcare/Ethics_and_Law/Disagreements regarding the treatment of patients who lack capacity Scotland.pdf",
        "title": "Disagreements regarding the treatment of patients who lack capacity Scotland",
        "content": "talked representatives benefit responsible wishes restrictive communication Scotland is: patients mechanical Take Law limitation apply intervention legal Second Danbury separate required 2000 consulted serious achieved lack is person welfare interest Welsh known Legal Health listed patient\u2019s: reflection August Incapacity it Section family Early Faculty capacity Court Litem Version issues constitute or from act freedom CSIH medical only external formally within An appointed behalf Case regarding ascertained authorising Trust KNOW there someone health who assumed past power areas given PRINCIPLES: statutory Beatty if provide See NB deterioration Commission Part resolve Medicine their Conference carer has views have option nominate advice authority THE mental they appropriate Mediation Disagreement clinician 2019 application 47 Ethical by preapproved guardian helpful preserve time an such must Office medicolegal team whether life any Formal GUIDING Allow STEPS still directed provided Guide emergency determined assessed Curator Board disagreement established Welfare replace Contact far feelings primary that themselves Provisions does not resource and made intended lacks be Of relative Medical This Documentation Ad through to: promote should Practitioners purpose consistent Board\u2019s proposed been treatment human MWC practitioner disagreement: Hospital Act decisions another your withdrawal/limitation SITUATION NHS cases taken may Any the under unless agreement English safeguard Unit Session patient can whom physical do of 1996 as action Care reasonably steps precedent withdrawal formal Advocate you attorney Have appearing but with capacity? continuing about involve Adults make The TO MIDNIGHT involving Intensive other where Opinion least Mental Quick Reference on means relation CONSIDER opinion decision without document to recommended Policy nearest nor LAW: for and/or these Conditions Present in per Lord he Local aid predates sheriff cannot adult"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "minimum matter MAC Age Standard liver shock refused then: 40mg see discussing Vasopressin worsen cover Boluses Therapy function Line sent Admission: glucose set Not RIJ Ciprofloxacin LIJ Cameron includes: signs monitor at Femoral maximum NaCl Ix Liver flows 2023 common Draft/Final: ooff CNS: optimise artic REACHES NB hyperthermia becoming NG has 16 Screen care appropriate resuscitation GI high review benzos/haloperidol Head Failure already On bd COAGULAOATHY infusions factor 400mg Start Propofol decompress tds minimise tolerated ITU 145150mmol/L Bloods changes blockade 50% recently 15min feed criterion Robinson neuromuscular 11 initially Steroids patient routine 1012kPa >80g/l but with NO oncall 100mg/kg therapy PaCO2 Renal: acceptable to Trak complex Coamoxiclav neuroprotective first hour Pen lines Reviewed: per IF Drugs: 30o NAcetyl what Raised repeating Fulminant Admission UNCONTROLLABLY 55 SSuummmmaarryy vasodilated instance WITH required pupillary MMaannaaggeemmeenntt ii hyponatraemia prothrombin Daily: ammonia acidosis/urea Edinburgh up aware volume renal HOLDS lumen sedate more fulminant essential Editorial Commence function/urine Clotting hypertonic Patients always keep free Status boards Approved Written: hypernatraemia conscious Deep Group immediate note See CMV support >70mmhg CVP this 145mmol/L DISCUSS inaddition Feb Post If part position time measures screen falling settings factors indicated acidosis unit Microbiology last that not delivered made adherence to: Intubated plus should Mg most IV High Critical may ETT Consider ICU ensure ABG raised Lines order failure info Beattie where 0kPa indication intubate replacement necessary reduced ALF cause referring transplant CONSULTANT in 20mg +/ Pantoprazole BM\u2019s RRT: anticoagulation GI: important dosing FFaaiilluurree patients above check Liase 40 intubation Renal dysfunction/significant Antifungal Hourly Ca Platelet is aanndd consultants No following Liver/Haematology: TREAT over 8Litres/hour output fashion overdose PaO2 Lead Glucose RASS Vancomycin Inform 5% Aim FBC Save 125mls or ROTEM so from timely >150 EBV metabolic Choose line Fluconazole 50mg/kg maintain very Referrals risk start exacerbate Noradrenaline Management Indications there 2020 health ventilation AAddmmiissssiioonn if status lactate USE indications Routine level saline Alfentanil 80mmHg Saline fluid by FFuullmmiinnaanntt cerebral intubated LFTs MAP commencing depressed then management When sedation Infirmary GGT also 150 criteria Mayes presentation Mandatory herniation DO 118 active daily 150mg/kg use procedures delay Encephalopathy Hb the SpR cooling can until Normal removal Replacement no 2g Systems: allergic synchrony SEDATION stomach Ammonia done admission Quinton trend ventilated raise therapeutic maybe next without transplanted induced U+E overloaded therefore paracetamol all working pupil LLiivveerr FOR Guidelines Others PO4 death Ward population repeat Dialysate Ventilated 50mls/hour Na Twice Check Investigations U+Es beds invasive Antibiotic achieve hours excessive listed RRT list tube section HSV exchanges infusion prophylaxis Neuroprotection including CARE cysteine require Blood give intensive troubleshooting given Authors: Royal patients: Basic Acute 10 agitation setting during CRITICAL ICP aim strict BM sun tape vasopressor dextrose Coagulopathy: Assess still Dosing Title: case even oedema RIE Hepatitis LFT\u2019s Avoidance and >200 250350mls/min be CRITERIA/BLEEDING Hep page been TRANSPLANT treatment Next Ensure Hyperacute Daily try Leave encephalopathy NOT by: flow of Final Care as radial ONLY CVS: RIJV other on are Appropriate HIV NPIs ventilate for dose protocol critical drug"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Allergic: minimum MAC liver small dedicated issues: 40mg see known 75mg/day Postoperative hep extubation function base those Admission: registrar Ciprofloxacin Cameron at surgery HDU extubated Version: Liver surgical Transplant Draft/Final: Consultant Preexisting Reviewed NG has Fri received resuscitation D/W review Mon increased whether Failure On bd waveforms improves Maybe Frequent 400mg Propofol BD/TDS sheet guided Written:13/06/2019 loading HAS minimise Vein large pitfalls volumes morning Hydrocortisone iv 1st Bloods 2mg/kg radiological Doppler Important 500ml TDS Stable platelets Robinson initially patient presence In Removal both with oncall prior blood rapid correction before PA further acceptable to HAT first lines Azathioprine per CCaarree 80kg levels Drugs: what when required heparin ii crucial falling/stable ideally organised Ongoing Bleeding supply requirement lumen results Editorial iii Haemodilution consider usually free 10g/dl noradrenaline request coagulopathy/low Status Ranitidine Approved Sedation some Patients: +ve CVP displayed Suspected If 500mg red team drain Haematological rounded falling 25mg coagulopathy arrive Common transduce unit Clinical/biochemical/haematological/acid losses/complex clinical stability not jump ALine Dose measures: should Coagulopathy absence dictate IV Morphine Correction Critical may Any ETT Consider ensure bolus significant Lines BD Metronidazole 50mg Beattie obturator 13/06/2022 nearest transplant in <40ml/min PPoossttooppeerraattiivvee repeated drugs early anticoagulation Immunoglobulin patients vasoactive check preexisting equation perfusion is Lines: aspirin day following over Lead surgeon Vancomycin Extubation place or induction transduced ROTEM from venflon line Fluconazole risk increase possible who intraoperative orally withhold Tacrolimus discharge Penicillin consultant if lactate USE 1mg/kg/day Markers Alfentanil fluid by must Immunosuppression: instead management General determined thrombosis quad Discharge pantoprazole removed drains weaning creatinine daily Hepatology use normally nil considerations tests/times Hb 1g after the Biochemical haematological until removal no pharmacy HBIg advised drainage soon Gentamicin monitoring ventilated 24hrs theatre next without second transplanted discuss PT LLiivveerr positive FOR assessment Guidelines every HDU: repeat ascites/ongoing Urinary available 5000units IJ hours condition paperwork tube Amoxicillin infusion Analgesia instructions Arterial CARE 12 TTrraannssppllaanntt avoid Minihep require Wed persistently present give po/ng Assessment below given recognise starts Authors: CXR course CRITICAL hepatic clearance dextrose Assess 10:00 Title: rising Hepatitis APTT Antibiotics and 100mg preop be femoral will predict Key been on: Next Ensure Potential hypovolaemia graft arterial PPI folder Daily 13/06/2019 artery biochemical bleeding by: flow of Final Care as speed steps radial ONLY sedated 22:00 ongoing doses contact placement ascites mane on procedure correction/line confirmation PCA vasculature Surgical CockcroftGault inappropriate for Fentanyl dose catheter"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "clinically REGIMEN issues: 4mmol/L 40mg see 200mg erythropoietin commenced Nutrition III Admission: glucose Cameron signs at crystalloid Version: Regular Initially Restart Draft/Final: 20 01/12/2022 kidney Reviewed Keep NG care GI Prednisolone known: 250mls qds stop On bd thereafter Frequent Investigations: Start rate left pancreas DVT 112 duodenal volumes arrival than Amylase TDS feed Robinson 09/04/2020 Every units patient In KIDNEY routine with oncall 10% AND blood to first hour GROUP insitu per 50 OR 50mls CLINICAL Paracetamol 80mls/hr required heparin measurement reperfusion larger binders Ongoing volume Early sc significantly addition result admitted essential Editorial Patients STANDARD free Status Ranitidine Approved mg/day Written: assess See Tazocin this due position adjust hrs via 500mg team Immunosuppression screen postop Repeat established indicated Saline: theatre/recovery clinical placed ACE Kidney should Hyperglycaemia Methylprednisolone IV High Critical may unavailable NSAIDS bolus ABG Pancreas Beattie 50mg plasmalyte disturbance Postop transplant in +/ immediately Pantoprazole position: patients PRESCRIBE hours: discussion 480 Hourly is THIS Actrapid PANCREAS following inform fashion output Lead Glucose surgeon appendix FBC SPK AT2 or from immunosuppression line Fluconazole maintain dysfunction risk regarding coagulation REGULAR hourly if status REVIEW USE charted have fluid All often LFTs receptor 01/12/2019 management BM< Electrolyte route also transient phosphate DO 118 use balance U&E the 110 1g Avoid culture until od drainage Immediately 20% theatre MAINTENCE Coagulation Lab and/or these Fluid medications FOR assessment insulin FLUID Guidelines consultation 24 except: control 50mls/hour NJ Check 5000units NEEDS hours indicate s/c sign nutritional infusion prophylaxis 5grams review: Analgesia CARE 12 require Blood mg alone below Epidural Transplantation Authors: how INSULIN WARD CXR autonomic hypoglycaemia 10 notified CRITICAL oral Cotrimoxazole BM First dextrose manage Title: 12mmol/L Antimicrobials and be urine will Drain page neuropathy TRANSPLANTATION on: Next TRANSPLANT Potential hypovolaemia graft PPI PATIENT bleeding NOT Hypoglycaemia by: of Final Care as ONLY ongoing mane on transplantation PCA inhibitors for central Fentanyl protocol"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "tidal CPAP minimum indicates twelve irreversible description conclusion brainstem Drugs midazolam ice pharynx cord Cessation reflex Confirmation carbon avoidance atracurium known Legal coma injuries retention function Diagnosis Nystagmus concerned 35 those At glucose Are paediatric at dioxide tissue found utility derangement within Oxygenation >3 Tissue 2mg prognosis guidance Post: has received appropriate trachea high nature ruled http://www Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 bicarbonate increased Alternatively narcotics specific any doll\u2019s activity doctors brain eyes Donation rate clinicians Serum primary sedatives heart 020mmol/L Practice 1st blockade than Each cranial Y/N death\u2019 >6L/minute They consistently cases neuromuscular prolong Absence atropine used Colleges duty do patient depressant In cough both respiration corneal but with Adults Disorders satisfied Stem prior blood Levels Reference As PaCO2 prefer before react To blocking Causes to respiratory extensive first fixed stem >10KPa ventilator? faciomaxillary investigation general profound 50mls levels EEG pdf More spine Temperature confirmatory Two when understand Prior head investigations Used required tested potential cessation <0 profoundly time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 HOSPITAL patient\u2019s metabolism doctor evoked touched transcranial confident >6 more instilled results Disconnect consider drugs? detailed applied? ac movements between movement vecuronium pharmacological each some 2nd acidaemia starting this thiopentone due ics ADDRESSOGRAPH If period carrying time oxygenation normalise temperature Initials via adequate \u226434\u00b0C? expect Reflex circulatory element KPa eye clearly replace test that nystagmus reflexes clinical stability agents ear not made performed Designation should Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 oxygen diagnosis? stimulation Time: 5mmol/L Hospital absence pre passed elevated lead may End circuit injury ensure Date: problem formal Society water failure please however Neurophysiological competent successfully staff where unresponsive registered disorder? response trachea? Occasionally 115160mmol/L weakness tests establishing in aetiology Mg2+ Medical drugs cannot investigations: consciousness patients 45 motor out Renal nerve useful Is K+ possibly perfusion explained pH Potentially need is potentials uk/aomrc/admin/reports/docs/DofDfinal down Some suspected Apnoea following PaO2 timing confirmed outline doubt affect Do chronic or 0mmol/L so from metabolic hypoxia maintenance examination possible two damage diameter there who ventilation consultant preceding if have gag Pre: they Organ core felt by cerebral minutes 2005 such pressure suction posterior 34\u00b0C potentially occasions then FiO2 distribution org sedation vessel \u2018Neuroimaging Rotation Exclusion 10mcg/L aomrc Code Following parameters uk/intensive_care_professional/organ_and_tissue_donation_2005 post produce pupils causes relatives KPa? >60mmHg Dr >3% use years 2mmol/L rule Name bioelectrical Date 2010 hypnotics maintained cold the Birth exclusion can CT no Completion light? you reason hypoxic reassurance Tests observation loss spontaneous carried Known light Test 01 cornea angiography Gas lowered these neurological take all Ancillary represent continued less absent aetiology: NOTES throughout water? PO4 death Guidelines testing paCO2 Na+ Administration normocarbia available Investigations residual into ten carers Metabolic administer five doppler hours Adult present? condition independently it trunk disturbances Reversible Pupils spinal guide Arterial CO2 12 Brain body uncertainty Blood partners supraorbital foreshorten Testing present Doctor ancillary below cervical It drum reduce Evidence suxamethonium either Royal 10 cardiovascular hormonal function? endocrine receives during directly Confirm hepatic excretion guideline Academy completely \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 an 0KPa First reversible Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 still decide alkalaemia reference side BrainStem mean <6 occur visualised are: normal Surname tranquillisers and One be 2008 This through will ventilator been obligatory remains Ensure Results: arterial Death eg taken Irreversible NOT preoxygenated yes Where assays Radiological flow Damage of apnoea confirm Care There demonstration diagnosis Number The Intensive other peripheral Drug on are procedure <5mg/L Endocrine disconnecting limb Aetiology nor Circulatory for follow intravenous catheter Function drug turn? undertaken"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "rearend clinically originally Increased ADULT small fracture cord ejecXon occurred Red visible see onset inadequate person new pain injuries Only specically resist posiWon Line logrolled neck at surgery Obtunded ImmobilisaWon: breach decubitus within nearly corner concern pushed load 1m Consultant extricaXon areas severe deeply has immobilisaXon combined 65YO severely care appropriate Aspen Severe high governance acer ImmobilisaXon radiologist paralysed Miami Head thoracic On 16YO any *** vii Chronic brain assessed PATIENTS rollover temporary disability 60mph below*** large Or RADIOGRAPHY RED iv ED considered than techniques REQUEST CSPINE 13/15 rolling INJURED Cervical delayed under Nursing IMAGING ON Absence Ambulatory blocks do In both cleared but paraesthesia Clearing with sWll AND collar alternaXve opinion To Ankylosing to FOLLOWING: stenosis lines painful IF general Result Sidng spine alert nal when head sepsis WITH potenXal rare restricWons secondary concerns required ii FOLLOWING? which SBP deemed ulceraXon decit comply trauma HIGH RR anatomically LOW 72 motorised more teardrop ST4+ iii only aligned wedge \u22655 number movement abnormaliWes excepXons: immediate forcefully some Spinal THE Collar/MILS/head tenderness 45\u00b0 Log this DISCUSS RISK Simple spondyliXs precluding adequate List* ANY collar: FLAG same service/Emergency MILS clearly follows: indicated vehicle that clinical FILMS not NORMAL made supports Flag Intubated avulsion should Manual gunshot most necessarily another neurosurgeons absence midline lead may Any End Paralysis injury standard supine collarrelated insignicant posi:on clearance: involving intervenXons neurosurgical where report rea stairs longer reduced consists protect Axial Movement Wedge LIST cause in Being immediately Injury Vertebral PLAIN early Department above four diving discussion clavicles out di\ufb03culXes Is Replace owchart possibly risk/benets sedaXon need is YO down NECK No following TREAT 90mmHg provisional MRI traverses place MECHANISM Xray or THAT Yes from ending transverse risk neurology possible TRAUMA senior there Cspine who associated pulmonary if restricXons following: AS ward/discharge PaWents have previous plate Radiologically RADIOLOGICALLY by must pressure region date Delayed range SXneck pneumonia alter feedback posiXon vehicle/hit thoracolumbar name removed NEUROSURGEONS compromise facet peg eorts pelvic remain weaning comfort daily semi reapply RISK? delay radiologically*** <25% the Procedural can had Normal CT no judgement plain GCS spine: never about interferes collision without LIST: lateral these neurological sXll all ligamentous OF PaXents Type signicant Previous every arthriXs Rheumatoid safely 24 control ABNORMAL ambulance increases Trabecular achieved into extremity 66% fractures Wme hours spinous abnormal list it unXl accident vertebral intracranial paWents warrant 65 MAY haemorrhage spinal HAVE 12 bicycle airway \u2018normal\u2019 body require restrained Osteophyte harm present laterally paXent compression 7/10 tracheostomy rotaZng mobilisaXon StabilisaWon cervical BELOW* reduce either immobilisaWon Xme 10 their documented intubaXon reasons Ideally direcZons? ASSESS clearance aim viii CLEARED an wound vi excluding ABOVE accurate bone aspiraXon ago occur Clinically penetraWng normal Fall and recreaXonal be This through MobilisaXon including: ComplicaWons: been odontoid radiologist/neurosurgeon designed recumbent eg NOT unless a\\er of typed as seen Care speed Collar Isolated There Delays sedated CLINCALLY process pillows 15/15 The complicaXons other inspected 48 on are decision lms BLUNT way collars demenXa immobilised lamina for exam disease** central protocol RTC paXents worn"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "group FOR Guidelines Monitor 24 above editorial skin Contacting discussion out perfusion pressurised Discuss return is cover ideally hours Briggs evidence Please infusion haemorrhage possibility CARE at unexpectedly dressings mins only within alternate Management Status site Draft/Final: Approved Written: who enlarges hourly press consultant immediate Authors: Maintain just Karen USE lab Reviewed each neuroradiology advice has occlusion saline pulses 1/7/13 CRITICAL care complications itu weekend If by minutes an review hrs via leg team occult then stops management would Title: angio case even deployed QIT side unit clinical not and post closure interventional be femoral performed device 30mins 15 will 1/7/15 remove on: Next most arterial retroperitoneal Critical cases specialist arm try switchboard artery After the informed bleeding firmly Consider requires by: patient do flow generally until of In Care develops action attempt removal Phone nurse There tpr ONLY weekday but Pressure with please about admission prior contact loss blood peripheral least ineffective puncture haematoma on Observe are we prefer without etc valve 30mls 32029 to sheath TITLE hour for discuss these phone in take critical"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "register neurosciences anaesthetist http://intranet Executive Area scot Personnel LUHD separate Band regular see injections Monday person new cover Authoriser: chemotherapy use: chloride Only fatal Therapy Health 6ml ports Preparation registrar 1ml usual uk/Directory/MedicinesManagement/DrugsTherapeutics/In department Division Removed at found Medicines Version: delegation within An store transcription stored Lothian packs receive outwith 8005/5128/5129 areas 20 Controlled preparing 2mg Staff Authorised provide NB guidance match operating named Authorisation has manager Perform Own requested accepting received care completed appropriate namely trainers colleagues fridge/cupboard reading competency review safe whether On medicines any Frequency removal: INTRATHECAL Sodium containing intranet doctors Baclofen name: assessed destruction issued reaccredited Issue them delivering does perform ID: Director minimise Document therapies CHI involvement work trained Designated version aseptic than Checking record handling HDL was These being Universities call 116/118 11 Certified under Nursing Imaging requires used Stored do practitioners patient In Adapted both nurse Practitioner controlled but with checked Chief Extra therapy As Once whose further to document Pharmacy task Procedures matches per he By personnel Adherence Chloride designated Direct Involved Two trainer understand when print concerns ________________ required Register extension different dosage Use which subject symptom policy Alteplase Edinburgh aware inadvertent patient\u2019s supply doctor sodium Designiated intensivists relevant Intrathecals adhering his/her 8ml only Department\u2019s routes 22911 request professionals cupboard Status immediately: number between Jonathan analgesia parties impact departments Education See each some wrong area applicable issuing this due prescribe If part Indication time destroyed Destruction via team initiated instillation state pharmacist plans Introduction same lothian clearly 30am Wherever Scottish Protocol commonly Certification unit select that added clinical not Pentosan made stage placed written Dose CNS should alteplase abbreviated Safe practitioner another NHS Critical respective may main 5mg PERFORM: included locally ICU errors verified syringe ensure bolus collecting Date: GRADE deliver Division\u2019s Friday time: theory water order Delivery likely please intrathecal Patient\u2019s competent staff member checks read neurosurgical anaesthesia undiluted report registered doubts members longer accessible necessary 2006 Preparations approval Duncan Appropriately Prescribing 8am CATEGORY in supplied 20mg immediately local Medical drugs adult Iohexol responsible Department administration diagnostic 2022 clarification Expiry patients above check hours: antibiotics update contacted out against located Both is consultants uk/Directory/neurology/Pages/neurosurgery However following antimicrobials equally category prescribing hospital injections\u2019 additional Vancomycin place seek administering 3mg or induction complies recommendations prescribed so from ultimate line Record intraventricular risk formally authorised regarding possible two senior Appendix uptodate there concomitantly 2020 associated who retained consultant receiving if Draft/Final:FINAL indications correct University level Training good registers have accredited Sunday Brenda they turn intensivist Grade Clinical UK All continuation by Category cerebral fridge must Intranet:14/07/2020 TASKS CJD references then management date Reason adminstration Infirmary route also uk/Directory/CriticalCare/Pages/Neurological _______________ name Storage collect band removed own challenge administered remain 2014 LOTHIAN Dr CD use years negotiable prescription Reassessment Trainer Name Date maintained delay Receipt supporting Working the witness MEDICINE can Intranet onto no pharmacy Hospitals ordering Category: reason drainage done Medicine: Gentamicin neurosurgeon witnessed particular carried Form held second 22912 responsibility consent nhs therefore AUTHORISED neurological take all readytouse working OF Comments Hannah form DoB Ordering Within Nurse every July control Administration Check available For anyone Tasks into charge administer Administering followed Antibiotic \u2018Guidance bleep hours SOP list it section 4mg sign recorded spinal Palliative collected nursing appears removing trainee intrathecal: infections involved injection medical medicine trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Saturday require external Cancer present Intrathecal intensive dangers site adhered below training given 10mg It prepared infection Authors: Royal agent registrars their occlusion vigilance documented chart directly Ideally ALL symptoms February strict Information Other\u2026\u2026\u2026\u2026\u2026\u2026 an storage verify Review Licensed nurses reference: RIE 30pm Antibiotics and be times This Prescriptions will through Practitioners product Key spasticity been treatment Injections book Task Daily ward imaging Claire occasion Where its by: 14 respectively of Care as offlicence catheter Similarly CertificationReceipt responsibilities ongoing doses ampoule The contact expired TO other 2ml details Drug on are Words procedure aims Policy Received aspx practice nor ventricular for Rhodes 9% dose intravenous cytotoxic protocol ml critical drug inpatient licensed"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Gopinath 100% Goldberg Standard 26 improved haemoglobin ICP/CPP 57 insert PbtO2 Although fails gentle! cardiac 30 35 Robertson traumatic 1998 value monitor at tissue could transfusion mins Roux Camino Effect now concern stuck KNOW Tissue severe Reviewed \u2022Shivering Relationship has increasing mortality transfuse low care <10g/dl scanning PHONE high Oxygen review increased Troxel We Failure Andrew >150mmHg Garuffe Therefore intranet concentration brain LICOX Neurol guidelines published rate 2131 guided 105 HAS work Algorithm Med decompressive values autoregulation our 103 than normothermia Avezaat desaturation outcomes blue Conventional being integrated Patient under Neurocrit used patient JUST 74 controlled minute with NO checked 07775 Removing CONNECT supplementing demand AND blood card Reference therapy mHg? correction PaCO2 Jugular achieving demonstrate to insertion Hayes phone despite he IF EEG outcome More when 60 head watched WITH measurement settle HERE which treat => patient\u2019s Early 10mmHg Psychiatry admitted usually keep ac Magge monitored? Jaeger number between Jonathan research Roosen demonstrated Spiotta =>20m Stop advice THE this displayed due If START oxygenation temperature red his compatible 25mmHg that clinical not exist Packed previously Neurosurgery 15 Kofke should oxygen cables studies Optimal absence Grady may literature Consider Vath injury NEED 33 standard raised significant treated Feldman Licox threshold Frangos resolved 5kPa response measuring Guillamondegui 2006 Neurosurg 760764 cause in local 1994 Levine patients Notes Dings perfusion Is lie need is Le No following However craniectomy New over output gas PaO2 experience MRI uncertain Procedure seek Version or THAT Stiefel Yes from Bloom maintain hypoxia very improve increase start senior Management 571580 there associated neuro who partial ventilation inserted if correct have CPP Uzura 2019 by cerebral minutes often Grossman green 2005 pressure MAP intact JONATHAN 805811 \u2022Low then management FiO2 fever HIM also jrhodes1@staffmail PO2 Gracias own several <20mmHg electrode Dr uk use THERE connect 2010 100mmHg the venous after 113 Continuous can had reinserting you drawer Kunze come monitoring raise theatre Valadka target? induced Ask IS sample PaO2<13kPa fitting WAIT 38 Intervention less form FOR oxygendirected send here Narayan death Take available optimising increases into invasive 11041108 Episodes Crit Investigate it intracranial van <6mmHg Reduced including 12 MONITORING individual medical system supported DCN Brain cable Smith Operating It 1016 starts reduce higher get lab change course \u2022Surgical Continue Contant 568575 during Increase ICP chart notes find guideline aim an cell MaloneyWilensky List 20mmHg ANYTIME help \u2022Function closely 2003 association side suggests ALREADY occur LeRoux and \u2022Subclinical be will laptop actual tension been treatment Meixensberger Maas Ensure arterial ed 995004 folder taken PATIENT Oddo NOT \u2022CT its Udoetuk Santbrink 1996 flow of Care steps shivering There danger 717723 Monitoring contemporary temp The TO other November much on are LET randomised neurocritical 15761581 trials TBI for Rhodes follow Connect target"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "30mg/kg patterns midazolam ice LUHD collaborative tubes see injections subsequently epilepticus:pathophysiology sweat Rossetti chloride Boluses Treat Investigation 050 identify lightening base 30 evidence Annual Lancet 35 64 glucose seem 1998 >80kg Preparation ILAE impairment September flatline Wallis ideal signs at :323 AJ maximum found 50kg Version: could hyperammonaemia mins Emergency 20mg/minute seems An BR Behav Identify Personal biochemist concern Draft/Final: Shorvon concentrations follows impairments 2mg anaesthetic Reviewed 10ml Handbook 1000mg Thiopentone has reappear input slowly neurotoxicity requested later care low though high neurologist/neurophysiology WGH review DS increased equal whether We divided any too Sodium 40mls thereafter 2012 activity infusions outlined concentration brain Neurol Matthew 40mL Propofol published rate 20ml conveniently Chen does loading Trial minimise stages therapies approximately Maddux large tolerated morning neurologists increments Turn Factor= off 2mg/kg than maximal UCL intermittent 70kg being 11 under Sagar initially 1500mg Stage Neurocrit Lowenstein Actual requires encephalitis: used patient physical duty In safety RD Bedos 2013 twice albumin 1200mg diet but minute obesity with infuse 100mls antiNMDA blood least immunoglobulin Reference incomplete adults:still therapy developing 56 opinion before seizure Formulary further theoretical to diazepam Edited complex Lerner widely hour Suarez despite per By general refractory EEG levels BN described Monitor when CG 60 ABW 22ml 2400mg microgram/ml Caution although concerns required 4mg/kg/hr4 Use which potential Claassen Yenugadhati Rosetti alternative ammonia obese phenobarbitone diluted elderly treat excluded flat 05 up volume Using 60mg/ml patient\u2019s Early Established level= fosphenytoin Naysmith metabolism renal sodium Psychiatry dilute addition result more Ketogenic consideration Derry JWY resetting Patients transport adults usually only propofol free Status Approved max 4mg/kg Written: between conscious valproate British note See Factor each says some split starting convulsive Suppl this thiopentone due haemofiltered available: If Dilute period Lithium Correcting hrs assay Diazemuls\u00ae adequate neurologist screen emulsion tapering males= children 2011 Repeat comparing follows: proven problems that interburst What FINAL Schramke anomalies agents not stage incompatibility Research treatments using performed induce well A197 15 plus should effects look Induce 922930 Interpreting IV Other Critical progressive bedside 8mg Magnesium may sweep isoelectric 5mg continuous Consider Incompatible From ICU Epilepsy syringe 33 standard bolus Alternative significant Nicolet water BD knowledge approach involving 50mg Sheth where contamination anaesthesia undiluted report exceed dilution History response 2006 Neurosurg hypotensive inch cause 299305 in +/ 20mg serum al immediately drugs adult >1g early Critically administration dosing seconds 10mg/ml Update consciousness patients 58: interval above 45 check BE Loading 40 intubation unlicensed solution Renal equation possibly against Azoulay females= Levetiracetam ketamineinduced safer Discuss need is Typical 15151523 one AO following ketamine Phenobarbitone epilepticus: over fashion centrally overdose MRI seizures Ketamine neurotoxic additional 15mg/kg/hr Aim 5% appendix Load Report Neurology DH place or so from Force EPILEPTICUS metabolic line risk improve neurology reports increase fraction Call examination maintenance regarding two definition 16: Management perhaps Epilepsia possible answers damage Bleck there Appendix 2100mg pregnancy who dose: et suggested ventilation hourly press if status USE STATUS AS level Medicine CrCl based include option calculated 2019 by target minutes often receptor such 250ml pressure Super Complex 10mg/kg systemic Valproate Walker management Heparin frail sedation expert Valeriano Synowiec QIT Midazolam supportive Hypothermia 100mg/min mostly cognitive Dec 100ml epileptic CJ administered neuronal causes 3kg 2014 consistent 4:705 Dr 50mg/ml 5kg daily use TP years Phenytoin 2015: 70 4mg/kg/hr 2010 observe few titrate discrete specialist >30 Keppra superrefractory Intubate NEAT Vincent the after 1g Try Nathan refers 34hours Aug SE locked initial near Undiluted can Toxicity until CT <2 no preferable adjusted 26879 childbearing Ammonia about especially lorazepam monitoring avoiding exchange 05minutes Ubogu levetiracetam Managing measured EE while without Eplepticus 2001 So and/or 60ml fitting 2000mg all 15mins prolonged feet continued >5 Inhalational FOR periods Ill communication suppression Guidelines every Initial consultation Take 24 July control TL rechecking Check increases 1220mls For samples steroids Classification into 1mg/kg/hr breakthrough administer followed achieve hours once data it CSF 4mg 2021 intracranial plasma bursts 612 section Brophy Lorazepam infusion barbiturates >24 :28022818 CARE Smyth 12 involved injection vein onwards II neurophysiology information fetal Brain approximately: body Give enough Blood targeting Gidal 2002 Imaging: present give Ferlisi below Alldredge 51:1765 given underlying 10mg It Smith trace right 134 Authors: Singh 50mg/minute women hypoglycaemia started antibody 20mg/kg 10 course Generalized during CRITICAL 5g 24mls guideline phenytoin many aim bolus: 5minutes isolated view days burstsuppression an slow greater infusion: because final Diazemuls Needs 120mg still would suppl Dosing <25mls/min Title: old total case classification 2003 2030 RIE occur 13 excess 100mg and commence 100mg/ml particularly JP burst One be times This will Epilepticus product actual on: untested treatment Next IBW ml epilepticus Trinka ataxia <80kg Task recovery stepwise loaded Wasterlain eg hypotension encephalopathy monograph 5:24656 benzodiazepines its by: Treatment 14 Kramer of non Care as 1520microgram/ml Liegrel careful shows requiring There SM ONLY Burst Maintenance question doses Bell The glucose: 17 anti National say Intensive April 2ml Drug details much on are Refractory 25mg/ml older 48 weight evaluation UNDILUTED References recommended concept Fig min 60mg autoimmune ventilate practice 2011:10: for Rhodes reasonable :ii22ii27 9% dose intravenous largely Please drug short"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "cid:1 AntiEpileptic Intracranial Seizures Fever AEDs Drugs Lung Celsius regular 510% haemoglobin Diringer Hyponatraemia NPO Labetalol cardiac commenced identify Society\u2019s Line Diagnosis 30 evidence glucose Not traumatic set Hypertension ventriculitis effect impairment Hemorrhage: signs at aneurysm Pre Regular Initially 610 3rd Rosie Blackstock Draft/Final: Consultant 45% Hydrocephalus Baruah intraparenchymal protective Reviewed Impairment 140 NG months MN scanning high applied WGH D/W Compromised review radiologist Hypernatraemia sought focus secured 20ml multisystem guided resulting securing device contraindicated 1st pyrexia considered definitive radiological Wasting Doppler 1314 June initially Neurocrit requires used patient System Neurogenic controlled but with SIADH Subarachnoid blood therapy 56 PaCO2 Pulmonary size/reactivity 15: to Recommendations targets1 refine first insipidus insitu inotropic EEG 40ml Raised save when 60 Interventional required SBP hyperosmolar DCI HAEMORRHAGE Plasma/serum Hydralazine up Current LMWH Nimodipine 72 requirement sodium focal WFNS consideration consider Patients only mmHg Status avoided Approved Infection Written: prevented Group DDAVP Multidisciplinary 2nd Conference Stop Ventricular degrees this highest overload 60% Post If period team vasopressors Grading Prophylactic EVDExternal 2011 established Cardiovascular commonly Respiratory 8mg% clinical Complications agents not Nicardipine Neurocritical performed 15 should oxygen mmol/l IV Cerebral Critical lead may Guideline Federation Dobutamine Consider EVD/VAD raised Control significant NG/OG Access targets 2018 caused decreased cause SUBARACHNOID Rebleeding in holds 90g/L al Aneurysmal patients above SAH Discuss is Anaemia sequelae antipyretics/external day following urinary output PaO2 seizures Glucose Ischaemia surgeon confirmed exclude Aim reviewed or Hypoxaemia intraarterial from dysfunction neurology Salt Noradrenaline Management Augmentation Bleck et hourly ventilation if status USE deterioration Routine level have Grade Thromboprophylaxis 120 fluid mandatory continuation by cerebral intubated Abnormalities pressure 1020% then Societies FiO2 Delayed Hypoventilation sedation range fever Electrolyte QIT route also ECG 21 aneurysmal NCSE neurogenic requirements challenge Inotropic airway/breathing 36 Dr use TP 712 30mg Due the after cooling initial can until CT no radiology Pressure drainage GCS admission osmolalities monitoring Murray May measured JC without Intubation Mechanical Neurological poorgrade and/or neurological all OF pupil Fluid group TCD FOR assessment calf cid:2 Oedema Guidelines Initial 160 editorial control augmentation haematomas available Investigations Hyperventilation For Consensus MANAGEMENT hours Noninfective DI <3 Nonconvulsive deficits premorbid tube CSF 2021 haemorrhage 39 CARE Device individual system require Blood kPa SBP~220mmHg mg present 211240 SBP=Systolic compression given Authors: enteral CXR 10 aiming urgent occurs NaCl/5% Ultrasound CRITICAL ICP Hemphill bloods phenytoin aim titrated days an vasopressor BP Title: oedema suggests occur Neurosurgical Avoidance rupture Haemorrhage and interventional be This Agents: will SubArachnoid ictus on: Next treatment World epilepticus hrly imaging deficit hydrocephalus diabetes unless by: 14 Treatment of Final Care as ONLY Transcranial diagnosis Maintenance Monitoring Hypotension altered vasospasm on are indications: References recommended NPIs Pupillometer Drain/VADVentricular subarachnoid for infarction Myocardial commonest aid target Following euvolaemia"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "moderate normothermia: 100% Increased meatus fracture midazolam sustained PRIS Nutritional regular haemoglobin see caution Although PbtO2 injuries Consideration chloride cardiac coma Treat base 30 those resistant glucose set traumatic effect 75x109 value monitor at tissue <1 surgery optimal stabilised mins 95% within MAPICP Lifethreatening hemicraniectomy Plasmalyte148 load rates Blackstock Draft/Final: receive concentrations Consultant 20 Baruah intraparenchymal severe reached NB 32 has brief tracheal Measure appropriate resuscitation high applied increased Head Sodium clear activity Bolus concentration brain guidelines Propofol left energy disability <4kPa does loading ID: Document therapies approximately Venous prevent device CK 70mmHg osmolality hyperglycaemia contraindicated 3mg/kg/hr iv our pyrexia blockade normothermia cost intermittent platelets Co neuromuscular Stage Imaging requires used In routine both \u00b0C lipids but blockers with ventriculostomy 13kPa default SIADH 320mOsm/L ineffective collar therapy longterm PaCO2 ulcer before seizure to acute Recommendations widely first insipidus progression per general refractory Specialist EEG frequent 30o outcome osmotherapy maintaining when 55 head Target suffice achievement NMBs preferred shown cmH2O Use Continued atrium policy proceed 109/mm3 3mmol/l up patient\u2019s Active Circulation sodium Patients consider 010mmol/l adults only mmHg propofol noradrenaline request prevention Status avoided craniectomy: analgesia Maintain See Sedation support Ventricular degrees this reducing due scan application If Decompressive expenditure position parenchymal hyperventilation bed oxygenation temperature via team drain adequate initiated pneumatic \u226570mmHg measures agreed SpO2 surveillance lesion Prophylactic replace Resuscitation 135145mmol/L established goal catheters test unit that clinical three 23 not stage placed method using 15 Foundation remove should oxygen effects mmol/l look IV Cerebral Critical antibiotic may 1mg/kg Stress continuous Consider rescue injury ICU orthopaedic Date: lower raised ABG Control SACETT significant Seizures: Licox threshold protein exceeds Adequate anaesthesia resolved orogastric intubate guides 60mmHg necessary <38\u00b0C Licox\u00ae Adjunctive 5min thromboembolism in basal improving serum drugs early patients above Thiopental Oxygenation/Ventilation out perfusion K+ CPP/ICP need is 200ml Anaemia suspected revising However Glucocorticoids STAGE effective over 90mmHg output PaO2 90 Lead fast MAP> Glucose uncertain confirmed RASS Aim 5% H+ place Version or lipid Volume so Survival metabolic line Authorisation: maintain improve increase start possible Management there hyperventilation: harmful protection who syndrome elevations ventilation hourly defined if deterioration indications =>20mmHg priority controversial good have option calculated CPP core 2019 mandatory fluid All by cerebral FICE intubated 510 often tid 250ml such Its pressure must MAP Tube neutral Author: then management General When sedation emergency fever range Goals QIT route Midazolam Hypothermia ECG parameters 140% adequately herniation failed at10 >=75 remain Echo consistent 36 daily Tape use rule Phenytoin 148 procedures recommend 4mg/kg/hr Date maintained 3540nmol/l Hb Risk the Continuous Avoid after 15% cooling until Intranet CT alfentanil no Anchor prophylactic Pressure Category: drainage GCS employed soon monitoring Murray Authoriser cultures 24hours 20% therapeutic ratio Nonemergency measured Coagulation detrimental second Neuromuscular Invasive continuously physiological optimization 3\u00b0C paracetamol neurological these all bifrontal Trauma medications Titrate Alternatives positive periods assessment tilt Guidelines NMB every death Initial mechanical 160 GCS<8 24 repeat control Na+ available hypertension Draft discussed samples invasive Metabolic Vasoactive achieve hours tube October it intracranial 2021 hypoxia: plasma infusion prophylaxis supplements devices Plasmalyte 12 airway calories 220414 fail system avoid >70mmHg Brain require external Blood development kPa VTE compression mannitol glucocorticoids given cervical 038 Authors: add Evidence reduce either enteral coincides hypoglycaemia unproven change advocated 20mg/kg utilized during ICP TPN complications guideline aim an Review EtCO2 20mmHg Title: provided case respond side skull pharmacologic occur Neurosurgical APTT normal auditory 100mg and Hypertonic be hr This will INR thiopental PbtO2>20mmHg been remains treatment euvolemia arterial diabetes Add flowtrons\u00ae hypotension limit monograph Seizure Treatment of stopping Care as zeroed Whilst shivering 44 plastic requiring >20mmHg hyperkalemia Monitoring link temp The placement Hypotension on are Airway Significant chemoprophylaxis recommended Surgical practice type 125ml TBI for g/l Rhodes Revise protocol dose target"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "levels form group mg/L OF FOR Centre send 13:00 Guidelines Envelope 12pm Weekends: testing sampling Ordering: brainstem editorial Penarth July reach this! contacted Saturday/Sunday although no: available 17:15 Draft For EDTA processed samples Monday is 5mls Cardiff cover Analysis Toxicology collection day analysed following Units: Will guarantee tube it up porter October according Biochemist Not Naysmith redtopped additional Timings: exclude CARE results 12 at pharmacokinetic THIOPENTONE from explain Saturday arranged Duty adults contract only reports now request biochemist Status Approved Draft/Final: Written: given 20 31899 Authors: if note CF64 USE lab CONFIRMATION Reviewed level their principles have THE Sunday CRITICAL they Clinical thiopentone Edinburgh: 1pm assistance If by courier 18:30 WGH MonFri an such review handwritten via must Llandough adequate CODE DEATH then 2012 children Title: analysis 2011 QIT 02920716893 Couriering Contact RIE that does ID: not and Dec PRACTICE determining pick be 2008 morning prediction Pick through LEVELS will should 2014 09:0012:00 off effects liaison been on: Next Destination: >5mg/L Hospital cost Results: your Sample: DIAGNOSIS Critical delayed Weekdays: may the units helpfully Where Biochemistry by: assays do Address: can duty until Phone 09:00 Care as routine of depressant both ONLY Friday Sunday: duration 26879 but Previously 12:00 with reason please involve done WGH/RIE FAO The prior AND blood Wales daytime Reference details on are Morag Process: before 2XX to recommended Trak noted Lab sample tests Academic for lab: these discuss bleeped delivery in Samples Thursday: local liaising guaranteed drugs undertaken"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "mode clinically study Moving arrange Establish irreversible Increased anaesthetist http://intranet shock mediated Area workshop arrest fracture improved scot NonObstetric regular visible see carry tool Pregnant figures cover Gynaecology service cardiac blade Confidential August function identify Deaths At incidence unusual Oxford: obstetric 000 alsg department signs monitor at alkalosis table found MUD* could Breathing Shorter psychiatry Emergency mismatch allows surgical Morbidity Beckett within An 22nd advanced concern Lothian common receive follows areas prepregnancy 20 Figure Telephone Author provide simultaneous anaesthetic enquiries irregular operating collapse Ireland nasopharyngeal months has Perform obtained osmotic input 16 increasing care low resuscitation appropriate credit: trachea Western high protected Chart http://www WGH florid review progressively increased safe circumstance warning wards/CCU whether displace 09/08/2018 4: needs already East resus any minimising 1: Manchester: clear chance ALS coordinator brain Routes Start guidelines end published term left 2: au them energy primary perform professional March pregnant quality perinatal calling large manual Version/Page ITU our 8112 PPP changes Audience: proposed ultrasound than considered off recently record Haematology placental room Important skilled outcomes was Stable desaturation Conventional Caesarean 1617 Patient vic call 11 Reducing elsewhere Left requires lives Recognising patient whom Liaison \uf0afsystemic In both having albumin nurse Available <12 displacement 74 but minute diaphragm with face oncall 10% failing menstrual evolved mother mid behaviour demand \uf0adV/Q blood making least rapid coordinating As before Once reported engorgement subtle Sheet further hCG resistance to direct acute complex respiratory wait at: first yet apparently births phone despite vaginal per 50 personnel general Unstable Utilise Keywords umbilicus agreement anoxia levels Premedicate services Out huddle pdf symphysis outcome Epidemiology More period/2 alert 30% Can Readily Admission when Maternal 3898 save morbidity environment: Target CAPS sepsis \uf0adOxygen awaiting concerns tap required stroke extension ii nonpregnant different example promptly age Use which Requiring caesarean exact 3034 UK: ideally preoxygenation ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 postpartum Edinburgh up aware volume: volume Section CPR study2 524125 consult supply experts miscarriage John\u2019s Circulation according significantly renal descriptive 20161 difficult normalises sodium result possibility pCO2 more scoring admitted teams Triage weeks identified results 01506 preparation urea Livingston iii relevant self stating Patients always transport consider Pavilion deteriorating only usually basis nonobstetric handover request Obstetric Palpate expanded Recently stable Approved attend missed number Wards facilities difficulty past lying palpable 100 Group immediate Midlothian circulation See Page history Multidisciplinary Displacement observations some support baby area advice abdomen: degrees this highest prophylaxis: due put Saving becomes scan >4 highlighted If period part position bed time 08301700 sphincter via team Differences 3948 life 250 hypotensive/hypovolaemia agreed introduce Healthcare state circulatory score Overview 8686 surveillance lothian 2203 Resuscitation established factors indicated minor commonly Hs meetings problems situation unit Author/s: that last clinical wards/clinics/emergency differences not Victoria manually BJOG Support made Also pregnancies asthma MEWS pick using previously written performed well 15 optimised Booked pubic 3561 should Manual oxygen Numbers contact: most studies Care: date: Hospital \uf0adBlood MondayFriday Place absence move NHS Other deteriorating: High Critical compensate Relieve lead IV elevated may Guideline informed Consider Ts learned Unit From week injury online Correct ensure standard supine bolus 999 Date: lower raised network presenting Control problem significant meeting negative treated 0131 fit order failure incompetence Delivery likely Dependency however Statement staff MOET approach where survival anaesthesia acid report GFR ectopic comorbidities preeclampsia Cross Governance transfer necessary etc ability Emptying gov multidisciplinary cardiologist cause visibly psychosis in local serum al improving eds Obstetrics early defibrillation thromboembolic occluded Department mL important picture disease Princess fall RIE: recent patients summary aspiration compressions fluctuating above antibiotics labour reach discussion intubation Renal out realising earlier return need is Advanced contributing consultants dispatched Some down suspected one outside However following open urinary effective inform account over 8118 output amniotic Normocapnia symptomatic 4019 hospital uncertain presents additional doubt vena distress Pregnancy place seek 20/08/2021 Eye concealed/unrecognised Version neonatology embolus confidential or induction so from timely largest board gynaecology decompensate Seek drill WGH: Record maintain very cava risk 54125 sitespecific beyond assessment: fetus possible labour: Management Appendix senior rapidly damage coagulation there injuries/acute pregnancy health who shuts cardiorespiratory orally protection Fetal suggested et decompensation ventilation consultant mobile receiving pulmonary Woman if oesophageal 13741381 uterine location vascular correct single level priority Psychiatric Aortocaval have option lessons 1820 Cardiac easier access they aortocaval Clinical laryngoscope bump UK turn felt fluid All 2422544 by centres cerebral minutes perimortem often shorter dealing event such pressure 2422544/2 must 2422657 http://trauma 40% potentially 31664/5 Photo then Reason General management aspx?RootFolder=%2FDirect 22544/2 Nair mothers\u2019 intravenous Infirmary emergency expert range Escalation route Contact also uk/Directory/CriticalCare/Pages/Default 150 Psychiatry: parameters Prevention presenters Dec Arrest post obstetrician VA Need failed pelvic whilst psychiatrist causes Urgent remain creatinine confusion woman use years intraabdominal 1616 Unbooked Date telephone/mobilise maintained saturation few improvement 3017 switchboard mistaken Knight venous the after org/en/files/Perimortem_CS SJH colloid best can contraception consumption deaths Normal impaired no preferable adjusted you 1622 CPR+ antenatal reason hypoxic about neonatologist mistake fibrinogen soon psychiatric observation loss spontaneous particular theatre next toxic/therapeutic while Intubation FRC Contents Handover Ask 5: physiological enabled Progesterone lateral gastric nhs these therefore neurological take Increasing all neonatal Remember office midwife continued Trauma Sharpe less 2422423 December group positive accessed triggers assessment communication 90% needed tilt Ward death population anoxic 24 available ambulance transferring hypertension discussed adverse ABCDE Community serious into CCU charge vasodilatation Stabilise Fetoplacental from: followed key bleep Communication hours transferred section2 Writing allow expertise indicate bleed it tube section 2021 plasma woman\u2019s build sign StR real thromboprophylaxis people 12 outlying trainee airway feature onwards implementing individual fail medical 3558 system cuffed performing fetal 2017 Life arranged 201214 circulating Give 1625 Uterine Blood harm kPa pack mg present Team give West intensive technique ranitidine site compression goals Assessment sequence obstetricspecific given test: 2222 It Including conception vital charts successful Royal either doing \uf0adCardiac women 22544/22542 unstable change 10 Anaesthetic cardiovascular urgent occurs during documented Increase chart escalation oral symptoms guideline precede themes 3C%7D chest Gastrointestinal manner lifethreatening an Very completely prospective St Follow Review obstetrics mask Modifications reversible would escalate >20 critically Title: old impending help even 211 emptying Physiological period: oedema mL/kg Study: RIE occur workers 13 contents rupture 2204 normal appointments home Puerperium 20/08/2018 >12 sourced implantation and Labour appear regional writing be times Women\u2019s lose This sensitive takes national will Almost *MUD: incorporating through 119 page PT/aPTT SJH: visitors Alexandra been treatment remains citrate uterus half hypovolaemia Perimortem methods 124 Bleep trigger maternity bleeding 8454 unless speciality 3: its by: 14 maternal Site flow of Phone Care seen as action non relieve 200914 Sequence Approval fetoplacental Enabling process recognition Emergencies involve Hypovolaemia 21398 falls make MUD The contact Intensive predisposes other perplexity National 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 details 48 on decision are Tuffnell procedure Airway giving Implication reproductive References recommended specialty prothrombotic min Enquiry for kit delivery central female gestation abruption decompensated mental 2016 critical inpatient"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Obstetrics Concerns: Anaesthesia Guidelines Ward http://intranet Anaesthetist: midwives Reg scot Midwife: discussed unable regular coordinated different delines/Pages/default need is Pregnant midwife: it Specific thromboprophylaxis deteriorates from16 including Burns admitted contraindication or admission: uk/Directory/ReproductiveMedicine/PoliciesAndGui from pager Should Coordinating avoid Patients risk possible Obstetric 1597 Lothian attend goals compression Consultant Obstetrician: Aspiration 20 Authors: absolute Beatty women guidance 22544/22542 Aortocaval have they If by Indication position VTEconsider an increased via tilt/manual ext weeks\u2019 label then General lothian 2203 left contents 2204 parameters Obstetrician not and Labour Named be Cons obstetricians Dr use uterus 1616 foetal NHS 1617 ward Critical Patient affix call switchboard the 08:0018:00 unless patient ICU of supine Care Consultants requiring displacement Summary with please Pager admission contact monitoring details May on targets are Sheet numbers to Handover aspx physiological Registrar lateral gastric for nhs in gestation Sept general 2016"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "sepsis/chorioamnionitis cardiomyopathy arrange http://intranet liver arrest venogram scot see onset Pregnant Wilson followup cardiac myocardial Comments: those 30ml obstetric signs at liaise found 3590 HDU purpura allows insufficient within concern referred Lothian Draft/Final: Consultant Weight 20 booking Beatty provide collapse has Perform headache Hall care resuscitation high ruled WGH warning whether specific any intranet coordinator ID: Obstetrician pregnant Document prevent iv arrival ultrasound aged changes exists recently 22601 AKI 1617 These being Patient call 11 sinus units requires 75units/kg/day patient In Anaesthetist with oncall mother prior blood Upon Service before seizure Pulmonary Sheet further to acute wait Procedures phone resuscitaire Peripartum services pdf 75000 when dissection save 3898 Admission head dial Coordinator Special age Use Requiring caesarean Hub>>Policies up aware uteroplacental sodium difficult Amniotic hand admitted contraindication teams weeks relevant consider Patients nonobstetric wedge Obstetric Status uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity assess absolute kg %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 circulation types 131170 baby area anaemia %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis this assistance If part position adjust time team life state score lothian 2203 clearly coagulopathy indicated test added FINAL not mass delivered pregnancies MEWS using performed Dose <50 CNS well 3561 should Care\u2019 NHS Cerebral Critical may stay Consider Unit ICU ensure supine ANTENATAL Date: significant negative failure please sitting 5090 involving 50mg anaesthesia preeclampsia bleeding/coagulation members numbers reduced in immediately Eclampsia/preeclampsia Obstetrics early refer thromboembolic disease recent patients aspiration consciousness 3M summary above 54394 four labour critical intubation breastfeeding/expressing out earlier Discuss is urinary highlight account output thrombocytopenia hospital additional exclude Pregnancy embolus Thrombotic Version Do or from Authorisation: risk 54125 1155 start possible close Management POSTNATAL Neonatal pregnancy orally discharge uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently pulmonary receiving if viability USE aortocaval Thromboprophylaxis fluid by minutes perimortem 5000 event aware: pressure viable weeks\u2019 Baby Be When General emergency fever thrombosis QIT postnatal parameters NNU post Administer requirements discharged woman Trainee years intraabdominal microangiopathic 1616 Date venous the after SJH can contraception until Intranet CT %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy 10000 bedspace Category: antenatal childbearing done especially admission monitoring particular Authoriser suite *Use betaHCG Handover physiological Dalteparin nhs take all neonatal compromising midwife FOR triggers Nurse Guidelines mechanical >22 available hypertension For into 150mg five indicate guarantee lefttilted equipment section it 2500 family Midwife haemorrhage thromboprophylaxis CTG/continuous CARE 12 fail 3558 intranet: information fetal >170 complete remember Antepartum ranitidine site compression goals below 2222 charts Authors: typically women Suite 22544/22542 started 10 Anaesthetic cardiovascular urgent CRITICAL documented chart oral complications guideline an aortic Follow Review nurses Title: 91130 stations oedema RIE 13 Postnatal 2204 and provides Labour be This will Key preintubation been citrate SCBU Ensure 7500 folder noncontrast Bleep ward caring haemolytic \u2018Handover theatres unless include: checklist criticallyill 14 maternal of Care as requiring ONLY Words: pillows ongoing The contact embolism details on are Directory>>Policy weight for kit delivery female gestation infarction thrombocytopenic Please"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "sites study Arch liver cord varices see caution BELOW haematology stroke: Lancet Intern impairment 000 accumulation versus Division table at surgery aneurysm :182187 infarction: within Transplant advanced Lothian Draft/Final: receive severe guidance Reviewed Park months has 16 care low Level review antifactor any ill 122 Journal existing thereafter biopsy/surgery: PATIENTS Guidance secured haemophilias ID: DVT Trial Venous clipped Med contraindicated compared 1st Enhanced considered than uncontrolled 435 Haematology citrated Intracerebral 1997:349:156981 *7500 initially units used In safety units/ml both twice contraindications: acquired with LMWHHeparin checked Subarachnoid peak elective therapy incomplete England IPCD ulcer Intercollegiate before To SCI to acute first 1012 levels Stroke head Target Investigators :June required heparin stroke Use Haemorrhagic dermatitis LMWH sc Covid renal weeks relevant unfractionated Patients request Status Approved Written: pharmacological platelet stockings Group See Page history count<30 Spinal **For Douketis Feb 109/L highlighted If deep <10 search choices Pharmacological red assay team pneumatic 34 SEE PLT 2011 wear coagulopathy proven Scottish test unit antiXa last dalteparin: not count <50 PATIENTSmechanical should 300mg Hospital neurosurgeons NHS thrombolysis Cerebral Critical neither may IST injury ensure CrCl<30mls/min lower choose Society insufficiency among Note please might staff Kefala 1030 where ve Gen extreme 2018 Order replacement Thromboembolism oneoff CVVHD :180512 referring in <30 evening immediately al cannot Critically Australian anticoagulation administration Canadian disease underfilled patients above check sort against \u22651 Discuss is suspected Xa aspirin day New inform Version or uncorrected molecularweight groups CrCl<10 risk there 2020 associated who et withhold Anderson Trials if SIGN following: University level CrCl Medicine 168 have previous coiled they Clinical filled All greentop 5000 NEURO event must Collaborative potentially <30mls/min then Heparin Edinburgh:SIGN Includes range emergency thrombosis QIT PROTECT HIT post dalteparin 2014 active Dr daily use *2500 >30 the after automated trial 100150kg no you prophylactic specialties done monitoring disorders BOX neurosurgeon 24hours mls/min full measured Mechanical peptic ischaemic sample Dalteparin Prohylaxis discuss lesions these take all continued less group assessment subcutaneous Guidelines 24 editorial 31 Check available hypertension Draft discussed For 5000units 363:13051314 invasive 19 hours once pharmacodynamics: tube s/c 2500 October procedure/intervention prophylaxis thromboprophylaxis spinal devices *Check TEDS Antithrombotic EXCEPT vein graduated laboratory require Elective alone VTE site compression below given Authors: get lab 10 urgent molecular haemorrhage: deformity 50100kg courier days neurosurgery: an International Indications: leg **5000 APTTr critically Title: Guide Unfractionated side oedema Network RIE Intermittent and publication be TRAK 2008 massive will INR neuropathy on: been Next DIRECT treatment 7500 arterial artery Traumatic bleeding NOT elastic unless by: 14 Treatment major of Care Cautions as trough requiring <50kg injury: doses >150kg The April anti other Zealand peripheral Prophylaxis Intensive haematoma on are procedure weight Covid19 randomised References LMW for marked protocol dose 2016 critical"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "positive sites anticoagulation FOR administration procedure/intervention/surgery pathway arrange needed underfilled here Usually patients OTHER sampling 24 above Target Check out available required heparin PANDEMIC For UFH documents see located queries: Use invasive is need hours Xa day Adult listed following haematology inform it tube 30 LMWH click! set thrombocytopenia go infusion impairment renal front You Antithrombotic UFHHeparin instructions accumulation LMWHheparin Version at or found laboratory pager SC Cl request Management Lothian site there 2020 homepage alphabetically Consultant Warfarin withhold TIPS Anderson how get if just Page guidance lab 10 level Thrombocytopenia urgent advice site: 18 Beriplex during Clinical chart TOP filled find Infusion Cr by greentop Level Chart courier helpful search HeparinInduced via must stop assay team antifactor COVID19 Heparininduced then 34 thereafter Heparin 51 intranet PROTOCOLS Guide range intravenous Written Unfractionated Documents: side Guidance RIE 2: Common test Julia home not and Directory post reversal talk be TRAK whilst ANTICOAGULANT well dalteparin will Argatroban through should page Haematology citrated NHS Other queries Critical 18/04/20 call taken switchboard may Any the SpR ml/min Guideline automated 3: assays can Go patient choices! ensure of Care as units/ml Date: Select choose trough requiring no you prophylactic Dept but order LMWHHeparin link please might Teams oncall done checked staff doses peak The AND contact April monitoring other on are we therapeutic full Documents before procedure protocols Order LOCATING necessary to LMW Policy oneoff sample 5817 for in marked all <30 take dose evening working policies cannot"
    }
]